User Image Cart Icon 0 Search Image

Diabetes & cancer

  1. A case of advanced cervical esophagealย cancerย with liver cirrhosis andย diabetesย mellitus showing a complete response by radiation therapy after the operation for โ€ฆ
  2. A case of an elderly woman with concurrent pancreaticย cancerย and slowly progressive type 1ย diabetesย mellitus
  3. A case of centralย diabetesย insipidus caused by metastatic small cell lungย cancer
  4. A Case of Centralย diabetesย Insipidus in Patient with Non-small Cell Lungย cancer.
  5. A case ofย diabetesย mellitus accompanied by tumor-forming pancreatitis that was difficult to distinguish from pancreaticย cancer
  6. A case of effective weekly paclitaxel administration for advanced gastricย cancerย associated withย diabetesย mellitus-about the control of blood glucose when โ€ฆ
  7. A Case of Fulminant Type 1ย diabetesย Mellitus and Diabetic Ketoacidosis Caused by Adjuvant Chemotherapy for Colonย cancer
  8. A case of lungย cancerย with pituitary metastases presented byย diabetesย insipidus
  9. A case of nephrogenicย diabetesย insipidus caused by obstructive uropathy due to prostateย cancer
  10. A Case of Pituitary Metastasis of Breastย cancerย Presenting asย diabetesย Insipidus and Panhypopituitarism.
  11. A case of small cell lungย cancerย associated withย diabetesย insipidus and Cushingโ€™s syndrome
  12. A case of type 2ย diabetesย and metastatic liverย cancerย exhibiting hypercholesterolemia with abnormal lipoproteins
  13. A Case of Ulcerative Colitis Combined with Follicular Thyroidย cancerย and Gestationalย diabetesย Mellitus
  14. A case-control study ofย diabetesย mellitus andย cancerย risk
  15. A Clinical Analysis of Endometrialย cancerย Accompanied by Hypertension andย diabetesย Mellitus
  16. A clinical prediction model to assess risk for pancreaticย cancerย among patients with new-onsetย diabetes
  17. A clinical prediction model to assess risk for pancreaticย cancerย among patients with pre-diabetes.
  18. A clinical prediction nomogram to assess risk of colorectalย cancerย among patients with type 2ย diabetes
  19. A cohort study of metformin and colorectalย cancerย risk among patients withย diabetesย mellitus
  20. A cohort study of the risk ofย cancerย associated with type 2ย diabetes
  21. A COMPARISON OF SPIRITUAL DEVELOPMENT BETWEEN HEALTHY INDIVIDUALS AND PATIENTS SUFFERING FROMย cancerย ANDย diabetes
  22. A Comprehensive Analysis ofย diabetesย Self-Management among with Men with Prostateย cancerย in the United States: Evidence from the National Health and Nutrition โ€ฆ
  23. A Connecting Switch Among Aging,ย diabetesย and Tumor: Avenue Leading toย cancerย Therapeutics
  24. A cross-sectional study of health-related quality of life deficits in individuals with comorbidย diabetesย andย cancer
  25. Aย diabetesย pay-for-performance program and the competing causes of death amongย cancerย survivors with type 2ย diabetesย in Taiwan
  26. A dietary pattern protective against type 2ย diabetesย in the European Prospective Investigation intoย cancerย and Nutrition (EPIC)โ€”Potsdam Study cohort
  27. A genetic link between type 2ย diabetesย and prostateย cancer
  28. A genetic relationship betweenย diabetesย andย cancer
  29. A high diet quality based on dietary recommendations is not associated with lower incidence of type 2ย diabetesย in the Malmรถ Diet andย cancerย Cohort
  30. A high rate of undiagnosedย diabetesย in new uterineย cancerย patients
  31. A historical cohort study on glycemic-control andย cancer-risk among patients withย diabetes
  32. A Hybrid Machine Learning Scheme to Analyze the Risk Factors of Breastย cancerย Outcome in Patients withย diabetesย Mellitus.
  33. A meta-analysis of cohort studies on the association betweenย diabetesย and the risk of primary liverย cancer
  34. A meta-analysis ofย diabetesย mellitus and the risk of prostateย cancer
  35. A molecular rheostat at the interface ofย cancerย andย diabetes
  36. A national observation study ofย cancerย incidence and mortality risks in type 2ย diabetesย compared to the background population over time
  37. A new approach for diagnosis ofย diabetesย and prediction ofย cancerย using ANFIS
  38. A new ฤฑnsight ฤฑnto metformin action:ย diabetes, prostateย cancer, and ฤฑon channels
  39. A new link betweenย diabetesย andย cancer: enhanced WNT/ฮฒ-catenin signaling by high glucose
  40. A New Role for an Old Drug: Metformin Targets Micro RNA s in Treatingย diabetesย andย cancer
  41. A noninvasive method to detectย diabetesย mellitus and lungย cancerย using the stacked sparse autoencoder
  42. A novel approach for the diagnosis ofย diabetesย and liverย cancerย using ANFIS and improved KNN
  43. A NOVEL APPROACH IN COLORECTALย cancerย ANDย diabetesย MANAGEMENT: ROLE OF METFORMIN AND RAPAMYCIN
  44. A novel design and analysis of high-sensitivity biosensor based on nano-cavity for detection of blood component,ย diabetes,ย cancerย and glucose concentration
  45. A novel mechanistic pathway linkingย diabetesย to colorectalย cancer: Role of AMPK and mTOR
  46. A novel method for studying the temporal relationship between type 2ย diabetesย mellitus andย cancerย using the electronic medical record
  47. A Novel Pathway Linking Oxidative Stress and Inflammation: Prevention ofย cancer, Sepsis, Asthma,ย diabetesย and Uveitis by Aldose Reductase Inhibition.
  48. A novel therapeutic approach to colorectalย cancerย inย diabetes: role of metformin and rapamycin
  49. A patient withย diabetesย and breastย cancerย in whom virilization was caused by a testosterone-producing mature cystic teratoma containing a brenner tumor
  50. A pilot study evaluating steroid-inducedย diabetesย after antiemetic dexamethasone therapy in chemotherapy-treatedย cancerย patients
  51. A population-based cohort study of all-cause and site-specificย cancerย incidence among patients with type 1ย diabetesย mellitus in Taiwan
  52. A Potential Screening Strategy of Pancreaticย cancerย in New Onsetย diabetesย Patients Using Serum CA19-9 in Combination With Age and BMI: 7
  53. A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2ย diabetesย and Prostateย cancer
  54. A Progressive Stack Face-based Network for Detectingย diabetesย Mellitus and Breastย cancer
  55. A prospective study of the associations between treatedย diabetesย andย cancerย outcomes
  56. A Prospective Study of the Associations Between Treatedย diabetesย Mellitus andย cancerย Outcomes
  57. A prospective study of type 2ย diabetes, metformin use, and risk of breastย cancer
  58. A prospective Swedish study on body size, body composition,ย diabetes, and prostateย cancerย risk
  59. A retrospective study of the impact ofย diabetesย mellitus on survival in patients with lungย cancer
  60. A retrospective study of the impact ofย diabetesย mellitus on survival in patients with tungย cancer
  61. A retrospective study on the role ofย diabetesย and metformin in colorectalย cancerย disease progression.
  62. A retrospective study on the role ofย diabetesย and metformin in colorectalย cancerย disease survival
  63. A retrospective-analysis of the correlation betweenย diabetesย mellitus andย cancer
  64. A review of cohort studies on the association between history ofย diabetesย mellitus and occurrence ofย cancer
  65. A review of current knowledge: Role ofย diabetes,ย cancerย and cytochrome P450
  66. A review of the etiology and biomarkers of pancreaticย cancer, with emphasis on the role ofย diabetes
  67. A Review of the Quality of Life of Hemodialysis, Breastย cancer, and Type 2ย diabetesย Mellitus Patients
  68. A risk stratification schema for predictingย diabetesย mellitus inย cancerย survivors.
  69. A simple screening score to predictย diabetesย inย cancerย patients: A Korean nationwide population-based cohort study
  70. A Study of the Peopleโ€™s Medicine Scheme in Mumbai and Thane region, India with reference toย cancerย andย diabetesย medicines
  71. A study on implementation of national programme for prevention and control ofย cancer,ย diabetes, cardiovascular diseases and stroke in Udupi district, Karnataka
  72. A study on utilization of diagnostic and therapeutic services of National Program for Prevention and Control ofย cancer,ย diabetesย and Cardiovascular Diseases โ€ฆ
  73. A SUCCESSFUL CASE OF GASTRICย cancerย WITHย diabetesย MELLITUS IN 84 YEAR OLD MAN, TOTAL GASTRECTOMIZED WITH TRANSVERSE COLECTOMY
  74. A SURVEY ON IMPROVING THE PERFORMANCE OFย cancerย ANDย diabetesย DETECTION BY USING NOVEL TECHNIQUE OF MACHINE LEARNING
  75. A Survey on The Roles of Life Style and Its Modification in The Prevention and Management ofย cancer,ย diabetes, Blood Pressure and Stroke
  76. A systematic review of cases ofย diabetesย mellitus following immune checkpoint inhibitor therapy forย cancer
  77. A systematic review of the literature exploring the interplay between prostateย cancerย and type twoย diabetesย mellitus
  78. A systematic review study on the communication betweenย diabetesย andย cancer: The serious risk ofย cancerย in diabetic patients
  79. A twenty-first centuryย cancerย epidemic caused by obesity: the involvement of insulin,ย diabetes, and insulin-like growth factors
  80. A ubiquitous membrane fusion protein ฮฑSNAP: a potential therapeutic target forย cancer,ย diabetesย and neurological disorders?
  81. Aberrant Expression of Sialidase inย cancerย andย diabetes
  82. Aberrant methylation of the Ras-related associated withย diabetesย gene in human primary esophagealย cancer
  83. Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostateย cancerย patients with type 2ย diabetesย receiving glucose-lowering โ€ฆ
  84. ABO blood group andย diabetesย mellitus influence the risk for pancreaticย cancerย in a population from China
  85. ABO blood type,ย diabetesย and risk of gastrointestinalย cancerย in northern China
  86. ABO blood type, long-standingย diabetes, and the risk of pancreaticย cancer
  87. Abolishย cancerย progenitor cells in a mouse model ofย diabetesย associated hepatocellular carcinoma
  88. Aboriginal and Torres Strait islander health: Accuracy of patient selfโ€report of screening forย diabetes, high cholesterol and cervicalย cancer
  89. Abstract A08: Human preadipocytes promote pancreaticย cancerย cellular growth in aย diabetes-specific manner
  90. Abstract A23:ย cancerย outcomes in theย diabetesย prevention program outcomes study
  91. Abstract A23: Metformin as a potent antiangiogenic factor: Fromย diabetesย toย cancerย angioprevention
  92. Abstract A27: Association betweenย diabetesย pharmacotherapies and bladderย cancer: A Medicare epidemiologic study
  93. Abstract A58: Interaction ofย diabetesย and obesity in postmenopausal breastย cancerย risk among black women
  94. Abstract A76:ย diabetesย and risk of bladderย cancerย among postmenopausal women in the Iowa Womenโ€™s Health Study
  95. Abstract B026: Occurrence of comorbidities among diverse hospiceย cancerย patients with and withoutย diabetes
  96. Abstract B17: Type 2ย diabetes, metformin, and ovarianย cancerย survival: An analysis of tumor registry and electronic medical record data.
  97. Abstract B43: Type 2ย diabetesย mellitus and colorectalย cancerย risk in Hispanics: A pilot case-control study
  98. Abstract B45: Obesity,ย diabetes, other comorbidities and survival in a cohort of women with ovarianย cancer
  99. Abstract B94: Relationship of overweight andย diabetesย with prostateย cancerย stages in Mexican Americans: A population-based case-control study
  100. Abstract C077: The association betweenย diabetes, plasma fructosamine, and risk of mortality after invasive breastย cancerย among Hispanic and non-Hispanic white โ€ฆ
  101. Abstract C28: An exploratory study of co-occurrence of breastย cancerย andย diabetesย in medically underserved Latinas
  102. Abstract CT198: Efficacy of metfOrmin in PrevenTIng glucocorticoid-inducedย diabetesย in Melanoma, breAst or Lungย cancerย patients with brain metastases: The phase โ€ฆ
  103. Abstract GS2-09:ย diabetesย risk reduction diet and survival following breastย cancer
  104. Abstract LB-18: Statins use prevents ovarianย cancerย recurrence in women withย diabetesย mellitus.
  105. Abstract LB-190: Ethnic differences in the relationship betweenย diabetes, adiposity measures and breastย cancer-specific mortality
  106. Abstract LB-278: Metformin exposure on survival in localized breastย cancerย patients with type IIย diabetesย mellitus using electronic health records
  107. Abstract LB-285: Glycemia is positively associated with prostateย cancerย mortality in white and black men withoutย diabetesย when better classifying hyper-and โ€ฆ
  108. Abstract LB-296: Breastย cancerย metabolism in association withย diabetes
  109. Abstract LB-421:ย diabetesย pharmacotherapy: A potential modifier of breastย cancerย prognosis
  110. Abstract P1-08-05: Type 2ย diabetesย and survival outcomes among a multi-ethnic cohort of breastย cancerย patients
  111. Abstract P1-10-02: Type IIย diabetesย and subtype-specific breastย cancerย risk in medically underserved black and white women
  112. Abstract P2-07-06: Obesity, dyslipidemia, andย diabetesย as risk factors for trastuzumab-related cardiotoxicity in breastย cancerย patients
  113. Abstract P2-08-11: High prevalence and incidence of new onsetย diabetesย in metastatic breastย cancer
  114. Abstract P2-11-09: Weight Change and Risk of Incidentย diabetesย After Breastย cancer
  115. Abstract P3-02-10: The possible association among breastย cancer,ย diabetesย mellitus and GLP-1 receptor
  116. Abstract P3-10-32: Breastย cancerย Patients with Type 2ย diabetesย Trend To Be Associated with Poor Prognosis
  117. Abstract P344: Association ofย diabetesย andย cancerย Mortality in American Indians: The Strong Heart Study
  118. Abstract P4-12-07:ย diabetesย Increases the Risk of Breastย cancer
  119. Abstract P4-13-08:ย diabetes, Related Factors and Breastย cancerย Risk
  120. Abstract P5-12-04: Association of adjuvant endocrine therapy withย diabetesย among women with postmenopausal breastย cancerย in the Womenโ€™s Health Initiative (WHI)
  121. Abstract P6-09-05: Insulin Resistance,ย diabetesย Mellitus and Breastย cancerย Risk in Pre-and Postmenopausal Women: Modification Effect by Moderate Physical โ€ฆ
  122. Abstract P6-10-03: The association between type-2ย diabetesย and risk of mortality after invasive breastย cancerย among Hispanic and non-Hispanic white women from โ€ฆ
  123. Abstract P6-10-12: Metformin increases survival in hormone receptor-positive, Her2-positive breastย cancerย patients withย diabetes
  124. Abstract PD11-05:ย diabetesย decreases overall survival in women with breastย cancerย in the southern community cohort study
  125. Abstract PD4-6: Characteristics associated with nonadherence to medications for hypertension,ย diabetes, and dyslipidemias among breastย cancerย survivors
  126. Abstract PL05-02: Current therapies forย diabetes-will they reduceย cancerย risk?
  127. Abstract PO-159: Mediation of black/white race disparity in triple-negative breastย cancer: Effect of type 2ย diabetesย mellitus
  128. Abstract PO-215:ย diabetesย and the quality of adjuvant therapy in Medicaid-insured women with breastย cancer
  129. Abstract PO-237: Colorectalย cancerย screening in patients with type 2ย diabetesย mellitus
  130. Abstract PS11-19: Metformin improves the survival in Chinese early invasive breastย cancerย patients with type 2ย diabetesย mellitus
  131. Abstract SY02-02: Shared risk factors forย diabetes, cardiovascular disease, andย cancerย in a low-income population
  132. Abstract SY02-04: Risk factors associated withย cancer, type 2ย diabetes, and cardiovascular disease in the multiethnic cohort: Comparisons across ethnic groups
  133. Abstract# 2111: Effect of IGF gene polymorphisms alone or in interaction withย diabetesย on the risk of pancreaticย cancer
  134. Abstract# 2938: Treatment forย diabetesย mellitus-2 could prevent pancreaticย cancerย cell growth
  135. Acanthosis nigricansโ€”decreased extracellular matrix viscosity:ย cancer, obesity,ย diabetes, corticosteroids, somatotrophin
  136. Accelerated muscle and adipose tissue loss may predict survival in pancreaticย cancerย patients: the relationship withย diabetesย and anaemia
  137. ACS/ADA/AHA issue core recommendations for preventingย cancer, cardiovascular disease, andย diabetes
  138. Activation ofย cancer-related and mitogen-activated protein kinase signaling pathways in human mature osteoblasts isolated from patients with type 2ย diabetes
  139. Activation of protein kinase p70S6K1 in peripheral blood mononuclear cells of patients withย cancerย andย diabetes
  140. Activities and polymorphisms of MMP-2 and MMP-9, smoking,ย diabetesย and risk of prostateย cancer
  141. ADA, ACS Spotlightย diabetesโ€“cancerย Links
  142. Adapted geometric semantic genetic programming forย diabetesย and breastย cancerย classification
  143. Additional risk ofย diabetesย exceeds the increased risk ofย cancerย caused by radiation exposure after the Fukushima disaster
  144. Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-siteย cancerย risk in patients with type 2ย diabetes
  145. Additive interaction between the renin-angiotensin system and lipid metabolism forย cancerย in type 2ย diabetes
  146. Addressing different biases in analysing drug use onย cancerย risk inย diabetesย in nonโ€clinical trial settingsโ€”what, why and how?
  147. Adenosine monophosphateโ€“activated protein kinase: a central regulator of metabolism with roles inย diabetes,ย cancer, and viral infection
  148. Adherence to a healthy Nordic food index is associated with a lower risk of type-2ย diabetesโ€”The Danish diet,ย cancerย and health cohort study
  149. Adherence to breast and cervicalย cancerย screening in Spanish women withย diabetes: associated factors and trend between 2006 and 2010
  150. Adherence to Dietary Indexes byย diabetesย and Hypertension Status among PLCOย cancerย Screening Trial Participants
  151. Adherence to oralย diabetesย medications and glycemic control during and following breastย cancerย treatment
  152. Adherence to the Danish food-based dietary guidelines and risk of type 2ย diabetes: the Danish diet,ย cancer, and health cohort
  153. Adiponectin as a potential key player in metabolic syndrome: Insights into atherosclerosis,ย diabetesย andย cancer
  154. Adiposity andย diabetesย in breast and prostateย cancer
  155. Adiposity-mortality relationships in type 2ย diabetes, coronary heart disease, andย cancerย subgroups in the UK Biobank, and their modification by smoking
  156. Adiposity, history ofย diabetes, and risk of pancreaticย cancerย in postmenopausal women
  157. Adiposity, type 2ย diabetesย and the metabolic syndrome in breastย cancer
  158. Adopting Nrf2 and NF-ฮบB fromย cancer: Is there any role of the duo inย diabetes?
  159. ADRB2 Gโ€“G haplotype associated with breastย cancerย risk among Hispanic and non-Hispanic white women: interaction with type 2ย diabetesย and obesity
  160. Adult life after childhoodย cancerย in Scandinavia:ย diabetesย mellitus following treatment forย cancerย in childhood
  161. Advanced breastย cancerย in a relatively young man with severe obesity and type 2ย diabetesย mellitus
  162. Advanced glycation end products inย diabetes,ย cancerย and phytochemical therapy
  163. Advances in the studies of the link betweenย diabetesย andย cancer
  164. Adverse drug reactions associated with the use of liraglutide in patients with type 2ย diabetesโ€“focus on pancreatitis and pancreasย cancer
  165. Adverse glycaemic effects ofย cancerย therapy: indications for a rational approach toย cancerย patients withย diabetes
  166. African American breast and endometrialย cancerย survivors with type 2ย diabetes: Perceived barriers and preferred components for a physical activity program
  167. Age-related differences in the consequences of obesity on cardiovascular disease, type 2ย diabetes, osteoarthritis,ย cancer, physical function, osteoporosis, cognitive โ€ฆ
  168. Age, gender and type 2ย diabetesย contribute to the risk of gastricย cancer: a retrospective single institution analysis
  169. AIDS,ย diabetes, and lungย cancerย mortality at the northern Mexican border: 1979-1997
  170. Akt enzyme: new therapeutic target inย cancerย andย diabetes?
  171. Akt2 Redox-regulation in Breastย cancerย andย diabetes
  172. Alarmins in chronic noncommunicable diseases: atherosclerosis,ย diabetesย andย cancer
  173. All-cause, cardiovascular, andย cancerย mortality rates in postmenopausal white, black, Hispanic, and Asian women with and withoutย diabetesย in the United States: the โ€ฆ
  174. Allโ€causeย cancerย mortality over 15 years in multiโ€ethnic Mauritius: The impact ofย diabetesย and intermediate forms of glucose tolerance
  175. Alpha-glucosidase inhibitors and risk ofย cancerย in patients withย diabetesย mellitus: a systematic review and meta-analysis
  176. Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure,ย diabetesย andย cancer
  177. Altered intracellular calcium fluxes in pancreaticย cancerย inducedย diabetesย mellitus: Relevance of the S100A8 Nโ€terminal peptide (NTโ€S100A8)
  178. Alternative splicing of insulin receptor mRNA inย cancerย and type 2ย diabetesย mellitus: a review
  179. Americanย diabetesย Association 60th Scientific Sessions, 2000: glucose tolerance,ย diabetesย andย cancer, glycemic control, monitoring, and related topics
  180. AMP-activated protein kinase: a target for old drugs againstย diabetesย andย cancer
  181. AMPK activators as a drug forย diabetes,ย cancerย and cardiovascular disease
  182. AMPK-a nutrient and energy sensor with roles inย diabetes,ย cancerย and viral infection
  183. AMPK: a target for drugs and natural products with effects on bothย diabetesย andย cancer
  184. AMPK: therapeutic target forย diabetesย andย cancerย prevention
  185. An analysis of the impact of irrational beliefs and illness representation in predicting distress inย cancerย and type IIย diabetesย patients
  186. An assessment of the shared allelic architecture between type IIย diabetesย and prostateย cancer
  187. An Australian man who stays he developed bladderย cancerย after using aย diabetesย drug is taking legal action against the drugโ€™s manufacturer and distributor
  188. An autopsy case of pulmonary tumor thrombotic microangiopathy due to rapidly progressing colonย cancerย in a patient with type 2ย diabetes
  189. An ecological association between the prevalence ofย diabetesย Mellitus and the incidence of colorectalย cancer
  190. An elevated HbA1c level is associated with short-term adverse outcomes in patients with gastrointestinalย cancerย and type 2ย diabetesย mellitus
  191. An epidemiology study of the relationship between pancreaticย cancerย andย diabetesย mellitus
  192. An experimental model ofย diabetesย andย cancerย in rats
  193. An extended Myc network contributes to glucose homeostasis inย cancerย andย diabetes
  194. An integrated care pathway forย cancerย patients withย diabetes: A proposal from the Italian experience
  195. An integrative hypothesis linkingย cancer,ย diabetesย and atherosclerosis: the role of mutations and epigenetic changes
  196. An optimization approach to improve classification performance inย cancerย andย diabetesย prediction
  197. An uncommon case of T1b breastย cancerย with diabetic mastopathy in type IIย diabetesย mellitus
  198. An Unusual Case of Emphysematous Cystitis in Nonย diabetesย Metastatic Lungย cancerย Patient Undergoing Chemotherapy
  199. Anabolic and pro-metabolic functions of CREB-CRTC in skeletal muscle: advantages and obstacles for type 2ย diabetesย andย cancerย cachexia
  200. Analysis and prediction of breastย cancerย andย diabetesย disease datasets using data mining classification techniques
  201. Analysis of cardiovascular events orย diabetesย mellitus during androgen deprivation therapy in Korean prostateย cancerย patients
  202. Analysis of clinical data in breastย cancerย patients with type 2ย diabetes
  203. Analysis of clinical features in colorectalย cancerย patients with Type 2ย diabetes
  204. ANALYSIS OF CLINICAL FEATURES OF COLORECTALย cancerย PATIENTS COMBINED TYPE 2ย diabetesย MELLITUS
  205. Analysis of Drug Use in Clinical Comprehensive Therapy for Advanced Lungย cancerย Patients withย diabetesย Mellitus
  206. Analysis of functional genetic polymorphisms in prostateย cancerย and type 2ย diabetes: Mucin 1 and growth hormone receptor
  207. Analysis of gene expression patterns and metabolomics correlated to obesity,ย diabetes, and outcomes in patients with epithelial ovarianย cancer
  208. Analysis of microrna signatures as biomarker to investigate interlink between type 2ย diabetesย and breastย cancer
  209. Analysis of perioperative treatment on 43 cases of gastricย cancerย complicated withย diabetesย mellitus [J]
  210. Analysis of Serum Growth Differentiation Factor-15 in Progression of Breastย cancerย in Type IIย diabetesย Mellitus Patients
  211. Analysis of the association ofย diabetesย mellitus withย cancerย using autopsy records
  212. Analysis of the changes of blood glucose after radiotherapy in pancreaticย cancerย patients associated withย diabetesย mellitus and their related factors
  213. Analysis of the efficacy of surgical treatment for 80 elderly laryngealย cancerย patients with type 2ย diabetes
  214. Analysis on 57 cases of saving anus surgery for rectalย cancerย patients incorporatedย diabetes
  215. Analyzing Targeted Nucleosome Position and Occupancy inย cancer, Obesity, andย diabetes
  216. Androgen deprivation therapy and risk forย diabetesย and cardiovascular disease in prostateย cancerย survivors
  217. Androgen Deprivation Therapy in Patients with Advanced Prostateย cancerย and Type 2ย diabetesย Impairs Glucose and Lipid Metabolism: 64
  218. Androgen deprivation therapy increases the risk ofย diabetesย and non-cancerย mortality in prostateย cancerย patients: a meta-analysis
  219. Androgen deprivation therapy,ย diabetesย and poor physical performance status increase fracture risk in Chinese men treated for prostateย cancer
  220. Androgen receptor overexpression in prostateย cancerย in type 2ย diabetes
  221. Androgen-deprivation therapy andย diabetesย control among diabetic men with prostateย cancer
  222. Androgens,ย diabetesย and prostateย cancer
  223. Angiogenesis and inflammation at the crossroads betweenย diabetesย andย cancer: PS226
  224. Angiopoietin-like protein 2 is a useful biomarker for pancreaticย cancerย that is associated with type 2ย diabetesย mellitus and inflammation
  225. Angiotensin receptor blockade and risk ofย cancerย in type 2ย diabetesย mellitus: a nationwide case-control study
  226. Animal product consumption and mortality because of all causes combined, coronary heart disease, stroke,ย diabetes, andย cancerย in Seventh-day Adventists
  227. Annual fasting plasma glucose variation increases risk ofย cancerย incidence and mortality in patients with type 2ย diabetes: the Taichungย diabetesย Study
  228. Annual glycemic variations and risk ofย cancerย among Chinese patients with type 2ย diabetesย mellitus: A population-based cohort study in Shanghai
  229. Anti-diabetic medications and risk of pancreaticย cancerย in patients withย diabetesย mellitus: a systematic review and meta-analysis
  230. Anti-Diabetic Medications and Risk of Pancreaticย cancerย in Patients Withย diabetesย Mellitus: A Systematic Review and Meta-Analysis
  231. Anti-diabetic medications and risk of primary liverย cancerย in persons with type IIย diabetes
  232. Anti-diabetic medications do not influence risk of lungย cancerย in patients withย diabetesย mellitus: a systematic review and meta-analysis
  233. Anti-diabetic treatment andย cancerย occurrence among patients with type IIย diabetesย mellitus
  234. Antidiabetic medication, statins and the risk and prognosis of non-endometrioid endometrialย cancerย in women with type 2ย diabetes
  235. Antidiabetic medication, statins and the risk of endometrioid endometrialย cancerย in patients with type 2ย diabetes
  236. Antidiabetic medications and mortality risk in individuals with pancreaticย cancerโ€“relatedย diabetesย and postpancreatitisย diabetes: a nationwide cohort study
  237. Antidiabetic medications and the risk of colorectalย cancerย in patients withย diabetesย mellitus: a systematic review and meta-analysis
  238. Antidiabetic medications use andย cancerย risk in type 2ย diabetes
  239. Antioxidant genes,ย diabetesย and dietary antioxidants in association with risk of pancreaticย cancer
  240. Application of microbiological and immunological enteral nutrition in patients with gastrointestinalย cancerย complicated withย diabetesย mellitus
  241. Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) inย diabetes, obesity andย cancer
  242. Applications of nanotechnology in drug delivery systems for the treatment ofย cancerย andย diabetes
  243. Approaches to gene therapy of complex multigenic diseases:ย cancerย as a model and implications for cardiovascular disease andย diabetes
  244. AREย diabetesย MELLITUS AND CHROMOSOME 17Q12 GENETIC VARIANTS ASSOCIATED WITH PROSTATEย cancerย AGGRESSIVENESS?
  245. Are metformin, statin and aspirin use still associated with overall mortality among colorectalย cancerย patients withย diabetesย if adjusted for one another?
  246. Are the Differentย diabetesย Subgroups Correlated With All-Cause,ย cancer-Related, and Cardiovascular-Related Mortality?
  247. Are We doing a Better Job of Understanding Co-morbidity Conditions in Health Care (cancer, Tuberculosis, Hypertension,ย diabetes, etc.?
  248. Aspects รฉpidรฉmiologiques de lโ€™association diabรจte etย cancer: Epidemiological features of theย diabetesโ€“cancerย association
  249. Assessing bladderย cancerย risk in type 2ย diabetesย clinical trials: the dapagliflozin drug development program as a โ€˜case studyโ€™
  250. Assessing the relationship between institutionalย cancerย andย diabetesย mortality rates using National Death Index data
  251. Assessment of Blood Donation Safety by People Diagnosed withย diabetes, Hypertension, Malaria andย cancer
  252. Assessment of classification algorithms in the diagnosis ofย diabetesย and breastย cancer
  253. ASSESSMENT OFย diabetesย MELLITUS AS A MADHUMEHA ANDย cancerย RISKโ€“A REVIEW
  254. Assessment of implementation of the national programme for the prevention and control ofย cancer,ย diabetes, cardiovascular diseases, and stroke at โ€ฆ
  255. Assessment of quality of life in patients withย cancerย andย diabetesย 2 in Northern Greece
  256. Association between androgen-deprivation therapy and incidence ofย diabetesย among males with prostateย cancer
  257. Association between body mass index and obesity-relatedย cancerย risk in men and women with type 2ย diabetesย in primary care in the Netherlands: a cohort โ€ฆ
  258. Association Between Breastย cancerย andย diabetes
  259. Association betweenย cancerย antigen 19โ€9 andย diabetesย risk: A prospective and Mendelian randomization study
  260. Association betweenย cancerย prevalence and use of thiazolidinediones: results from the Vermontย diabetesย Information System
  261. Association between consumption of dairy products and incident type 2ย diabetesโ€”insights from the European Prospective Investigation intoย cancerย study
  262. Association betweenย diabetesย andย cancerย in Indian and US Populations using Longitudinal Study Design
  263. Association betweenย diabetesย and colorectalย cancerย risk in a homogeneous canadian population
  264. Association betweenย diabetesย and esophagealย cancer, independent of obesity, in the United States Veterans Affairs population
  265. Association betweenย diabetesย and oncological outcomes in patients undergoing neoadjuvant chemo-radiotherapy for rectalย cancer
  266. Association betweenย diabetesย mellitus and adverse characteristics of breastย cancerย at presentation
  267. Association betweenย diabetesย mellitus and breastย cancerย risk: a meta-analysis of the literature
  268. Association betweenย diabetesย mellitus and kidneyย cancer
  269. Association betweenย diabetesย mellitus and lungย cancer: metaโ€analysis
  270. Association betweenย diabetesย mellitus and oncological outcomes in bladderย cancerย patients undergoing radical cystectomy
  271. Association betweenย diabetesย mellitus and subsequent ovarianย cancerย in women: A systematic review and meta-analysis of cohort studies
  272. Association betweenย diabetesย or antidiabetic therapy and lungย cancer: A metaโ€analysis
  273. Association betweenย diabetes,ย diabetesย treatment and risk of developing endometrialย cancer
  274. Association between diagnosedย diabetesย and self-reportedย cancerย among US adults: findings from the 2009 Behavioral Risk Factor Surveillance System
  275. Association between duration and type of androgen deprivation therapy and risk ofย diabetesย in men with prostateย cancer
  276. Association between exposure to desalinated sea water and ischemic heart disease,ย diabetesย mellitus and colorectalย cancer; A population-based study in Israel
  277. Association between gestationalย diabetesย mellitus and subsequent risk ofย cancer: a systematic review of epidemiological studies
  278. Association between glucoseโ€lowering treatment andย cancerย metastasis among patients with preexisting type 2ย diabetesย and incident malignancy
  279. Association between metabolic syndrome,ย diabetesย mellitus and prostateย cancerย risk
  280. Association between metabolic syndrome, obesity,ย diabetesย mellitus and oncological outcomes of bladderย cancer: a systematic review
  281. Association between metformin and the risk of gastricย cancerย in patients with type 2ย diabetesย mellitus: a meta-analysis of cohort studies
  282. Association between metformin use and mortality after cervicalย cancerย in older women withย diabetes
  283. Association between metformin use and mortality in patients with type 2ย diabetesย mellitus and localized resectable pancreaticย cancer: a nationwide population โ€ฆ
  284. Association between pancreaticย cancerย and metformin use in patients with type 2ย diabetes
  285. Association between postprandial hyperglycemia at clinic visits and all-cause andย cancerย mortality in patients with type 2ย diabetes: a long-term historical cohort study โ€ฆ
  286. Association between socioeconomic status and mortality, cardiovascular disease, andย cancerย in patients with type 2ย diabetes
  287. Association Between Statins andย cancerย Incidence inย diabetes: a Cohort Study of Japanese Patients with Type 2ย diabetes
  288. Association between the TCF7L2 polymorphism and colorectalย cancerย does not differ byย diabetesย and obesity statuses
  289. Association between type 2ย diabetesย andย cancerย incidence in China: data in hospitalized patients from 2006 to 2013
  290. Association between type 2ย diabetesย andย cancerย incidence in Taiwan: data from a prospective community-based cohort study
  291. Association between type 2ย diabetesย and risk ofย cancerย mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium
  292. Association between type 2ย diabetesย mellitus (T2DM), diabetic therapies and clinical outcomes in patients (pts) with metastatic colorectalย cancerย (mCRC).
  293. Association between type 2ย diabetesย mellitus risk factors with breastย cancerย in Mexican women
  294. Association between type 2ย diabetes, curative treatment and survival in men with intermediateโ€and highโ€risk localized prostateย cancer
  295. Association between type IIย diabetesย and colonย cancerย among Japanese with reference to changes in food intake
  296. Association between uric acid,ย cancerย incidence and mortality in patients with type 2ย diabetes: Shanghaiย diabetesย registry study
  297. Association of aย diabetesย risk score with risk of myocardial infarction, stroke, specific types ofย cancer, and mortality: a prospective study in the European Prospective โ€ฆ
  298. Association of Adipose Tissue Distribution With Type 2ย diabetesย in Breastย cancerย Patients
  299. ASSOCIATION OF ANGIOTENSIN-RECEPTOR BLOCKERS WITHย cancerย RISK IN PATIENTS WITH TYPE 2ย diabetesย MELLITUS
  300. Association of antidiabetic medication and statins with breastย cancerย incidence in women with type 2ย diabetes
  301. Association of arterial hypertension,ย diabetesย mellitus and inflammation withย cancerย incidence and mortality
  302. Association of breastย cancerย andย diabetesย mellitus in Korean postmenopausal women
  303. Association of Comorbidย diabetesย With Clinical Outcomes and Healthcare Utilization in Colorectalย cancerย Survivors.
  304. Association of Delta-6-Desaturase expression with aggressiveness ofย cancer,ย diabetesย mellitus, and multiple sclerosis: a narrative review
  305. Association ofย diabetesย andย cancerย mortality in American Indians: the Strong Heart Study
  306. Association ofย diabetesย andย cancer-diagnoses in primary care practices in Germany.
  307. Association ofย diabetesย andย diabetesย treatment with incidence of breastย cancer
  308. Association ofย diabetesย and Other Clinical and Sociodemographic Factors With Guideline-concordant Breastย cancerย Treatment for Breastย cancer
  309. Association ofย diabetesย and perineural invasion in pancreaticย cancer
  310. Association ofย diabetesย mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostateย cancer
  311. Association ofย diabetesย mellitus and metformin use with oncological outcomes of patients with nonโ€muscleโ€invasive bladderย cancer
  312. Association ofย diabetesย mellitus with biological behaviors of colorectalย cancer
  313. Association ofย diabetesย mellitus with increased mortality in patients receiving curative surgery for colonย cancer.
  314. Association ofย diabetesย mellitus with prostateย cancerย grade and prostate-specific antigen in Chinese biopsy population
  315. Association ofย diabetesย mellitus with prostateย cancer: nested caseโ€“control study (Prostate testing forย cancerย and treatment study)
  316. Association ofย diabetesย mellitus with thyroidย cancerย risk: A meta-analysis of cohort studies
  317. Association ofย diabetesย Status With Survival After Immune Checkpoint Inhibitor Treatment for Advanced Lungย cancer: a Retrospective Study in Japan
  318. Association ofย diabetesย Susceptibility Gene Calpain-10 with Pancreaticย cancerย Among Smokers
  319. Association ofย diabetesย with colorectalย cancerย treatment and outcomes.
  320. Association ofย diabetesย with colorectalย cancerย treatment and outcomes.
  321. Association ofย diabetesย with mammographic breast density and breastย cancerย in the Minnesota breastย cancerย family study
  322. Association ofย diabetesย with oralย cancer-an enigmatic correlation
  323. Association ofย diabetesย with perineural invasion and overall survival in surgically resected patients with pancreaticย cancer.
  324. Association ofย diabetesย with prostateย cancerย risk in the multiethnic cohort
  325. Association ofย diabetesย with survival among cohorts of Indigenous and non-Indigenous Australians withย cancer
  326. Association of dipeptidyl peptidase 4 inhibitors with risk of metastases in patients with type 2ย diabetesย and breast, prostate or digestive systemย cancer
  327. Association of endometrial hyperplasia andย cancerย with a history of gestationalย diabetes
  328. Association of endometrial hyperplasia orย cancerย with a history of gestationalย diabetes-results from a population-based study in Washington State, 1987-2013
  329. association of Family history of Type 2ย diabetesย with Prostateย cancer: a national cohort study
  330. Association of genetic susceptibility variants for type 2ย diabetesย with breastย cancerย risk in women of European ancestry
  331. Association of hypertension,ย diabetes, stroke,ย cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review
  332. Association of metformin intake with bladderย cancerย risk and oncologic outcomes in type 2ย diabetesย mellitus patients: a systematic review and meta-analysis
  333. Association of metformin with breastย cancerย incidence and mortality in patients with type IIย diabetes: a GRADE-assessed systematic review and meta-analysis
  334. Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colonย cancerย in Patients With Type 2ย diabetes
  335. Association of serum anti-gad antibody and hla haplotypes with type 1ย diabetesย mellitus triggered by nivolumab in patients with nonโ€“small cell lungย cancer
  336. Association of serum C-peptide concentrations withย cancerย mortality risk in pre-diabetesย or undiagnosedย diabetes
  337. Association of serum paraoxonase 1 activities, polymorphisms and oxidative stress in breastย cancerย patients with type 2ย diabetesย mellitus
  338. Association of tamoxifen use and increasedย diabetesย among Asian women diagnosed with breastย cancer
  339. Association of the consumption of common food groups and beverages with mortality fromย cancer, ischaemic heart disease andย diabetesย mellitus in Serbia, 1991 โ€ฆ
  340. Association of the severity ofย diabetes-related complications with stage of breastย cancerย at diagnosis among elderly women with pre-existingย diabetes
  341. Association of thiazolidinediones with gastricย cancerย in type 2ย diabetesย mellitus: a population-based caseโ€“control study
  342. Association of thiazolidinediones with liverย cancerย and colorectalย cancerย in type 2ย diabetesย mellitus
  343. Association of type 2ย diabetesย genetic variants with breastย cancerย survival among Chinese women
  344. Association of type 2ย diabetesย mellitus and antidiabetic medication with risk of prostateย cancer: a population-based case-control study
  345. Association of type 2ย diabetesย mellitus and the risk of colorectalย cancer: a meta-analysis and systematic review
  346. Association of type 2ย diabetesย susceptibility variants with advanced prostateย cancerย risk in the Breast and Prostateย cancerย Cohort Consortium
  347. Association of type 2ย diabetesย withย cancer: A meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people
  348. Association of type 2ย diabetesย with in-hospital complications among women undergoing breastย cancerย surgical procedures. A retrospective study using the โ€ฆ
  349. Association study of type 2ย diabetesย genetic susceptibility variants and risk of pancreaticย cancer: an analysis of PanScan-I data
  350. Associations betweenย diabetesย and quality of life among breastย cancerย survivors
  351. Associations betweenย diabetesย medication use and risk of second breastย cancerย events and mortality
  352. Associations of change in television viewing time with biomarkers of postmenopausal breastย cancerย risk: the Australianย diabetes, Obesity and Lifestyle Study
  353. Associations ofย diabetesย mellitus with site-specificย cancerย mortality in the Asia-Pacific region
  354. Associations of hemoglobin A1c with risk ofย diabetes-relatedย cancers in theย cancerย Prevention Study-II Nutrition Cohort (CPS-II NC)
  355. Associations of hyperglycemia and insulin usage with the risk ofย cancerย in type 2ย diabetes: the Hong Kongย diabetesย registry
  356. Associations of sedentary lifestyle, obesity, smoking, alcohol use, andย diabetesย with the risk of colorectalย cancer
  357. Associations of Telomere Length andย diabetesย with Pancreaticย cancer
  358. Associations of type 2ย diabetesย andย diabetesย treatment with breastย cancerย risk and mortality: a population-based cohort study among British women
  359. Asymptomatic acute pancreatitis due to tamoxifen-induced severe hypertriglyceridemia in a patient withย diabetesย mellitus and breastย cancer
  360. At the intersection ofย diabetesย andย cancer: the role of angiogenesis and inflammation
  361. Atezolizumab-induced autoimmuneย diabetesย in a patient with metastatic lungย cancer
  362. Atrial natriuretic peptide and type 2ย diabetesย development, evidence of causal association from the prospective Malmรถ diet andย cancerย study
  363. Attitude toward death in healthy people and patients withย diabetesย andย cancer
  364. Attitudes, perceptions, and family coping in pediatricย cancerย and childhoodย diabetes
  365. Atypicalย diabetesย insipidus in small cell lungย cancer: paraneoplastic syndrome or metastatic disease?
  366. Atypical early onset ofย diabetes, deafness and lungย cancerย in a male patient with mitochondrial mutations in peripheral mononuclear cells
  367. Author Correction: Dipeptidyl peptidase-4 inhibitors andย cancerย risk in patients with type 2ย diabetes: a meta-analysis of randomized clinical trials
  368. Author Correction: Genomic Prediction of 16 Complex Disease Risks Including Heart Attack,ย diabetes, Breast and Prostateย cancer
  369. Authorsโ€™ reply to editorial linked to their umbrella review of meta-analyses of observational studies on type 2ย diabetesย andย cancer
  370. Autoimmuneย diabetesย superimposed on type 2ย diabetesย in a patient initiated on immunotherapy for lungย cancer
  371. Automatic Extraction of Useful Information from Food-Health Articles related toย diabetes, Cardiovascular Disease andย cancer
  372. Award of the Foundation for the State of Kuwait Prize for the Control ofย cancer, Cardiovascular Diseases andย diabetesย in the Eastern Mediterranean Region
  373. Bamboo extract in the prevention ofย diabetesย and breastย cancer
  374. Behavioral genetics of the depression/cancerย correlation: a look at the Ras oncogene family and the โ€˜cerebralย diabetesย paradigmโ€™
  375. Benefits of screening for pancreaticย cancerย in new-onsetย diabetesย mellitus
  376. BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2ย diabetesย and breastย cancer
  377. Beyondย diabetesย mellitus: role of metformin in non-muscle invasive bladderย cancer
  378. Biguanide therapy forย diabetesย andย cancerย & a novel methyltransferase that regulates energy expenditure and adiposity and is elevated in manyย cancers
  379. Bio-Inspired and Nanotechnology-Enabled Drug Delivery forย diabetesย and Brainย cancer
  380. Bioactive Flavonoid Apigenin and Its Nanoformulations: A Promising Hope forย diabetesย andย cancer
  381. Biochemical mechanisms connectingย diabetesย andย cancer. Effects of methormine
  382. Biogenesis of silver nanoparticles to treatย cancer,ย diabetes, and microbial infections: a mechanistic overview
  383. Biologic evaluation ofย diabetesย and local recurrence in non-small cell lungย cancer
  384. Biology of circulating nucleic acids and possible roles in diagnosis and treatment inย diabetesย andย cancer.
  385. Bitter melon as a therapy forย diabetes, inflammation, andย cancer: a panacea?
  386. Bittergourd (Momordica charantia) scavenges free radicals by enhancing the expression of superoxide dismutase in in vitro models ofย diabetesย andย cancer
  387. Blacks more likely to die ofย cancerย andย diabetes
  388. Bladderย cancerย In Patients With Type 2ย diabetesย Treated With Pioglitazone, A Comparative Study
  389. Blood glucose concentrations and breastย cancerย risk in women withoutย diabetes: a meta-analysis
  390. BMI and weight: their relation toย diabetes, CVD,ย cancerย and allcause mortality
  391. Body fat distribution,ย diabetes, and prostateย cancerย in Afro-Caribbean men: the Tobago Prostateย cancerย Survey
  392. Body iron stores and risk of type 2ย diabetes: results from the European Prospective Investigation intoย cancerย and Nutrition (EPIC)-Potsdam study
  393. Body mass index andย cancerย risk among Chinese patients with type 2ย diabetesย mellitus
  394. Body mass index andย cancerย risk in patients with type 2ย diabetes: a doseโ€“response meta-analysis of cohort studies
  395. Body mass index andย cancerย risk in patients with type 2ย diabetes: a doseโ€“response meta-analysis of cohort studies
  396. Body mass index andย diabetesย are important prognostic signatures for bilateral breastย cancerย prognosis
  397. Body mass index and obesity-andย diabetes-associated genotypes and risk for pancreaticย cancer
  398. Body mass index and obesity-relatedย cancerย risk in men and women with type 2ย diabetesย (ZODIAC-56)
  399. Body mass index and the risk ofย cancerย incidence in patients with type 2ย diabetesย in Japan: Results from the National Centerย diabetesย Database
  400. Body mass index history and risk of type 2ย diabetes: results from the European Prospective Investigation intoย cancerย and Nutrition (EPIC)โ€“Potsdam Studyโ€“
  401. Body mass index,ย diabetesย and intrahepatic cholangiocarcinoma risk: the liverย cancerย pooling project and meta-analysis
  402. Body mass index,ย diabetesย and survival after diagnosis of endometrialย cancer: a report from the HUNT-Survey
  403. Body mass index,ย diabetes, and triple-negative breastย cancerย prognosis
  404. Body mass index, physical activity and the risk of pancreaticย cancerย in relation to smoking status and history ofย diabetes: a large-scale population-based cohort study โ€ฆ
  405. Body mass index, type 2ย diabetes, and insulin prescription in adolescents and young adults withย cancer
  406. Body mass index, waist circumference,ย diabetes, and risk of liverย cancerย for US adults
  407. Body mass,ย diabetesย and smoking, and endometrialย cancerย risk: a follow-up study
  408. Body size in different periods of life,ย diabetesย mellitus, hypertension, and risk of postmenopausal endometrialย cancerย (Sweden)
  409. Breast and prostateย cancerย survivors in a diabetic cohort: results from the Living withย diabetesย Study
  410. Breastย cancerย andย diabetesย mellitus
  411. Breastย cancerย andย diabetesย mellitus: Complex interactions
  412. Breastย cancerย andย diabetes.
  413. Breastย cancerย in women withย diabetesย mellitus type 2
  414. Breastย cancerย incidence before and after diagnosis of type 2ย diabetesย mellitus in women: increased risk in the prediabetesย phase
  415. Breastย cancerย increasesย diabetesย risk
  416. Breastย cancerย patients withย diabetesย mellitus: Defining the population and assessing outcomes.
  417. Breastย cancerย Radiotherapy Associatedย diabetesย Mellitus Case Reports
  418. Breastย cancerย resistance protein andย diabetes
  419. Breastย cancerย withย diabetesย insipidus
  420. Breastย cancer,ย diabetesย mellitus and usefulness of immunonutrition
  421. Breastย cancer: Increased Risk of Cardiotoxicity Found with Trastuzumab for Elderly Patients with Heart Disease,ย diabetes
  422. Breast, cervical and colorectalย cancerย screening in adults withย diabetes: a systematic review and meta-analysis
  423. Brief report: the risk of posttraumatic stress disorder in mothers of children diagnosed with pediatricย cancerย and type Iย diabetes
  424. Bromodomain coactivators inย cancer, obesity, type 2ย diabetes, and inflammation
  425. Burden ofย cancerย associated with type 2ย diabetesย mellitus in Japan, 2010โ€“2030
  426. Burden ofย cancerย attributable to obesity, type 2ย diabetesย and associated risk factors
  427. Burden ofย diabetesย and oralย cancerย in India
  428. Burden ofย diabetesย inย cancerย inpatients
  429. Burden of Health Disparities in Chronic Illnesses: A Report on Cardiovascular Disease,ย diabetes, andย cancerย in La Crosse County
  430. Cadmium exposure and incidence ofย diabetesย mellitus-results from the Malmรถ Diet andย cancerย study
  431. Can aย diabetesย Drug Preventย cancerย Death?
  432. Can aspirin reduce the risk of colorectalย cancerย in people withย diabetes? A populationโ€based cohort study
  433. Canย diabetesย Change the Intrinsic Subtype Specificity of Breastย cancer
  434. Can endogenous hyperinsulinaemia explain the increased risk ofย cancerย development and mortality in type 2ย diabetes: evidence from mouse models
  435. Can luteolin be a therapeutic molecule for both colonย cancerย andย diabetes?
  436. Can metformin change the prognosis of pancreaticย cancer? Retrospective study for pancreaticย cancerย patients with pre-existingย diabetesย mellitus type 2
  437. Can pancreaticย cancerย be detected by adrenomedullin in patients with new-onsetย diabetes? The PaCANOD cohort study protocol
  438. cancerย among patients withย diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden
  439. cancerย among patients with type 2ย diabetesย mellitus: a population-based cohort study in northeastern Italy
  440. cancerย and cholesterol: understanding the V-shaped association in patients withย diabetes
  441. cancerย andย diabetes
  442. cancerย andย diabetes
  443. cancerย andย diabetes
  444. cancerย andย diabetesย mellitus a review of the literature
  445. cancerย andย diabetesย mellitus based on autopsy data
  446. cancerย andย diabetesโ€a followโ€up study of two populationbased cohorts of diabetic patients
  447. cancerย andย diabetes, an increasing common combination: Improving knowledge among oncology nurses.
  448. cancerย andย diabetes: are there similarities?
  449. cancerย andย diabetes: are we ready for prime time?
  450. cancerย andย diabetes: new links and new challenges
  451. cancerย andย diabetes: two pathological conditions in which adrenomedullin may be involved
  452. cancerย as a metabolic disease andย diabetesย as aย cancerย risk?
  453. cancerย biology and prevention inย diabetes
  454. cancerย biology inย diabetes
  455. cancerย cachexia andย diabetes: similarities in metabolic alterations and possible treatment,
  456. cancerย detection rates following enrolment in a disease management programme for type 2ย diabetes
  457. cancerย has overtaken cardiovascular disease as the commonest cause of death in Scottish type 2ย diabetesย patients: A populationโ€based study (The Ayrshireย diabetesย โ€ฆ
  458. cancerย inย diabetesย patients: Basing a wrong conclusion on a wrong or on a correct analyses.
  459. cancerย in patients admitted to hospital withย diabetesย mellitus aged 30 years and over: record linkage studies
  460. cancerย in south Karnataka and its paradoxical relation toย diabetesย mellitus
  461. cancerย incidence among Finnish people with type 2ย diabetesย during 1989โ€“2014
  462. cancerย incidence and mortality in patients with insulin-treatedย diabetes: a UK cohort study
  463. cancerย incidence and mortality in patients with insulin-treatedย diabetes: a UK cohort study
  464. cancerย incidence and mortality in patients with type 2ย diabetesย treated with human insulin: a cohort study in Shanghai
  465. cancerย incidence in a population-based cohort of patients hospitalized withย diabetesย mellitus in Denmark
  466. cancerย incidence in patients with type 1ย diabetesย mellitus: a population-based cohort study in Sweden
  467. cancerย incidence in patients with type 2ย diabetesย mellitus in Minhang District of Shanghai
  468. cancerย incidence in patients with type 2ย diabetesย mellitus: a population-based cohort study in Shanghai
  469. cancerย incidence in persons with type 1ย diabetes: a five-country study of 9,000ย cancers in type 1 diabetic individuals
  470. cancerย incidence in the National Health and Nutrition Survey I. Follow-up data:ย diabetes, cholesterol, pulse and physical activity.
  471. cancerย incidence in type 1ย diabetes: A 5-country study of 9,000ย cancers in type 1 diabetic individuals Electronic Supplementary Material
  472. cancerย incidence in type 2ย diabetesย patients-first results from a feasibility study of the D2C cohort
  473. cancerย morbidity in patients withย diabetesย mellitus
  474. cancerย of the breast,ย diabetesย and pathological glucose tolerance
  475. cancerย of the organs of the reproductive system in women with type 2ย diabetes. Effects of antidiabetic therapy
  476. cancerย of unknown primary is associated withย diabetes
  477. cancerย Patients with Undiagnosed and Poorly Managedย diabetesย Mellitus
  478. cancerย patients with undiagnosed and poorly managedย diabetesย mellitus.
  479. cancerย prediction for type-2ย diabetesย using machine learning
  480. cancerย prevention with aย diabetesย pill?
  481. cancerย recording in patients with and without type 2ย diabetesย in the Clinical Practice Research Datalink primary care data and linked hospital admission data โ€ฆ
  482. cancerย recording in patients with type 2ย diabetesย in primary care and hospital admission data: IJPDS (2017) Issue 1, Vol 1: 314 Proceedings of the IPDLN โ€ฆ
  483. cancerย risk among patients hospitalized for Type 1ย diabetesย mellitus: a populationโ€based cohort study in Sweden
  484. cancerย risk among patients with type 2ย diabetesย mellitus: a population-based prospective study in China
  485. cancerย risk among patients with type 2ย diabetes: A realโ€world study in Shanghai, China
  486. cancerย risk among people with type 1 and type 2ย diabetes: disentangling true associations, detection bias, and reverse causation
  487. cancerย risk associated with insulin glargine among adult type 2ย diabetesย patientsโ€“a nationwide cohort study
  488. cancerย risk associated with use of metformin and sulfonylurea in type 2ย diabetes: a meta-analysis
  489. cancerย risk due to type 2ย diabetes
  490. cancerย risk for patients using thiazolidinediones for type 2ย diabetes: a meta-analysis
  491. cancerย risk in Chineseย diabetesย patients: a retrospective cohort study based on management data
  492. cancerย risk in dialyzed patients with and withoutย diabetes
  493. cancerย risk in patients aged 30 years and above with type 2ย diabetesย receiving antidiabetic monotherapy: a cohort study using metformin as the comparator
  494. cancerย risk in patients withย diabetesย mellitus
  495. cancerย risk in patients with type 2ย diabetesย mellitus and their relatives
  496. cancerย Risk in Patients with Type 2ย diabetesย on Antidiabetic Monotherapy: A Population Based Cohort Study Using National Insurance Health Service Database
  497. cancerย risk in people withย diabetes: does physical activity and adiposity modify the association? Prospective data from the HUNT Study, Norway
  498. cancerย risk in people with type 1 and type 2ย diabetesย in Australia
  499. cancerย risk in type 2ย diabetes
  500. cancerย risk in type 2ย diabetesย mellitus: metabolic links and therapeutic considerations
  501. cancerย risk is higher in years before and shortly after type 2ย diabetesย diagnosis, study shows
  502. cancerย risks among patients with type 2ย diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan
  503. cancerย risks fromย diabetesย therapies: evaluating the evidence
  504. cancerย risks of anti-hyperglycemic drugs for type 2ย diabetesย treatmentโ€“a clinical appraisal
  505. cancerย screening rate in people withย diabetesย in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009
  506. cancerย Signaling Transcriptome Is Upregulated in Type 2ย diabetesย Mellitus
  507. cancerย specific mortality in insulin-treated type 2ย diabetesย patients
  508. cancerย stem cells generated by alcohol,ย diabetes, and hepatitis C virus
  509. cancerย susceptibility in two rat models of spontaneousย diabetes
  510. cancerย treatment and cellular stress induced type 2ย diabetesย mellitus
  511. cancerย withย diabetes: Prevalence, metabolic control, and survival in a general oncology practice.
  512. cancerย withย diabetes: prevalence, metabolic control, and survival in an academic oncology practice
  513. cancer-related side effects andย diabetesย self-management.
  514. cancer-suppressing enzyme adds a link to type 2ย diabetes
  515. cancer, cardiovascular disease andย diabetesย mortality among women with a history of endometrialย cancer
  516. cancer,ย diabetes, and angiotensin blockade: a question of hypohydration.
  517. cancer, Heart Disease, andย diabetesย in Workers Exposed to 2,3,7,8-Tetrachlorodibenzo- p -dioxin
  518. cancer, heart, andย diabetesย societies join to publicise uninsured Americans
  519. cancer, obesity, andย diabetes: TKIs exert multiple effects on glucose homeostasis
  520. cancer, obesity,ย diabetes, and antidiabetic drugs: is the fog clearing?
  521. cancer, type 2ย diabetes, and ageing: news from flies and worms
  522. Candidate gene polymorphisms forย diabetesย mellitus, cardiovascular disease andย cancerย are associated with longevity in Koreans
  523. Capnocytophaga sputigena pneumonia and bacteremia in a patient withย diabetesย and gastricย cancer
  524. Carbohydrate intake and incidence of type 2ย diabetesย in the European Prospective Investigation intoย cancerย and Nutrition (EPIC)-Potsdam Study
  525. Carbohydrate quantity and quality and risk of type 2ย diabetesย in the European Prospective Investigation intoย cancerย and Nutritionโ€“Netherlands (EPIC-NL) study
  526. Cardiorespiratory fitness as a predictor ofย cancerย mortality among men with pre-diabetesย andย diabetes
  527. Cardiovascular comorbidity and ovarianย cancerย patient survival: history of hypertension, heart disease, andย diabetes, evidence from the Ovarianย cancerย Association โ€ฆ
  528. Cardiovascular disease,ย cancer, and mortality among people with type 2ย diabetesย and alcoholic or nonalcoholic fatty liver disease hospital admission
  529. Cardiovascular diseases,ย diabetesย mellitus, andย cancerย in the occupied Palestinian territory
  530. Cardiovascular morbidity,ย diabetesย andย cancerย risk among children and adolescents with severe obesity
  531. Cardiovascular,ย cancerย and mortality events after bariatric surgery in people with and without preโ€existingย diabetes: A nationwide study
  532. Cardiovascular,ย diabetes, andย cancerย strips: evidences, mechanisms, and classifications
  533. Care of esophagealย cancerย patients withย diabetesย mellitusโ€“preoperative management and treatment
  534. Care Plan for Resuming the Physical Activity of Patients With Pancreaticย cancerย andย diabetesย After Surgery
  535. CARING (cancerย Risk and INsulin analoGues): the association ofย diabetesย mellitus andย cancerย risk with focus on possible determinants-a systematic review and a โ€ฆ
  536. Case of small cell lungย cancerย complicated withย diabetesย insipidus and Cushing syndrome due to ectopic adrenocorticotropic hormone secretion
  537. Case report of severe Cushingโ€™s syndrome in medullary thyroidย cancerย complicated by functionalย diabetesย insipidus, aortic dissection, jejunal intussusception โ€ฆ
  538. Case-control study ofย diabetes-related genetic variants and pancreaticย cancerย risk in Japan
  539. Caseโ€“control study ofย diabetes, obesity, physical activity and risk of endometrialย cancerย among Mexican women
  540. Causal Evaluation of Laboratory Markers in Type 2ย diabetesย onย cancerย and Vascular Diseases Using Various Mendelian Randomization Tools
  541. Causative relationship betweenย diabetesย mellitus and breastย cancerย in various regions of Saudi Arabia: an overview
  542. Cause of death for those withย diabetesย and/orย cancerย provides further support for an important role of vitamin D in reducing risk of many types of disease
  543. Cause-specific mortality in endometrioid endometrialย cancerย patients with type 2ย diabetesย using metformin or other types of antidiabetic medication
  544. Cause-specific mortality in Scottish patients with colorectalย cancerย with and without type 2ย diabetesย (2000โ€“2007)
  545. Causes of death in men with prevalentย diabetesย and newly diagnosed high-versus favorable-risk prostateย cancer
  546. Centralย diabetesย insipidus and Cushingโ€™s syndrome due to ectopic ACTH production by disseminated small cell lungย cancer: a case report
  547. Centralย diabetesย insipidus caused by pituitary metastasis of lungย cancer
  548. Centralย diabetesย insipidus caused by pituitary metastasis of lungย cancer
  549. Centralย diabetesย insipidus caused by pituitary metastasis of lungย cancer
  550. Centralย diabetesย Insipidus: An Unusual Initial Presentation of Lungย cancer
  551. Ceritinib aggravates glycemic control in insulin-treated patients withย diabetesย and metastatic ALK-positive lungย cancer
  552. Challenges and perspectives in the treatment ofย diabetesย associated breastย cancer
  553. Challenges and Rewards of Pharmacotherapy Selection in Patients Newly Diagnosed with Lungย cancerย andย diabetesย Mellitus
  554. Challenges in the management of people withย diabetesย andย cancer
  555. Challenges of imaging forย cancerย in patients withย diabetesย and obesity
  556. Change in the incidence ofย diabetesย mellitus in oralย cancerย patients based on a long-term comparative study
  557. Changes in blood glucose of elderly patients with gastricย cancerย combined with type 2ย diabetesย mellitus after radical operation and the effect of mediation โ€ฆ
  558. Changes in glucose-lowering drug use before and afterย cancerย diagnosis in patients withย diabetes
  559. Changes in intake of dairy product subgroups and risk of type 2ย diabetes: modelling specified food substitutions in the Danish Diet,ย cancerย and Health cohort
  560. Changes in medication management after a diagnosis ofย cancerย among medicare beneficiaries withย diabetes
  561. Changes on blood glucose of different operation scheme after gastrectomy for gastricย cancerย in patients complicated withย diabetesย mellitus
  562. Characteristics and prognosis of breastย cancerย patients with type-2ย diabetesย mellitus
  563. Characteristics associated with nonadherence to medications for hypertension,ย diabetes, and dyslipidemia among breastย cancerย survivors
  564. Characteristics of the clinical course of breastย cancerย in patients withย diabetesย mellitus
  565. Characteristics of treatment of patients with breastย cancerย andย diabetesย mellitus
  566. Characterizing hyperglycemia inย cancerย patients withย diabetesย in an Emergency Center
  567. Chemical Investigations ofย diabetesย Mellitus, Malaria, and Castrate-Resistant Prostateย cancer
  568. Chemokine like receptor-1 (CMKLR-1) receptor: a potential therapeutic target in management of chemerin induced type 2ย diabetesย mellitus andย cancer
  569. Chemotherapy and glycemic control in patients with type 2ย diabetesย andย cancer: a comparative case analysis
  570. Childhoodย cancerย Survivors Have Moreย diabetes
  571. Childhoodย cancer, type 1ย diabetesย and other immune diseases: healthcare visits in the year before diagnosis in Taiwan
  572. Chinese herbal products and the reduction of risk of breastย cancerย among females with type 2ย diabetesย in Taiwan: A caseโ€“control study
  573. Cholesterol drugs improve breastย cancerย prognosis in women withย diabetesย mellitus
  574. Christian Religious Coping with HIV,ย cancer, andย diabetes: African American Women and the Churchโ€™s Response
  575. Chronic diseases and health care: new trends inย diabetes, arthritis, osteoporosis, fibromyalgia, low back pain, cardiovascular disease, andย cancer
  576. Chronic Lowโ€grade Inflammation in Obesity andย diabetesย associated Colorectalย cancerย Development.
  577. Chronic pancreatitis, type 3cย diabetes, and pancreaticย cancerย risk
  578. Circulating nucleic acids in plasma and serum: roles in diagnosis and prognosis inย diabetesย andย cancer.
  579. Circulating soluble receptor for advanced glycation end products and other factors in type 2ย diabetesย patients with colorectalย cancer
  580. Circulating soluble urokinase plasminogen activator receptor predictsย cancer, cardiovascular disease,ย diabetesย and mortality in the general population
  581. Circulating vascular endothelial growth factor (VEGF) levels in advanced stageย cancerย patients compared to normal controls andย diabetesย mellitus patients with critical โ€ฆ
  582. Cisplatin nephrotoxicity aggravated by cardiovascular disease andย diabetesย in lungย cancerย patients
  583. Classification ofย cancerย for Type 2ย diabetesย Using Machine Learning Algorithm
  584. Clinical analysis of breastย cancerย patients with type 2ย diabetesย mellitus in Xinjiang
  585. Clinical analysis of endometrialย cancerย patients with obesity,ย diabetes, and hypertension
  586. Clinical challenges in caring for patients withย diabetesย andย cancer
  587. Clinical characteristics of pancreaticย cancerย according to the presence ofย diabetesย mellitus
  588. Clinical course ofย diabetesย after gastrectomy according to type of reconstruction in patients with concurrent gastricย cancerย and type 2ย diabetes
  589. Clinical differences between patients with new-onsetย diabetesย and those without it in a cohort of individuals with pancreaticย cancer
  590. Clinical effects of postoperative early enteral nutrition for the gastricย cancerย patients withย diabetesย [J]
  591. Clinical epidemiological analysis of the relationship between pancreaticย cancerย andย diabetesย mellitus: data from a single institution in China
  592. Clinical features and molecular phenotypes of breastย cancerย in patients with type-2ย diabetesย mellitus
  593. Clinical improvement ofย diabetesย mellitus type 1 by bD-mannuronic acid (M2000) in a breastย cancerย patientโ€”as a case report
  594. Clinical outcome of pancreaticย cancerย patients withย diabetesย mellitus: isย diabetesย a poor prognostic factor?
  595. Clinical pathological characteristics and prognostic analysis of 1,013 breastย cancerย patients withย diabetes
  596. Clinical pathological characteristics of breastย cancerย patients with secondaryย diabetesย after systemic therapy: a retrospective multicenter study
  597. Clinical Research on the Relationship between Type 2ย diabetesย Mellitus and Colorectalย cancer
  598. Clinical review 63:ย diabetesย and pancreaticย cancer: clues to the early diagnosis of pancreatic malignancy
  599. Clinical significance of serum lncRNAย cancerย susceptibility candidate 2 (CASC2) for chronic renal failure in patients with type 2ย diabetes
  600. Clinical significances of superoxide dismutases: changes in aging,ย diabetes, ischemia, andย cancer
  601. Clinical study of cytidine deaminase in serum ofย cancerย thalassemia andย diabetesย patients
  602. Clinical Translational Research:ย cancer,ย diabetes, and Cardiovascular Disease
  603. Clinically confirmed type 2ย diabetesย mellitus and colorectalย cancerย risk: a population-based, retrospective cohort study
  604. Clinically defined type 2ย diabetesย mellitus and prognosis in early-stage breastย cancer
  605. Clinicopathologic characteristics and prognostic analysis of luminal B breastย cancerย patients withย diabetes
  606. Clinicopathologic features of breastย cancerย patients with type 2ย diabetesย mellitus in southwest of China
  607. Clinicopathological and prognostic features of operable nonโ€small cell lungย cancerย patients withย diabetesย mellitus
  608. Clinicopathological characteristics and prognosis of breastย cancerย patients with type 2ย diabetesย mellitus
  609. Clinicopathological characteristics of colorectalย cancerย complicated with type 2ย diabetesย mellitus: analysis of clinicopathological data from 3, 202 colorectalย cancerย โ€ฆ
  610. Clinicopathological characteristics of type 2ย diabetesย mellitus complicated with colorectalย cancer
  611. Clinicopathological features of pancreaticย cancer-relatedย diabetes.
  612. Close Relationship betweenย diabetesย andย cancer
  613. Co-existing prostateย cancerย andย diabetesย mellitus: implications for patient outcomes and care
  614. Co-Managing Patients with Type 1ย diabetesย andย cancer
  615. Co-morbilities and survival of patients initially diagnosed with extensive-stage small cell lungย cancer: Impact of hypertension,ย diabetesย and chronic hepatitis B โ€ฆ
  616. Co-occurrence ofย diabetesย and breastย cancerย among women by ethnicity
  617. Co-occurrence ofย diabetes, myocardial infarction, stroke, andย cancer: quantifying age patterns in the Dutch population using health survey data
  618. Codon 72 polymorphisms of p53 are associated with obesity,ย diabetes, and race in breastย cancer
  619. Coffee consumption and risk of type 2ย diabetes, cardiovascular diseases, andย cancer
  620. Cohort profile: the Australian and New Zealandย diabetesย andย cancerย collaboration (ANZDCC)
  621. Cohort study ofย cancerย incidence in patients with type 2ย diabetes: record linkage of encrypted data from an external cohort with data from the epidemiologicalย cancerย โ€ฆ
  622. Cohort study of insulin glargine and risk of breast, prostate, and colorectalย cancerย among patients withย diabetes
  623. Cohort study of pioglitazone andย cancerย incidence in patients withย diabetes
  624. Colonย cancerย Patients withย diabetesย Have Increased Risk of Recurrence
  625. Colorectal and prostateย cancerย risk inย diabetes: metformin, an actor behind the scene
  626. Colorectalย cancerย andย diabetes
  627. Colorectalย cancerย associated with BMI, physical activity,ย diabetes, and blood glucose.
  628. Colorectalย cancerย in patients with type 2ย diabetesย mellitus: A single-center experience
  629. COLORECTALย cancerย IN PATIENTS WITH TYPE 2ย diabetesย MELLITUS: PRELIMINARY RESULTS FROM AN ONGOING CASE-CONTROL STUDY
  630. Colorectalย cancerย outcomes, recurrence, and complications in persons with and withoutย diabetesย mellitus: a systematic review and meta-analysis
  631. Colorectalย cancerย Risks According to Sex Differences in Patients With Type IIย diabetesย Mellitus: A Korean Nationwide Population-Based Cohort Study
  632. Colorectalย cancerย screening in North Carolina: associations withย diabetesย mellitus and demographic and health characteristics
  633. Colorectalย cancer,ย diabetesย and survival: epidemiological insights
  634. Colorectalย cancer: another complication ofย diabetesย mellitus?
  635. Colorectalย cancer: Histopathologic differences in tumor characteristics between patients with and withoutย diabetes
  636. Combination of type 2ย diabetesย and smoking increases totalย cancerย mortality in Japanese men using competing risk analysis: the Tanno-Sobetsu study
  637. Combined effect of obesity andย diabetesย on early breastย cancerย outcome: a prospective observational study
  638. Combined effect of obesity andย diabetesย on early breastย cancerย outcome: a prospective observational study
  639. Combined effects of obesity and type 2ย diabetesย contribute to increased breastย cancerย risk in premenopausal women
  640. Comment A turning point for chronic kidney disease inย diabetesย Perioperative FLOT: new standard for gastricย cancer?
  641. Comment on โ€œPersonal History ofย diabetesย as Important as Family History of Colorectalย cancerย for Risk of Colorectalย cancer: A Nationwide Cohort Studyโ€
  642. Comment on Andersen et al, Pancreatitisโ€“diabetesโ€“Pancreaticย cancer: Summary of an NIDDK-NCI Workshop
  643. Comment on: Need for Differentiatingย diabetes-Specific Mortality from Total Mortality when Comparing Metformin with Insulin Regardingย cancerย Survival
  644. Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lungย cancerย in Patients With Type 2ย diabetes.ย diabetesย Care 2013; 36: 124โ€“129
  645. Comment on: Suissa and Azoulay. Metformin and the risk ofย cancer: time-related biases in observational studies.ย diabetesย Care 2012; 35: 2665โ€“2673
  646. Comment on: Suissa and Azoulay. Metformin and the Risk ofย cancer: Time-Related Biases in Observational Studies.ย diabetesย Care 2012; 35: 2665โ€“2673
  647. Comment on: Torres-Mejรญa et al. Moderate-Intensity Physical Activity Ameliorates the Breastย cancerย Risk in Diabetic Women.ย diabetesย Care 2012; 35: 2500โ€“2502
  648. Commentary on โ€œToxicity after external beam radiotherapy for prostateย cancer: An analysis of late morbidity in men withย diabetesย mellitus.โ€ Kalakota K, Liauw SL โ€ฆ
  649. Comments onโ€ Use of metformin and risk of kidneyย cancerย in patients with type 2ย diabetesโ€œ, Chin-Hsiao Tseng, Eur Jย cancer, 2016, No. 52, pp. 19-25.
  650. Common targets for a deadly duo ofย diabetesย mellitus and colonย cancer: Catching two fish with one worm
  651. Commonly usedย diabetesย and cardiovascular medications andย cancerย recurrence andย cancer-specific mortality: a review of the literature
  652. Comorbidย diabetesย mellitus and risk of death after diagnosis of colorectalย cancer: a population-based study
  653. Comorbidities as predictors of incidental prostateย cancerย after Holmium laser enucleation of the prostate:ย diabetesย and high-riskย cancer
  654. Comorbidity is associated with higher risk of financial burden in Medicare beneficiaries withย cancerย but not heart disease orย diabetes
  655. Comparative safety ofย diabetesย medications and risk of incident invasive breastย cancer: a population-based cohort study
  656. Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladderย cancerย in older US adults with type 2ย diabetes
  657. Comparative study ofย diabetesย mellitus resolution according to reconstruction type after gastrectomy in gastricย cancerย patients withย diabetesย mellitus
  658. Comparing Survival Functions with Doubly Interval-Censored Data: An Application toย diabetesย Surveyed by Koreanย cancerย Prevention Study
  659. Comparing the patterns of hypertension and type 2ย diabetesย mellitus in patients with colorectalย cancer
  660. Comparison of AIS and fuzzy c-means clustering methods on the classification of breastย cancerย andย diabetesย datasets
  661. Comparison of Bee and BMI Based on Charted Versus Measured Height and Weight ofย diabetesย Mellitus andย cancerย Patients
  662. Comparison ofย diabetesย management status betweenย cancerย survivors and the general population: results from a Korean population-based survey
  663. Comparison of Health Hardness and Life Expectancy in Patients withย diabetesย and Breastย cancer
  664. Competing interests in a lungย cancerย with metastasis to the pituitary gland: syndrome of inappropriate ADH secretion versusย diabetesย insipidus
  665. Complete Healing fromย cancerย diabetesย Leukemia and Other Chronic Disorders
  666. Computational analysis of single nucleotide polymorphisms (SNPs) in PPAR gamma associated with obesity,ย diabetesย andย cancer
  667. Confirmation of the role ofย diabetesย in the local recurrence of surgically resected non-small cell lungย cancer
  668. Confirmation of the role ofย diabetesย in the local recurrence of surgically resected non-small cell lungย cancer.
  669. Confounding Factors of theย diabetes-Metformin-cancerย Relationship
  670. Connecting the Dots Between Obesity,ย diabetesย andย cancer
  671. Considerations for developing chronic care system for traumatic brain injury based on comparisons ofย cancerย survivorship andย diabetesย management care
  672. Consortium for the study of chronic pancreatitis,ย diabetes, and pancreaticย cancer: from concept to reality
  673. Continuous androgen-deprivation therapy increased risk forย diabetesย and fragility fractures in older men with prostateย cancer
  674. Contribution of biomarkers for pancreaticย cancer-associated new-onsetย diabetesย to pancreaticย cancerย screening
  675. Contribution ofย diabetesย to the incidence and prevalence of comorbid conditions (cancer, periodontal disease, fracture, impaired cognitive function, and depression): a โ€ฆ
  676. Contribution of type 2ย diabetesย to all-cause mortality, cardiovascular disease incidence andย cancerย incidence in white Europeans and South Asians: findings โ€ฆ
  677. Contribution of type 2ย diabetesย to all-cause mortality, cardiovascular disease incidence andย cancerย incidence in white Europeans and South Asians: findings from the โ€ฆ
  678. Control of luminal type A intrinsic subtype enriched transcription factor network by insulin: implications ofย diabetesย on breastย cancerย classification.
  679. Controversies Related toย diabetesย and Risk of Bladderย cancer.
  680. Controversy regarding gastricย cancerย andย diabetes
  681. Conventional hypoglycaemic agents and the risk of lungย cancerย in patients withย diabetes: a meta-analysis
  682. Convergence and divergence of genetic and modular networks betweenย diabetesย and breastย cancer
  683. Copeptin, a marker of vasopressin, in abdominal obesity,ย diabetesย and microalbuminuria: the prospective Malmรถ Diet andย cancerย Study cardiovascular cohort
  684. Correction to: Exploring the bi-directional relationship between pancreaticย cancerย andย diabetesย mellitus: a retrospective study
  685. Correction to: The relationship betweenย diabetes, prostate-specific antigen screening tests, and prostateย cancer.
  686. Correction: Sex-specific Association between Family History ofย diabetesย and Risk of Colorectalย cancer: Two Prospective Cohort Studies
  687. Correction: Survival Benefits of Metformin for Colorectalย cancerย Patients withย diabetes: A Systematic Review and Meta-Analysis
  688. Correlates Between Colorectalย cancerย Screening andย diabetesย Mellitus Among Residents of Ohio Appalachia: 1455
  689. Correlation between blood glucose level and the prognosis of postoperative pancreaticย cancerย patients withย diabetes
  690. Correlation between BMI,ย diabetesย Mellitus, and Outcomes in Patients Treated with BCG Immunotherapy for Non-Muscle Invasive Bladderย cancer
  691. Correlation Between Body Mass Index,ย diabetesย and Outcome in a Cohort of Egyptian Early Breastย cancerย Patients
  692. Correlation between circadian rhythm related genes, type 2ย diabetes, andย cancer: insights from metanalysis of transcriptomics data
  693. Correlation betweenย diabetesย prevalence and subsequentย cancerย mortality in North Carolina counties
  694. Correlation between renin-angiotensin system (RAS) related genes, type 2ย diabetes, andย cancer: Insights from metanalysis of transcriptomics data
  695. Correlation between treatment ofย diabetesย mellitus and developmentย cancer
  696. Correlations of microRNA-124a and microRNA-30d with clinicopathological features of breastย cancerย patients with type 2ย diabetesย mellitus
  697. Cost-effectiveness of adjuvant therapy for treatment of stage II colonย cancerย in patients withย diabetes.
  698. Covid-19 and long term conditions: what if you haveย cancer,ย diabetes, or chronic kidney disease?
  699. Critical role of Dipeptidyl Peptidase IV: A therapeutic target forย cancerย &ย diabetes
  700. Critical role of dipeptidyl peptidase IV: a therapeutic target forย diabetesย andย cancer
  701. Cullin-1 promotes cell proliferation in human breastย cancerย and is related toย diabetes
  702. Cultural worldviews and perceived risk of colonย cancerย andย diabetes
  703. Current drug information: Pioglitazone associated with increased risk of bladderย cancerย among people with type 2ย diabetes
  704. Current drug information: Thiazolidinediones associated with increased risk of bladderย cancerย among adults with type 2ย diabetes
  705. Cyclophosphamide and epirubicin-inducedย diabetesย mellitus in breastย cancer: A rare occurrence
  706. Cytochrome P450: polymorphisms and roles inย cancer,ย diabetesย and atherosclerosis
  707. Cytokine synergism in apoptosis: its role inย diabetesย andย cancer
  708. Cytokines in the interface of metabolomics basedย cancerย and type-2ย diabetes
  709. Cytolysis and karyopyknosis in postmenopausal vaginal smears as markers of endometrialย cancer,ย diabetesย and obesity. Studies based on a ten-year follow-up.
  710. Cytoplasmic ATM protein kinase: an emerging therapeutic target forย diabetes,ย cancerย and neuronal degeneration
  711. Dapagliflozin Protects Doxorubicin-induced Cardiotoxicity in Breastย cancerย Patients Withย diabetesย via Suppressing ER Stress
  712. Data mining applications to dermatological diseases, colorectalย cancer,ย diabetes, cardiology and medical audit systems
  713. Data mining Twitter forย cancer,ย diabetes, and asthma insights
  714. Data on BMI,ย diabetesย mellitus and non-muscle invasive bladderย cancerย recurrence and progression from the Nijmegen Bladderย cancerย study conducted in The โ€ฆ
  715. Data report on inflammatory Cโ€“C chemokines among insulin-using women withย diabetesย mellitus and breastย cancer
  716. Dataset on growth factor levels and insulin use in patients withย diabetesย mellitus and incident breastย cancer
  717. Death by lungย cancerย or byย diabetes? The unintended consequences of quitting smoking
  718. Debatingย cancerย andย diabetesย in Vienna
  719. Decavanadate salts of cytosine and metformin: a combined experimental-theoretical study of potential metallodrugs againstย diabetesย andย cancer
  720. Deciphering the complex interplay between pancreaticย cancer,ย diabetesย mellitus subtypes and obesity/BMI through causal inference and mediation analyses
  721. Deciphering the scalene association among typeโ€2ย diabetesย mellitus, prostateย cancer, and chronic myeloid leukemia via enrichment analysis of diseaseโ€gene โ€ฆ
  722. Decreased incidence of nonmelanoma skinย cancerย in patients with type 2ย diabetesย mellitus using insulin: a pilot study
  723. Decreased risk of colorectalย cancerย among patients with type 2ย diabetesย receiving Chinese herbal medicine: a population-based cohort study
  724. Decreased serum thrombospondin-1 levels in pancreaticย cancerย patients up to 24 months prior to clinical diagnosis: association withย diabetesย mellitus
  725. Decreased survival among lungย cancerย patients with co-morbid tuberculosis andย diabetes
  726. Defective Lipolysis Inย diabetesย Andย cancer
  727. Defining the molecular nexus ofย cancer, type 2ย diabetesย and cardiovascular disease
  728. Degarelix treatment is compatible withย diabetesย and antithrombotic therapy in patients with prostateย cancer
  729. Delivery of small molecule and RNA for the treatment of type 1ย diabetesย and prostateย cancer
  730. Demodex species positivity among patients withย cancer, on hemodialysis and withย diabetesย mellitus
  731. Demographic changes in the burden ofย diabetesย andย cancer
  732. Demographic Characteristics, Survival and Prognostic Factors of Early Breastย cancerย Patients with Type 2ย diabetesย Mellitus: A Hospital-Based Cohort Study
  733. Detection bias and overestimation of bladderย cancerย risk in type 2ย diabetes: a matched cohort study
  734. Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treatedย cancerย Patients with Type 2ย diabetesย Mellitus
  735. Determination of polymorphism of K-ras and DPC4 genes in pancreaticย cancerย in the background ofย diabetesย mellitus
  736. Determining the Impact of aย cancerย Diagnosis onย diabetesย Management: A Systematic Literature Review
  737. Developing a clinical and genetic risk prediction model forย diabetesย mellitus among survivors of childhoodย cancer
  738. Development and characterisation of a multifunctional hybrid nano-flora composite for the prevention and management ofย cancer,ย diabetes, blood pressure and โ€ฆ
  739. Development of a prediction model for colorectalย cancerย among patients with type 2ย diabetesย mellitus using a deep neural network
  740. Development of a prediction model for pancreaticย cancerย in patients with type 2ย diabetesย using logistic regression and artificial neural network models
  741. Development of a web-based liverย cancerย prediction model for type IIย diabetesย patients by using an artificial neural network
  742. Development of the national Expected Screening Rate for cardiovascular disease, type 2ย diabetes, cervicalย cancerย and colorectalย cancerย as a benchmark for โ€ฆ
  743. Development of the RapidMist drug delivery system for the treatment ofย diabetes, cardiovascular diseases and breakthroughย cancerย pain
  744. Development of type 1ย diabetesย afterย cancerย immunotherapy
  745. Dexrazoxane improves cardiac autonomic function in epirubicin-treated breastย cancerย patients with type 2ย diabetes
  746. Dexrazoxane protects breastย cancerย patients withย diabetesย from chemotherapy-induced cardiotoxicity
  747. diabetesย after hormone therapy in breastย cancerย survivors: a case-cohort study
  748. diabetesย alone should not be a reason for withholding adjuvant chemotherapy for stage III colonย cancer
  749. diabetesย and adiposity: a heavy load forย cancer
  750. diabetesย and altered carbohydrate metabolism in patients withย cancer
  751. diabetesย and beta-adrenergic blockage are risk factors for metastatic prostateย cancer
  752. diabetesย and body mass index are associated with neuropathy and prognosis in colonย cancerย patients treated with capecitabine and oxaliplatin adjuvant โ€ฆ
  753. diabetesย and breastย cancerย among women with BRCA1 and BRCA2 mutations
  754. diabetesย and breastย cancerย in T aiwanese women: a detection bias?
  755. diabetesย and breastย cancerย mortality in Black women
  756. diabetesย and breastย cancerย risk in a population-based case-control study of Hispanic and white, non-Hispanic women living in US Southwestern states
  757. diabetesย and breastย cancerย risk: a meta-analysis
  758. diabetesย and breastย cancerย subtypes
  759. diabetesย and breastย cancer: the womenโ€™s healthy eating & living study
  760. diabetesย andย cancer
  761. diabetesย andย cancer
  762. diabetesย andย cancer
  763. diabetesย andย cancer
  764. diabetesย andย cancer
  765. diabetesย andย cancer
  766. diabetesย andย cancer
  767. diabetesย andย cancer
  768. diabetesย andย cancer
  769. diabetesย andย cancer
  770. diabetesย andย cancer
  771. diabetesย andย cancer
  772. diabetesย andย cancer
  773. diabetesย andย cancer
  774. diabetesย andย cancer
  775. diabetesย andย cancer
  776. diabetesย andย cancer
  777. diabetesย ANDย cancer
  778. diabetesย andย cancer
  779. diabetesย andย cancer
  780. diabetesย andย cancerย (1): evaluating the temporal relationship between type 2ย diabetesย andย cancerย incidence
  781. diabetesย andย cancerย (2): evaluating the impact ofย diabetesย on mortality in patients withย cancer
  782. diabetesย ANDย cancerย AMONG VETERANS
  783. diabetesย andย cancerย I: risk, survival, and implications for screening
  784. diabetesย andย cancerย II: role ofย diabetesย medications and influence of shared risk factors
  785. diabetesย andย cancerย in veterans of Operation Ranch Hand after adjustment for calendar period, days of spraying, and time spent in Southeast Asia
  786. diabetesย andย cancerย mortality: a multifaceted association
  787. diabetesย andย cancerย risk for all and specific sites among Japanese men and women
  788. diabetesย andย cancerย risk in the REDUCE trial.
  789. diabetesย andย cancerย risk: A Mendelian randomization study
  790. diabetesย andย cancerย screening rates among Appalachian and non-Appalachian residents of Kentucky
  791. diabetesย andย cancerย screening: a win-win situation or a zero game?
  792. diabetesย andย cancerย Screening: A Win-Win Situation or a Zero Game?โ€”Reply
  793. diabetesย andย cancer-a dangerous liaison?
  794. diabetesย andย cancer-Related Mechanisms.
  795. diabetesย andย cancerโ€”an AACE/ACE consensus statement
  796. diabetesย andย cancer, common threads and missing links
  797. diabetesย andย cancer: 5 years into the recent controversy
  798. diabetesย andย cancer: a 2013 synopsis
  799. diabetesย andย cancer: A comprehensive review
  800. diabetesย andย cancer: a consensus report
  801. diabetesย andย cancer: A critical appraisal of the pathogenetic and therapeutic links
  802. diabetesย andย cancer: a postulated relationship
  803. diabetesย andย cancer: a review of current knowledge
  804. diabetesย andย cancer: an injurious association
  805. diabetesย andย cancer: Associations, mechanisms, and implications for medical practice
  806. diabetesย andย cancer:ย cancerย should be screened in routineย diabetesย assessment
  807. diabetesย andย cancer: could vitamin D provide the link?
  808. diabetesย andย cancer: Debating the link through Ca2+/cAMP signalling
  809. diabetesย andย cancer: Epidemiologic and physiopathogenic links
  810. diabetesย andย cancer: epidemiological and biological links
  811. diabetesย andย cancer: Epidemiological evidence and molecular links
  812. diabetesย andย cancer: Epidemiological Evidence and Molecular Links
  813. diabetesย andย cancer: Epidemiological Evidence and Molecular Links Series [Book Review]
  814. diabetesย andย cancer: epidemiological, clinical, and experimental perspectives
  815. diabetesย andย cancer: Epidemiological, Clinical, and Experimental Perspectives
  816. diabetesย andย cancer: epidemiology and potential mechanisms
  817. diabetesย andย cancer: Evidence for Risk, Methodology and Implications
  818. diabetesย andย cancer: findings from the REACTION study: REACTION.
  819. diabetesย andย cancer: impact on health-related quality of life
  820. diabetesย andย cancer: isย diabetesย causally related toย cancer?
  821. diabetesย andย cancer: Is there a Link?
  822. diabetesย andย cancer: looking at the multiligand/RAGE axis
  823. diabetesย andย cancer: pathophysiological fundamentals of a โ€˜dangerous affairโ€™
  824. diabetesย andย cancer: placing the association in perspective
  825. diabetesย andย cancer: the mechanistic implications of epidemiological analyses from the Hong Kongย diabetesย Registry
  826. diabetesย andย cancer: The Problem of Reverse Causality and Missing Links
  827. diabetesย andย cancer: The Road Ahead
  828. diabetesย andย cancer: two diseases with obesity as a common risk factor
  829. diabetesย andย cancer: Unraveling the Complexity
  830. diabetesย andย cancer.
  831. diabetesย ANDย cancer.
  832. diabetesย and cardiovascular disease during androgen deprivation therapy for prostateย cancer
  833. diabetesย and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostateย cancer
  834. diabetesย and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostateย cancer.
  835. diabetesย and cardiovascular disease mortality among a population-based cohort of women with and without breastย cancer
  836. diabetesย and clinical outcome in patients with metastatic colorectalย cancer: CALGB 80405 (Alliance)
  837. diabetesย and colorectalย cancerย incidence in the cohort of Swedish men
  838. diabetesย and colorectalย cancerย prognosis: a meta-analysis
  839. diabetesย and colorectalย cancerย screening among men and women in the USA: National Health Interview Survey: 2008, 2010
  840. diabetesย And Colorectalย cancer: Could Ampk Signaling Pathway Explains The Link?
  841. diabetesย and differences in detection of incident invasive breastย cancer
  842. diabetesย and endometrialย cancer
  843. diabetesย and endometrialย cancerย in the Iowa womenโ€™s health study
  844. diabetesย and endometrialย cancer: an evaluation of the modifying effects of other known risk factors
  845. diabetesย and endometrialย cancer: An evaluation of the modifying effects of other known risk factors.
  846. diabetesย and endometrialย cancer: an Italian caseโ€control study
  847. diabetesย and endometrialย cancer: effect modification by body weight, physical activity and hypertension
  848. diabetesย and gastricย cancer: the potential links
  849. diabetesย and hyper-insulinemia as predictors of colorectalย cancerย risk in a prospective cohort of women
  850. diabetesย and infarcted papillary thyroidย cancer.
  851. diabetesย and insulin therapy, but not metformin, are related to hepatocellularย cancerย risk
  852. diabetesย and its link withย cancer: providing the fuel and spark to launch an aggressive growth regime
  853. diabetesย and its relationship with pancreaticย cancer
  854. diabetesย and kidneyย cancerย outcomes: a propensity score analysis
  855. diabetesย and kidneyย cancerย risk among post-menopausal women: The Iowa womenโ€™s health study
  856. diabetesย and kidneyย cancerย survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis
  857. diabetesย and kidneyย cancer: A direct or indirect association?
  858. diabetesย and liverย cancerย risk: A stronger effect in Whites than Blacks?
  859. diabetesย and lungย cancerย among postmenopausal women
  860. diabetesย and metabolic syndrome in survivors of childhoodย cancer
  861. diabetesย and Metformin Association with Recurrence Score in a Large Oncotype Database of Breastย cancerย Patients
  862. diabetesย and mortality in men with locally advanced prostateย cancer: analyses of RTOG 92โ€“02
  863. diabetesย and mortality in men with locally advanced prostateย cancer: RTOG 92-02
  864. diabetesย and mortality in patients with prostateย cancer: a meta-analysis
  865. diabetesย and Obesity and Their Association with Increased Acute Urinary Symptoms in Prostateย cancerย Patients After Receiving Interstitial LDR Brachytherapy
  866. diabetesย AND OBESITY INDUCE TRANSCRIPTOMIC AND METABOLOMIC CHANGES ENHANCING PANCREATICย cancerย AGGRESSIVENESS
  867. diabetesย and onset of natural menopause: results from the European Prospective Investigation intoย cancerย and Nutrition
  868. diabetesย and other comorbidities in breastย cancerย survival by race/ethnicity: the California Breastย cancerย Survivorship Consortium (CBCSC)
  869. diabetesย AND OUTCOMES AFTER RADICAL PROSTATECTOMY-ARE RESULTS AFFECTED BY OBESITY AND RACE? RESULTS FROM THE SHARED EQUAL โ€ฆ
  870. diabetesย and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regionalย cancerย hospital database
  871. diabetesย and overall survival among breastย cancerย patients in the US military health system
  872. diabetesย and pancreaticย cancer
  873. diabetesย and pancreaticย cancer
  874. diabetesย and pancreaticย cancer
  875. diabetesย and pancreaticย cancer
  876. diabetesย and pancreaticย cancer
  877. diabetesย and pancreaticย cancer
  878. diabetesย and pancreaticย cancer
  879. diabetesย and pancreaticย cancer
  880. diabetesย and pancreaticย cancer
  881. diabetesย and pancreaticย cancer
  882. diabetesย and pancreaticย cancerย survival: a prospective cohort study
  883. diabetesย and pancreaticย cancerย survival: a prospective cohort-based study
  884. diabetesย and Pancreaticย cancerโ€”A Dangerous Liaison Relying on Carbonyl Stress
  885. diabetesย and Pancreaticย cancer: A Bidirectional Relationship Perspective
  886. diabetesย and pancreaticย cancer: both cause and effect
  887. diabetesย and pancreaticย cancer: chicken or egg?
  888. diabetesย and Pancreaticย cancer: Reply
  889. diabetesย and prognosis in a breastย cancerย cohort
  890. diabetesย and prognosis in older persons with colorectalย cancer
  891. diabetesย and prostateย cancerย (CaP): Clinical characteristics and disparity in outcomes
  892. diabetesย and Prostateย cancerย Aggressiveness at Diagnosis and Progression in White Americans and Black Americans from the North Carolina-Louisiana Prostate โ€ฆ
  893. diabetesย and prostateย cancerย risk in the REDUCE trial
  894. diabetesย and prostateย cancerย screening in black and white men
  895. diabetesย and risk of bladderย cancerย among postmenopausal women in the Iowa Womenโ€™s Health Study
  896. diabetesย and risk of bladderย cancer: a study using the National Health Insurance database in Taiwan
  897. diabetesย and risk of bladderย cancer: evidence from a caseโ€control study in New England
  898. diabetesย and risk of breastย cancerย in Asian-American women
  899. diabetesย and risk ofย cancer
  900. diabetesย and risk ofย cancer
  901. diabetesย and risk ofย cancerย incidence: results from a population-based cohort study in northern Italy
  902. diabetesย and risk of early-onset colorectalย cancer
  903. diabetesย and Risk of Endometrialย cancer: a Meta-analysis [J]
  904. diabetesย and risk of endometrialย cancer: a population-based prospective cohort study
  905. diabetesย and risk of incidentย cancer: a large population-based cohort study in Israel
  906. diabetesย and risk of incident colorectalย cancerย in a prospective cohort of women
  907. diabetesย and risk of pancreaticย cancer: a pooled analysis from the pancreaticย cancerย cohort consortium
  908. diabetesย and risk of pancreaticย cancer: a pooled analysis of three large caseโ€“control studies
  909. diabetesย and risk of prostateย cancerย in a prospective cohort of US men
  910. diabetesย and risk of prostateย cancer: a study using the National Health Insurance
  911. diabetesย and risk of subsequent gastricย cancer: a population-based cohort study in Taiwan
  912. diabetesย and sex-specific colorectalย cancerย risks in Newfoundland and Labrador: a population-based retrospective cohort study
  913. diabetesย and smoking as predictors ofย cancerย in Indigenous adults from rural and remote communities of North Queenslandโ€“A 15โ€year follow up study
  914. diabetesย and theย cancerย Patient
  915. diabetesย and the Development of Pancreaticย cancerย [J]
  916. diabetesย and the risk for colorectalย cancer
  917. diabetesย and the risk of biochemical recurrence in patients with treated localized prostateย cancer: a meta-analysis
  918. diabetesย and the Risk ofย cancerย Death: A Case-Cohort Study in Taiwanese Men
  919. diabetesย and the risk of death in men with favorable or high-risk prostateย cancerย following radiation therapy
  920. diabetesย and the risk of lungย cancer
  921. diabetesย and the risk of non-Hodgkinโ€™s lymphoma and multiple myeloma in the European Prospective Investigation intoย cancerย and Nutrition.
  922. diabetesย and the risk of pancreaticย cancer
  923. diabetesย and the risk of pancreaticย cancer
  924. diabetesย and the risk of prostateย cancer
  925. diabetesย and the risk of prostateย cancer: the role ofย diabetesย treatment and complications
  926. diabetesย and Thyroidย cancerย in Chinatown: Diversity and Acculturation
  927. diabetesย and thyroidย cancerย mortality: a 12โ€year prospective followโ€up of Taiwanese
  928. diabetesย and thyroidย cancerย risk in the National Institutes of Health-AARP Diet and Health Study
  929. diabetesย and thyroidย cancerย risk: literature review
  930. diabetesย and urothelialย cancerย risk: the Multiethnic Cohort study
  931. diabetesย as a predictor of colonย cancerย prognosis: A single institution based retrospective data analysis.
  932. diabetesย as a presenting feature of pancreaticย cancer: A case report
  933. diabetesย as a prognostic factor in HER-2 positive breastย cancerย patients treated with targeted therapy
  934. diabetesย as a Risk Factor for Breastย cancer
  935. diabetesย as a risk factor for death following endometrialย cancer
  936. diabetesย as a risk factor of hospitalization in the surgical ward due toย cancerย in the elderly and middle-aged population
  937. diabetesย as a risk factor of pancreaticย cancer
  938. diabetesย as a risk factor toย cancer: Functional role of fermented papaya preparation as phytonutraceutical adjunct in the treatment ofย diabetesย andย cancer
  939. diabetesย as Independent Risk Factor forย cancerย after Heart and Lung Transplantation
  940. diabetesย as risk factor for pancreaticย cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells
  941. diabetesย associated with abnormal p53 immunohistochemical patterns in colorectalย cancer
  942. diabetesย associated with short survival in pancreaticย cancer
  943. diabetesย association of polyps and colonย cancer.
  944. diabetesย but not insulin increases the risk of lungย cancer: a Taiwanese population-based study
  945. diabetesย but not insulin is associated with higher colonย cancerย mortality
  946. diabetesย care afterย cancerย diagnosis in patients with type 2ย diabetesย and colorectal-or breastย cancerย treated with curative intent
  947. diabetesย care management duringย cancerย treatment.
  948. diabetesย Care Management in theย cancerย Center: Challenging Current Models of Care to Optimize Outcomes for a Complex Population
  949. diabetesย care management patterns before and after aย cancerย diagnosis: A SEERโ€Medicare matched cohort study
  950. diabetesย Comorbidity and All-Cause, Cardiovascular, andย cancerย Mortality in US Adults
  951. diabetesย conveys a higher risk of gastricย cancerย mortality despite an age-standardised decreasing trend in the general population in Taiwan
  952. diabetesย Could Be a Warning Sign of Pancreaticย cancer: A Case Report and Literature Review
  953. diabetesย decreases FDG accumulation in primary lungย cancer
  954. diabetesย drug helps towards immunity againstย cancer
  955. diabetesย drug is linked with bladderย cancerย risk
  956. diabetesย drug may be associated with increase in risk of bladderย cancer
  957. diabetesย Genes and Prostateย cancerย in the Atherosclerosis
  958. diabetesย genes and prostateย cancerย in the Atherosclerosis Risk in Communities study
  959. diabetesย has protective effect against metastasis in patients with non-small cell lungย cancer
  960. diabetesย inย cancerย Patients: Risks, Goals and Management
  961. diabetesย in elderly patients with breastย cancerย in the United States: An analysis of data from the Surveillance, Epidemiology, and End Results (SEER)โ€“Medicare โ€ฆ
  962. diabetesย in midlife and risk ofย cancerย in late life: a nationwide Swedish twin study
  963. diabetesย in relation to biliary tractย cancerย and stones: a population-based study in Shanghai, China
  964. diabetesย in relation to breastย cancerย relapse and all-cause mortality in elderly breastย cancerย patients: a FOCUS study analysis
  965. diabetesย increases risk of gastricย cancerย after Helicobacter pylori eradication: a territory-wide study with propensity score analysis
  966. diabetesย increases the risk of breastย cancer: a meta-analysis
  967. diabetesย increases the risk of colorectalย cancerย in Puerto Rico
  968. diabetesย increases the risk of liver, pancreas, and gastricย cancerย among the Puerto Rican population
  969. diabetesย influencesย cancerย risk in patients with increased carotid atherosclerosis burden
  970. diabetesย insipida porย cancerย de pulmon
  971. diabetesย insipidus and adrenal insufficiency in a patient with metastatic breastย cancer
  972. diabetesย insipidus and anterior pituitary insufficiency due to breastย cancerย metastasis
  973. diabetesย insipidus and breastย cancer
  974. diabetesย insipidus and breastย cancer-planning radiotherapy by the use of MRT
  975. diabetesย insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroidย cancer
  976. diabetesย insipidus as a main symptom ofย cancer
  977. diabetesย insipidus as the first symptom caused by lungย cancerย metastasis to the pituitary glands: clinical presentations, diagnosis, and management
  978. diabetesย insipidus as the initial symtom in a patient with lungย cancer: Case report
  979. diabetesย insipidus caused by isolated intracranial metatstases in patient with breastย cancer
  980. diabetesย insipidus caused by pituitary gland metastasis accompanied by iris metastasis of small cell lungย cancer: case presentation and review of the literature
  981. diabetesย insipidus due to pituitary metastasis from bladderย cancer
  982. diabetesย insipidus due to pituitary metastasis of breastย cancer
  983. diabetesย insipidus in a patient with small-cell lungย cancer: a paradox?
  984. diabetesย is a useful diagnostic clue to improve the prognosis of pancreaticย cancer
  985. diabetesย is an important risk factor for metastasis in non-muscle-invasive bladderย cancer
  986. diabetesย is associated with chronic liver disease and liverย cancerย in the adult population of Puerto Rico
  987. diabetesย is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectalย cancer
  988. diabetesย Is Associated With Socioeconomic Disparities and More Comorbidities in Colorectalย cancerย Surgery: A Nationwide Inpatient Sample Study: 2041
  989. diabetesย is not a predisposing factor for pancreaticย cancer-new evidence
  990. diabetesย Is Not Associated With Longer Survival in Patients With Lungย cancerโ€”Reply
  991. diabetesย management and self-care education for hospitalized patients withย cancer
  992. diabetesย Management and Self-Care Education for Hospitalized Patients Withย cancer
  993. diabetesย management before and afterย cancerย diagnosis: missed opportunity
  994. diabetesย management inย cancerย patients
  995. diabetesย may increase risk for oralย cancerย through the insulin receptor substrate-1 and focal adhesion kinase pathway
  996. diabetesย May Increase Womenโ€™s Risk Of Developing Colorectalย cancer
  997. diabetesย medication use in association with survival among patients of breast, colorectal, lung, and gastricย cancer
  998. diabetesย medication use in association with survival among patients of breast, colorectal, lung, or gastricย cancer
  999. diabetesย medications andย cancerย risk: review of the literature
  1000. diabetesย medications andย cancer: A way out of uncertainty
  1001. diabetesย Medications, Prostate-Specific Antigen Values, and the Chemoprevention of Prostateย cancer
  1002. diabetesย mellitus (DM), serum glucose, and outcome in gastroesophageal (GE)ย cancer
  1003. diabetesย mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectalย cancer
  1004. diabetesย mellitus amongย cancerย survivors
  1005. diabetesย mellitus and age are risk factors of interval colonย cancer: a case-control study
  1006. diabetesย mellitus and bladderย cancerโ€”an epidemiological relationship?
  1007. diabetesย mellitus and breastย cancer
  1008. diabetesย mellitus and breastย cancer
  1009. diabetesย mellitus and breastย cancer
  1010. diabetesย MELLITUS AND BREASTย cancerย OUTCOMES
  1011. diabetesย mellitus and breastย cancerย outcomes: a systematic review and meta-analysis
  1012. diabetesย mellitus and breastย cancer: a retrospective population-based cohort study
  1013. diabetesย mellitus and breastย cancer. A retrospective follow-up study
  1014. diabetesย mellitus andย cancer
  1015. diabetesย mellitus andย cancer
  1016. diabetesย Mellitus andย cancer
  1017. diabetesย mellitus andย cancerย in Werner syndrome
  1018. diabetesย mellitus andย cancerย incidence: the Atherosclerosis Risk in Communities (ARIC) cohort study
  1019. diabetesย mellitus andย cancerย of the digestive organs: an Italian population-based cohort study
  1020. diabetesย mellitus andย cancerย risk in a network of case-control studies
  1021. diabetesย mellitus andย cancerย risk in a populationโ€based caseโ€“controlstudy among men from Montreal, Canada
  1022. diabetesย mellitus andย cancerย risk: a multisite case-control study
  1023. diabetesย mellitus andย cancerย risk: pooled analysis of eight cohort studies in Japan
  1024. diabetesย mellitus andย cancerย risk: review of the epidemiological evidence
  1025. diabetesย mellitus andย cancer: the different expression of these diseases in Israeli Arabs and Jews
  1026. diabetesย mellitus andย cancer.
  1027. diabetesย mellitus and carbohydrate metabolism in patients withย cancer
  1028. diabetesย Mellitus and Colorectalย cancerย Risk
  1029. diabetesย mellitus and colorectalย cancerย risk.
  1030. diabetesย mellitus and colorectalย cancerโ€“a revealed connection
  1031. diabetesย mellitus and epithelial ovarianย cancerย in Chinese women: a retrospective cohort study
  1032. diabetesย mellitus and gynecologicย cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives
  1033. diabetesย mellitus and HbA1c levels associated with high grade prostateย cancer
  1034. diabetesย mellitus and healthโ€related quality of life in prostateย cancer: 5โ€year results from the Prostateย cancerย Outcomes Study
  1035. diabetesย Mellitus and Hypertension are Risk Factor for Endometrialย cancer
  1036. diabetesย mellitus and hypertension increase the risk of colorectalย cancerย mortality; a robust Bayesian adjustment analysis
  1037. diabetesย mellitus and incidence and mortality of colorectalย cancer: a systematic review and meta-analysis of cohort studies
  1038. diabetesย mellitus and incidence and mortality of gastricย cancer: a meta-analysis
  1039. diabetesย mellitus and incidence and mortality of kidneyย cancer: a meta-analysis
  1040. diabetesย Mellitus and Incidence of Bladder and Kidneyย cancer: An Exposure-Control Matched Study
  1041. diabetesย mellitus and incidence of kidneyย cancer: a meta-analysis of cohort studies
  1042. diabetesย Mellitus and Incident Gastroentericย cancer
  1043. diabetesย mellitus and increased risk of biliary tractย cancer: systematic review and meta-analysis
  1044. diabetesย mellitus and increased risk ofย cancer: focus on metformin and the insulin analogs
  1045. diabetesย mellitus and kidneyย cancerย risk: the results of Japan Collaborative Cohort Study for Evaluation ofย cancerย Risk (JACC Study)
  1046. diabetesย mellitus and liverย cancerย risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population
  1047. diabetesย mellitus and longโ€term mortality of ovarianย cancerย patients. A systematic review and metaโ€analysis of 12 cohort studies
  1048. diabetesย Mellitus and Metformin Are Not Associated With Breastย cancerย Pathologic Complete Response
  1049. diabetesย mellitus and mortality from all-causes,ย cancer, cardiovascular and respiratory disease: evidence from the Health Survey for England and Scottish Health โ€ฆ
  1050. diabetesย mellitus and obesity among participants receiving screening forย cancerย in the Republic of the Marshall Islands
  1051. diabetesย mellitus and obesity as risk factors for pancreaticย cancer
  1052. diabetesย Mellitus and Oralย cancer: Are They Connected?
  1053. diabetesย Mellitus and Oralย cancer: Is There a Causal Association?
  1054. diabetesย mellitus and oralย cancer/oral potentially malignant disorders: A systematic review and metaโ€analysis
  1055. diabetesย mellitus and outcomes of colorectalย cancer
  1056. diabetesย mellitus and ovarianย cancerย (Sweden)
  1057. diabetesย mellitus and ovarianย cancerย risk: a systematic review and meta-analysis of observational studies
  1058. diabetesย mellitus and ovarianย cancer: More complex than increasing risk
  1059. diabetesย mellitus and ovarianย cancer: more complex than just increasing risk
  1060. diabetesย mellitus and pancreasย cancer
  1061. diabetesย mellitus and pancreaticย cancerย in a population-based case-control study in the San Francisco Bay Area, California
  1062. diabetesย mellitus and pancreaticย cancer-cause or result?
  1063. diabetesย mellitus and pancreaticย cancer-cause or result?
  1064. diabetesย mellitus and pancreaticย cancer: a case-control study in Greater Montreal, Quebec, Canada
  1065. diabetesย Mellitus and Pancreaticย cancer: A Risk Assessment
  1066. diabetesย mellitus and pancreaticย cancer: why the association matters?
  1067. diabetesย mellitus and primary liverย cancer: risk factor or real cause?
  1068. diabetesย mellitus and prognosis in women with breastย cancer: a systematic review and meta-analysis
  1069. diabetesย mellitus and prostateย cancerย metabolism: Is there a relationship?
  1070. diabetesย mellitus and prostateย cancerย risk
  1071. diabetesย mellitus and prostateย cancerย risk
  1072. diabetesย mellitus and prostateย cancerย risk among older men: population-based caseโ€“control study
  1073. diabetesย mellitus and prostateย cancerย risk in Asian countries: a meta-analysis
  1074. diabetesย mellitus and prostateย cancerย risk in the Prostate, Lung, Colorectal, and Ovarianย cancerย Screening Trial
  1075. diabetesย mellitus and prostateย cancerย risk of different grade or stage: a systematic review and meta-analysis
  1076. diabetesย mellitus and prostateย cancerย risk; a nationwide caseโ€“control study within PCBaSe Sweden
  1077. diabetesย mellitus and responsiveness of endometrial hyperplasia and early endometrialย cancerย to conservative treatment
  1078. diabetesย mellitus and risk of bladderย cancer: a meta-analysis
  1079. diabetesย mellitus and risk of bladderย cancer: a meta-analysis of cohort studies
  1080. diabetesย mellitus and risk of bladderย cancer: a meta-analysis of cohort studies
  1081. diabetesย mellitus and risk of breastย cancer: a metaโ€analysis
  1082. diabetesย mellitus and risk ofย cancerย in T akayama: A populationโ€based prospective cohort study in J apan
  1083. diabetesย mellitus and risk ofย cancer-specific mortality among patients with clear cell renal cell carcinoma undergoing nephrectomy.
  1084. diabetesย mellitus and risk of colorectalย cancerย in the Singapore Chinese Health Study
  1085. diabetesย mellitus and risk of colorectalย cancerย mortality in Japan: the Japan Collaborative Cohort Study
  1086. diabetesย mellitus and risk of colorectalย cancer: a meta-analysis
  1087. diabetesย mellitus and risk of endometrialย cancer: a meta-analysis
  1088. diabetesย mellitus and risk of gastricย cancer: a systematic review and meta-analysis of observational studies
  1089. diabetesย mellitus and risk of kidneyย cancer: a meta-analysis
  1090. diabetesย mellitus and risk of large bowelย cancer
  1091. diabetesย mellitus and risk of ovarianย cancer. A systematic review and meta-analysis of 15 cohort studies
  1092. diabetesย mellitus and risk of pancreaticย cancerย in China: A meta-analysis based on 26 case-control studies
  1093. diabetesย mellitus and risk of pancreaticย cancer: a meta-analysis of cohort studies
  1094. diabetesย mellitus and risk of prostateย cancerย (United States)
  1095. diabetesย mellitus and risk of prostateย cancerย in the European Prospective Investigation intoย cancerย and Nutrition
  1096. diabetesย mellitus and risk of prostateย cancerย in the European Prospective Investigation intoย cancerย and Nutrition.
  1097. diabetesย mellitus and risk of prostateย cancerย in the health professionals followโ€up study
  1098. diabetesย mellitus and risk of prostateย cancer-A focus on shared risk factors and survivor bias
  1099. diabetesย mellitus and risk of prostateย cancer: a meta-analysis
  1100. diabetesย mellitus and risk of prostateย cancer: an updated meta-analysis based on 12 caseโ€“control and 25 cohort studies
  1101. diabetesย mellitus and risk of thyroidย cancer: a meta-analysis
  1102. diabetesย mellitus and site-specific colorectalย cancerย risk in Korea: a case-control study
  1103. diabetesย mellitus and subsite-specific colorectalย cancerย risks in the Iowa Womenโ€™s Health Study
  1104. diabetesย mellitus and subsite-specific colorectalย cancerย risks in the Iowa Womenโ€™s Health Study
  1105. diabetesย mellitus and survival after a diagnosis of breastย cancer: A meta-analysis
  1106. diabetesย mellitus and survival of esophagealย cancerย patients after esophagectomy: a systematic review and meta-analysis
  1107. diabetesย mellitus and survival of nonโ€small cell lungย cancerย patients after surgery: A comprehensive systematic review and metaโ€analysis
  1108. diabetesย mellitus and the incidence and mortality of colorectalย cancer: a metaโ€analysis of 24 cohort studies
  1109. diabetesย mellitus and the incidence of colorectalย cancer: an updated systematic review and meta-analysis
  1110. diabetesย mellitus and the occurrence of colorectalย cancer: an updated meta-analysis of cohort studies
  1111. diabetesย Mellitus and the Risk for Developingย cancer
  1112. diabetesย mellitus and the risk of bladderย cancer: a PRISMA-compliant meta-analysis of cohort studies
  1113. diabetesย mellitus and the risk of bladderย cancer: an Italian caseโ€“control study
  1114. diabetesย mellitus and the risk ofย cancerย formation: Possible link and review of literature
  1115. diabetesย mellitus and the risk ofย cancer: results from a large-scale population-based cohort study in Japan
  1116. diabetesย mellitus and the risk ofย cancer.
  1117. diabetesย mellitus and the risk of gastricย cancer: a meta-analysis of cohort studies
  1118. diabetesย mellitus and the risk of gastrointestinalย cancerย in women compared with men: a meta-analysis of cohort studies
  1119. diabetesย mellitus and the risk of ovarianย cancer: a systematic review and meta-analysis of cohort and caseโ€“control studies
  1120. diabetesย mellitus and the risk of postmenopausal breastย cancer: A retrospective population-based cohort study.
  1121. diabetesย mellitus and the risk of primary liverย cancer
  1122. diabetesย mellitus and the risk of prostateย cancer
  1123. diabetesย mellitus and the risk of prostateย cancerย in Italy
  1124. diabetesย mellitus and the risk of prostateย cancer: an update and cumulative meta-analysis
  1125. diabetesย mellitus as a predictor ofย cancerย mortality in a large cohort of US adults
  1126. diabetesย mellitus as a result of pancreaticย cancer
  1127. diabetesย mellitus as a risk factor forย cancer: stress or viral etiology?
  1128. diabetesย mellitus as a risk factor for gastrointestinalย cancerย among American veterans
  1129. diabetesย mellitus as a risk factor for pancreaticย cancer: a meta-analysis
  1130. diabetesย mellitus as a risk factor for prostateย cancerย progression after radical prostatectomy in an Hispanic population
  1131. diabetesย Mellitus as a Risk Factor of Interval Colonย cancer
  1132. diabetesย mellitus as a risk-factor for colorectalย cancerย literature reviewโ€“current situation and future perspectives
  1133. diabetesย mellitus as an early symptom of pancreaticย cancerย diagnosed three years later
  1134. diabetesย mellitus as an independent risk factor for lungย cancer: a meta-analysis of observational studies
  1135. diabetesย mellitus carries a risk of esophagealย cancer: a meta-analysis
  1136. diabetesย mellitus carries a risk of gastricย cancer: a meta-analysis
  1137. diabetesย mellitus correlates with increased risk of pancreaticย cancer: a populationโ€based cohort study in Taiwan
  1138. diabetesย MELLITUS DOES NOT INCREASE THE RISK OF METASTATIC COLONย cancer: A CASE CONTROL STUDY: 353
  1139. diabetesย mellitus following platinum-based chemotherapy in gynecologicย cancerย patients
  1140. diabetesย mellitus following platinum-based chemotherapy in gynecologicย cancerย patients
  1141. diabetesย mellitus inย cancerย patients treated with combination interleukin 2 and ฮฑ-interferon
  1142. diabetesย mellitus in childhood and young adultย cancerย survivors: A meta-analysis.
  1143. diabetesย mellitus in long-term survivors of childhoodย cancer: increased risk associated with radiation therapy: a report for the childhoodย cancerย survivor study
  1144. diabetesย mellitus in major head and neckย cancerย surgery
  1145. diabetesย mellitus in major head and neckย cancerย surgery: Systematic review and metaโ€analysis
  1146. diabetesย mellitus in pancreaticย cancerย and the need for diagnosis of asymptomatic disease
  1147. diabetesย mellitus in pancreaticย cancerย follow-up.
  1148. diabetesย mellitus in pancreaticย cancerย patients in the Czech Republic: sex differences
  1149. diabetesย mellitus in pancreaticย cancer: is it a causal relationship?
  1150. diabetesย Mellitus in the Middle-Aged and Elderly Population (> 45 Years) and Its Association with Pancreaticย cancer: An Updated Review
  1151. diabetesย mellitus increased mortality rates more in gender-specific than in nongender-specificย cancerย patients: a retrospective study of 149,491 patients
  1152. diabetesย mellitus increases postoperative mortality in non-small cell lungย cancer
  1153. diabetesย mellitus increases the risk of bladderย cancer: an updated meta-analysis
  1154. diabetesย mellitus increases the risk of bladderย cancer: an updated meta-analysis of observational studies
  1155. diabetesย mellitus increases the risk of early gastricย cancerย development
  1156. diabetesย mellitus is a predictive factor for radiation pneumonitis after thoracic radiotherapy in patients with lungย cancer
  1157. diabetesย MELLITUS IS A RISK FACTOR FOR COLONย cancer: A CASE CONTROL STUDY IN HALF A MILLION VETERANS: 352
  1158. diabetesย MELLITUS IS A RISK FACTOR FOR PANCREATICย cancer: A CASE CONTROL STUDY IN HALF A MILLION VETERANS: 168
  1159. diabetesย mellitus is an independent risk factor for colorectalย cancer
  1160. diabetesย mellitus is associated with an increased risk of gastricย cancer: a cohort study
  1161. diabetesย mellitus is associated with breastย cancer: systematic review, meta-analysis, and in silico reproduction.
  1162. diabetesย mellitus is associated with elevated risk of mortality amongst patients with prostateย cancer: a metaโ€analysis of 11 cohort studies
  1163. diabetesย Mellitus is Associated with High Grade and High Stage in Urinary Bladderย cancer
  1164. diabetesย mellitus is associated with liver metastasis of colorectalย cancerย through production of biglycan-richย cancerย stroma
  1165. diabetesย mellitus is associated with occultย cancerย in endometrial hyperplasia
  1166. diabetesย mellitus is associated with unfavorable pathologic features, increased postoperative mortality, and worse long-term survival in resected pancreaticย cancer
  1167. diabetesย mellitus negatively impacts survival of patients with colonย cancer, particularly in stage II disease
  1168. diabetesย mellitus predicts occurrence of cirrhosis and hepatocellularย cancerย in alcoholic liver and non-alcoholic fatty liver diseases
  1169. diabetesย Mellitus raise the Risk for Interval Colorectalย cancerย and Advanced Colorectal Adenomas
  1170. diabetesย mellitus reduces prostateย cancerย risk-no function of age at diagnosis or duration of disease
  1171. diabetesย mellitus stimulates pancreaticย cancerย growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway
  1172. diabetesย Mellitus Type 2 and Prolonged Exposure to Estrogen as Risk Factors for Development of Breastย cancerย in Women of Age 35-70 in Yerevan: A Case-Control โ€ฆ
  1173. diabetesย mellitus type 2 and subsite-specific colorectalย cancerย risk in men and women: results from the Netherlands Cohort Study on diet andย cancer
  1174. diabetesย mellitus type 2 drives metabolic reprogramming to promote pancreaticย cancerย growth
  1175. diabetesย mellitus type 2 is associated with increased tumor expression of programmed death-ligand 1 (PD-L1) in surgically resected non-small cell lung โ€ฆ
  1176. diabetesย mellitus type 2โ€“an independent risk factor forย cancer?
  1177. diabetesย mellitus with poor glycemic control increases bladderย cancerย recurrence risk in patients with upper urinary tract urothelial carcinoma
  1178. diabetesย Mellitusโ€“A Prognostic Factor in Breastย cancer?
  1179. diabetesย mellitus, body size and bladderย cancerย risk in a prospective study of Swedish men
  1180. diabetesย mellitus, family history, and colorectalย cancer
  1181. diabetesย mellitus, genetic variants in the insulinโ€like growth factor pathway and colorectalย cancerย risk
  1182. diabetesย mellitus, glycated haemoglobin and C-peptide levels in relation to pancreaticย cancerย risk: a study within the European Prospective Investigation into โ€ฆ
  1183. diabetesย mellitus, hyperglycaemia andย cancer
  1184. diabetesย mellitus, insulin treatment,ย diabetesย duration, and risk of biliary tractย cancerย and hepatocellular carcinoma in a European cohort
  1185. diabetesย mellitus, metformin and head and neckย cancer
  1186. diabetesย mellitus, other medical conditions and familial history ofย cancerย as risk factors for pancreaticย cancer
  1187. diabetesย mellitus, other medical conditions and pancreaticย cancer: a caseโ€control study
  1188. diabetesย mellitus, race and the odds of high grade prostateย cancerย in men treated with radiation therapy
  1189. diabetesย mellitus, race, and the odds of high-grade prostateย cancerย in men diagnosed with prostateย cancerย in the United States.
  1190. diabetesย Mellitus: a Clinical Condition Associated with Metabolic Syndrome and Colorectalย cancerย Risk
  1191. diabetesย mellitus: a risk factor for pancreaticย cancer?
  1192. diabetesย mellitus: A significant coโ€morbidity in the setting of lungย cancer?
  1193. diabetesย mellitus: influences onย cancerย risk
  1194. diabetesย outcomes in patients with a history of breastย cancer.
  1195. diabetesย outcomes in patients with breastย cancer.
  1196. diabetesย pharmacotherapies and bladderย cancer: a medicare epidemiologic study
  1197. diabetesย Phenotypes in Transgenic Pancreaticย cancerย Mouse Models
  1198. diabetesย Plus Weight Loss Signals Increased Pancreaticย cancerย Risk
  1199. diabetesย promotes DMH-induced colorectalย cancerย by increasing the activity of glycolytic enzymes in rats
  1200. diabetesย promotes invasive pancreaticย cancerย by increasing systemic and tumour carbonyl stress in Kras G12D/+ mice
  1201. diabetesย Protects from Prostateย cancerย by Downregulating
  1202. diabetesย protects from prostateย cancerย by downregulating androgen receptor: new insights from LNCaP cells and PAC120 mouse model
  1203. diabetesย risk in childhoodย cancerย survivors: a population-based study
  1204. diabetesย Self-Management amongย cancerย Survivors: Differences by Diagnosis and Treatment
  1205. diabetesย status and post-load plasma glucose concentration in relation to site-specificย cancerย mortality: findings from the original Whitehall study
  1206. diabetesย therapies affect pancreaticย cancerย risk
  1207. diabetesย therapy andย cancerย risk: causal effects and other plausible explanations
  1208. diabetesย therapy andย cancerย risk: Where do we stand when treating patients?
  1209. diabetesย therapy and lungย cancer
  1210. diabetesย Treatment and Risks of Adverse Breastย cancerย Outcomes Among Elderly Breastย cancerย Patients: A SEER-Medicare Analysis
  1211. diabetesย treatments andย cancerย risk: the importance of considering aspects of drug exposure
  1212. diabetesย treatments and risks of adverse breastย cancerย outcomes among early-stage breastย cancerย patients: a SEER-medicare analysis
  1213. diabetesย type 2 and pancreaticย cancer: a history unfolding
  1214. diabetesย type II, other medical conditions and pancreaticย cancerย risk: a prospective study in The Netherlands
  1215. diabetes-associated angiotensin activation enhances liver metastasis of colonย cancer
  1216. diabetes-related complications and pancreaticย cancerย incidence in the Multiethnic Cohort
  1217. diabetes-Specific Modulation of Peripheral Blood Gene Expression Signatures in Colorectalย cancer
  1218. diabetesโ€“associated dysregulated cytokines andย cancer
  1219. diabetes, abnormal glucose, dyslipidemia, hypertension, and risk of inflammatory and other breastย cancer
  1220. diabetes, and Incident Colorectalย cancerย in Men and Women: A Prospective Analysis from the European Prospective Investigation intoย cancerโ€“Norfolk Study
  1221. diabetes, Antidiabetic Medications andย cancerย Risk in Type 2ย diabetes: Focus on SGLT-2 Inhibitors
  1222. diabetes, antidiabetic medications, and pancreaticย cancerย risk: an analysis from the International Pancreaticย cancerย Case-Control Consortium
  1223. diabetes, antidiabetic medications, and pancreaticย cancerย risk: an analysis from the International Pancreaticย cancerย Case-Control Consortium
  1224. diabetes, antihyperglycemic medications andย cancerย risk: smoke or fire?
  1225. diabetes, blood glucose lowering drugs andย cancerย risk
  1226. diabetes, body fatness, and insulin prescription among adolescents and young adults withย cancer
  1227. diabetes, body size, and risk of endometrialย cancer
  1228. diabetes, breastย cancerย and mammographic density in the Minnesota breastย cancerย family study
  1229. diabetes,ย cancerย and iron
  1230. diabetes,ย cancerย and obesity: unequivocal association
  1231. diabetes,ย cancerย and treatmentโ€“a mini-review
  1232. diabetes,ย cancerย and weight: a Metabolic Typing survey
  1233. diabetes,ย cancerย Link Is New Research Focus
  1234. diabetes,ย cancer, and metformin: connections of metabolism and cell proliferation
  1235. diabetes, chronic kidney disease andย cancerย risk
  1236. diabetes, colonย cancerย and Wnt beta-catenin signaling pathways
  1237. diabetes, colorectalย cancerย and cyclooxygenase 2 inhibition
  1238. diabetes,ย diabetesย risk factors and treatments, and breastย cancer
  1239. diabetes,ย diabetesย therapies andย cancer: whatโ€™s the link?
  1240. diabetes,ย diabetesย treatment and breastย cancerย prognosis
  1241. diabetes,ย diabetesย treatment, and mammographic density in Danish Diet,ย cancer, and Health cohort
  1242. diabetes,ย diabetesย treatment, and risk of thyroidย cancer
  1243. diabetes, gall stone disease, and pancreaticย cancer.
  1244. diabetes, gestationalย diabetesย and the risk ofย cancerย in women: epidemiologic evidence and possible biologic mechanisms
  1245. diabetes, glucose control, glucose lowering medications, andย cancerย risk: A 10-year population-based historical cohort
  1246. diabetes, Glycated Hemoglobin, and Risk ofย cancerย in the UK Biobank Study
  1247. diabetes, hypoglycemic drugs and pancreaticย cancer
  1248. diabetes, insulin andย cancerย risk
  1249. diabetes, insulin andย cancerย risk The molecular role of insulin signaling and hyperinsulinemia inย cancerย development and progression inย diabetesย patients
  1250. diabetes, insulin andย cancerย risk: you and your patient
  1251. diabetes, Insulin Resistance, andย cancer: An Update
  1252. diabetes, insulin therapy, and colorectalย cancer
  1253. diabetes, insulin treatment, andย cancerย risk: what is the evidence?
  1254. diabetes, insulin use, andย cancerย risk: are observational studies part of the solutionโ€“or part of the problem?
  1255. diabetes, insulin use, and gastricย cancer: a population-based analysis of the Taiwanese
  1256. diabetes, insulin use, smoking, and pancreaticย cancerย mortality in Taiwan
  1257. diabetes, insulin-use and risk of colorectalย cancerย in a US cohort study
  1258. diabetes, insulin, and risk ofย cancer
  1259. diabetes, metabolic syndrome, and breastย cancer: a review of the current evidence
  1260. diabetes, metformin and breastย cancer: a tangled web
  1261. diabetes, metformin andย cancerย risk in myotonic dystrophy type I
  1262. diabetes, metformin and incidence of and death from invasiveย cancerย in postmenopausal women: results from the womenโ€™s health initiative
  1263. diabetes, metformin use, and colonย cancer: a population-based cohort study in Taiwan
  1264. diabetes, metformin use, and colorectalย cancerย survival in postmenopausal women
  1265. diabetes, metformin use, and colorectalย cancerย survival in women: A retrospective cohort study.
  1266. diabetes, metformin, and breastย cancerย in postmenopausal women
  1267. diabetes, Metformin, and Lungย cancer: Retrospective Study of the Korean NHIS-HEALS Database
  1268. diabetes, obesity andย cancer: risk and anti-risk factors
  1269. diabetes, obesity, and breastย cancer
  1270. diabetes, obesity, andย cancerโ€”pathophysiology and clinical implications
  1271. diabetes, obesity, and subsequent risk of postmenopausal breastย cancerย among white and black women in the Southern Community Cohort Study
  1272. diabetes, obesity, and survival in a large cohort of early-stage breastย cancerย patients.
  1273. diabetes, obesity, and the metabolic syndrome as prognostic factors in stages I to III colorectalย cancerย patients
  1274. diabetes, obesity, insulin resistance: different pathways toย cancer?
  1275. diabetes, overweight and risk of postmenopausal breastย cancer: a case-control study in Uruguay
  1276. diabetes, pancreaticย cancerย and vitamin D. Is there a link?
  1277. diabetes, pancreaticย cancer, and metformin therapy
  1278. diabetes, pancreatogenicย diabetes, and pancreaticย cancer
  1279. diabetes, physical activity and breastย cancerย among Hispanic women
  1280. diabetes, physical activity and endometrialย cancer
  1281. diabetes, plasma glucose and incidence of colorectalย cancerย in Chinese adults: a prospective study of 0.5 million people
  1282. diabetes, plasma glucose and incidence of pancreaticย cancer: A prospective study of 0.5 million C hinese adults and a metaโ€analysis of 22 cohort studies
  1283. diabetes, plasma glucose, and incidence of fatty liver, cirrhosis, and liverย cancer: a prospective study of 0.5 million people
  1284. diabetes, prediabetesย andย cancerย mortality
  1285. diabetes, prostateย cancerย screening and risk of low-and high-grade prostateย cancer: an 11 year historical population follow-up study of more than 1 million โ€ฆ
  1286. diabetes, smoking, alcohol use, and family history ofย cancerย as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis
  1287. diabetes, treatments forย diabetesย and their effect onย cancerย incidence and mortality: attempts to disentangle the web of associations
  1288. diabetes, Weight Change, and Pancreaticย cancerย Risk
  1289. diabetes:ย diabetesย therapy andย cancerย risk
  1290. diabetes: risk factor for the development of pancreaticย cancerย or manifestation of the disease?
  1291. Diabetic ketoacidosis caused by fulminant type 1ย diabetesย during adjuvant chemotherapy for colonย cancer: A case report
  1292. Diabetic Status after Radical Gastrectomy in Gastricย cancerย Patients with Type 2ย diabetesย Mellitus
  1293. Diagnosing and monitoring endocrine dysfunction,ย diabetes, and obesity in a cohort of adult survivors of childhoodย cancer
  1294. Diagnosis and survival of pancreaticย cancerย in relation to depression andย diabetesย history: A population-based study in Finland
  1295. Diagnosis and treatment of 17 cases of pulmonary tuberculosis complicated byย diabetesย misdiagnosed lungย cancer
  1296. Diagnosis of Breastย cancerย andย diabetesย using Hybrid Feature Selection Method
  1297. Diagnostic yield of the plasma free amino acid index for pancreaticย cancerย in patients withย diabetesย mellitus
  1298. Diastatic activity of the blood inย cancer, syphilis andย diabetes
  1299. Diet quality and risk of type 2ย diabetes: a prospective study in the Malmo Diet andย cancerย cohort
  1300. Diet,ย diabetesย andย cancerโ€“How and Why?
  1301. Dietary energy density predicts the risk of incident type 2ย diabetes: the European Prospective Investigation ofย cancerย (EPIC)-Norfolk Study
  1302. Dietary fat and the risk of clinical type 2ย diabetes: the European prospective investigation ofย cancer-Norfolk study
  1303. Dietary intake of carbohydrates and risk of type 2ย diabetes: The European Prospective Investigation intoย cancer-Norfolk study
  1304. Dietary intake of total, animal, and vegetable protein and risk of type 2ย diabetesย in the European Prospective Investigation intoย cancerย and Nutrition (EPIC)-NL study
  1305. Dietary vitamin D intake and risk of type 2ย diabetesย in the European Prospective Investigation intoย cancerย and Nutrition: the EPIC-InterAct study
  1306. Differences in Biological Behavior of Colorectalย cancerย between Patients With and Withoutย diabetes: 590
  1307. Differences inย cancerย survival among white and blackย cancerย patients by presence ofย diabetesย mellitus: Estimations based on SEERโ€Medicareโ€linked data resource
  1308. Differences in Serum Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen Levels between Pancreaticย cancerย Patients with or Withoutย diabetesย Mellitus
  1309. Different domains of self-reported physical activity and risk of type 2ย diabetesย in a population-based Swedish cohort: the Malmรถ diet andย cancerย study
  1310. Differential expression and signaling activation of insulin receptor isoforms A and B: a link between breastย cancerย andย diabetes
  1311. Differential impact of anti-diabetic treatments on pancreaticย cancerย cell growth in cell culture conditions mimicking different stages in the natural history ofย diabetesย โ€ฆ
  1312. Differential impact of obesity andย diabetesย mellitus on survival after liver resection for colorectalย cancerย metastases
  1313. Differential relationship between colorectalย cancerย andย diabetesย in a nationally representative sample of adults
  1314. Diminishing differences in treatment between colorectalย cancerย patients with and withoutย diabetes: a population-based study
  1315. Diminishing differences in treatment between patients with colorectalย cancerย with and withoutย diabetes: a populationโ€based study
  1316. Dipeptidyl peptidase-4 inhibitors andย cancerย risk in patients with type 2ย diabetes: a meta-analysis of randomized clinical trials
  1317. Discriminant, identifiable plasma metabolites in pancreaticย cancer-associatedย diabetes-candidate early-detection biomarkers
  1318. Discriminant, identifiable plasma metabolites in pancreaticย cancerโ€“associatedย diabetes.
  1319. Discussion on the surgical treatment ofย cancerย of esophageal and cardiac withย diabetesโ€”โ€”Clinical report of 31 cases
  1320. Disease Detection Analytics: A Simple Linear Convex Programming Algorithm for Breastย cancerย andย diabetesย Incidence Decisions
  1321. Disease-Proof: Slash Your Risk of Heart Disease,ย cancer,ย diabetes, and Moreโ€“by 80 Percent
  1322. Disease-specific mortality among stage Iโ€“III colorectalย cancerย patients withย diabetes: a large population-based analysis
  1323. Disease-specific mortality and secondary primaryย cancerย in well-differentiated thyroidย cancerย with type 2ย diabetesย mellitus
  1324. Diseases of Civilizationโ€“cancer,ย diabetes, Obesity and Acneโ€“the Implication of Milk, IGF-1 and mTORC1
  1325. Diseases of malfunction of body mechanisms.(Heart disease,ย diabetes,ย cancerย etc.) risk by occupation, and correlation, male and female, with vehicle travel
  1326. Disparities in receipt of screening tests forย cancer,ย diabetesย and high cholesterol in Ontario, Canada: a population-based study using area-based methods
  1327. Dissecting mechanisms involved in the aetiological overlap between Type 2ย diabetesย andย cancer
  1328. Distances over Incompleteย diabetesย and Breastย cancerย Data Based on Bhattacharyya Distance
  1329. Diverse transitions inย diabetesย status during the clinical course of patients with resectable pancreaticย cancer
  1330. DNA damage and efficacy of DNA repair in patients with type 2ย diabetesย and coexisting colorectalย cancer.
  1331. Do colorectalย cancerย resections improveย diabetesย in long-term survivors? A caseโ€“control study
  1332. Do hyperglycemia andย diabetesย affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation andย cancer? A โ€ฆ
  1333. Do variants associated with susceptibility to pancreaticย cancerย and type 2ย diabetesย reciprocally affect risk?
  1334. Does a prostateย cancerย diagnosis affect management of pre-existingย diabetes? Results from PCBaSe Sweden: a nationwide cohort study
  1335. Does a single nucleotide polymorphism in the FGFR explain the connection betweenย diabetesย andย cancer?
  1336. Does A1c predict surgical complications? A retrospective chart review of patients with Type IIย diabetesย Mellitus and Endometrialย cancer
  1337. Does Aspirin Decrease Risk of Specific Breastย cancerย Subtype in Women withย diabetes?
  1338. Does body fat distribution promote familial aggregation of adult onsetย diabetesย mellitus and postmenopausal breastย cancer?
  1339. Does body mass index and adult height influenceย cancerย incidence among Chinese living with incident type 2ย diabetes?
  1340. Does body mass index and adult height influenceย cancerย incidence among people living with incident type 2ย diabetes
  1341. Doesย cancerย risk increase with HbA 1c, independent ofย diabetes?
  1342. Does chronic obstructive pulmonary disease with or without type 2ย diabetesย mellitus influence the risk of lungย cancer? Result from a population-based cohort โ€ฆ
  1343. Does comorbidity influence the risk of myocardial infarction orย diabetesย during androgen-deprivation therapy for prostateย cancer?
  1344. Doesย diabetesย affect [18 F] FDG standardised uptake values in lungย cancer?
  1345. Doesย diabetesย mellitus affect presentation, stage and survival in operable pancreaticย cancer?
  1346. Doesย diabetesย mellitus as a comorbid condition affect the health-related quality of life in prostateย cancerย survivors? Results of a population-based observational study โ€ฆ
  1347. Doesย diabetesย mellitus as a comorbid condition affect the healthโ€related quality of life in prostateย cancerย survivors? Results of a populationโ€based observational study
  1348. Doesย diabetesย mellitus have an impact on the prognosis for patients with cervicalย cancer?
  1349. Doesย diabetesย mellitus increase the risk of high-grade prostateย cancerย in patients undergoing radical prostatectomy?
  1350. Doesย diabetesย mellitus influence standardized uptake values of fluorodeoxyglucose positron emission tomography in colorectalย cancer?
  1351. Doesย diabetesย mellitus influence the efficacy of FDG-PET in the diagnosis of cervicalย cancer?
  1352. Doesย diabetesย mellitus influence the prognosis of patients with lungย cancer?
  1353. Doesย diabetesย mellitus modify the association between 17q12 risk variant and prostateย cancerย aggressiveness?
  1354. Doesย diabetesย mellitus play an independent prognostic role in kidneyย cancer?
  1355. Doesย diabetesย mellitus with or without gallstones increase the risk of gallbladderย cancer? Results from a population-based cohort study
  1356. Doesย diabetesย really impact on postoperative survival in patients with colorectalย cancer?
  1357. Doesย diabetesย therapy influence the risk ofย cancer?
  1358. Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, stroke,ย diabetesย mellitus, andย cancerย in Panama
  1359. Does Hyperinsulinemia in Type-IIย diabetesย Mellitus Influence Disease Presentation and Long-Term Treatment Outcomes of Localized Prostateย cancer?
  1360. Does Metformin affect ER, PR, IGF-1R, ฮฒ-catenin and PAX-2 expression in women withย diabetesย mellitus and endometrialย cancer?
  1361. Does Metformin Protect the Bone Marrow of Patients withย diabetesย Treated with 131I for โ€จThyroidย cancer?
  1362. Does pre-existingย diabetesย affect prostateย cancerย prognosis? A systematic review
  1363. Does the hospitalization after aย cancerย diagnosis modify adherence to process indicators ofย diabetesย care quality?
  1364. Does the use of incretinโ€based medications increase the risk ofย cancerย in patients with typeโ€2ย diabetesย mellitus?
  1365. Does Type 2ย diabetesย increase the risk of developingย cancer?
  1366. Does use of metformin protect againstย cancerย in Type 2ย diabetesย mellitus?
  1367. Dose effect of thiazolidinedione onย cancerย risk in type 2ย diabetesย mellitus patients: a sixโ€year populationโ€based cohort study
  1368. Dose-dependent relationship between metformin and colorectalย cancerย occurrence among patients with Type 2ย diabetesโ€”A nationwide cohort study
  1369. Downregulation of androgen receptor is strongly associated withย diabetesย in triple negative breastย cancerย patients
  1370. DPP4i, thiazolidinediones, or insulin and risks ofย cancerย in patients with type 2ย diabetesย mellitus on metforminโ€“sulfonylurea dual therapy with inadequate โ€ฆ
  1371. Drug-induced liver injury after switching from tamoxifen to anastrozole in a patient with a history of breastย cancerย being treated for hypertension andย diabetes
  1372. Drugโ€“subphenotype interactions forย cancerย in type 2ย diabetesย mellitus
  1373. Drugs,ย diabetesย andย cancer
  1374. Duration ofย diabetesย and pancreaticย cancerย in a case-control study in the Midwest and the Iowa Womenโ€™s Health Study (IWHS) cohort
  1375. Dysregulated mitochondrial dynamics and metabolism in obesity,ย diabetes, andย cancer
  1376. Early Life: Epigenetic Effects on Obesity,ย diabetes, andย cancer
  1377. Editorial (Thematic Issue: Nutrition And Immunology Inย diabetes,ย cancerย and Infectious Diseases)
  1378. Effect of aspirin onย cancerย chemoprevention in Japanese patients with type 2ย diabetes: 10-year observational follow-up of a randomized controlled trial
  1379. Effect of Billroth โ…ก Gastrectomy on Type 2ย diabetesย Mellitus in Patients with Gastricย cancer
  1380. Effect of blood glucose level on the prognosis of breastย cancerย patients with type 2ย diabetesย mellitus
  1381. Effect ofย diabetesย and Obesity on Disparities in Prostateย cancerย Outcomes
  1382. Effect ofย diabetesย mellitus and glycemic control on the prognosis of non-muscle invasive bladderย cancer: a retrospective study
  1383. Effect ofย diabetesย Mellitus and Glycemic Control on the Prognosis of Non-muscle Invasive Bladderย cancer: A Retrospective Study
  1384. Effect ofย diabetesย mellitus on high-grade prostateย cancerย detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL
  1385. Effect ofย diabetesย mellitus on outcomes of colorectalย cancer
  1386. Effect ofย diabetesย Mellitus on Patients Receiving Robotic-Assisted Laparoscopic Radical Prostatectomy for Prostateย cancer
  1387. Effect ofย diabetesย mellitus on survival in patients with gallbladderย cancer: a systematic review and meta-analysis
  1388. Effect ofย diabetesย Mellitus on Survival in Patients with Gallbladderย cancer: A Systematic Review and Meta-analysis
  1389. Effect ofย diabetesย mellitus on survival in patients with pancreaticย cancer: a systematic review and meta-analysis
  1390. Effect ofย diabetesย mellitus on the development of radiation pneumonitis in patients with non-small cell lungย cancer
  1391. Effect ofย diabetesย mellitus on the epidemiology and outcomes of colonย cancer
  1392. Effect ofย diabetesย on endometrialย cancerย recurrence and survival
  1393. Effect ofย diabetesย on neurological adverse effects and chemotherapy induced peripheral neuropathy in advanced colorectalย cancerย patients treated with different โ€ฆ
  1394. Effect ofย diabetesย Treatment on Breastย cancerย Outcomes: A Systematic Review and Meta-analysis
  1395. Effect of different chemotherapy combined with radiotherapy for the treatment of non๎€‘ small cell lungย cancerย complicated with type 2ย diabetes
  1396. Effect of different glucose-lowering therapies onย cancerย incidence in type 2ย diabetes: an observational population-based study
  1397. Effect of digestive tract reconstructions after distal gastrectomy on gastricย cancerย patients complicated withย diabetes
  1398. Effect of dipeptidyl peptidase-4 inhibitors on cisplatin-induced acute nephrotoxicity inย cancerย patients withย diabetesย mellitus: A retrospective study
  1399. Effect of glitazones onย cancerย mortality in type 2ย diabetes
  1400. Effect of human insulin on breastย cancerย risk in Taiwanese women with type 2ย diabetes.
  1401. Effect of hypoglycemic agents on survival outcomes of lungย cancerย patients withย diabetesย mellitus: a meta-analysis
  1402. Effect of hypoglycemic agents on survival outcomes of patients with lungย cancerย andย diabetesย mellitus: A systematic review and meta-analysis.
  1403. Effect of insulin-like growth factor gene polymorphisms alone or in interaction withย diabetesย on the risk of pancreaticย cancer
  1404. Effect of metformin in the prognosis of patients with smallcell lungย cancerย combined withย diabetesย mellitus.
  1405. Effect of metformin on the risk of prostateย cancerย in patients with type 2ย diabetesย by considering different confounding factors: a meta-analysis of observational studies
  1406. Effect of multimodal information delivery forย diabetesย care on colorectalย cancerย screening uptake among individuals with type 2ย diabetes
  1407. Effect of nursing intervention on patients with breastย cancerย accompanied byย diabetesย during the perioperative period
  1408. Effect of Nuts on Markers ofย cancerย and Coronary Heart Disease Risk in Type 2ย diabetes: A Dose Response Study
  1409. Effect of obesity, dyslipidemia, andย diabetesย on trastuzumab-related cardiotoxicity in breastย cancer
  1410. Effect of perioperative nursing on blood sugar and complication of patients with gastricย cancerย complicated withย diabetesย mellitus
  1411. Effect of previousย diabetesย therapy on tumor receptor phenotype in breastย cancer: comparison of metformin and sulphonylurea derivatives
  1412. Effect Of Secoisolariciresinol Diglucoside (Sdg) On Colonย cancerย Associated Withย diabetesย Mellitus.
  1413. Effect of Three Procedures of Digestive Tract Reconstructions after Distal Gastrectomy on Blood Sugar of Gastricย cancerย Patients Complicated withย diabetes
  1414. Effect of type 2ย diabetesย and antihyperglycemic drug therapy on signs of tumor invasion in papillary thyroidย cancer
  1415. Effect of type 2ย diabetesย mellitus on prognosis of nonmetastatic renal cellย cancer
  1416. Effect of type 2ย diabetesย predisposing genetic variants on colorectalย cancerย risk
  1417. Effect of uncontrolledย diabetesย on outcomes after cystectomy in patients with bladderย cancer: a population-based study
  1418. Effect of yoga on chemo-radiotherapy inducedย diabetesย and hypertension (CRID-H) among cervicalย cancerย patients at a regionalย cancerย institute in south India
  1419. Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostateย cancerย withย diabetes
  1420. Effects of aspirin or clopidogrel on colorectalย cancerย chemoprevention in patients with type 2ย diabetesย mellitus
  1421. Effects of Breastย cancerย and Type 2ย diabetesย Mellitus on Pulmonary Volumes and Pressures in Adult Women
  1422. Effects of Breastย cancerย and Type 2ย diabetesย Mellitus on Pulmonary Volumes and Pressures in Adult Women
  1423. Effects ofย cancerย comorbidity on disease management: making the case forย diabetesย education (a report from the SOAR program)
  1424. Effects of continuing nursing care on postoperative quality of life and blood glucose control in patients with bladderย cancerย andย diabetesย mellitus
  1425. Effects ofย diabetesย mellitus on prognosis of the patients with colorectalย cancerย undergoing resection: a cohort study with 945 patients
  1426. Effects ofย diabetesย on Ovarianย cancer: Data Analysis and Modeling Study
  1427. Effects of metformin dose onย cancerย risk reduction in patients with type 2ย diabetesย mellitus: a 6โ€year followโ€up study
  1428. Effects of metformin on breastย cancerย risk and mortality in patients with type 2ย diabetes
  1429. Effects of Metformin on Breastย cancerย Risk and Mortality in Type 2ย diabetesย Mellitus: A Systematic Review and Meta-analysis
  1430. Effects of metformin on survival outcomes of lungย cancerย patients with type 2ย diabetesย mellitus: a meta-analysis
  1431. Effects of metformin on survival outcomes of pancreaticย cancerย patients withย diabetes: A meta-analysis
  1432. Effects of metformin treatment on radiotherapy efficacy in patients withย cancerย andย diabetes: A systematic review and meta-analysis
  1433. Effects of Newly Diagnosedย cancerย on Medication Management of Prevalentย diabetes
  1434. Effects of propofol and sevoflurane on blood glucose, hemodynamics, and inflammatory factors of patients with type 2ย diabetesย mellitus and gastricย cancer
  1435. Efficacy of metformin for locally advanced rectalย cancerย complicatingย diabetesย mellitus.
  1436. Elderlyย diabetesย and the correlation of colorectalย cancerย research
  1437. Electronic nose: A non-invasive technology for breath analysis ofย diabetesย and lungย cancerย patients
  1438. Elevated hemoglobin A1c levels are associated with worse survival in advanced pancreaticย cancerย patients withย diabetes
  1439. Elevated levels of CA 19-9 and CEA in pancreaticย cancer-associatedย diabetes
  1440. Emerging link betweenย diabetesย andย cancer
  1441. Emerging roles of cadmium and heme oxygenase in type-2ย diabetesย andย cancerย susceptibility
  1442. Emerging trends in pancreaticย cancerย andย diabetes.
  1443. Empagliflozin-induced ketoacidosis in a patient presenting with new-onset type 2ย diabetesย mellitus due to indolent pancreaticย cancer
  1444. Empirically supported treatments of disease-related symptoms in pediatric psychology: asthma,ย diabetes, andย cancer.
  1445. Enabling the nationโ€™s schools to help prevent heart disease, stroke,ย cancer, COPD,ย diabetes, and other serious health problems
  1446. Endocrinopathy in Pancreaticย cancerย Is Characterized by Reduced Islet Size and Density with Preserved Endocrine Composition as Compared to Type 2ย diabetesย โ€ฆ
  1447. Energy sensing pathways: Bridging type 2ย diabetesย and colorectalย cancer?
  1448. Enhanced System to Achieve Better Classification Performance in Forecastingย diabetesย and Breastย cancer
  1449. Enhancement of Oโ€‘linked Nโ€‘acetylglucosamine modification promotes metastasis in patients with colorectalย cancerย and concurrent type 2ย diabetesย mellitus
  1450. Enhancing ensemble prediction accuracy of breastย cancerย survivability andย diabetesย diagnostic using optimized EKF-RBFN trained prototypes
  1451. Epidemiological bases and molecular mechanisms linking obesity,ย diabetes, andย cancer
  1452. Epidemiological dimensions of the association between type 2ย diabetesย andย cancer: A review of observational studies
  1453. Epidemiological evidence of a relationship between typeโ€1ย diabetesย mellitus andย cancer: a review of the existing literature
  1454. Epidemiology and molecular mechanisms tying obesity,ย diabetes, and the metabolic syndrome withย cancer
  1455. Epidemiology and outcomes of previously undiagnosedย diabetesย in older women with breastย cancer: an observational cohort study based on SEER-Medicare
  1456. Epidemiology ofย diabetesย andย cancer
  1457. Epidemiology ofย diabetesย andย cancer: Lessons learnt
  1458. Epigenetic mechanisms of breastย cancerย prevention by the Type IIย diabetesย mellitus agent metformin
  1459. Epithelial Mesenchymal Transition and Progression of Breastย cancerย Promoted byย diabetesย Mellitus in Mice Are Associated with Increased Expression of Glycolytic โ€ฆ
  1460. Epithelial-mesenchymal transition phenotype, metformin, and survival for colorectalย cancerย patients withย diabetesย mellitus II
  1461. Erratum to: Non-metabolisable insulin glargine does not promote breastย cancerย growth in a mouse model of type 2ย diabetes
  1462. Erratum to: The impact ofย diabetesย process and outcome quality measures on overall survival in patients with co-morbid colorectalย cancer
  1463. Essential roles for the non-canonical IฮบB kinases in linking inflammation toย cancer, obesity, andย diabetes
  1464. Estimating the causal effect of BMI on mortality risk in people with heart disease,ย diabetesย andย cancerย using Mendelian randomization
  1465. Ethnic differences in the relationships betweenย diabetes, early age adiposity and mortality among breastย cancerย survivors: the Breastย cancerย Health Disparities Study
  1466. Ethno-medicinal plants for treatment ofย diabetes,ย cancerย and heart diseases: Evidence based documentation from dependent stakeholders
  1467. European Association for the Study ofย diabetesย Annual Conference Explores Links Betweenย diabetesย andย cancer
  1468. Evaluating the effect ofย diabetesย on the prognosis of gastricย cancerย using a propensity score matching method
  1469. Evaluating the prevalence ofย diabetesย mellitus subtypes in childhoodย cancerย survivors: a systematic review protocol
  1470. EVALUATING THE ROLE OFย diabetesย AND THEย diabetesย RELATED GENE, TCF2, IN PROSTATEย cancerย RISK AMONG AFRICAN-AMERICAN, CAUCASIAN โ€ฆ
  1471. Evaluation of a mixed meal test for diagnosis and characterization of pancrEaTogEniCย diabetesย secondary to pancreaticย cancerย and chronic pancreatitis โ€ฆ
  1472. Evaluation of lipid peroxidation activity at intravenous administration of gold nanorods in rats with simulatedย diabetesย and transplanted liverย cancer
  1473. Evaluation of National Programme for Prevention and Control ofย cancer,ย diabetes, Cardiovascular disease and Stroke (NPCDCS) in Gandhinagar district, Gujarat.
  1474. Evaluation of siRNA mediated Silencing of IKKฮฑ in Prostateย cancerย and CD40 in Type-1ย diabetes
  1475. Evaluation of the association between gestationalย diabetesย mellitus at first pregnancy andย cancerย within 10 years postpartum using National health insurance data in โ€ฆ
  1476. Evaluation of the impact ofย diabetesย mellitus on the biology of prostateย cancer
  1477. Evaluation the Rate ofย cancerย Risk in Patients withย diabetes: A Systematic Review
  1478. Evidence for DNA damage as a biological link betweenย diabetesย andย cancer
  1479. Examination of cause-of-death data quality among New York City deaths due toย cancer, pneumonia, orย diabetesย from 2010 to 2014
  1480. Examination of the complex relationships among dietary components, type IIย diabetes, weight change, and breastย cancerย risk among Singaporean Chinese women
  1481. Examining knownย diabetesย risk variants for association with prostateย cancerย in a multiethnic population
  1482. Examining patterns of multivariate, longitudinal symptom experiences among older adults with type 2ย diabetesย andย cancerย via cluster analysis
  1483. Examining the association between statins and lungย cancerย incidence in patients with type 2ย diabetesย mellitus
  1484. Examining the effects of metformin on survival outcome in stage II/III colorectalย cancerย patients withย diabetesย mellitus.
  1485. Examining the Impact of First Nations Status on the Relationship Betweenย diabetesย andย cancer
  1486. Examining the multilevel influences onย diabetesย and hypertension clinical care management among breastย cancerย patients
  1487. Examining the relationship betweenย diabetesย and prostateย cancerย through changes in screening guidelines
  1488. Excess body weight andย cancerย risk in patients with type 2ย diabetesย who were registered in Swedish Nationalย diabetesย Registerโ€“register-based cohort study โ€ฆ
  1489. Excess body weight,ย diabetesย andย cancer: epidemiologic evidence implicating hormonal and metabolic mechanisms
  1490. Excess risk of primary liverย cancerย in patients withย diabetesย mellitus
  1491. Excess risk of thyroidย cancerย in individuals with type 1ย diabetesย compared to those withoutย diabetesย in Finland; nationwide study
  1492. Excessive weight, inflammation,ย diabetes, andย cancer: Relationships and differences by race
  1493. Exercise and patient populations: A community-based exercise intervention onย cancerย and Type 2ย diabetes
  1494. Exercise training prevents endometrial hyperplasia and biomarkers for endometrialย cancerย in rat model of type 1ย diabetes
  1495. Exocrine pancreaticย cancer, cigarette smoking, andย diabetesย mellitus: a case-control study in northern Italy
  1496. Exosomes: Mediators and Therapeutic Targets ofย diabetesย and Pancreaticย cancer
  1497. Expanding the therapeutic spectrum of metformin: fromย diabetesย toย cancer
  1498. Experience on Treating Oesophagus Cardiaย cancerย Combined withย diabetesย 52 Cases in Peri-operation Period
  1499. Exploiting theย cancerย andย diabetesย metabolic connection for therapeutic purposes
  1500. Exploratory study of impact ofย cancerโ€related posttraumatic stress symptoms onย diabetesย selfโ€management amongย cancerย survivors
  1501. Exploring online support spaces: using cluster analysis to examine breastย cancer,ย diabetesย and fibromyalgia support groups
  1502. Exploring opportunities for colorectalย cancerย screening and prevention in the context ofย diabetesย self-management: an analysis of the 2010 National Health Interview โ€ฆ
  1503. Exploring the association betweenย diabetesย and breastย cancerย morbidity: considerations for quality care improvements among Latinas
  1504. Exploring the association betweenย diabetesย and breastย cancerย outcomes among Latinas.
  1505. Exploring the bi-directional relationship between pancreaticย cancerย andย diabetesย mellitus: a retrospective study
  1506. Exploring the complex and paradoxical relationships between Type 2ย diabetes, obesity andย cancer, as a framework for risk prediction models
  1507. Exploring the impact of metformin onย cancerย risk inย diabetesย patients
  1508. Exploring the link betweenย diabetesย and pancreaticย cancer
  1509. Exploring the therapeutic ability of fenugreek against type 2ย diabetesย and breastย cancerย employing molecular docking and molecular dynamics simulations
  1510. Exposure to Electric and Magnetic Fields (EMF) Linked to Neuro-Endocrine Stress Syndrome: Increased Cardiovascular Disease,ย diabetes, &ย cancer
  1511. Expression and significance of SIRT1 in breastย cancerย withย diabetesย meilitus
  1512. Expression and significance of SIRT1 in breastย cancerย withย diabetesย mellitus
  1513. Expression characteristics of proteins of the insulin-like growth factor axis in non-small cell lungย cancerย patients with preexisting type 2ย diabetesย mellitus
  1514. Expression of HIF-1ฮฑ and correlation with angiogenesis in tissue of breastย cancerย complicated withย diabetes
  1515. Expression of long non-coding RNA H19 in colorectalย cancerย patients with type 2ย diabetes
  1516. Expression of microRNAs: potential molecular link between obesity,ย diabetesย andย cancer
  1517. Expression of protein kinase p70S6K in leukocytes of patients withย cancerย andย diabetesย mellitus
  1518. Extracellular matrix glycation and RAGE activation. A missing piece in the puzzle of the association betweenย diabetesย andย cancer
  1519. Factors associated withย cancer-and non-cancer-related deaths among Taiwanese patients withย diabetesย after 17 years of follow-up
  1520. Factors associated with local, distant, overall recurrence in surgically-resected non-small cell lungย cancerย and the role ofย diabetesย in local recurrence
  1521. Factors that may influence the risk ofย cancerย inย diabetes
  1522. Familialย diabetesย frequency as a factor in diabetics suffering fromย cancer
  1523. Familialย diabetesย is associated with reduced risk ofย cancerย in diabetic patients: a possible role for metformin
  1524. Family caregiversโ€™ strains: comparative analysis ofย cancerย caregiving with dementia,ย diabetes, and frail elderly caregiving
  1525. Familyย diabetesย and its consequences inย cancerย patients
  1526. Family disease history and perceived risk for Type 2ย diabetes, cardiovascular disease,ย cancerย and depression
  1527. Family histories ofย diabetesย mellitus and breastย cancerย and incidence of postmenopausal breastย cancer
  1528. Family history and perceived risk ofย diabetes, cardiovascular disease,ย cancer, and depression
  1529. Family history ofย diabetesย and pancreaticย cancer
  1530. Family history ofย diabetesย and pancreaticย cancerย as risk factors for pancreaticย cancer: the PACIFIC study
  1531. Fasting Plasma Glucose Variability and Gastricย cancerย Risk in Individuals Withoutย diabetesย Mellitus: A Nationwide Population-Based Cohort Study
  1532. Fastingโ€Mimicking Diet and Risk Factors for Aging,ย diabetes,ย cancerย and Cardiovascular Disease
  1533. Fatty acid synthase: association with insulin resistance, type 2ย diabetes, andย cancer
  1534. Fear of progression in patients withย cancer,ย diabetesย mellitus and chronic arthritis
  1535. Features immuno-genetic, clinical and morphological characteristics of breastย cancerย in patients with type 2ย diabetesย melliuts
  1536. Fight against chronic diseases (high blood pressure, stroke,ย diabetesย andย cancer) in Pakistan; cost-effective interventions
  1537. Financial Burden Over Time in Older Adults withย cancer, Heart Disease, orย diabetes
  1538. Food patterns in relation to weight change and incidence of type 2ย diabetes, coronary events and stroke in the Malmรถ Diet andย cancerย cohort
  1539. For better or worse: FFAR1 and FFAR4 signaling inย cancerย andย diabetes
  1540. For colorectalย cancerย patients with type IIย diabetes, could metformin improve the survival rate? A meta-analysis
  1541. Forecasting of breastย cancerย andย diabetesย using ensemble learning
  1542. Formulation of a Multifunctional Flora Composite for the Prevention and Management ofย cancer,ย diabetes, Blood Pressure and Stroke
  1543. Foundation for the state of Kuwait prize for the control ofย cancer, cardiovascular diseases andย diabetesย in the Eastern Mediterranean
  1544. Foundation for the state of Kuwait prize for the control ofย cancer, cardiovascular diseases andย diabetesย in the Eastern Mediterranean Region
  1545. Four lifestyle factors preventย cancer,ย diabetes, and CVD
  1546. Frailty andย diabetesย status in older patients withย cancer: impact on mortality in the ANCRAGE cohort
  1547. Free radical scavenging ability of Aspalathus linearis in two in vitro models ofย diabetesย andย cancer
  1548. Free radical scavenging ability of Aspalathus linearis in two in vitro models ofย diabetesย andย cancer
  1549. Frequency of type 2ย diabetesย in family and itโ€™s changes in diabetic patients affected or not affected withย cancer
  1550. Fromย diabetesย toย cancer: Glucose makes the difference
  1551. Fromย diabetesย toย cancer: New applications for targeting AMPK in the clinical setting
  1552. From obesity toย diabetesย andย cancer: epidemiological links and role of therapies
  1553. Fructosamine andย diabetesย as predictors of mortality among Hispanic and non-Hispanic white breastย cancerย survivors
  1554. Fucoidan Structure and Its Impact on Glucose Metabolism: Implications forย diabetesย andย cancerย Therapy
  1555. FUMARATE METABOLISM INย cancerย AND TYPE 2ย diabetes
  1556. Functional informed genomeโ€wide interaction analysis of body mass index,ย diabetesย and colorectalย cancerย risk
  1557. Galectin-3 and S100A9: Novel Diabetogenic Factors Mediating Pancreaticย cancerโ€“Associatedย diabetes
  1558. Gastricย cancerย diagnosed after Helicobacter pylori eradication inย diabetesย mellitus patients
  1559. Gastrointestinalย cancerย incidence in type 2ย diabetesย mellitus; results from a large population-based cohort study in the UK
  1560. Gastrointestinalย cancerย incidence in type 2ย diabetesย mellitus: results from a large retrospective population-based cohort study
  1561. Gastrointestinal tractย cancerย andย diabetesย mellitus
  1562. Gaussian graphical models identified food intake networks and risk of type 2ย diabetes, CVD, andย cancerย in the EPIC-Potsdam study
  1563. GCN2 and FGF21 are likely mediators of the protection fromย cancer, autoimmunity, obesity, andย diabetesย afforded by vegan diets
  1564. GDF-15 is associated withย cancerย incidence in patients with type 2ย diabetes
  1565. Genderโ€specific effects of oral hypoglycaemic agents onย cancerย risk in type 2ย diabetesย mellitus
  1566. Gene polymorphisms and their association withย diabetesย and hypertension in African American and Latina breastย cancerย patients
  1567. Gene signature for prognosis in comparison of pancreaticย cancerย patients withย diabetesย and non-diabetes
  1568. Gene-and pathway-based genomics of breastย cancerย and type 2ย diabetesย in African American women
  1569. Generation and biological characteristics of a mouse model of breastย cancerย that copresents withย diabetesย mellitus
  1570. Genes and molecular mechanisms affecting the correlation between liverย cancerย andย diabetesย mellitus
  1571. Genes Associated withย cancer, Schizophrenia and Type 2ย diabetesย in the Circassian and Chechen Populations in Jordan
  1572. Genes related toย diabetesย may be associated with pancreaticย cancerย in a population-based case-control study in Minnesota
  1573. Genesโ€“environment interactions in obesity-andย diabetes-associated pancreaticย cancer: a GWAS data analysis
  1574. Genetic Architecture ofย diabetesย Mellitus in Long-term Survivors of Childhoodย cancer
  1575. Genetic Basis Linking Variants forย diabetesย and Obesity with Breastย cancer
  1576. Genetic polymorphisms ofย diabetesโ€related genes, their interaction withย diabetesย status, and breastย cancerย incidence and mortality: The Long Island Breastย cancerย โ€ฆ
  1577. Genetic susceptibility to type 2ย diabetesย and breastย cancerย risk in women of European and African ancestry
  1578. Genetic susceptibility to type 2ย diabetesย is associated with reduced prostateย cancerย risk
  1579. Genetic testing for maturity onsetย diabetesย of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectalย cancer
  1580. Genetic testing of constitutive sensitivity to metformin inย cancerย patients with and withoutย diabetes
  1581. Genetic variants for type 2ย diabetesย and new-onsetย cancerย in Chinese with type 2ย diabetes
  1582. Genome-wide association studies in aging-related processes such asย diabetesย mellitus, atherosclerosis andย cancer
  1583. Genome-wide gene-diabetesย and gene-obesity interaction scan in the pancreaticย cancerย case control consortium
  1584. Genomewide gene-diabetesย and gene-obesity interaction scan in 7095 cases and 10710 controls from Pancreaticย cancerย Cohort Consortium and Pancreaticย cancerย โ€ฆ
  1585. Genomic Epidemiology of Human Papillomavirus (HPV), Prostateย cancer, andย diabetes
  1586. Genomic prediction of 16 complex disease risks including heart attack,ย diabetes, breast and prostateย cancer
  1587. Gestationalย diabetesย and risk of breastย cancerย in African American women
  1588. Gestationalย diabetesย and risk of incident primaryย cancer: a large historical cohort study in Israel
  1589. Gestationalย diabetesย and risk of incident primaryย cancer: A large population-based cohort study in Israel.
  1590. Gestationalย diabetesย and the risk of breastย cancerย among women in the Jerusalem Perinatal Study
  1591. Gestationalย diabetesย as a risk factor for pancreaticย cancer: a prospective cohort study
  1592. Gestationalย diabetesย may increase risk of endometrialย cancerย later in life: Results of a population-based study in Washington State, 1987โ€“2012
  1593. Gestationalย diabetesย mellitus and maternal breastย cancerย risk: a meta-analysis of the literature
  1594. Gestationalย diabetesย mellitus and risk of incident primaryย cancer: A population-based retrospective cohort study.
  1595. Gestationalย diabetesย mellitus and subsequentย cancerย risk: shared risk factors, causality or confounding?
  1596. Gestationalย diabetesย mellitus may be associated with increased risk of breastย cancer
  1597. Gestationalย diabetes, type IIย diabetes, and mammographic breast density in a US racially diverse population screened for breastย cancer
  1598. GI hormonal changes inย diabetesย influence pancreaticย cancerย growth
  1599. Glargine safety,ย diabetesย andย cancer
  1600. Global and regional effects of bladderย cancerย risk associated with pioglitazone therapy in patients withย diabetes
  1601. GLP-1 based therapy forย diabetesย and potential of thyroidย cancer
  1602. GLP-1 receptor agonist as treatment forย cancerย as well asย diabetes: beyond blood glucose control
  1603. GLP-1 receptor agonists and risk ofย cancerย in type 2ย diabetes: an updated meta-analysis of randomized controlled trials
  1604. Glucagon-like peptide (GLP)-1 and the synthetic analogue exenatide: From novel therapy forย diabetesย to growth inhibition of breastย cancerย cells.
  1605. Glucagon-like peptide-1 analogues and risk of breastย cancerย in women with type 2ย diabetes: population based cohort study using the UK Clinical Practice โ€ฆ
  1606. Glucagon/insulin ratio as a potential biomarker for pancreaticย cancerย in patients with new-onsetย diabetesย mellitus
  1607. Glucose lowering therapies andย cancerย specific mortality in adult insulin-treatedย diabetes
  1608. Glucose transporters: their abnormalities and significance in type 2ย diabetesย andย cancer
  1609. Glucose-lowering agents andย cancerย mortality rates in type 2ย diabetes: assessing effects of time-varying exposure
  1610. Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linkingย diabetesย toย cancer
  1611. Glucose-Regulated TET2 Activity Linksย cancerย toย diabetes
  1612. Glucoseโ€lowering with exogenous insulin monotherapy in type 2ย diabetes: dose association with allโ€cause mortality, cardiovascular events andย cancer
  1613. Glycaemic control in people with type 2ย diabetesย mellitus during and afterย cancerย treatment: A systematic review and meta-analysis
  1614. Glycated haemoglobin,ย diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation ofย cancerย and Nutrition (EPIC-Norfolk)
  1615. Glycated hemoglobin and risk of stroke in people without knownย diabetesย in the European Prospective Investigation intoย cancerย (EPIC)โ€“Norfolk prospective โ€ฆ
  1616. Glycated hemoglobin predicts all-cause, cardiovascular, andย cancerย mortality in people without a history ofย diabetesย undergoing coronary angiography
  1617. Glycated hemoglobin,ย diabetesย treatment andย cancerย risk in type 2ย diabetes. A case-control study
  1618. Glycemia control using A1C level in terminalย cancerย patients with preexisting type 2ย diabetes
  1619. Glycemic changes after gastrectomy in non-morbidly obese patients with gastricย cancerย andย diabetes.
  1620. Glycemic control and survival of patients with coexistingย diabetesย mellitus and gastric or esophagealย cancer
  1621. Glycemic equilibrium ofย cancerย patients withย diabetes
  1622. Glycemic Status, Insulin Resistance, and Risk of Pancreaticย cancerย Mortality in Individuals With and Withoutย diabetes
  1623. Glycogen synthase kinase 3 (GSKโ€3) inhibitors as new promising drugs forย diabetes, neurodegeneration,ย cancer, and inflammation
  1624. GO-25: Doseย diabetesย medication reduce recurrence of endometrialย cancer?
  1625. Gonadotrophin-releasing hormone agonists,ย diabetesย and cardiovascular disease in men with prostateย cancer: which metabolic syndrome?
  1626. Gonadotropin-releasing hormone agonists and the risks of type 2ย diabetesย and cardiovascular disease in men with prostateย cancer
  1627. Good glycaemic control is associated with a better prognosis in breastย cancerย patients with type 2ย diabetesย mellitus
  1628. Greater development of 1, 2-dimethylhydrazine-induced colonย cancerย in a rat model of type 2ย diabetesย mellitus
  1629. Growth defect blocksย cancerย andย diabetes
  1630. Growth differentiation factor 15 is positively associated with incidence ofย diabetesย mellitus: the Malmรถ Diet andย cancerโ€“Cardiovascular Cohort
  1631. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling,ย cancer, andย diabetesย in humans
  1632. GSK3 inhibitors in the therapeutic development ofย diabetes,ย cancerย and neurodegeneration: past, present and future
  1633. Guest editorial: areย diabetes-related wounds and amputations worse thanย cancer
  1634. GW28-e0695 High-Density Lipoprotein Cholesterol andย cancerย Risk Among Chinese with or withoutย diabetesย Mellitus in Kailuan Cohort
  1635. H eterogeneity in risk of prostateย cancer: AS wedish populationโ€based cohort study of competing risks and T ype 2ย diabetesย mellitus
  1636. HbA1C andย cancerย risk in patients with type 2ย diabetesโ€“a nationwide population-based prospective cohort study in Sweden
  1637. HDL cholesterol andย cancerย risk among patients with type 2ย diabetes
  1638. HDL of patients with type 2ย diabetesย mellitus elevates the capability of promoting breastย cancerย metastasis
  1639. HE LINK BETWEENย diabetes,ย diabetesย TREATMENT ANDย cancer
  1640. Head and neckย cancerย patients: impact ofย diabetesย mellitus on surgical outcomes
  1641. Health literacy and behavior related toย cancerย andย diabetesย among higher secondary students
  1642. Health professionalsโ€™ views of current treatment pathways forย cancerย patients with comorbidย diabetes
  1643. Health-related quality of life for men with prostateย cancerย andย diabetes: a longitudinal analysis from CaPSURE
  1644. Healthcare utilization and direct medical cost in the years during and afterย cancerย diagnosis in patients with type 2ย diabetesย mellitus
  1645. Healthy gardens/healthy lives: Navajo perceptions of growing food locally to preventย diabetesย andย cancer
  1646. Healthy lifestyle and life expectancy free ofย cancer, cardiovascular disease, and type 2ย diabetes: prospective cohort study
  1647. Heart disease risk factors,ย diabetes, and prostaticย cancerย in an adult community
  1648. Helicobacter pylori infection and Hyperglycemia/diabetesย are associated with an increased risk of gastricย cancer
  1649. Hepatocellularย cancer: the impact of obesity, type 2ย diabetesย and a multidisciplinary team
  1650. Hepatocellular carcinoma as a leading cause ofย cancer-related deaths in Japanese type 2ย diabetesย mellitus patients
  1651. Herbal Medicines forย diabetesย andย cancerโ€”A Global Perspective
  1652. High glucose andย diabetesย increaseย cancerย risk
  1653. High Norepinephrine Status Induced Growth of Colorectalย cancerย With Type 2ย diabetesย Mellitus Benefited From ADP-Ribosyltransferase 1
  1654. High prevalence ofย diabetesย in patients with pancreaticย cancerย in central Anatolia, Turkey
  1655. High prevalence ofย diabetesย mellitus and impaired glucose tolerance in liverย cancerย patients: a hospital based study of 4610 patients with benign tumors or โ€ฆ
  1656. High processed meat consumption is a risk factor of type 2ย diabetesย in the Alpha-Tocopherol, Beta-Caroteneย cancerย Prevention study
  1657. High rates of endometrialย cancerย among Pacific women in New Zealand: the role ofย diabetes, physical inactivity, and obesity
  1658. High-density lipoprotein of patients with breastย cancerย complicated with type 2ย diabetesย mellitus promotesย cancerย cells adhesion to vascular endothelium via ICAM-1 โ€ฆ
  1659. Highโ€density lipoprotein of patients with type 2ย diabetesย mellitus elevates the capability of promoting migration and invasion of breastย cancerย cells
  1660. Higher Circulating Adiponectin Concentrations Predict Incidentย cancerย in Type 2ย diabetesโ€“The Adiponectin Paradox
  1661. Higher Concentrations of Glucose or Insulin Increase the Risk of Various Types ofย cancerย in Obesity or Type 2ย diabetesย by Decreasing the Expression of โ€ฆ
  1662. Higher expression of proteins in IGF/IR axes in colorectalย cancerย is associated with type 2ย diabetesย mellitus
  1663. Higher glucose and insulin levels are associated with risk of liverย cancerย and chronic liver disease mortality among men without a history ofย diabetes
  1664. Higher prevalence of lymph node metastasis in prostateย cancerย in patients withย diabetes
  1665. Higher Prevalence of Prostateย cancerย among Veterans with Type 2ย diabetes
  1666. Higher risk of colorectalย cancerย in patients with newly diagnosedย diabetesย mellitus before the age of colorectalย cancerย screening initiation
  1667. Higher risk of mortality from lungย cancerย in Taiwanese people withย diabetes
  1668. Higher whole-grain intake is associated with lower risk of type 2ย diabetesย among middle-aged men and women: the Danish diet,ย cancer, and health cohort
  1669. Hijacking of endocrine and metabolic regulation inย cancerย andย diabetes
  1670. Hijacking of Endocrine and Metabolic Regulation inย cancerย andย diabetes
  1671. Hints that Glitazones,ย diabetesย Drugs, May Work Against Breastย cancer
  1672. Histone deactylase inhibitors as novel target forย cancer,ย diabetes, and inflammation
  1673. History ofย cancerย and the use of ACE inhibitors: results from the Vermontย diabetesย information system.
  1674. History ofย diabetesย and risk of head and neckย cancer: a pooled analysis from the international head and neckย cancerย epidemiology consortium
  1675. History ofย diabetesย and risk of head and neckย cancer: a pooled analysis from the international head and neckย cancerย epidemiology consortium.
  1676. History ofย diabetesย mellitus and risk of breastย cancerย in asian women: A meta-epidemiological analysis of population-based cohort studies
  1677. History ofย diabetesย mellitus and risk of prostateย cancerย in physicians
  1678. History ofย diabetesย Mellitus and Risk of Prostateย cancer: A Meta-Epidemiological Study of Population-Based Cohort Studies in East Asian Men
  1679. History ofย diabetesย mellitus and subsequent prostateย cancerย risk in the NIH-AARP Diet and Health Study
  1680. History ofย diabetesย mellitus and the risk of prostateย cancer: the Ohsaki Cohort Study
  1681. History ofย diabetesย mellitus as a risk factor for pancreaticย cancer: The Iowa Womenโ€™s Health study
  1682. History ofย diabetes, clinical features of prostateย cancer, and prostateย cancerย recurrence-data from CaPSURE TM (United States)
  1683. History of gestationalย diabetesย mellitus and risk of incident invasive breastย cancerย among parous women in the Nursesโ€™ Health Study II prospective cohort
  1684. History of hypertension, heart disease, andย diabetesย and ovarianย cancerย patient survival: evidence from the ovarianย cancerย association consortium
  1685. History of lower-limb complications and risk ofย cancerย death in people with type 2ย diabetes
  1686. History of treated hypertension andย diabetesย mellitus and risk of renal cellย cancer
  1687. HNF1B and JAZF1 genes,ย diabetes, and prostateย cancerย risk
  1688. Homeostasis,ย diabetesย andย cancer
  1689. Hormonal therapy for breastย cancerย andย diabetesย incidence among postmenopausal women
  1690. Hormonal-metabolic pattern of postmenopausal females with new onset ofย diabetesย mellitus type 2: the role ofย cancerย and hereditary predisposition toย diabetes
  1691. Hormonal-metabolic pattern of postmenopausal females with new onset ofย diabetesย mellitus type 2: the role ofย cancerย and hereditary predisposition toย diabetes
  1692. Hormonal, metabolic and genetic predictors of metformin efficacy in patients withย diabetesย mellitus andย cancer
  1693. How do people interpret their family histories ofย diabetes, coronary disease, orย cancer?
  1694. How doesย diabetesย Mellitus Influence Early Postoperative Results and Survival in Rectalย cancer?
  1695. How shift work and a destabilized circadian system may increase risk for development ofย cancerย and type 2ย diabetes
  1696. Human antiโ€NKp46 antibody for studies of NKp46โ€dependent NK cell function and its applications for type 1ย diabetesย andย cancerย research
  1697. Human insulin to increase breastย cancerย risk in Taiwanese women with type 2ย diabetes.
  1698. Hybrid feature selection based weighted least squares twin support vector machine approach for diagnosing breastย cancer, hepatitis, andย diabetes
  1699. Hyperactivation of Akt/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidneyย cancerย patients withย diabetes
  1700. Hyperglycemia among hospitalizedย cancerย patients with co-existingย diabetesย mellitus.
  1701. Hyperglycemia during Adjuvant Chemotherapy as a Prognostic Factor in Breastย cancerย Patients withoutย diabetes
  1702. Hyperglycemia, classified with multiple biomarkers simultaneously in men withoutย diabetes, and risk of fatal prostateย cancer
  1703. Hyperinsulinemia and type 2ย diabetes: impact onย cancer
  1704. Hyperinsulinemia, impaired glucose tolerance, andย diabetesย mellitus in survivors of childhoodย cancer: prevalence and risk factors
  1705. Hypertension,ย diabetes, cognitive impairment, renalย cancer, polymyalgia rheumatica and chronic hemodialysis treatment: so many diseases or just only one?
  1706. Hypophysial disorder in mammaryย cancerย and its relation toย diabetesย insipidus
  1707. IDDF2019-ABS-0075 Serum metabonomic analysis and establishment of diagnostic model of pancreaticย cancerย associatedย diabetes
  1708. IDDF2020-ABS-0051 Association between type-2ย diabetesย mellitus and platelet distribution width in patients with primary liverย cancer
  1709. Identification of key candidate genes and pathways for relationship between ovarianย cancerย andย diabetesย mellitus using bioinformatical analysis
  1710. Identification of proteins implicated in the development of pancreaticย cancer-associatedย diabetesย mellitus by iTRAQ-based quantitative proteomics
  1711. Identification of Therapeutic Targets inย diabetesย induced Breastย cancerย Metastasis
  1712. Identifying clinical factors associated with an increased risk ofย diabetesย Mellitus amongย cancerย survivors.
  1713. Illuminating theย diabetesโ€“cancerย link
  1714. Immunologic predictors ofย diabetesย mellitus in menopausal breastย cancerย patients
  1715. Immunomodulatory perspectives of potential biological spices with special reference toย cancerย andย diabetes
  1716. Impact ofย cancerย on adherence to glucose lowering drugs in individuals withย diabetes
  1717. Impact ofย cancerย on adherence to glucose-lowering drug treatment in individuals withย diabetes
  1718. Impact ofย cancerย on use of glucose-lowering drug treatment in individuals withย diabetes: potential mechanisms
  1719. Impact ofย cancerย on use of glucose-lowering drug treatment in individuals withย diabetes: potential mechanisms. Reply to Pouwer F
  1720. Impact ofย cancerย related stress on illness beliefs and glycemic control in breastย cancerย survivors with comorbidย diabetes.
  1721. Impact of clinical pharmacy recommendations and patient counselling program among patients withย diabetesย andย cancerย in outpatient oncology setting
  1722. Impact of consumption of animal products on cardiovascular disease,ย diabetes, andย cancerย in developed countries
  1723. Impact of detection bias on the risk of gastrointestinalย cancerย and its subsites in type 2ย diabetesย mellitus
  1724. Impact ofย diabetesย and hyperglycemia on health care utilization, infection risk, and survival in patients withย cancerย receiving glucocorticoids with chemotherapy
  1725. Impact ofย diabetesย and hyperglycemia on health care utilization, infection risk, and survival in patients withย cancerย receiving glucocorticoids with chemotherapy.
  1726. Impact ofย diabetesย and hyperglycemia on outcomes in advanced breastย cancerย patients.
  1727. Impact ofย diabetesย and hyperglycemia on survival in advanced breastย cancerย patients
  1728. Impact ofย diabetesย and Hyperglycemia on Survival in Advanced Breastย cancerย Patients
  1729. Impact ofย diabetesย and insulin use on prognosis in patients with resected pancreaticย cancer: an ancillary analysis of NRG Oncology RTOG 9704
  1730. Impact ofย diabetesย and metformin use on prostateย cancerย outcome of patients treated with radiation therapy: results from a large institutional database.
  1731. Impact ofย diabetesย comorbidity on the efficacy and safety of FOLFOX first-line chemotherapy among patients with metastatic colorectalย cancer: a pooled analysis of two โ€ฆ
  1732. Impact ofย diabetesย Complications on Breastย cancerย Screening, Diagnosis, and Prognosis among Elderly Women with Pre-existingย diabetesย Using the SEER โ€ฆ
  1733. Impact ofย diabetesย duration and chronic pancreatitis on the association between type 2ย diabetesย and pancreaticย cancerย risk
  1734. Impact ofย diabetesย mellitus and insulin use on survival after colorectalย cancerย diagnosis: theย cancerย Prevention Study-II Nutrition Cohort
  1735. Impact ofย diabetesย mellitus on clinical outcomes in patients undergoing surgical resection for pancreaticย cancer: a retrospective, cohort study
  1736. Impact ofย diabetesย mellitus on clinical outcomes of pancreaticย cancerย after surgical resection: A systematic review and meta-analysis
  1737. Impact ofย diabetesย mellitus on clinical presentation and prognosis of pancreaticย cancer
  1738. Impact ofย diabetesย mellitus on clinicopathological factors and prognosis of patients with colorectalย cancer.
  1739. Impact ofย diabetesย mellitus on clinicopathological factors and relation with radiation pneumonitis in 332 patients with lungย cancer
  1740. Impact ofย diabetesย mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breastย cancer
  1741. Impact ofย diabetesย mellitus on complications of chemotherapy and outcomes in older patients with breastย cancer
  1742. Impact ofย diabetesย mellitus on epithelial ovarianย cancerย survival
  1743. impact ofย diabetesย Mellitus on Head and neckย cancerย patients Undergoing concurrent chemoradiotherapy
  1744. Impact ofย diabetesย Mellitus on Head and Neckย cancerย Patients Undergoing Concurrent Chemoradiotherapy
  1745. Impact ofย diabetesย mellitus on head and neckย cancerย patients undergoing surgery
  1746. Impact ofย diabetesย mellitus on oncological outcomes after radical hysterectomy for early stage cervicalย cancer
  1747. Impact ofย diabetesย mellitus on outcomes in patients with colonย cancer
  1748. Impact ofย diabetesย Mellitus on Outcomes in Patients With Stage II and III Colonย cancer
  1749. Impact ofย diabetesย mellitus on postoperative outcomes in individuals with non-small-cell lungย cancer: A retrospective cohort study
  1750. Impact ofย diabetesย mellitus on the detection of prostateย cancerย via contemporary multi (โ‰ฅ 12)โ€core prostate biopsy
  1751. Impact ofย diabetesย mellitus on the outcome of colonย cancer
  1752. Impact ofย diabetesย mellitus on the outcome of pancreaticย cancer
  1753. Impact ofย diabetesย mellitus on the survival of pancreaticย cancer: a meta-analysis
  1754. Impact ofย diabetesย Mellitus on the Treatment Outcomes of Chemotherapy in Women with Breastย cancerโ€”A Population-Based Prospective Cohort Study
  1755. Impact ofย diabetesย mellitus on treatment outcomes in patients with nasopharyngealย cancer
  1756. Impact ofย diabetesย onย cancerย chemotherapy outcome: A retrospective analysis.
  1757. Impact ofย diabetesย on clinicopathologic and genetic features of colorectalย cancerย formation.
  1758. Impact ofย diabetesย on Colorectalย cancerย Outcomes
  1759. Impact ofย diabetesย on Colorectalย cancerย Screening Rates in US Adults
  1760. Impact ofย diabetesย on colorectalย cancerย stage and mortality risk: a population-based cohort study
  1761. Impact ofย diabetesย on early complications after pancreaticoduodenectomy in patients with pancreaticย cancer
  1762. Impact ofย diabetesย on oncologic outcome of colorectalย cancerย patients: colon vs. rectalย cancer
  1763. Impact ofย diabetesย on outcome and toxicity of neoadjuvant (chemo) radiation for rectalย cancer
  1764. Impact ofย diabetesย on overall andย cancer-specific mortality in colorectalย cancerย patients
  1765. Impact ofย diabetesย on postoperative outcomes following colonย cancerย surgery
  1766. Impact ofย diabetesย on prognosis of gastricย cancerย patients performed with gastrectomy
  1767. Impact ofย diabetesย on site-specific oncologic outcome in stage I-III colorectalย cancer.
  1768. Impact ofย diabetesย on the outcomes of patients with castration-resistant prostateย cancerย treated with docetaxel: a pooled analysis of three phase III studies
  1769. Impact ofย diabetesย status and medication on presentation, treatment, and outcome of stage II colonย cancerย patients
  1770. Impact ofย diabetesย Status on Long Term Oncological Outcome of Stage II Colorectalย cancer
  1771. Impact ofย diabetesย type II and chronic inflammation on pancreaticย cancer
  1772. Impact ofย diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2โ€“positive primary breastย cancerย โ€ฆ
  1773. Impact of glycemic control and metformin use on the recurrence and progression of non-muscle invasive bladderย cancerย in patients withย diabetesย mellitus
  1774. Impact of glycemic traits, type 2ย diabetesย and metformin use on breast and prostateย cancerย risk: a Mendelian randomization study
  1775. Impact of Gonadotropin-releasing Hormone Agonist on Cardiovascular Disease andย diabetesย Mellitus in Prostateย cancerย Patients: A Nationwide Population-based โ€ฆ
  1776. Impact of improvement ofย diabetesย on survival after radical pancreatic resection in patients with pancreaticย cancerย andย diabetes
  1777. Impact of metformin on metastases in patients with breastย cancerย and type 2ย diabetes
  1778. Impact of metformin on survival in patients with type IIย diabetesย and metastatic colorectalย cancer.
  1779. Impact of Metformin Use on Survival in Patients with Gastricย cancerย andย diabetesย Mellitus Following Gastrectomy
  1780. Impact of obesity during adulthood on chronic disease:ย diabetes, hypertension, metabolic syndrome, cardiovascular disease, andย cancer.
  1781. Impact of pre-existing type-2ย diabetesย on patient outcomes after radical resection for gastricย cancer: a retrospective cohort study
  1782. Impact of socioโ€economic status on breastย cancerย screening in women withย diabetes: a populationโ€based study
  1783. Impact of stress onย diabetesย self-management inย cancerย survivors.
  1784. Impact of the duration ofย diabetesย mellitus (DM) on the outcomes of metastatic pancreaticย cancerย (mPC) treated with gemcitabine (G): A retrospective study
  1785. Impact of the duration ofย diabetesย mellitus on the outcome of metastatic pancreaticย cancerย treated with gemcitabine: a retrospective study
  1786. Impact of transcriptional and posttranscriptional regulation of HNF4A and its target genes onย diabetesย andย cancer
  1787. Impact of transcriptional and posttranscriptional regulation of HNF4A and its target genes onย diabetesย andย cancer
  1788. Impact of type 2ย diabetesย mellitus on short-term and long-term outcomes of patients with esophageal squamous cellย cancerย undergoing resection: a โ€ฆ
  1789. Impact of type 2ย diabetesย mellitus on the prognosis of early stage triple-negative breastย cancerย in Peopleโ€™s Republic of China
  1790. Impact on different type of gastrectomy reconstruction in patients with gastricย cancerย andย diabetes
  1791. Impacts of new-onset and long-termย diabetesย on clinical outcome of pancreaticย cancer
  1792. Impacts of New-Onset and Longstandingย diabetesย on the Incidence and Mortality of Pancreaticย cancer: Population Based Big-Cohort Study.
  1793. Impaired glucose metabolism andย diabetesย and the risk of breast, endometrial, and ovarianย cancer
  1794. Implications of breastย cancerย withย diabetesย mellitus on patient outcomes and care
  1795. Implications of pancreaticย cancerย withย diabetesย mellitus on patient outcomes and care: A matched case-control study.
  1796. Implications of prostateย cancerย withย diabetesย mellitus on patient outcomes and care: A matched case-control study.
  1797. Implications of the hyperinsulinaemia-diabetesโ€“cancerย link for preventive efforts.
  1798. Implications of type1/2ย diabetesย mellitus in breastย cancerย development: a general female population-based cohort study
  1799. Importance ofย diabetesย in inhibition of pancreaticย cancerย by streptozotocin
  1800. Importance of glycemic control inย cancerย patients withย diabetes: treatment through end of life
  1801. Improve the performance ofย cancerย andย diabetesย detection using novel technique of machine learning
  1802. Improved progression free survival for patients withย diabetesย and locally advanced non-small cell lungย cancerย (NSCLC) using metformin during concurrent โ€ฆ
  1803. Improvement of type 2ย diabetesย in a lungย cancerย patient treated with Erlotinib
  1804. Improvement of type 2ย diabetesย mellitus after gastricย cancerย surgery: short-term outcome analysis after gastrectomy
  1805. Improving Coordination of Care Among Healthcare Professionals and Patients Withย diabetesย andย cancer.
  1806. Improving health engagement and lifestyle management for breastย cancerย survivors withย diabetes
  1807. Improving lifestyle behaviors after breastย cancerย treatment among African American women with and withoutย diabetes: Role of health care professionals
  1808. Improving Mฤori access toย cancer,ย diabetesย and cardiovascular health care: Key informant interviews
  1809. Improving outcome prediction in individuals with colorectalย cancerย andย diabetesย by accurate assessment of vascular complications: Implications for clinical โ€ฆ
  1810. Improving prediction accuracy of breastย cancerย survivability andย diabetesย diagnosis via RBF networks trained with EKF models
  1811. In-vitro analysis of glucose and quercetin effects on m-TOR and Nrf-2 expression in HepG2 cell line (diabetesย andย cancerย connection)
  1812. Incidence and mortality risks ofย cancerย in patients with type 2ย diabetes: a retrospective study in Shanghai, China
  1813. Incidence and peculiarities of thyroidย cancerย in patients with type 2ย diabetesย mellitus
  1814. Incidence and predictors of all-cause and site-specificย cancerย in type 2ย diabetes: the Fremantleย diabetesย Study
  1815. Incidence and Predictors ofย diabetesย Mellitus after a Diagnosis of Early-Stage Breastย cancerย in the Elderly Using Real-World Data
  1816. Incidence of bladderย cancerย in patients with type 2ย diabetesย treated with metformin or sulfonylureas
  1817. Incidence of bladderย cancerย in type 2ย diabetesย mellitus patients: A population-based cohort study
  1818. Incidence of breastย cancerย in women with type 2ย diabetes
  1819. Incidence ofย cancerย in a population-based cohort of patients with type 2ย diabetes
  1820. Incidence of carbapenem-resistant Pseudomonas aeruginosa inย diabetesย andย cancerย patients
  1821. Incidence ofย diabetesย afterย cancerย development: a Korean national cohort study
  1822. Incidence ofย diabetesย among patients with colorectalย cancer.
  1823. Incidence ofย diabetesย among postmenopausal breastย cancerย survivors
  1824. Incidence ofย diabetesย and its predictive factors inย cancerย patients treated with phosphatidylinositol 3 kinase inhibitors
  1825. Incidence ofย diabetesย in colorectalย cancerย survivors
  1826. Incidence ofย diabetesย mellitus, cardiovascular diseases, andย cancerย in patients undergoing malabsorptive surgery (biliopancreatic diversion and biliointestinal bypass) โ€ฆ
  1827. Incidence of human papillomavirusโ€related anogenital precancerย andย cancerย in women withย diabetes: A nationwide registryโ€based cohort study
  1828. Incidence of medication-treated depression and anxiety associated with long-termย cancer, cardiovascular disease,ย diabetesย and osteoarthritis in community โ€ฆ
  1829. Incidence of metallo-beta-lactamase-producing Pseudomonas aeruginosa inย diabetesย andย cancerย patients
  1830. Incidence of Pancreaticย cancerย Associated Insulin Dependentย diabetesย at an Inner City Hospital
  1831. Incidence of type 2ย diabetesย among oralย cancerย patients in Hungary
  1832. Incidence of type 2ย diabetesย using proposed HbA1c diagnostic criteria in the European Prospective Investigation ofย cancerโ€“Norfolk cohort: implications for preventive โ€ฆ
  1833. Incidences ofย diabetesย and prediabetesย among female adult breastย cancerย patients after systemic treatment
  1834. Incidentย cancerย risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2ย diabetesย mellitus
  1835. Incident type 2ย diabetesย duration andย cancerย risk: a prospective study in two US cohorts
  1836. Increased 30-day Mortality in Patients withย diabetesย Mellitus Undergoing Surgery for Colorectalย cancer
  1837. Increased 30-Day Mortality Risk in Patients Withย diabetesย Mellitus After Colonย cancerย Surgery: A Mediation Analysis
  1838. Increased 30โ€day mortality in patients withย diabetesย undergoing surgery for colorectalย cancer
  1839. Increasedย cancerย incidence around the time of type 2ย diabetesย diagnosis (ZODIAC-49)
  1840. Increasedย cancerย incidence risk in type 2ย diabetesย mellitus: results from a cohort study in Tyrol/Austria
  1841. Increasedย cancerย mortality in type 2ย diabetesย (ZODIAC-3)
  1842. Increasedย cancerย risk with drug use among patients withย diabetes: Are the biased methods the culprit?
  1843. Increasedย cancer-related mortality for patients with type 2ย diabetesย who use sulfonylureas or insulin
  1844. Increasedย cancer-related mortality for patients with type 2ย diabetesย who use sulfonylureas or insulin: Response to Bowker et Al.
  1845. Increasedย cancer-related mortality for patients with type 2ย diabetesย who use sulfonylureas or insulin: Response to Farooki and Schneider
  1846. Increased Expressions of Matrix Metalloproteinases (MMPs) in Prostateย cancerย Tissues of Men with Type 2ย diabetes
  1847. Increased kidneyย cancerย risk inย diabetesย mellitus patients: a population-based cohort study in Lithuania
  1848. Increased mortality for colorectalย cancerย patients with preexistingย diabetesย mellitus: an updated meta-analysis
  1849. Increased oxidative stress in obesity: implications for metabolic syndrome,ย diabetes, hypertension, dyslipidemia, atherosclerosis, andย cancer
  1850. Increased prevalence of prior breastย cancerย in women with newly diagnosedย diabetes
  1851. Increased risk of bladderย cancerย with pioglitazone therapy in patients withย diabetes: a meta-analysis
  1852. Increased risk ofย cancerย death with type 2ย diabetes, finds Asian study
  1853. Increased risk ofย cancerย in patients with type 2ย diabetesย mellitus: a retrospective cohort study in China
  1854. Increased risk of colonย cancerย in men in the pre-diabetesย phase
  1855. Increased risk of colorectalย cancerย in type 2ย diabetesย is independent of diet quality
  1856. Increased risk of kidneyย cancerย in a cohort of Lithuanianย diabetesย mellitus patients
  1857. Increased risk of metabolic syndrome,ย diabetesย mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostateย cancer
  1858. Increased risk of site-specificย cancerย in people with type 2ย diabetes: a national cohort study
  1859. Increased risk of site-specificย cancerย in people with type 2ย diabetes: a national cohort study
  1860. Increased serum levels of betatrophin in pancreaticย cancer-associatedย diabetes
  1861. Increased survival in lungย cancerย patients withย diabetesย mellitus: A large cohort study
  1862. Increasing risk ofย diabetesย mellitus in postmenopausal women with newly diagnosed primary breastย cancer
  1863. Incretin-based drugs and the incidence of colorectalย cancerย in patients with type 2ย diabetes
  1864. Incretin-based therapy and risk of pancreaticย cancerย in patients with type 2ย diabetesย mellitus: a meta-analysis of randomized controlled trials
  1865. Incretin-Based Therapy and Risk of Pancreaticย cancerย in Patients with Type 2ย diabetesย Mellitus: A Meta-Analysis of Randomized Controlled Trials.: 20
  1866. Incretinโ€based drugs and risk of lungย cancerย among individuals with type 2ย diabetes
  1867. Incretinโ€based therapies and risk of pancreaticย cancerย in patients with type 2ย diabetes: A metaโ€analysis of randomized controlled trials
  1868. Incretins andย cancerย of the bile duct in type 2ย diabetes
  1869. Incretins,ย diabetes, pancreatitis and pancreaticย cancer: what the GI specialist needs to know
  1870. Independent and joint effect of type 2ย diabetesย and gastric and hepatobiliary diseases on risk of pancreaticย cancerย risk: 10-year follow-up of population-based โ€ฆ
  1871. Independent associations between low-density lipoprotein cholesterol andย cancerย among patients with type 2ย diabetesย mellitus
  1872. Indispensability of Chemotherapy in Estrogen Receptorโ€“Negative Early Breastย cancerย in Elderly Women withย diabetesย Mellitus
  1873. Individuals withย diabetesย Have an Increased Risk of Colonย cancer: A Cross-Sectional Analysis: 1073
  1874. Induction of myasthenia gravis, myositis, and insulin-dependentย diabetesย mellitus by high-dose interleukin-2 in a patient with renal cellย cancer
  1875. Infection, antibiotic therapy and risk of colorectalย cancer: A nationwide nested caseโ€“control study in patients with Type 2ย diabetesย mellitus
  1876. Infectious and allergic diseases,ย cancer, andย diabetes
  1877. Infectious tenosynovitis of the long head of the biceps caused by methicillin-resistant Staphylococcus aureus in a patient withย diabetesย and small cell lungย cancer
  1878. Inflammation in Colorectalย cancerย Inflammatory Bowel Disease, andย diabetesย Mellitus: The Link
  1879. Inflammation, Type 2ย diabetes, andย cancer: Identifying Biomarkers Associated with Colorectalย cancerย and Type 2ย diabetes, and the Use of microRNA Molecules as a โ€ฆ
  1880. Inflammatory bowel disease, colorectalย cancerย and type 2ย diabetesย mellitus: The links
  1881. Influence and mechanism of miR-99a suppressing development of colorectalย cancerย (CRC) withย diabetesย mellitus (DM)
  1882. Influence of age on incidentย diabetesย (DM) and cardiovascular disease (CVD) among prostateย cancerย survivors receiving androgen deprivation therapy (ADT).
  1883. Influence of age on incidentย diabetesย and cardiovascular disease in prostateย cancerย survivors receiving androgen deprivation therapy
  1884. Influence of alimentary tract reconstruction on gastricย cancerย patients complicated with type 2ย diabetesย mellitus (a report of 67 cases)
  1885. Influence of Breastย cancerย and Metastases on Incidence ofย diabetes
  1886. Influence of concurrentย diabetesย mellitus on clinical progression and response to androgen deprivation therapy in patients with advanced prostateย cancer.
  1887. Influence ofย diabetesย Melitus, BMI, and HBA1C in High Grade Prostateย cancer
  1888. Influence ofย diabetesย mellitus and nodal distribution in endometrialย cancerย and correlation to clinico-pathological prognostic factors.
  1889. Influence ofย diabetesย mellitus on changes in plasma osmotic pressure during bowel preparation in patients undergoing radical resection for colonย cancer
  1890. Influence ofย diabetesย mellitus on mortality in breastย cancerย patients
  1891. Influence ofย diabetesย mellitus type 2 and prolonged estrogen exposure on risk of breastย cancerย among women in Armenia
  1892. Influence ofย diabetesย on susceptibility to experimental pancreaticย cancer
  1893. Influence ofย diabetesย on the interpretation of PET scans in patients with esophagealย cancer
  1894. Influence ofย diabetesย on the risk of urothelialย cancerย according to body mass index: a 10-year nationwide population-based observational study
  1895. INFLUENCE OF DIFFERENT GASTROINTESTINAL RECONSTRUCTIONS ON TYPE โ…กย diabetesย IN PATIENTS WITH DISTAL GASTRICย cancer
  1896. Influence of gastrectomy for stomachย cancerย on type 2ย diabetesย mellitus for patients with a body mass index less than 30 kg/m2
  1897. Influence of Hypertension andย diabetesย on Postoperative Outcomes Inย cancerย Patients Undergoing Moderate/High Risk Surgical Procedures
  1898. Influence of Hypertension on the Survival of Non-Small Cell Lungย cancerย Patients with Type 2ย diabetesย Mellitus
  1899. Influence of insulin therapy for type 2ย diabetesย mellitus onย cancerย incidence.
  1900. Influence of metformin intake on the risk of bladderย cancerย in type 2ย diabetesย patients
  1901. Influence of pathogenetic factors of type 2ย diabetesย on activation of PI3K/AkT/mTOR pathway and on the development of endometrial and breastย cancer
  1902. Influence of Preexistingย diabetesย on Survival After a Breastย cancerย Diagnosis in First Nations Women in Ontario, Canada
  1903. Influence of type 2ย diabetesย mellitus on Khorana venous thromboembolism risk in colorectalย cancerย patients
  1904. INFLUENCE OF TYPE โ…กย diabetesย ON SHORT-TERM SURGICAL OUTCOMES OF PATIENTS WITH GASTRICย cancer
  1905. Influence on blood sugar and nutrition indicators from EN or TPN for postoperative patients with gastricย cancerย andย diabetesย [J]
  1906. Influences from the treatment of thyroid disease andย diabetesย mellitus on breastย cancerย prognosis
  1907. Initial metformin or sulphonylurea exposure andย cancerย occurrence among patients with type 2ย diabetesย mellitus
  1908. Innovative approaches in oral, inhalational, and transdermal drug delivery forย cancerย andย diabetesย treatment.
  1909. Inotodiol suppresses proliferation of breastย cancerย in rat model of type 2ย diabetesย mellitus via downregulation of ฮฒ-catenin signaling
  1910. Insights into the relationships betweenย diabetes, prediabetes, andย cancer
  1911. Insulin glargine andย cancerย risk in patients withย diabetes: a meta-analysis
  1912. INSULIN RESISTANCE IN PATIENTS WITH PANCREATIC AND COLORECTALย cancerย DIAGNOSED AGAINST THE BACKGROUND OF TYPE 2ย diabetesย โ€ฆ
  1913. Insulin Resistance Is a Common Core Tethered toย diabetesย and Pancreaticย cancerย Risk
  1914. Insulin Resistance, Metabolic Syndrome andย diabetesย in Women at High Risk for Breastย cancer
  1915. Insulin therapy andย cancerย in type 2ย diabetes
  1916. Insulin therapy andย cancerย risk inย diabetesย mellitus
  1917. Insulin therapy and colorectalย cancerย risk among type 2ย diabetesย mellitus patients
  1918. Insulin therapy and colorectalย cancerย risk among type 2ย diabetesย mellitus patients: a systemic review and meta-analysis
  1919. Insulin therapy and the risk of colorectalย cancerย in patients with type 2ย diabetes: a metaโ€analysis of observational studies
  1920. Insulin therapy contributes to the increased risk of colorectalย cancerย inย diabetesย patients: a meta-analysis
  1921. Insulin therapy inย diabetesย andย cancerย risk: current understanding and implications for future study
  1922. Insulin therapy, duration ofย diabetesย linked toย cancerย risk
  1923. Insulin use andย cancerย risk in patients with type 2ย diabetes: a systematic review and meta-analysis of observational studies
  1924. Insulin use and smoking jointly increase the risk of bladderย cancerย mortality in patients with type 2ย diabetes
  1925. Insulin use, hormone receptor status and hematopoietic cytokinesืณ circulation in women withย diabetesย mellitus and breastย cancer
  1926. Insulin-increasingย diabetesย therapies raise risk of death fromย cancer
  1927. Insulin-like growth factor genetic variation, colorectalย cancerย andย diabetes
  1928. Insulin-like growth factor system gene expression in women with type 2ย diabetesย and breastย cancer
  1929. Insulin-like growth factor-I, interleukin-1 ฮฑ and ฮฒ in pancreaticย cancer: role in tumor invasiveness and associatedย diabetes
  1930. Insulin-mediated acceleration of breastย cancerย development and progression in a nonobese model of type 2ย diabetes
  1931. Insulin, glucose and the increased risk ofย cancerย in patients with type 2ย diabetes
  1932. Intake of 12 food groups and disability-adjusted life years from coronary heart disease, stroke, type 2ย diabetes, and colorectalย cancerย in 16 European countries
  1933. Intake of dietary saturated fatty acids and risk of type 2ย diabetesย in the European Prospective Investigation intoย cancerย and Nutrition-Netherlands cohort โ€ฆ
  1934. Intensive glucose control and risk ofย cancerย in patients with type 2ย diabetes
  1935. Intensive glycaemic control andย cancerย risk in type 2ย diabetes: a meta-analysis of major trials
  1936. Intensive versus conventional insulin therapy in type 2ย diabetesย patients undergoing D2 gastrectomy for gastricย cancer: a randomized controlled trial
  1937. Intensive weight loss intervention andย cancerย risk in adults with type 2ย diabetes: analysis of the Look AHEAD randomized clinical trial
  1938. Interaction and joint effect of ALT and chronic liver disease on liverย cancerย in type 2ย diabetesย patients
  1939. Interactions betweenย diabetesย andย cancer
  1940. Interactions between PPAR gamma and the canonical Wnt/beta-catenin pathway in type 2ย diabetesย and colonย cancer
  1941. Interim Report-September 2011 Cohort Study of Pioglitazone andย cancerย Incidence in Patients withย diabetesย Mellitus Extended Follow-up (1997-2009)
  1942. Interrelationship between oxidative stress, DNA damage andย cancerย risk inย diabetesย (Type 2) in Riyadh, KSA
  1943. Intersections and clinical translations ofย diabetesย mellitus withย cancerย promotion, progression and prognosis
  1944. Intratumoural leukocyte infiltration is a prognostic indicator among pancreaticย cancerย patients with type 2ย diabetes
  1945. Investigating the Mechanisms Underlying the Link Betweenย diabetesย andย cancer
  1946. Investigation of the biological function of fibroblast activation protein and its potential as a therapeutic target inย cancerย andย diabetes
  1947. Investigation of the presence of polymorphism in exons 2 and 3 of the DIRAS3 gene in women with breastย cancerย andย diabetes
  1948. Involvement of Adrenomedullin Expression in Tumor Cells and Stroma in the Development ofย diabetesย in Pancreaticย cancerย Patients
  1949. Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: fromย diabetes, obesity to cell cycle, andย cancer
  1950. Isย cancerย incidence different between type 2ย diabetesย patients compared to non-diabetics in hemodialysis? A study from the REIN registry
  1951. Is colorectalย cancerย associated withย diabetesย mellitus?
  1952. Isย diabetesย a causal agent for colorectalย cancer? Pathophysiological and molecular mechanisms
  1953. Isย diabetesย a risk factor for colorectalย cancer?
  1954. Isย diabetesย Associated with Progression to Dysplasia orย cancerย in Barrettโ€™s Esophagus?: 49
  1955. Isย diabetesย mellitus (DM) associated with worse outcomes in pancreaticย cancerย (PC)?
  1956. Isย diabetesย mellitus a negative prognostic factor for the treatment of advanced non-small-cell lungย cancer?
  1957. Isย diabetesย mellitus a prognostic factor for survival in patients with small cell lungย cancer?
  1958. Isย diabetesย mellitus a risk factor for ovarianย cancer? A case-control study in Utah and Washington (United States)
  1959. Isย diabetesย mellitus a risk factor for pancreaticย cancer?
  1960. Isย diabetesย mellitus an independent risk factor for colonย cancerย and rectalย cancer?
  1961. Isย diabetesย mellitus associated with increased incidence and disease-specific mortality in endometrialย cancer? A systematic review and meta-analysis of cohort โ€ฆ
  1962. Isย diabetesย mellitus associated with poorly differentiated prostateย cancerย (PCA)?
  1963. Isย diabetesย mellitus associated with prostateย cancerย incidence and survival?
  1964. Is there a link between BRCA1 and BRCA2 mutations and obesity, high blood pressure andย diabetesย mellitus in Romanian high-risk breastย cancerย cases?
  1965. Is there any relation betweenย diabetesย therapy andย cancerย risk?
  1966. Is there evidence for sex differences in the association betweenย diabetesย andย cancer?
  1967. Is there evidence for sex differences in the association betweenย diabetesย andย cancer? Reply to Dankner R, Boker LK, Freedman LS
  1968. Is type 2ย diabetesย a risk factor for pancreaticย cancer
  1969. Is type 2ย diabetesย causally associated withย cancerย risk? Evidence from a two-sample Mendelian randomization study
  1970. Is Type 2ย diabetesย Mellitus a Risk Factor for Pancreaticย cancerย and is Metformin Able to Prevent this Risk?
  1971. Is Type 2ย diabetesย Mellitus Causally Associated withย cancerย Risk? Evidence from a Two-Sample Mendelian Randomisation Study
  1972. Islet amyloid polypeptide in patients with pancreaticย cancerย andย diabetes
  1973. Islet hormone secretion in pancreaticย cancerย patients withย diabetes.
  1974. Islet inflammation: a causal link betweenย diabetesย and pancreaticย cancer?
  1975. Isoform-and Paralog-Switching in IR-Signaling: Whenย diabetesย Opens the Gates toย cancer
  1976. Kidneyย cancerย andย diabetesย mellitus: a population-based case-control study in Taiwan
  1977. Killing by lungย cancerย or byย diabetes? The trade-off between smoking and obesity
  1978. Killing by lungย cancerย or byย diabetes? The trade-off between smoking and obesity
  1979. Killing by lungย cancerย or byย diabetes? The trade-off between smoking and obesity
  1980. Knowledge, attitudes, and practices related to pet contact by immunocompromised children withย cancerย and immunocompetent children withย diabetes
  1981. KRAS-induced actin-interacting protein: a potent target for obesity,ย diabetesย andย cancer
  1982. Lactate, a neglected factor forย diabetesย andย cancerย interaction
  1983. Late effects of childhoodย cancerย treatment: severe hypertriglyceridaemia, central obesity, non alcoholic fatty liver disease andย diabetesย as complications of childhood โ€ฆ
  1984. Late-onsetย diabetesย and the link with pancreaticย cancer
  1985. Latest insights into the risk ofย cancerย inย diabetes
  1986. LEISURE-TIME PHYSICAL ACTIVITY AND THE ONSET OF TYPE 2ย diabetesย IN THE MALMร– DIET ANDย cancerย STUDY COHORT
  1987. Leptin and adiponectin in pancreaticย cancer: connection withย diabetesย mellitus.
  1988. Less advanced stages of colonย cancerย in patients with type 2ย diabetesย mellitus: an unexpected finding?
  1989. Less aggressive treatment and worse overall survival inย cancerย patients withย diabetes: a large population based analysis
  1990. Letter to the Editor-The impact of anti-diabetic drugs on colorectalย cancerย risk in a large cohort of women withย diabetes
  1991. Letter to the Editor: Comments on โ€œUse of metformin and risk of kidneyย cancerย in patients with type 2ย diabetesโ€, Chinโ€Hsiao Tseng, Eur Jย cancerย 2016; 52: 19 โ€ฆ
  1992. Lifestyle factors and mortality among adults withย diabetes: findings from the European Prospective Investigation intoย cancerย and Nutritionโ€“Potsdam study
  1993. Lifestyle interventions for four conditions: type 2ย diabetes, metabolic syndrome, breastย cancer, and prostateย cancer
  1994. Linking type 2ย diabetesย and gynecologicalย cancer: an introductory overview
  1995. Links among type 2ย diabetes,ย cancerย and metformin use: What have we learned?
  1996. Links between obesity,ย diabetesย and ethnic disparities in breastย cancerย among Hispanic populations
  1997. LIVERย cancerย PREDICTION FOR TYPE-IIย diabetesย USING CLASSIFICATION ALGORITHM.
  1998. Liver cirrhosis with high IgG4 in a patient with,ย diabetesย mellitus, ulcerative colitis with papillary thyroidย cancer, is it all related? which one to blame& is it time to raise โ€ฆ
  1999. Liver enzymes and incidentย diabetes: findings from the European Prospective Investigation intoย cancerย and Nutrition (EPIC)-Potsdam Study
  2000. Long nonโ€coding RNAE330013P06 promotes progression of breastย cancerย with type 2ย diabetes
  2001. Long-standingย diabetesย and its effects on outcomes in colonย cancer.
  2002. Long-term all-cause mortality inย cancerย patients with preexistingย diabetesย mellitus: a systematic review and meta-analysis
  2003. Long-termย diabetesย mellitus is associated with an increased risk of pancreaticย cancer: a meta-analysis
  2004. Long-termย diabetesย risk among endometrialย cancerย survivors in a population-based cohort study
  2005. Long-termย diabetesย risk among ovarianย cancerย survivors in a population-based cohort study
  2006. Long-term exposure to low-level arsenic in drinking water andย diabetesย incidence: a prospective study of the diet,ย cancerย and health cohort
  2007. Long-term follow-up for type 2ย diabetesย mellitus after gastrectomy in non-morbidly obese patients with gastricย cancer: the legitimacy of onco-metabolic surgery
  2008. Long-term Mortality inย cancerย Patients With Preexistingย diabetes
  2009. Long-term Mortality inย cancerย Patients With Preexistingย diabetesโ€”Reply
  2010. Long-term use of long-acting insulin analogs and breastย cancerย incidence in women with type 2ย diabetes
  2011. Longโ€term survival analysis of patients with nonโ€small cell lungย cancerย complicated with type 2ย diabetesย mellitus
  2012. Loss of microRNA expression is involved in the development and prognosis of breastย cancerย complicated by Type 2ย diabetesย mellitus
  2013. Lowย cancerย death rate in chronic dialysis patients withย diabetesย mellitus
  2014. Low HDL cholesterol, metformin use, andย cancerย risk in type 2ย diabetes: the Hong Kongย diabetesย Registry
  2015. Low LDL cholesterol, albuminuria, and statins for the risk ofย cancerย in type 2ย diabetes: the Hong Kongย diabetesย registry
  2016. Low National Breast and Cervicalย cancerย Screening Rates in American Indian and Alaska Native Women withย diabetes
  2017. Low national breast and cervicalย cancer-screening rates in American Indian and Alaska Native women withย diabetes
  2018. Low plasma level of atrial natriuretic peptide predicts development ofย diabetes: the prospective Malmรถ Diet andย cancerย study
  2019. Low triglyceride and nonuse of statins is associated withย cancerย in type 2ย diabetesย mellitus: the Hong Kongย diabetesย Registry
  2020. Low-dose aspirin reduces breastย cancerย risk in women withย diabetes: a nationwide retrospective cohort study in Taiwan
  2021. Low-fat dietary pattern among postmenopausal women influences long-termย cancer, cardiovascular disease, andย diabetesย outcomes
  2022. Lungย cancerย andย diabetes: A role for advanced glycation endโ€products?
  2023. Lungย cancerย presenting as Centralย diabetesย Insipidus
  2024. Lungย cancerย risk,ย diabetes, andย diabetesย treatments.
  2025. MA06. 07 Impact of Type 2ย diabetesย Mellitus and Its Metabolic Control on Prognosis of Unresectable Non-Small Cell Lungย cancerย Patients
  2026. Machine Learning in Healthcare: Breastย cancerย andย diabetesย Cases
  2027. Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases,ย diabetesย andย cancer
  2028. Mammary Adipose Tissue Control of Breastย cancerย Progression: Impact of Obesity andย diabetes
  2029. Management of colorectalย cancerย andย diabetes
  2030. Management of comorbidย diabetesย andย cancerย in the elderly
  2031. Management of comorbidย diabetesย andย cancer.
  2032. Management ofย diabetesย and pancreaticย cancer.
  2033. Management ofย diabetesย in patients withย cancer
  2034. Management ofย diabetesย mellitus in terminally illย cancerย patients
  2035. Managingย diabetesย inย cancerย patients
  2036. Managingย diabetesย mellitus in patients with advancedย cancer: a case note audit and guidelines
  2037. Managing people withย diabetesย during theย cancerย palliation in the era of simultaneous care
  2038. Mandibular reconstruction using 2-step bone transport in an irradiatedย cancerย patient with type 2ย diabetesย mellitus
  2039. Mass screening for endometrialย cancerย directed in risk groups of patients withย diabetesย and patients with hypertension
  2040. Mass spectrometry in the analysis of peptides involved inย cancer,ย diabetesย and long-term memory
  2041. Maternalย diabetesย and incidence of childhoodย cancerโ€“a nationwide cohort study and exploratory genetic analysis
  2042. Maternalย diabetesย and risk of childhoodย cancerย in the offspring
  2043. Maternal perceptions of paediatricย cancerย andย diabetesย in Cameroon
  2044. Maternal pre-pregnancy and gestationalย diabetes, obesity, gestational weight gain, and risk ofย cancerย in young children: a population-based study in California
  2045. Mathematical Medicine: Modeling Disease and Treatment Key words: Immune dynamics;ย cancer;ย diabetes; Ordinary differential equations
  2046. Matricaria Chamomile Protective Effect Against Type-2ย diabetesย Mellitus andย cancerย Cell Linings
  2047. Mean platelet volume may not be an independent prognostic factor in breastย cancerย patients with type 2ย diabetesย mellitus
  2048. Measures of impact:ย diabetesย and urothelialย cancer
  2049. Mechanism (s) of pancreaticย cancer-inducedย diabetes
  2050. Mechanism of protein kinase B activation by insulin IGF1 revealed by specific inhibitors of the phosphoinositide 3-kinase. Significance forย diabetesย andย cancer
  2051. Mediation of black/white disparities in triple negative breastย cancerย by socioeconomic position, reproductive factors andย diabetesย in the Nursesโ€™ Health Study Cohorts I โ€ฆ
  2052. Medically managed hypercholesterolemia and insulin-dependentย diabetesย mellitus preoperatively predicts poor survival after surgery for pancreaticย cancer
  2053. Mediterranean diet and type 2ย diabetesย risk in the European Prospective Investigation intoย cancerย and Nutrition (EPIC) study: the InterAct project
  2054. Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2ย diabetesย andย cancer
  2055. Meta-analysis of androgen deprivation therapy for prostateย cancerย related withย diabetes
  2056. Meta-analysis of mitochondrial T16189C polymorphism forย cancerย and Type 2ย diabetesย risk
  2057. Meta-analysis of the relationship between type 2ย diabetesย and the risk of kidneyย cancer
  2058. Metaโ€analysis of the association between sodiumโ€glucose coโ€transporterโ€2 inhibitors and risk of skinย cancerย among patients with type 2ย diabetes
  2059. Metabolic Adaptations inย diabetesย Mellitus andย cancer
  2060. Metabolic reprogramming in type 2ย diabetesย and the development of breastย cancer
  2061. Metabolic syndrome andย diabetesย mellitus in childhoodย cancerย survivors.
  2062. Metabolic syndrome and preโ€diabetesย contribute to racial disparities in breastย cancerย outcomes: hypothesis and proposed pathways
  2063. Metabolic syndrome and risk of incidentย diabetes: findings from the European Prospective Investigation intoย cancerย and Nutrition-Potsdam Study
  2064. Metabolic syndrome,ย diabetesย mellitus, and the subsequent development of prostateย cancer
  2065. Metabolic syndrome, type 2ย diabetes, andย cancer: epidemiology and potential mechanisms
  2066. Metastatic breastย cancerย presenting withย diabetesย insipidus
  2067. Metastatic breastย cancerย presenting withย diabetesย insipidus.
  2068. Metformin (M),ย diabetesย (DM), and colorectalย cancerย (CRC) survival among US veterans.
  2069. Metformin ameliorates testicular damage inย diabetesย and prostateย cancerย model
  2070. Metformin and biliary tractย cancerย in patients with type 2ย diabetes
  2071. Metformin and breast and gynecologicalย cancerย risk among women withย diabetes
  2072. Metformin andย cancerย in type 2ย diabetes
  2073. Metformin andย cancerย in type 2ย diabetes: a systematic review and comprehensive bias evaluation
  2074. Metformin and endometrialย cancerย risk in Chinese women with type 2ย diabetesย mellitus in Taiwan
  2075. Metformin and esophagealย cancerย risk in Taiwanese patients with type 2ย diabetesย mellitus
  2076. Metformin and Gastrointestinalย cancerย Development in Newly Diagnosed Type 2ย diabetes: A Population-Based Study in Korea
  2077. Metformin and lungย cancerย risk in patients with type 2ย diabetesย mellitus
  2078. Metformin and lungย cancerย risk of patients with type 2ย diabetesย mellitus: A metaโ€‘analysis
  2079. Metformin and pancreaticย cancerย risk in patients with type 2ย diabetes
  2080. Metformin and pancreaticย cancerย risk in Taiwanese patients with type 2ย diabetes
  2081. Metformin and Probiotics in the Crosstalk between Colitis-Associated Colorectalย cancerย andย diabetesย in Mice
  2082. Metformin and reduced risk ofย cancerย in the Hong Kongย diabetesย registry: real effect or immortal time bias?
  2083. Metformin and risk ofย cancerย among patients with type 2ย diabetesย mellitus: A systematic review and meta-analysis
  2084. Metformin and risk of developing nasopharyngealย cancerย in patients with type 2ย diabetesย mellitus
  2085. Metformin and sulfonylureas in relation toย cancerย risk in type IIย diabetesย patients: a meta-analysis using primary data of published studies
  2086. Metformin and the incidence ofย cancerย in patients withย diabetes: a nested case-control study
  2087. Metformin and the incidence of prostateย cancerย in patients with type 2ย diabetes
  2088. Metformin and the incidence of prostateย cancerย in patients with type 2ย diabetes
  2089. Metformin and the risk ofย cancerย in type 2ย diabetes: methodological challenges and perspectives
  2090. Metformin as a risk factor of pathogenesis of colorectalย cancerย in type 2ย diabetesย patients: a Meta-analysis
  2091. Metformin associated with increased survival in type 2ย diabetesย patients with pancreaticย cancerย and lymphoma
  2092. Metformin associated with lowerย cancerย mortality in type 2ย diabetes: ZODIAC-16
  2093. Metformin Associates With Aggressive Features of Endometrialย cancerย in Women With Type 2ย diabetes
  2094. Metformin association with lower prostateย cancerย recurrence in type 2ย diabetes: a systematic review and meta-analysis
  2095. Metformin changes the immune microenvironment of colorectalย cancerย in patients with type 2ย diabetesย mellitus
  2096. Metformin depresses overactivated Notch1/Hes1 signaling in colorectalย cancerย patients with type 2ย diabetesย mellitus
  2097. Metformin diminishes the unfavourable impact of Nrf2 in breastย cancerย patients with type 2ย diabetes
  2098. Metformin does not suppress the aromatase expression in breastย cancerย tissue of patients with concurrent type 2ย diabetes
  2099. Metformin effect on clinical course of non-small cell lungย cancerย (NSCLC) in patients (pts.) with concomitantย diabetesย mellitus (DM) after radical resection.
  2100. Metformin for liverย cancerย prevention in patients with type 2ย diabetes: a systematic review and meta-analysis
  2101. Metformin for primary colorectalย cancerย prevention in patients withย diabetes: A caseโ€control study in a US population
  2102. Metformin for Reducing Racial/Ethnic Difference in Prostateย cancerย Incidence for Men with Type 2ย diabetesย Running title: Metformin for Reducing Prostateย cancerย โ€ฆ
  2103. Metformin for reducing racial/ethnic difference in prostateย cancerย incidence for men with type IIย diabetes
  2104. Metformin has a positive therapeutic effect on prostateย cancerย in patients with type 2ย diabetesย mellitus
  2105. Metformin Impacts the Prognosis ofย cancerย Patients with Type 2ย diabetes
  2106. Metformin improves overall survival of colorectalย cancerย patients withย diabetes: a meta-analysis
  2107. Metformin improves survival and recurrence rate in patients withย diabetesย and gastricย cancer
  2108. Metformin improves survival in lungย cancerย patients with type 2ย diabetesย mellitus: A meta-analysis
  2109. Metformin increases overall survival in patients withย diabetesย undergoing surgery for colorectalย cancer
  2110. Metformin increases survival in hormone receptor-positive, HER2-positive breastย cancerย patients withย diabetes
  2111. Metformin Inhibits Thyrocyte Growth and Increases Complete Responses in Differentiated Thyroidย cancerย in Patients withย diabetes
  2112. Metformin is associated with a lower risk of colorectalย cancerย in Taiwanese patients with type 2ย diabetes: a retrospective cohort analysis
  2113. Metformin is associated with decreased skinย cancerย risk in Taiwanese patients with type 2ย diabetes
  2114. Metformin is associated with reduced odds for colorectalย cancerย among persons withย diabetes
  2115. Metformin is associated with reduced risk of pancreaticย cancerย in patients with type 2ย diabetesย mellitus: a systematic review and meta-analysis
  2116. Metformin is associated with slightly reduced risk of colorectalย cancerย and moderate survival benefits inย diabetesย mellitus: a meta-analysis
  2117. Metformin is associated with survival benefit inย cancerย patients with concurrent type 2ย diabetes: a systematic review and meta-analysis
  2118. Metformin is associated with survival benefit in pancreaticย cancerย patients withย diabetes: a systematic review and meta-analysis
  2119. Metformin May Cut Risk ofย cancerย in Type 2ย diabetes
  2120. Metformin may reduce bladderย cancerย risk in patients with type 2ย diabetes
  2121. Metformin may reduce bladderย cancerย risk in Taiwanese patients with type 2ย diabetes
  2122. Metformin may reduce breastย cancerย risk in Taiwanese women with type 2ย diabetes
  2123. Metformin may reduce oralย cancerย risk in patients with type 2ย diabetes
  2124. Metformin Preventsย cancerย in Type 2ย diabetes
  2125. Metformin prolongs survival in type 2ย diabetesย lungย cancerย patients with EGFR-TKIs
  2126. Metformin protects againstย diabetesโ€“induced heart injury and dunning prostateย cancerย model
  2127. Metformin reduces colonย cancerย risk in patients with type 2ย diabetes: a retrospective cohort analysis
  2128. Metformin reduces gastricย cancerย risk in patients with type 2ย diabetesย mellitus
  2129. Metformin reduces ovarianย cancerย risk in Taiwanese women with type 2ย diabetesย mellitus
  2130. Metformin Reduces Radiation-Induced Cardiac Toxicity Risk in Patients Havingย diabetesย and Breastย cancer: Results from the Taiwan National Cohort and Basic โ€ฆ
  2131. Metformin reduces the risk ofย cancerย in patients with type 2ย diabetes: An analysis based on the Korean Nationalย diabetesย Program Cohort
  2132. Metformin reduces thyroidย cancerย risk in Taiwanese patients with type 2ย diabetes
  2133. Metformin significantly reduces incident prostateย cancerย risk in Taiwanese men with type 2ย diabetesย mellitus
  2134. Metformin therapy and risk ofย cancerย in patients with type 2ย diabetes: systematic review
  2135. Metformin therapy and risk of colorectal adenomas and colorectalย cancerย in type 2ย diabetesย mellitus patients: A systematic review and meta-analysis
  2136. Metformin therapy associated with survival benefit in lungย cancerย patients withย diabetes
  2137. Metformin treatment andย cancerย risk: Cox regression analysis, with time-dependent covariates, of 320,000 persons with incidentย diabetesย mellitus
  2138. Metformin use and all-cause and prostateย cancer-specific mortality among men withย diabetes
  2139. Metformin use and cervicalย cancerย risk in female patients with type 2ย diabetes
  2140. Metformin use and its effect on gastricย cancerย in patients with type 2ย diabetes: a systematic review of observational studies
  2141. Metformin use and kidneyย cancerย outcomes in patients withย diabetes: a propensity score analysis
  2142. Metformin use and lungย cancerย risk in patients withย diabetes
  2143. Metformin use and pancreaticย cancerย survival among non-Hispanic White and African American US veterans withย diabetesย mellitus
  2144. Metformin use and pancreaticย cancerย survival in US veterans withย diabetesย mellitus: Are there racial differences?
  2145. Metformin use and renal cellย cancerย outcomes among patients withย diabetes.
  2146. Metformin use and risk ofย cancerย in patients with type 2ย diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural โ€ฆ
  2147. Metformin use and risk of lungย cancerย in patients withย diabetes.
  2148. Metformin Use and the Incidence of Colorectal and Lungย cancerย in Patients with Type 2ย diabetesย Mellitus
  2149. Metformin use and the risk ofย cancerย in patients withย diabetes: A nationwide sample cohort study
  2150. Metformin use associated with lower risk ofย cancerย in patients withย diabetesย mellitus type 2.
  2151. Metformin Use forย diabetesย May Reduceย cancerย Risk in DM1
  2152. Metformin use is associated with better survival of breastย cancerย patients withย diabetes: a meta-analysis
  2153. Metforminโ€”mode of action and clinical implications forย diabetesย andย cancer
  2154. Metformin, a first-line drug for type 2ย diabetesย mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervicalย cancerย cells
  2155. Metformin, Asian ethnicity and risk of prostateย cancerย in type 2ย diabetes: a systematic review and meta-analysis
  2156. Metformin, at concentrations corresponding to the treatment ofย diabetes, potentiates the cytotoxic effects of carboplatin in cultures of ovarianย cancerย cells
  2157. Metformin,ย diabetes, and survival among US veterans with colorectalย cancer
  2158. Metformin,ย diabetes, and Survival among US Veterans with Colorectalย cancer
  2159. Metformin,ย diabetes, and Survival among US Veterans with Colorectalย cancerโ€”Response
  2160. METFORMIN, STATINS AND THE RISK AND PROGNOSIS OF ENDOMETRIALย cancerย IN WOMEN WITH TYPE 2ย diabetes
  2161. Metformin, the aspirin of the 21st century: its role in gestationalย diabetesย mellitus, prevention of preeclampsia andย cancer, and the promotion of longevity
  2162. Metformin: a bridge betweenย diabetesย and prostateย cancer
  2163. Metformin: a salutary candidate for colorectalย cancerย treatment in patients withย diabetes
  2164. Metformin: on ongoing journey acrossย diabetes,ย cancerย therapy and prevention
  2165. Metformin: Possible Use of aย diabetesย Drug in Treatment ofย cancer
  2166. Methylglyoxal, a potent inducer of AGEs, connects betweenย diabetesย andย cancer
  2167. Metrics ofย diabetesย risk are only minimally improved by exercise training in postmenopausal breastย cancerย survivors
  2168. Metrics ofย diabetesย risk are only minimally improved by exercise training in postmenopausal breastย cancerย survivors
  2169. MicroRNA-30b is involved in the pathological process ofย diabetesย mellitus induced by pancreaticย cancerย by regulating plasminogen activator inhibitor-1
  2170. MicroRNA,ย diabetesย Mellitus and Colorectalย cancer
  2171. MicroRNAs 103 and 107 link type 2ย diabetesย and post-menopausal breastย cancer
  2172. MicroRNAs 103 and 107: potential molecular links betweenย diabetesย andย cancer
  2173. Microsatellite instability is inversely associated with type 2ย diabetesย mellitus in colorectalย cancer
  2174. Microvascular reconstruction in elderly oralย cancerย patients: doesย diabetesย status have a predictive role in free flap complications?
  2175. Middle-aged men with type 2ย diabetesย as potential candidates for pancreaticย cancerย screening: a 10-year nationwide population-based cohort study
  2176. Midlifeย cancer/diabetesย and risk of dementia and mild cognitive impairment: A population-based prospective cohort study in Japan
  2177. Milk intake and the risk of type 2ย diabetesย mellitus, hypertension and prostateย cancer
  2178. MiR-1231 decrease the risk ofย cancer-related mortality in patients combined with non-small cell lungย cancerย andย diabetesย mellitus
  2179. miRNAs in insulin resistance andย diabetes-associated pancreaticย cancer: the โ€˜minute and miracleโ€™molecule moving as a monitor in the โ€˜genomic galaxyโ€™
  2180. Mitochondrial dynamics in type 2ย diabetesย andย cancer
  2181. Modalities for assessing the nutritional status in patients withย diabetesย andย cancer
  2182. Model Checking a Synchronousย diabetesโ€“cancerย Logical Network
  2183. Model Checking of aย diabetesโ€cancerย Model
  2184. Model to determine risk of pancreaticย cancerย in patients with new-onsetย diabetes
  2185. Model to Determine Risk of Pancreaticย cancerย in Patients with New-onsetย diabetesย Running title: END-PAC Risk Stratification Score
  2186. Model-based in silico analysis of the PI3K/Akt pathway: the elucidation of cross-talk betweenย diabetesย and breastย cancer
  2187. Modeling effects ofย diabetesย and obesity co-morbidities in endometrialย cancerย development and progression
  2188. Moderating effects of sleep duration onย diabetesย risk amongย cancerย survivors: Analysis of the National Health Interview Survey in the USA
  2189. Modern Eggs, Not Wild Type Eggs, Predispose Risk of Cardiovascular Disease,ย diabetesย andย cancer?
  2190. Modest increase in risk of specific types ofย cancerย types in type 2ย diabetesย mellitus patients
  2191. Modification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations ofย diabetesย with breastย cancerย risk and survival
  2192. Modifications of fibronectin in age-related diseases:ย diabetesย andย cancer
  2193. Molecular Correlations between Breastย cancerย andย diabetesย Mellitus Type 2 Examined by In Silico analyses and Drug Inhibitory Effects
  2194. Molecular evidence of fieldย cancerization initiated byย diabetesย in colonย cancerย patients
  2195. Molecular mechanisms and therapeutic effects of (โˆ’)-epicatechin and other polyphenols inย cancer, inflammation,ย diabetes, and neurodegeneration
  2196. Molecular mechanisms of metformin forย diabetesย andย cancerย treatment
  2197. Molecular mechanisms of the cross-impact of pathological processes in combinedย diabetesย andย cancer. Research and clinical aspects
  2198. Molecular mechanisms underlying curcumin-mediated therapeutic effects in type 2ย diabetesย andย cancer
  2199. Molecular targets of functional foods and bioactive compounds in the prevention of type 2ย diabetesย and colonย cancer
  2200. MON-008 Use of National Death Index to Assessย cancerย Mortality andย diabetesย Relationship
  2201. MON-116 Metabolic Parameters inย cancerย Patients with and Withoutย diabetesย Mellitus
  2202. MON-678 Worseningย diabetesย Control in Breastย cancerย Patients Treated with Alpelisib
  2203. MON-LB306 Association Betweenย cancerย Related Beliefs andย diabetesย Medication Adherence Among Breastย cancerย Survivors With Comorbid Type 2ย diabetes
  2204. Mortality afterย cancerย among patients withย diabetesย mellitus: effect ofย diabetesย duration and treatment
  2205. Mortality afterย cancerย among patients withย diabetesย mellitus: effect ofย diabetesย duration and treatment:(questionable) classification of diabetic patients based โ€ฆ
  2206. Mortality afterย cancerย among patients withย diabetesย mellitus: effect ofย diabetesย duration and treatment:(questionable) classification of diabetic patients based on โ€ฆ
  2207. Mortality after incidentย cancerย in people with and without type 2ย diabetes: impact of metformin on survival
  2208. Mortality and glycemic control among patients withย diabetesย mellitus and uterine or ovarianย cancer
  2209. Mortality and glycemic control among patients with gastric and esophagealย cancerย andย diabetesย mellitus.
  2210. Mortality causes inย cancerย patients with type 2ย diabetesย mellitus
  2211. Mortality trends of liverย cancerย among patients with type 2ย diabetesย at the global and national level
  2212. MP-1.06: Isย diabetesย Mellitus Associated with Aggressive Characteristics in Prostateย cancer?
  2213. MP36-16 EFFECTS OFย diabetesย ON RENALย cancerย PROGNOSIS
  2214. MP37-08 THE ASSOCIATION BETWEENย diabetesย AND PROSTATEย cancer-SPECIFIC MORTALITY IS DIFFERENT IN OBESE AND NON-OBESE MEN AFTER โ€ฆ
  2215. MP54-12ย diabetesย MELLITUS IS ASSOCIATED WITH AN INCREASED RISK OFย cancer-SPECIFIC MORTALITY AMONG PATIENTS WITH CLEAR CELL RENAL โ€ฆ
  2216. MP59-12 ISย diabetesย MELLITUS ASSOCIATED WITHย cancerย SPECIFIC AND OVERALL SURVIVAL IN LOCALIZED CLEAR CELL RENAL CELL CARCINOMA?
  2217. MP72-13 OUTCOMES OF RADICAL CYSTECTOMY IN PATIENTS WITH BLADDERย cancerย AND UNCONTROLLEDย diabetes: A POPULATION-BASED STUDY
  2218. MP77-03ย diabetesย MELLITUS INCREASES BLADDERย cancerย RECURRENCE RISK IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA
  2219. MP77-14ย diabetesย MELLITUS, METFORMIN AND PROSTATEย cancer: RESULTS OF A PROSTATEย cancerย DATABASE ANALYSIS
  2220. mTOR Complex1โ€“S6K1 signaling: at the crossroads of obesity,ย diabetesย andย cancer
  2221. mTOR: from growth signal integration toย cancer,ย diabetesย and ageing
  2222. Multicenter results of long-limb bypass reconstruction after gastrectomy in patients with gastricย cancerย and type IIย diabetes
  2223. Multiple autoimmunity, type 1ย diabetesย (T1DM), autoimmune thyroiditis and thyroidย cancer: is there an association? A case report and literature review
  2224. Multivariate analysis on the effects ofย diabetesย and related clinical parameters on cervicalย cancerย survival probability
  2225. Mutant p53 and HbA1c in Type 2ย diabetesย Melitus Patients With and Withoutย cancer
  2226. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases,ย diabetesย andย cancer
  2227. Mycobacterium neoaurum Bloodstream Infection Associated with a Totally Implanted Subclavian Port in an Adult withย diabetesย and History of Colonย cancer
  2228. Myelotoxicity of cyclophosphamide, methotrexate and 5-fluorouracil regimen in the early stage breastย cancerย patients withย diabetesย mellitus
  2229. Nanomedicine:ย cancer,ย diabetes, and cardiovascular, central nervous system, pulmonary and inflammatory diseases
  2230. Nanoparticle-Based Delivery of Phytochemical Compounds Against Major Maladies:ย cancer,ย diabetes, and Cardiovascular Disease
  2231. Nanowires for earlyย cancerย andย diabetesย diagnosis via micro-RNA detection in urine extracellular vesicles
  2232. NATIONAL ESTIMATES OF UTILIZATION AND EXPENDITURES FOR PATIENTS WITHย diabetesย ANDย cancer
  2233. Nationwide trends in pancreatitis and pancreaticย cancerย risk among patients with newly diagnosed type 2ย diabetesย receiving dipeptidyl peptidase 4 inhibitors
  2234. NCOA5, a molecular link between type 2ย diabetesย and liverย cancer
  2235. Neither hormonal factors nor AGEs explain lower prostateย cancerย risk in older men withย diabetesย mellitus
  2236. Nephrogenicย diabetesย insipidus. An unusual presentation of recurrent rectalย cancer
  2237. Nerve growth factor as an important possible component of novel therapy forย cancer,ย diabetesย and cardiovascular diseases
  2238. Neurogenicย diabetesย insipidus: an unusual clinical presentation of small cell lungย cancer.
  2239. Neuronatin gene: imprinted and misfolded: studies in Lafora disease,ย diabetesย andย cancerย may implicate NNAT-aggregates as a common downstream โ€ฆ
  2240. Newย diabetesย drug: Colonย cancerย friend or foe?
  2241. New insight into metformin action:ย diabetes, prostateย cancer, ion channels
  2242. New insights in the molecular pathways linking obesity, type 2ย diabetesย andย cancer
  2243. New insights into pancreaticย cancer-induced paraneoplasticย diabetes
  2244. New onset of type 2ย diabetesย as a complication afterย cancerย diagnosis: A systematic review
  2245. NEW ONSET TYPE 1ย diabetesย AFTER DOUBLE IMMUNOTHERAPY FOR NEUROENDOCRINE LUNGย cancer
  2246. New resveratrol analogues for potential use inย diabetesย andย cancer
  2247. New users of metformin are at low risk of incidentย cancer: a cohort study among people with type 2ย diabetes
  2248. New-onsetย diabetesย after androgen-deprivation therapy for prostateย cancer: A nationwide propensity score-matched four-year longitudinal cohort study
  2249. New-onsetย diabetesย and pancreaticย cancer
  2250. New-onsetย diabetesย as an early sign of pancreaticย cancer
  2251. New-Onsetย diabetesย Confers Increased Risk for Pancreaticย cancerย in a Large Cohort of US Veterans: 732
  2252. New-onsetย diabetesย in pancreaticย cancer: a study in the primary care setting
  2253. New-onsetย diabetesย mellitus and risk of pancreaticย cancer: A systematic review and meta analysis.
  2254. New-onsetย diabetesย patients need pancreaticย cancerย screening?
  2255. New-onsetย diabetesย with a history of dyslipidemia predicts pancreaticย cancer
  2256. New-onsetย diabetes, longitudinal trends in metabolic markers, and risk of pancreaticย cancerย in a heterogeneous population
  2257. New-onsetย diabetes: a clue to the early diagnosis of pancreaticย cancer
  2258. New-onsetย diabetes: a potential clue to the early diagnosis of pancreaticย cancer
  2259. New-onsetย diabetes: aclue to the early diagnosis of pancreaticย cancer/Mechanism (s) of pancreaticย cancer-inducedย diabetes
  2260. New-Onset or Exacerbation ofย diabetesย Mellitus Is a Clue to the Early Diagnosis of Pancreaticย cancer
  2261. New-onset type 2ย diabetesย mellitusโ€“a high-risk group suitable for the screening of pancreaticย cancer?
  2262. New-onset type 2ย diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreaticย cancer
  2263. Newly Diagnosedย diabetesย Mellitus With Pancreaticย cancerย Manifested as Hyperglycemic Hyperosmolar State
  2264. Newly diagnosed type 2ย diabetesย may serve as a potential marker for pancreaticย cancer
  2265. News Briefs: Advances in Diagnosis/Treatment Options Forย diabetes,ย cancer, Incontinence, Peyronieโ€™s Disease
  2266. Nivolumab-induced autoimmuneย diabetesย mellitus presenting as diabetic ketoacidosis in a patient with metastatic lungย cancer
  2267. NK cell count and glucotransporter 4 (GLUT4) expression in subjects with type 2ย diabetesย and colonย cancer
  2268. No Association of Obesity and Type 2ย diabetesย Mellitus Related Genetic Variants With Colonย cancer
  2269. No association of risk variants forย diabetesย and obesity with breastย cancer: the Multiethnic Cohort and PAGE studies
  2270. No association of type 2ย diabetesย risk variants and prostateย cancerย risk: the multiethnic cohort and PAGE
  2271. No clear associations of adult BMI andย diabetesย mellitus with non-muscle invasive bladderย cancerย recurrence and progression
  2272. No effect of season of birth on risk of type 1ย diabetes,ย cancer, schizophrenia and ischemic heart disease, while some variations may be seen for pneumonia and โ€ฆ
  2273. Non-coding RNAs in IGF-1R signaling regulation: the underlying pathophysiological link betweenย diabetesย andย cancer
  2274. Non-enzymatic glycation of proteins: fromย diabetesย toย cancer
  2275. Non-enzymatic glycation of proteins: fromย diabetesย toย cancer
  2276. Non-metabolisable insulin glargine does not promote breastย cancerย growth in a mouse model of type 2ย diabetes
  2277. Novel blood biomarkers of pancreaticย cancerโ€“associatedย diabetesย mellitus identified by peripheral bloodโ€“based gene expression profiles
  2278. Novelย cancerย therapies and their association withย diabetes
  2279. Novel strategies halt cardiovascular,ย diabetes, andย cancerย strips
  2280. Nuclear factor kappa B (NF-ฮบB): a novel cause forย diabetes, coronary artery disease andย cancerย initiation and promotion?
  2281. Number of amalgam fillings in relation to cardiovascular disease,ย diabetes,ย cancerย and early death in Swedish women
  2282. Nursing evaluation on early enteral nntrition after operation inpatients of careinoma of stomachย cancerย complicated withย diabetesย [J]
  2283. Nursing for 49 Cases of Lungย cancerย Complicated withย diabetesย Mellitus at Chemotherapy [J]
  2284. Nursing intervention on senile rectalย cancerย complicated withย diabetes
  2285. Nursing onย cancerย patients withย diabetesย treated by chemotherapy regimen including taxanes agents
  2286. Nut consumption and risk ofย cancerย and type 2ย diabetes: a systematic review and meta-analysis
  2287. Nutrient Regulation of Transcription & Signaling by O-GlcNAc: Fundamental Roles inย diabetes, Neurodegeneration andย cancer
  2288. Nutrition and triple major risk of abdominal obesity: type 2ย diabetesย mellitus, cardiovascular diseases andย cancer.
  2289. Nutrition Interventions and Self-Management in Patients with Comorbidย cancerย andย diabetes: A Narrative Review
  2290. Nutrition Update: Pancreaticย cancerย andย diabetes
  2291. Nutrition,ย diabetes, andย cancer
  2292. Nutritional care withย diabetesย and ENTย cancer
  2293. Nutritional fats and the risk of type 2ย diabetesย andย cancer
  2294. Nutritional status and survival of 8247ย cancerย patients with or withoutย diabetesย mellitusโ€”results from a prospective cohort study
  2295. Nutritional therapy ofย cancerย withย diabetesย mellitus [J]
  2296. O-GlcNAc signaling: a metabolic link betweenย diabetesย andย cancer?
  2297. Obesity andย diabetesย as prognostic factors in patients with colorectalย cancer
  2298. Obesity Andย diabetesย Can Causeย cancer
  2299. Obesity andย diabetes: the increased risk ofย cancerย andย cancer-related mortality
  2300. Obesity and the risk of type 2ย diabetesย mellitus and certain types ofย cancer
  2301. Obesity and type 2ย diabetesย are associated with an increased risk of developingย cancerย and a worse prognosis; epidemiological and mechanistic evidence
  2302. Obesity as a factor in the development ofย cancerย in type 2ย diabetes
  2303. Obesity paradox: differential effects onย cancerย and noncancerย mortality in patients with type 2ย diabetesย mellitus
  2304. Obesity,ย diabetesย and aggressive prostateย cancerย hormone-naรฏve at initial diagnosis
  2305. Obesity,ย diabetesย and Breastย cancer: Defining Metabolic Oncogenesis
  2306. Obesity,ย diabetesย andย cancer: a mechanistic perspective
  2307. Obesity,ย diabetesย andย cancer: insight into the relationship from a cohort with growth hormone receptor deficiency
  2308. Obesity,ย diabetesย and the risk of colorectal adenoma andย cancer
  2309. Obesity,ย diabetesย and the Risk of Colorectal Adenoma andย cancer
  2310. Obesity,ย diabetesย mellitus and vascular disease: a complex relationship with prostateย cancer
  2311. Obesity,ย diabetesย mellitus, andย cancer
  2312. Obesity,ย diabetesย mellitus, and the risk of female breastย cancerย in Eastern China
  2313. Obesity,ย diabetes, and other factors in relation to survival after endometrialย cancerย diagnosis
  2314. Obesity,ย diabetes, and risk ofย cancer
  2315. Obesity,ย diabetes, and risk of prostateย cancer: results from the prostateย cancerย prevention trial
  2316. Obesity,ย diabetes, and survival outcomes in a large cohort of early-stage breastย cancerย patients
  2317. Obesity,ย diabetes,ย cancerย and cardiovascular risk: a trans-generational network
  2318. Obesity,ย diabetes, serum glucose, and risk of primary liverย cancerย by birth cohort, race/ethnicity, and sex: Multiphasic health checkup study
  2319. Obesity,ย diabetes, the cardiorenal syndrome, and risk forย cancer
  2320. OBESITY, HYPERINSULINEMIA, IGF-1, AND HYPERGLYCEMIA AS RISK FACTORS FOR COLORECTALย cancerย IN PATIENTS WITH TYPE 2ย diabetesย โ€ฆ
  2321. Obesity, insulin resistance and type 2ย diabetes: risk factors for breastย cancer
  2322. Obesity, type 2ย diabetesย andย cancer
  2323. Obesity, Type 2ย diabetesย andย cancerย Risk
  2324. Obesity, type 2ย diabetesย and risk of digestiveย cancer
  2325. Obesity, type 2ย diabetes, andย cancer: the insulin and IGF connection
  2326. Obesity, Type 2ย diabetes, andย cancer: The Insulin and Insulin-Like Growth Factor Connection.
  2327. Obesity, type-2ย diabetesย andย cancer: mechanistic insights
  2328. Obesity: Is it an Independent Risk Factor forย diabetesย andย cancer
  2329. Observation of application mode of insulin in perioperative colonย cancerย patients withย diabetesย mellitus
  2330. Observation of different infusion methods of insulin in TPN in gastricย cancerย patients withย diabetesย after operation
  2331. Occult colonย cancerย in a patient withย diabetesย and recurrent Klebsiella pneumoniae liver abscess
  2332. Older adults withย diabetesย andย cancer: Impact onย diabetesย self-management
  2333. Omission of dexamethasone from antiemetic treatment for highly emetogenic chemotherapy in breastย cancerย patients with hepatitis B infection orย diabetesย โ€ฆ
  2334. On the Correlation Between theโ€ Correctedโ€ย cancerย andย diabetesย Deathrates
  2335. On the status of ฮฒ-cell dysfunction and insulin resistance of breastย cancerย patient without history ofย diabetesย after systemic treatment
  2336. Onco-metabolism: defining the prognostic significance of obesity andย diabetesย in women with brain metastases from breastย cancer
  2337. Oncogenic Function of aย diabetesย Target SHIP2 Presents Novelย cancerย Therapeutic and Preventive Opportunities
  2338. Opioids and risk of type 2ย diabetesย in adults with non-cancerย pain
  2339. Opposite regulation of hepatic breastย cancerย resistance protein in type 1 and 2ย diabetesย mellitus
  2340. Optimal glycemic target level for colonย cancerย patients withย diabetes
  2341. OPTIMIZING LIFESTYLE REDUCES THE RISK OFย cancerย INย diabetes
  2342. Oralย cancerย in Taiwan: isย diabetesย a risk factor?
  2343. ORAL CONDITIONS OFย cancerย PATIENTS ASSOCIATED WITHย diabetesย AND ARTERIAL HYPERTENSION: CASE REPORT
  2344. Oral Glucose Lowering Agents andย cancerย in Type 2ย diabetesย Mellitus: Focus on Sulphonylurea Derivatives
  2345. Oral Insulin Secretagogues andย cancerย Risk in Type 2ย diabetesย Mellitus: An Updated Review
  2346. Oral insulin secretagogues, insulin, andย cancerย risk in type 2ย diabetesย mellitus
  2347. Orbital Cellulitis Following Hordeolum in an Immunocompromised Patient withย diabetesย and Breastย cancer-A Case Report
  2348. Osteopontin (OPN) isoforms,ย diabetes, obesity, andย cancer; what is one got to do with the other? A new role for OPN
  2349. Osteoprotegerin is up-regulated in pancreaticย cancers and correlates withย cancer-associated new-onsetย diabetes
  2350. Our experience with pancreaticย cancerย and its relation toย diabetesย mellitus
  2351. Outcome after curative surgery for gastricย cancerย patients with type 2ย diabetes
  2352. Outcome after gastrectomy in gastricย cancerย patients with type 2ย diabetes
  2353. Outcome effectiveness of therapeutic recreation camping program for adolescents living withย cancerย andย diabetes
  2354. Outcomes of preexistingย diabetesย mellitus in breast, colorectal, and prostateย cancer
  2355. Ovarianย cancerย Increases the Risk of Stroke, but Not in Patients with Hypertension,ย diabetesย or Both
  2356. Overall obesity, abdominal adiposity,ย diabetesย and cigarette smoking in relation to the risk of pancreaticย cancerย in two Swedish population-based cohorts
  2357. Overall Survival Found Worse in Study of Prostateย cancerย Patients withย diabetes, but Applicability for Now Probably Limited
  2358. Overweight, obesity,ย diabetes, and risk of breastย cancer: interlocking pieces of the puzzle
  2359. Oxidative Stress and its Clinical Consequences: Relationship betweenย diabetesย andย cancer
  2360. Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2ย diabetesย mellitus and breastย cancer
  2361. P-238 Metformin reduces biliary tractย cancerย in patients with type 2ย diabetes
  2362. P-268ย diabetesย and risk of pancreaticย cancer
  2363. P-glycoprotein associated withย diabetesย mellitus and survival of patients with pancreaticย cancer: 8-year follow-up
  2364. P0194 Association between abdominal obesity and type 2ย diabetesย and HSP70-2 (+ 1267) gene mutation in colorectalย cancer
  2365. P0293 PANDORAโ€™S BOXโ€“diabetesย INSIPIDUS UNVEILS METASTATICย cancer
  2366. P1-08-06: Breastย cancerย among Patients withย diabetes, Obesity and Abnormal Blood Lipidsโ€“A Population-Based Register Study in Sweden.
  2367. P5496 Sex differences in the association betweenย diabetesย and risk of cardiovascular disease,ย cancer, and all-cause and cause-specific mortality: a systematic review โ€ฆ
  2368. Painful neuropathy in a diabetic patient resulting from lungย cancerย and notย diabetes: A case report
  2369. Pan-PPAR Agonists as Potential Treatments for Type 2ย diabetes, and the Effect of Adipocyte-derived Fatty Acids in Breastย cancerย Therapy
  2370. Pancreaticย cancerย andย diabetes
  2371. Pancreaticย cancerย andย diabetes
  2372. Pancreaticย cancerย andย diabetes
  2373. Pancreaticย cancerย andย diabetesย mellitus
  2374. Pancreaticย cancerย andย diabetesย mellitus
  2375. Pancreaticย cancerย andย diabetesย mellitus
  2376. Pancreaticย cancerย andย diabetesย mellitus: A retrospective cohort study.
  2377. Pancreaticย cancerย andย diabetes: a two-way relationship in the perspective of diabetologist
  2378. Pancreaticย cancerย andย diabetes: Isย diabetesย a risk factor or the outcome?
  2379. Pancreaticย cancerย andย diabetes: is there a relationship? A caseโ€controlled study
  2380. Pancreaticย cancerย and its Relationship to New-onset Type 2ย diabetesย Mellitus
  2381. Pancreaticย cancerย and sugarย diabetes
  2382. Pancreaticย cancerย associated with obesity andย diabetes: an alternative approach for its targeting
  2383. Pancreaticย cancerย following incidentย diabetesย in African Americans and Latinos: the multiethnic cohort
  2384. Pancreaticย cancerย in type 1 and young-onsetย diabetes: systematic review and meta-analysis
  2385. Pancreaticย cancerย manifesting as Sister Mary Joseph nodule during follow up of a patient with type 2ย diabetesย mellitus: A case report
  2386. Pancreaticย cancerย presenting as new-onsetย diabetes
  2387. Pancreaticย cancerย triggersย diabetesย through TGF-ฮฒโ€“mediated selective depletion of islet ฮฒ-cells
  2388. Pancreaticย cancerโ€“association withย diabetesย mellitus and smoking
  2389. Pancreaticย cancer-associatedย diabetesย mellitus: an open field for proteomic applications
  2390. Pancreaticย cancer-Associatedย diabetes: Is a Nihilistic Approach Justifiable
  2391. Pancreaticย cancer-derived S-100A8 N-terminal peptide: aย diabetesย cause?
  2392. Pancreaticย cancer-inducedย diabetes: a call to action
  2393. Pancreaticย cancerโ€“associatedย diabetesย is an โ€œexosomopathyโ€
  2394. Pancreaticย cancerโ€“Associatedย diabetesย is Clinically Distinguishable From Conventionalย diabetes
  2395. Pancreaticย cancerโ€“associatedย diabetesย mellitus: prevalence and temporal association with diagnosis ofย cancer
  2396. Pancreaticย cancer, alcohol,ย diabetesย mellitus and gallโ€bladder disease
  2397. Pancreaticย cancer: associations of inflammatory potential of diet, cigarette smoking and long-standingย diabetes
  2398. Pancreaticย cancer: The importance of screening in atypicalย diabetesย presentations.
  2399. Pancreatic expression of immunoglobulin G in human pancreaticย cancerย and associatedย diabetes
  2400. Pancreatic polypeptide response to a mixed meal is blunted in pancreatic headย cancerย associated withย diabetesย mellitus
  2401. Pancreatitis and pancreaticย cancerย in patients with type 2ย diabetesย treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized โ€ฆ
  2402. Pancreatitis-diabetes-pancreaticย cancer: summary of an NIDDK-NCI workshop
  2403. Pancreatitis, pancreaticย cancer, andย diabetes
  2404. Partial cranialย diabetesย insipidus in breastย cancer: invisible pituitary metastases or uncanny coincidence
  2405. Pathogenegenetic mechanisms of oncogenesis inย diabetesย mel litus and analysis ofย cancerย incidence in patients w ithย diabetesย mellitus in the Precarpathian region
  2406. Pathogenesis of Pancreaticย cancer-Relatedย diabetesย Mellitus: Quo Vadis?
  2407. Pathogenic bacteria distribution and drug resistance of postoperative infection in elderly patients with gastricย cancerย complicated withย diabetesย mellitus
  2408. Pathologic and molecular characteristics of colorectalย cancerย in patients with type 2ย diabetes
  2409. Pathophysiological link betweenย diabetesย and colorectalย cancer: effect of diabetic microenvironment, metformin and 5-fluorouracil on AMPK activation, apoptosis and โ€ฆ
  2410. Patient outcomes from lungย cancerย andย diabetesย mellitus: a matched caseโ€“control study
  2411. Patient-centered prevention strategies for cardiovascular disease,ย cancerย andย diabetes
  2412. Patients diagnosed withย diabetesย are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lungย cancer
  2413. Pattern of increasing HbA1c levels in patients withย diabetesย mellitus before clinical detection of pancreaticย cancerย โ€“ a population-based nationwide case-control study
  2414. Pay more attention to the study of the relationship betweenย diabetesย mellitus andย cancer
  2415. PCN173 EFFECT OF METFORMIN ON SURVIVAL AMONG OVARIANย cancerย PATIENTS WITH COMORBIDย diabetes: A SYSTEMATIC REVIEW AND โ€ฆ
  2416. PD12-4: THE IMPACT OFย diabetesย MELLITUS ON PATIENTS RECEIVING ROBOTIC ASSISTED RADICAL PROSTATECTOMY FOR PROSTATEย cancer
  2417. PD13-09ย diabetesย SEVERITY AND METFORMIN ARE ASSOCIATED WITH INTRAVESICAL BACILLUS CALMETTE-GUERIN OUTCOMES IN NON MUSCLE โ€ฆ
  2418. PD19-02ย diabetesย MELLITUS AND PROSTATEย cancerย RISK IN A SINGLE INSTITUTIONAL BIOPSY SERIES
  2419. PDE5 inhibitors as therapeutics for heart disease,ย diabetesย andย cancer
  2420. Peer Reviewed: Aย diabetesย Pay-for-Performance Program and Risks ofย cancerย Incidence and Death in Patients With Type 2ย diabetesย in Taiwan
  2421. Peer Reviewed: Associations Between Colorectalย cancerย Screening and Glycemic Control in People Withย diabetes, Boston, Massachusetts, 2005-2010
  2422. Peer reviewed:ย diabetesย status and being up-to-date on colorectalย cancerย screening, 2012 behavioral risk factor surveillance system
  2423. Pemetrexed-induced acute renal failure, nephrogenicย diabetesย insipidus, and renal tubular acidosis in a patient with non-small cell lungย cancer
  2424. Perceived Determinants ofย cancerย Screenings in Women withย diabetes
  2425. Perceived experiences of discrimination in health care: a barrier forย cancerย screening among American Indian women with type 2ย diabetes
  2426. Perceived impact ofย cancerย treatment onย diabetesย self-management
  2427. Perceived impact ofย diabetesย management in patients withย cancer: the experience of a tertiary referral center
  2428. Perceived medical discrimination in American Indian women: Effect on health care decisions,ย cancerย screening,ย diabetesย services andย diabetesย management
  2429. Performance analysis of Machine learning classifiers for predictingย diabetesย and prostateย cancer
  2430. Performance of the colorectalย cancerย screening marker Sept9 is influenced by age,ย diabetesย and arthritis: a nested caseโ€“control study
  2431. Periodontal pathogens as risk factors of cardiovascular diseases,ย diabetes, rheumatoid arthritis,ย cancer, and chronic obstructive pulmonary diseaseโ€”is there cause for โ€ฆ
  2432. PERIOPERATIONAL MANAGEMENT OF CARDIACย cancerย & ITS CONCOMITANTย diabetesย MELLITUS
  2433. Perioperative Management for Patients with Esophageal and Cardiacย cancerย Complicated withย diabetesย Mellitus [J]
  2434. Perioperative Management of 288 Cases with Esophagealย cancerย or Cardiacย cancerย Complicated withย diabetesย Mellitus
  2435. Perioperative management of colonrectalย cancerย patients withย diabetesย mellitus
  2436. Perioperative management of esophagealย cancerย patients concomitent withย diabetes
  2437. Perioperative management of esophagealย cancerย patients concomitent withย diabetesย [J]
  2438. Perioperative management of gastricย cancerย withย diabetesย [J]
  2439. Perioperative management of large bowelย cancerย patients withย diabetesย mellitus
  2440. Perioperative management of patients of colonorectalย cancerย withย diabetesย mellitus
  2441. Perioperative Nursing for the Patients with Breastย cancerย Combined withย diabetesย Mellitus [J]
  2442. Perioperative nursing in patients with rentalย cancerย complicated withย diabetesย [J]
  2443. Perioperative nursing of cervicalย cancerย patients withย diabetesย mellitus
  2444. Perioperative nutrition support for esophagealย cancerย complicated withย diabetesย mellitus
  2445. Perioperative Treatment of Gastrointestinalย cancerย Combined withย diabetes
  2446. Perioperative treatment of patients with colorectalย cancerย andย diabetesย [J]
  2447. Perioperative treatment of patients with gastricย cancerย complicated withย diabetes
  2448. Peroxisome proliferator activated receptors at the crossroad of obesity,ย diabetes, and pancreaticย cancer
  2449. Peroxisome proliferator-activated receptor gamma (PPARฮณ) as a target for concurrent management ofย diabetesย and obesity-relatedย cancer
  2450. Personal history ofย diabetesย as important as family history of colorectalย cancerย for risk of colorectalย cancer: a nationwide cohort study
  2451. Personalizedย diabetesย andย cancerย medicine: A rationale for anti-diabetic nutrition (bitter melon) in a supportive setting
  2452. Personalized indicator thrombocytosis shows connection to staging and indicates shorter survival in colorectalย cancerย patients with or without type 2ย diabetes
  2453. Pharmacogenomics-Personalized treatment ofย cancer,ย diabetesย and cardiovascular diseases
  2454. Pharmacologic therapy ofย diabetesย and overallย cancerย risk and mortality: a meta-analysis of 265 studies
  2455. Pharmacoproteomic approach to the study of drug mode of action, toxicity, and resistance: applications inย diabetesย andย cancer
  2456. Pharmacotherapy ofย diabetesย andย cancerย risk
  2457. Phosphateย diabetesย associated with bone metastases of oat cell lungย cancer.
  2458. Phosphorylation of PRAS40 in leukocytes of patients withย cancerย andย diabetes
  2459. Phosphorylation of Protein Kinase Akt by Mtorc2 in Peripheral Blood Mononuclear Cells of Patients withย cancerย andย diabetes.
  2460. Physical activity and mental distress among Veteranย cancerย survivors with heart disease andย diabetes
  2461. Physical activity and risk of breastย cancer, colonย cancer,ย diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response โ€ฆ
  2462. Physical activity,ย diabetes, and risk of thyroidย cancer: a systematic review and meta-analysis
  2463. Physical activity,ย diabetes, and thyroidย cancerย risk: a pooled analysis of five prospective studies
  2464. Picture quiz:ย diabetesย insipidus in a woman with breastย cancer
  2465. Pioglitazone and bladderย cancerย in human studies: is itย diabetesย itself,ย diabetesย drugs, flawed analyses or different ethnicities?
  2466. Pioglitazone and lungย cancerย risk in Taiwanese patients with type 2ย diabetes
  2467. Pioglitazone and oralย cancerย risk in patients with type 2ย diabetes
  2468. Pioglitazone and risk of bladderย cancerย in type 2ย diabetesย mellitus patients: A systematic literature review and meta-analysis of observational studies using real-world โ€ฆ
  2469. Pioglitazone and thyroidย cancerย risk in Taiwanese patients with type 2ย diabetesย 2
  2470. Pioglitazone does not affect the risk of kidneyย cancerย in patients with type 2ย diabetes
  2471. Pioglitazone does not increase the risk of type IIย diabetesย in patients with bladderย cancer: A retrospective study
  2472. Pioglitazone prescription increases risk of bladderย cancerย in patients with type 2ย diabetes: an updated meta-analysis
  2473. Pioglitazone use and risk of bladderย cancerย and other commonย cancers in persons withย diabetes
  2474. Pioglitazone use and risk of bladderย cancerย in patients with type 2ย diabetes: retrospective cohort study using datasets from four European countries
  2475. Pioglitazone use in patients withย diabetesย and risk of bladderย cancer: a systematic review and meta-analysis
  2476. Pituitary metastasis from breastย cancerย presenting asย diabetesย insipidus
  2477. Pituitary metastasis: lungย cancerย presenting as bitemporal hemianopsia withย diabetesย insipidus and anterior pituitary deficiency
  2478. Pituitary stalk metastasis from lungย cancer, precedingย diabetesย insipidusโ€“case report and clinical review of the literature
  2479. Plasma adropin as a potential marker predicting obesity and obesity-associatedย cancerย in Korean patients with type 2ย diabetesย mellitus
  2480. Plasma Lipidome and Prediction of Type 2ย diabetesย in the Population-Based Malmรถ Diet andย cancerย Cohort
  2481. Plasma metals andย cancerย incidence in patients with type 2ย diabetes
  2482. Plasma proneurotensin and incidence ofย diabetes, cardiovascular disease, breastย cancer, and mortality
  2483. Plasma-free amino acid profiles are predictors ofย cancerย andย diabetesย development
  2484. Plasmalemmal vacuolar H+-ATPases in angiogenesis,ย diabetesย andย cancer
  2485. Platelet Hyperactivity and Dysfunction inย diabetesย andย cancer
  2486. Pleiotropic effects of single nucleotide polymorphophisms of EDIL3 gene: Association withย cancer, obesity, and type 2ย diabetes
  2487. Pleiotropy and pathway analyses of genetic variants associated with both type 2ย diabetesย and prostateย cancer
  2488. Pneumonia,ย diabetesย and prostateย cancer
  2489. PO-240 WWOX suppressor gene regulate glucose metabolism and warburg effect in case of gestationalย diabetesย mellitusas well as breastย cancer
  2490. POD-11.08:ย diabetesย and risk of death fromย cancerย of the prostate, kidney, and urinary bladder
  2491. Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction,ย diabetes,ย cancerย and mortality. The Tromsรธ Study
  2492. Poor glycemic control might compromise the efficacy of chemotherapy in nonโ€small cell lungย cancerย patients withย diabetesย mellitus
  2493. Poor glycemic control ofย diabetesย mellitus is associated with higher risk of prostateย cancerย detection in a biopsy population
  2494. Poorly controlledย diabetesย increases the risk of metastases and castrationโ€resistant prostateย cancerย in men undergoing radical prostatectomy: Results from the โ€ฆ
  2495. Population-based case-control study ofย diabetesย and breastย cancerย risk in Hispanic and non-Hispanic White women living in US southwestern states
  2496. Population-based estimation of mortality and occurrence ofย cancerย in patients with and withoutย diabetesย in Pune
  2497. Population-based estimation of mortality and occurrence ofย cancerย in patients with and withoutย diabetesย in Pune
  2498. Populationโ€based cohort studies of type 2ย diabetesย and stomachย cancerย risk in Chinese men and women
  2499. POS-03.118: Influence ofย diabetesย mellitus on the prognosis of prostateย cancerย patients
  2500. Positive association betweenย diabetesย mellitus and risk of colorectalย cancer.
  2501. Positive effect of metformin treatment in colorectalย cancerย patients with type 2ย diabetes: National cohort study
  2502. Possible link of pioglitazone with bladderย cancerย in Japanese patients with type 2ย diabetes
  2503. Post-challenge glucose concentration, impaired glucose tolerance,ย diabetes, andย cancerย mortality in men
  2504. Poster# 0598โ€“Type 2ย diabetesย Mellitus-A risk indicator for colorectalย cancer
  2505. Postmenopausal women withย diabetesย risk breastย cancer
  2506. Postmenopausal women with medically treatedย diabetesย have increased risk of lungย cancer
  2507. Postoperativeย diabetesย mellitus following resection of the body and tail of the pancreas for secondary invasion by gastricย cancer
  2508. Postoperative mortality inย cancerย patients with preexistingย diabetes: systematic review and meta-analysis
  2509. Postoperative serum carcinoembryonic antigen levels cannot predict survival in colorectalย cancerย patients with type IIย diabetes
  2510. Postpancreatitisย diabetesย confers higher risk for pancreaticย cancerย than type 2ย diabetes: Results from a nationwideย cancerย registry
  2511. Potential smoothened inhibitor from traditional Chinese medicine against the disease ofย diabetes, obesity, andย cancer
  2512. PP28 Exploring the Associations betweenย diabetesย and Site-Specificย cancerย Mortality: Evidence from the Health Survey for England and Scottish Health Survey linked โ€ฆ
  2513. PPAR-ฮณ agonists: therapeutic role inย diabetes, inflammation andย cancer
  2514. PPAR-ฮณ: A multifaceted transcription factor important inย diabetes, cardiovascular disease, andย cancer
  2515. Practical aspects of large register studies: Multiple states and multiple timescales: Theย diabetesย andย cancerย study.
  2516. Pre-and post-diagnosisย diabetesย as a risk factor for all-cause andย cancer-specific mortality in breast, prostate, and colorectalย cancerย survivors: A prospective โ€ฆ
  2517. Pre-diabetesย and breastย cancerย outcomes: Abrogating the confounding effect of anti-diabetic therapy.
  2518. Pre-existingย diabetesย and breastย cancerย prognosis among elderly women
  2519. Pre-existingย diabetesย and lungย cancerย prognosis
  2520. Pre-existingย diabetesย in early stage breastย cancerย patients is associated with lack of improvement in quality of life 2 years after diagnosis
  2521. Pre-existingย diabetesย mellitus and all-cause mortality inย cancerย patients: a register-based study in Latvia
  2522. Pre-existingย diabetesย mellitus increases the risk of gastricย cancer: a meta-analysis
  2523. Pre-existing type 2ย diabetesย and risk of lungย cancer: a report from two prospective cohort studies of 133 024 Chinese adults in urban Shanghai
  2524. Pre-existing type 2ย diabetesย and survival among patients with colorectalย cancer
  2525. Prebiotics, Probiotics, Synbiotics and Functional Foods in Control and Treatment of Type IIย diabetesย Mellitus and Colorectalย cancer
  2526. Prediabetesย and progression toย diabetesย among adult survivors of childhoodย cancerย in the St. Jude Lifetime Cohort.
  2527. Prediabetesย and type 2ย diabetesย mellitus and risk of thyroidย cancer
  2528. Prediabetes,ย diabetes, and risk of breastย cancer: a case-control study
  2529. Prediagnosticย diabetes, body mass index, and survival of endometrialย cancer: A prospective study.
  2530. Predicting values of lipids and white blood cell count for all-siteย cancerย in type 2ย diabetes
  2531. Predictive factors for differentiating pancreaticย cancer-associatedย diabetesย mellitus from common type 2ย diabetesย mellitus for the early detection of pancreaticย cancer
  2532. Predictive factors for the development ofย diabetesย inย cancerย patients treated with phosphatidylinositol 3-kinase inhibitors
  2533. Predictors for pancreaticย cancerย diagnosis following new-onsetย diabetesย mellitus
  2534. Predictors of the Onset of Type 1ย diabetesย Obtained from Real-World Data Analysis inย cancerย Patients Treated with Immune Checkpoint Inhibitors
  2535. Preexistingย diabetesย and risks of morbidity and mortality after gastrectomy for gastricย cancer: a nationwide database study
  2536. Preexistingย diabetes, metformin use and long-term survival in patients with prostateย cancer
  2537. Preoperative mean platelet volume predicts survival in breastย cancerย patients with type 2ย diabetes
  2538. Prevalence and clinical profile of pancreaticย cancerโ€“associatedย diabetesย mellitus
  2539. Prevalence and predictors of breast and cervicalย cancerย screening among Spanish women withย diabetes
  2540. Prevalence and predictors of comorbidย diabetesย among newly diagnosed Hispanicย cancerย patients in Connecticut
  2541. Prevalence and trends of receipt ofย cancerย screenings among US women with diagnosedย diabetes
  2542. Prevalence ofย diabetesย in aย cancerย population in a Malaga hospital
  2543. Prevalence ofย diabetesย in Japanese patients withย cancer
  2544. Prevalence ofย diabetesย in patients admitted to aย cancerย hospital
  2545. Prevalence ofย diabetesย Mellitus and Metabolic Syndrome in Prostateย cancerย Patients given Androgen Deprivation Therapy
  2546. Prevalence ofย diabetesย mellitus in pancreaticย cancerย compared to commonย cancers
  2547. Prevalence ofย diabetesย mellitus in pancreaticย cancerย patients
  2548. Prevalence ofย diabetesย mellitus in patients with newly evaluated papillary thyroidย cancer
  2549. Prevalence of diagnosedย cancerย according to duration of diagnosedย diabetesย and current insulin use among US adults with diagnosedย diabetes: findings from the โ€ฆ
  2550. Prevalence of hypertension and type 2ย diabetesย mellitus in patients with colorectalย cancerย and their median survival time: A cohort study
  2551. Prevalence, awareness, control, and treatment of hypertension andย diabetesย in koreanย cancerย survivors: a cross-sectional analysis of the fourth and fifth Korea โ€ฆ
  2552. PREVALENCE, METABOLIC CONTROL, AND SURVIVAL IN AN ACADEMIC ONCOLOGY PRACTICE:ย cancerย WITHย diabetes
  2553. Preventable diabetic complications after aย cancerย diagnosis in patients withย diabetes: a population-based cohort study
  2554. Preventingย cancer, cardiovascular disease, andย diabetes
  2555. Preventingย cancer, Cardiovascular Disease, andย diabetes: A Common Agenda
  2556. Preventingย cancer, cardiovascular disease, andย diabetes: a common agenda for the Americanย cancerย Society, the Americanย diabetesย Association, and the American โ€ฆ
  2557. Prevention and treatment effects of edible berries for three deadly diseases: Cardiovascular disease,ย cancerย andย diabetes
  2558. Prevention ofย diabetes-promoted colorectalย cancerย by (n-3) polyunsaturated fatty acids and (n-3) PUFA mimetic
  2559. Prevention ofย diabetes, hepatic injury, and colonย cancerย with dehydroepiandrosterone
  2560. Previous cholecystectomy, gastrectomy, andย diabetesย mellitus are not crucial risk factors for pancreaticย cancerย in patients with chronic pancreatitis
  2561. Primary careย cancerย andย diabetesย complications screening of black women with type 2ย diabetes
  2562. Primary study of the relationship betweenย diabetesย and pancreaticย cancer
  2563. Primate-specific long non-coding RNA (LncRNA) genes as regulators and drug target candidates in humanย cancerย andย diabetes
  2564. Probability of pancreaticย cancerย followingย diabetes: a population-based study
  2565. Prognosis of colorectalย cancerย patients withย diabetesย according to medication adherence: A population-based cohort study
  2566. Prognosis of ovarianย cancerย in women with type 2ย diabetesย using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
  2567. Prognosis of Patients with Colorectalย cancerย withย diabetesย According to Medication Adherence: A Population-Based Cohort Study
  2568. Prognosis of small cell lungย cancerย patients withย diabetesย treated with metformin
  2569. Prognostic factors for resected nonโ€small cell lungย cancerย in patients with type 2ย diabetesย mellitus
  2570. Prognostic Impact ofย diabetesย Mellitus on Colorectalย cancer
  2571. Prognostic Impact ofย diabetesย Mellitus on Overall Survival in a Nationwide Population-Based Cohort of Patients With Pancreaticย cancer
  2572. Prognostic influence of metformin as firstโ€line chemotherapy for advanced nonsmall cell lungย cancerย in patients with type 2ย diabetes
  2573. Prognostic significance ofย diabetesย mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostateย cancer
  2574. Prognostic significance ofย diabetesย mellitus in locally advanced non-small cell lungย cancer
  2575. Prognostic Significance of Obesity andย diabetesย Mellitus in Women With Brain Metastases From Breastย cancerย Should Be Revisited
  2576. Prognostic significance of type 2ย diabetesย in patients treated with surgery and irradiation for gingivalย cancer
  2577. Prognostic value of metformin for non-small cell lungย cancerย patients withย diabetes
  2578. Program/Abstract# 48 A fly approach toย cancerย andย diabetes
  2579. Progress in the relationship betweenย diabetesย and prognosis of colorectalย cancer
  2580. Progress in the study on the correlation between Type 2ย diabetesย mellitus and colorectalย cancer
  2581. Progress of relationship betweenย diabetesย and papillary thyroidย cancer
  2582. Prohibitinโ€“At the crossroads of obesity-linkedย diabetesย andย cancer
  2583. Prolonged survival in lungย cancerย patients withย diabetesย mellitus
  2584. Prolonged survival in patients with lungย cancerย withย diabetesย mellitus
  2585. Prolonged use of human insulin increases breastย cancerย risk in Taiwanese women with type 2ย diabetes
  2586. Proposed cut-off value of CA19-9 for detecting pancreaticย cancerย in patients withย diabetes: a case-control study
  2587. Prospective evaluation of type 2ย diabetesย mellitus on the risk of primary liverย cancerย in Chinese men and women
  2588. Prospective study of aย diabetesย risk reduction diet and the risk of breastย cancer
  2589. Prospective study of adult onsetย diabetesย mellitus (type 2) and risk of colorectalย cancerย in women
  2590. Prospective study ofย cancerย in Japanese patients with type 2ย diabetes: the Fukuokaย diabetesย Registry
  2591. Prospective study of colorectalย cancerย risk and physical activity,ย diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis
  2592. Prospective study ofย diabetesย mellitus and liverย cancerย in Japan
  2593. Prospective study of Type 2ย diabetesย mellitus, antiโ€diabetic drugs and risk of prostateย cancer
  2594. Prospective study reveals associations between colorectalย cancerย and type 2ย diabetesย mellitus or insulin use in men
  2595. Prostateย cancerย patients with unmanagedย diabetesย or on insulin have worse outcomes and toxicities after treatment with radiation therapy
  2596. Prostateย cancerย patients with unmanagedย diabetesย or receiving insulin experience inferior outcomes and toxicities after treatment with radiation therapy
  2597. Prostateย cancerย risk among men withย diabetesย mellitus (Spain)
  2598. Prostateย cancer, androgen deprivation therapy, obesity, the metabolic syndrome, type 2ย diabetes, and cardiovascular disease: a review
  2599. Prostateย cancer,ย diabetesย Link Points to Potential Treatment with Metformin
  2600. Prostateย cancer:ย diabetesย and prostateย cancerโ€”an open debate
  2601. Prostateย cancer: Hormone Therapy Associated withย diabetes, Cardiovascular Disease
  2602. Protective effect ofย diabetesย against metastasis in patients with nonโ€“small cell lungย cancer
  2603. Protein-bound glycosaminoglycans in serum of patients with lungย cancerย and patients withย diabetesย mellitus
  2604. Proteinuria predicts 10-yearย cancer-related mortality in patients with type 2ย diabetes
  2605. Proteomic analysis of pancreaticย cancerย associated withย diabetesย mellitus
  2606. Proteomics Analysis of Gastricย cancerย Patients withย diabetesย Mellitus
  2607. Psychological distress, resilience, social support and help-seeking behaviors in patients with type iiย diabetes, breastย cancerย and hypertension
  2608. PTEN link betweenย cancerย andย diabetes
  2609. PUK4 COMPARISON OF POSTTRANSPLANT NEW-ONSETย diabetesย ANDย cancerย BETWEEN PERITONEAL AND HEMODIALYSIS RECIPIENTS โ€ฆ
  2610. PWE-159ย diabetesย and Pancreaticย cancerโ€“Cause or Association?
  2611. pyridine (PhIP) induces gene expression changes in JAK/STAT and MAPK pathways related to inflammation,ย diabetesย andย cancer
  2612. Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treatingย diabetes, heart ischemia, andย cancer
  2613. Quality and outcomes ofย diabetesย care in patients diagnosed withย cancer
  2614. Quality ofย diabetesย care amongย cancerย survivors withย diabetes
  2615. Quality ofย diabetesย care in breast, colorectal, and prostateย cancer
  2616. Quality ofย diabetesย care inย cancer: a systematic review
  2617. Quantitative aspects of mitochondrial genome inย cancerย andย diabetes
  2618. Racial disparities and colorectalย cancerย survival in older adults with and withoutย diabetesย mellitus
  2619. Racial disparities in breastย cancerย mortality among women withย diabetesย mellitus.
  2620. Racial disparities in colorectalย cancerย incidence by type 2ย diabetesย mellitus status
  2621. Racial Variation in the Relationship ofย diabetesย with Pancreaticย cancerย Risk
  2622. Racial/ethnic disparities in the risk of posttraumatic stress disorder symptoms among mothers of children diagnosed withย cancerย and Type-1ย diabetesย mellitus.
  2623. Racial/Ethnicity Disparities In The Association Betweenย diabetesย And Pancreaticย cancerย In The Elderly Medicare Population
  2624. Radiation Dose and Volume to the Pancreas and Subsequent Risk ofย diabetesย Mellitus: A Report from the Childhoodย cancerย Survivor Study
  2625. Radiation dose and volume to the pancreas and subsequent risk ofย diabetesย mellitus: A report from the Childhoodย cancerย Survivor study.
  2626. Radiation dose to the pancreas and risk ofย diabetesย mellitus in childhoodย cancerย survivors: a retrospective cohort study
  2627. Radical gastrectomy combined with modified gastric bypass surgery for gastricย cancerย patients with type 2ย diabetes
  2628. Raised glucose concentrations andย diabetesย are associated withย cancerย risk
  2629. Rapid biochemical profiling of endothelial dysfunction inย diabetes, hypertension andย cancerย metastasis by hierarchical cluster analysis of Raman spectra
  2630. Rapid progression of breastย cancerย cell proliferation inย diabetes: Role of polyamines
  2631. Rare case of manifestation of erectile dysfunction soon after thyroidectomy because of thyroidย cancerย in 56-year-old man withย diabetesย mellitus type 2 and diabetic โ€ฆ
  2632. Ras-induced epigenetic inactivation of the RRAD (Ras-related associated withย diabetes) gene promotes glucose uptake in a human ovarianย cancerย model
  2633. Re: Androgen-Deprivation Therapy andย diabetesย Control among Diabetic Men with Prostateย cancer
  2634. Re: Excess Risk of Primary Liverย cancerย in Patients Withย diabetesย Mellitus
  2635. Re: metformin use and all-cause and prostateย cancer-specific mortality among men withย diabetes
  2636. Re: prospective study of adult onsetย diabetesย mellitus (Type 2) and risk of colorectalย cancerย in women
  2637. Real lifeย cancerย comorbidity in Greek patients withย diabetesย mellitus followed up at a singleย diabetesย center: an unappreciated newย diabetesย complication
  2638. Rebuild: Recover from Heart Disease,ย cancer,ย diabetesย and Other Serious Illness and be Healthier Than Ever Before
  2639. Recent Advances in Histone Glycation: Emerging role inย diabetesย andย cancer
  2640. Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment ofย diabetes, obesity, andย cancer
  2641. Recent advances in the management of thyroidย cancerย and type 2ย diabetes: highlights from the Annual Conference of the Society for Endocrinology (BES), March 15 โ€ฆ
  2642. Recent advances in the use of metformin: can treatingย diabetesย prevent breastย cancer?
  2643. Recent data on Mediterranean diet, cardiovascular disease,ย cancer,ย diabetesย and life expectancy.
  2644. Recognition of comorbidย diabetesย and obesity in hospital records of newly diagnosedย cancerย patients
  2645. Redefining the role of obesity, race andย diabetesย in Type I and Type II endometrialย cancers: Potential targets for treatment beyondย cancerย itself
  2646. Redox alterations in inflammatory diseases:ย diabetes, kidney failure andย cancer
  2647. Reduced risk of colorectalย cancerย with metformin therapy in patients with type 2ย diabetes: a meta-analysis
  2648. Reduced risk of prostateย cancerย among patients withย diabetesย mellitus
  2649. Reduced risk of prostateย cancerย in a cohort of Lithuanianย diabetesย mellitus patients
  2650. Reduced risk of prostateย cancerย in a cohort of Lithuanianย diabetesย mellitus patients.
  2651. Reduced risk of prostateย cancerย in a cohort of Lithuanianย diabetesย patients
  2652. Reducingย cancerย andย cancerย disparities: lessons from a youth-generatedย diabetesย prevention campaign
  2653. Reducing the gap by focusing the ethnicity and migration lenses: examples inย cancer, heart disease andย diabetes
  2654. Reference frameworks for the health management of measles, breastย cancerย andย diabetesย (type II).
  2655. Regarding measures of impact:ย diabetesย and urothelialย cancer
  2656. Regional variations inย cancerย screening rates found in women withย diabetes
  2657. Registry-based analysis ofย cancerย andย diabetesย combination: prevalence and features
  2658. Related Factors and Risk Prediction of Type 2ย diabetesย Complicated with Liverย cancer
  2659. RELATION BETWEEN COMPLICATIONS OF TYPE IIย diabetesย MELLITUS AND ANEMIA CAUSED BY CHEMOTHERAPY IN WOMEN WITH BREASTย cancer
  2660. Relation between dietary calcium and vitamin D and risk ofย diabetesย andย cancer: a review and perspective
  2661. Relation of prediabetesย and type 2ย diabetesย mellitus to thyroidย cancer
  2662. Relationship betweenย diabetesย andย diabetesย medications and risk of different molecular subtypes of breastย cancer
  2663. Relationship betweenย diabetesย and pancreaticย cancer
  2664. Relationship betweenย diabetesย and risk of second primary contralateral breastย cancer
  2665. Relationship betweenย diabetesย Mellitus and Clinicopathological Stages of Breastย cancerย at Diagnosis
  2666. Relationship betweenย diabetesย Mellitus and Colorectalย cancerย as well as its Metastasis
  2667. Relationship betweenย diabetesย Mellitus and Lymphatic Metastasis in Patients with Colorectalย cancer
  2668. Relationship betweenย diabetesย Mellitus and Risk of Colorectalย cancer: A META-ANALYSIS
  2669. Relationship betweenย diabetesย mellitus and the site of colorectalย cancer
  2670. Relationship between gestationalย diabetesย and endometrialย cancer
  2671. Relationship between HbA1c andย cancerย in people with or withoutย diabetes: a systematic review
  2672. RELATIONSHIP BETWEEN HISTORY OF GESTATIONALย diabetesย AND THE RISK OF BREASTย cancer: A POPULATION BASED COHORT STUDY
  2673. Relationship between metformin therapy and risk of colorectalย cancerย in patients withย diabetesย mellitus: a meta-analysis
  2674. Relationship between obesity,ย diabetesย and the risk of thyroidย cancer
  2675. Relationship between Obesity,ย diabetes, and the Risk of Thyroidย cancer
  2676. Relationship between pancreaticย cancerย andย diabetesย mellitus
  2677. Relationship between pancreaticย cancerโ€associatedย diabetesย and cachexia
  2678. Relationship between thymidine kinase 1 before radiotherapy and prognosis in breastย cancerย patients withย diabetes
  2679. Relationship between type 2ย diabetesย and pancreaticย cancer
  2680. Relationship between type 2ย diabetesย mellitus and risk of breastย cancer: a case-control study
  2681. Relationship ofย diabetesย and obesity withย cancerย incidence; review article
  2682. Relationship of metformin with the risk of pancreaticย cancerย in patients with type 2ย diabetes: a meta-analysis
  2683. Relationship of type IIย diabetesย and metformin use to ovarianย cancerย progression, survival, and chemosensitivity
  2684. Relationships are between metformin use and survival in pancreaticย cancerย patients concurrent withย diabetes: A systematic review and meta-analysis
  2685. Relationships of obesity andย diabetesย mellitus to other primaryย cancers in surgically treated gastricย cancerย patients
  2686. Remedial applications of exosomes inย cancer, infections andย diabetes
  2687. Renal Impairment Increases Serumย cancerย Antigen 125 Levels in Patients with Type 2ย diabetesย Mellitus
  2688. Renin angiotensin system inhibitors may attenuate low LDL cholesterolโ€relatedย cancerย risk in type 2ย diabetes
  2689. Reply to โ€˜Comment on โ€˜New-onset type 2ย diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreaticย cancerโ€
  2690. Reply to the letter by Fujishiro et al. concerning โ€œControversy regarding gastricย cancerย andย diabetesโ€
  2691. Report Clarifies Scientistsโ€™ Understanding of Association Betweenย diabetesย andย cancer
  2692. Report of the J apanย diabetesย Society/J apaneseย cancerย Association joint committee onย diabetesย andย cancer
  2693. Report of the Japanย diabetesย Society (JDS)/Japaneseย cancerย Association (JCA) joint committee onย diabetesย andย cancer, second report
  2694. Report of the Japanย diabetesย society/Japaneseย cancerย association joint committee onย diabetesย andย cancer, Second report
  2695. Report of the JDS/JCA joint committee onย diabetesย andย cancer
  2696. Repurposing of sodium valproate in colonย cancerย associated withย diabetesย mellitus: Role of HDAC inhibition
  2697. Research advances onย diabetes-associated pancreaticย cancer
  2698. Research on the relationship between RAGE and its ligand HMGB1, and prognosis and pathogenesis of gastricย cancerย withย diabetesย mellitus
  2699. Research Progress in New-onsetย diabetesย and Early Diagnosis of Pancreaticย cancer
  2700. Research Progress of 70 kDa Ribosomal Protein S6 Kinase (P70S6K) Inhibitors as Effective Therapeutic Tools for Obesity, Type IIย diabetesย andย cancer
  2701. Research Progress of Correlation between Type 2ย diabetesย Mellitus And Digestive Systemย cancerย Based on Meta-analysis
  2702. Research Progress of Relationship betweenย diabetesย and Colorectalย cancerย [J]
  2703. Research progress on the association ofย diabetesย with pancreaticย cancer
  2704. Resectability of pancreaticย cancerย andย diabetes
  2705. Resectability of presymptomatic pancreaticย cancerย and its relationship to onset ofย diabetes: a retrospective review of CT scans and fasting glucose values prior to โ€ฆ
  2706. Resolution of type 2ย diabetesย after gastrectomy for gastricย cancerย with long limb Roux-en Y reconstruction: a prospective pilot study
  2707. Response to Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lungย cancerย in Patients With Type 2ย diabetes.ย diabetesย Care 2013; 36: 124 โ€ฆ
  2708. Response to Comment on: Torres-Mejรญa et al. Moderate-Intensity Physical Activity Ameliorates the Breastย cancerย Risk in Diabetic Women.ย diabetesย Care 2012; 35 โ€ฆ
  2709. Response to Letter to the Editor:โ€ Higher Circulating Adiponectin Concentrations Predict Incidentย cancerย in Type 2ย diabetes-The Adiponectin Paradoxโ€
  2710. Response to Yang and Chan. Metformin and the Risk ofย cancer: Time-Related Biases in Observational Studies.ย diabetesย Care 2012; 35: 2665โ€“2673
  2711. RESPONSE: Re:ย diabetesย Mellitus and Risk of Colorectalย cancerย in the Singapore Chinese Health Study
  2712. Response: The Association between Type 2ย diabetesย Mellitus and Colorectalย cancer.
  2713. Response: The Risk of Bladderย cancerย in Korean Diabetic Subjects Treated with Pioglitazone (diabetesย Metab J 2012;36:371-8)
  2714. Response: The Risk of Bladderย cancerย in Korean Diabetic Subjects Treated with Pioglitazone (diabetesย Metab J 2012;36:371-8)
  2715. Results of a community survey to assess African American and Latino knowledge, perceptions, and life style practices related toย diabetesย andย cancer
  2716. Results of general internal medicine consultations forย diabetesย mellitus in 283ย cancerย patients
  2717. Resveratrolโ€™s potential in the adjunctive management of cardiovascular disease, obesity,ย diabetes, Alzheimer disease, andย cancer
  2718. Retinol binding protein 4: role inย diabetesย andย cancer
  2719. Retinol binding protein 4: role inย diabetesย andย cancer
  2720. Retracted: Worldwide burden ofย cancerย attributable toย diabetesย and high body-mass index: a comparative risk assessment
  2721. Retraction and republicationโ€”Worldwide burden ofย cancerย attributable toย diabetesย and high body-mass index: a comparative risk assessment
  2722. Retraction Notice to: Theย cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk ofย diabetes
  2723. Retrospective analysis of the relation betweenย diabetesย mellitus and endometrialย cancer
  2724. Retrospective analysis of the relationship between type 2ย diabetesย mellitus and colorectalย cancer
  2725. Retrospective database analysis ofย cancerย risk in patients with type 2ย diabetesย mellitus in China
  2726. Retrospective evaluation of Middle Eastern patients (pts) with type IIย diabetesย mellitus (DM) and colorectalย cancerย (CRC): Validation of metformin effect on overall โ€ฆ
  2727. Retrospective evaluation of patients with colorectalย cancerย (CRC) and type II non-insulin-dependentย diabetesย (NIDDM).
  2728. Reversal of enhanced pancreaticย cancerย growth inย diabetesย by insulin
  2729. Review of Associations Between Type 2ย diabetesย andย cancer
  2730. Risk analysis onย diabetesย mellitus patients complicating colorectalย cancer
  2731. Risk differences between prediabetesย andย diabetesย according to breastย cancerย molecular subtypes
  2732. Risk established between type IIย diabetesย mellitus andย cancer: a review
  2733. Risk factor, early diagnosis and overall survival on outcome of association between pancreaticย cancerย andย diabetesย mellitus: Changes and advances, a โ€ฆ
  2734. Risk factors and early signs of pancreaticย cancerย inย diabetes: screening strategy based onย diabetesย onset age
  2735. Risk factors forย cancerย development in type 2ย diabetes: a retrospective case-control study
  2736. Risk factors for elevated serum colorectalย cancerย markers in patients with type 2ย diabetesย mellitus
  2737. Risk factors for papillary thyroidย cancerย in obesity andย diabetesย mellitus
  2738. Risk factors for radiation esophagitis and pneumonitis in esophagealย cancerย patients withย diabetesย or hypertension
  2739. Risk factors of catheter-related bloodstream infections inย cancerย patients withย diabetes
  2740. Risk factors of familial pancreaticย cancerย in Japan: current smoking and recent onset ofย diabetes
  2741. Risk of bladderย cancerย among patients withย diabetesย treated with a 15 mg pioglitazone dose in Korea: a multi-center retrospective cohort study
  2742. Risk of bladderย cancerย in patients withย diabetesย mellitus: an updated meta-analysis of 36 observational studies
  2743. Risk of bladderย cancerย in patients withย diabetes: a retrospective cohort study
  2744. Risk of bladderย cancerย in patients withย diabetes: a retrospective cohort study.
  2745. Risk of breastย cancerย after onset of type 2ย diabetes: evidence of detection bias in postmenopausal women
  2746. Risk of breastย cancerย among daughters of mothers withย diabetes: a population-based cohort study
  2747. Risk of Breastย cancerย in Patients diagnosed with Type 2ย diabetesย (T2DM)
  2748. Risk ofย cancerย following hospitalization for type 2ย diabetes
  2749. Risk ofย cancerย in a large cohort of US veterans withย diabetes
  2750. Risk ofย cancerย inย diabetes: the effect of metformin
  2751. Risk ofย cancerย incidence and mortality associated withย diabetes: A systematic review with trend analysis of 203 cohorts
  2752. Risk of cardiovascular disease among Nordic childhoodย cancerย survivors withย diabetesย mellitus: A report from adult life after childhoodย cancerย in Scandinavia
  2753. Risk of causeโ€specific death in individuals withย cancerโ€”modifying roleย diabetes, statins and metformin
  2754. Risk of colonย cancerย recurrence in relation toย diabetes
  2755. Risk of colorectalย cancerย in patients withย diabetesย mellitus: A Swedish nationwide cohort study
  2756. Risk ofย diabetesย after para-aortic radiation for testicularย cancer
  2757. Risk ofย diabetesย among patients receiving primary androgen deprivation therapy for clinically localized prostateย cancer
  2758. Risk ofย diabetesย Associated Withย cancerย Development
  2759. Risk ofย diabetesย Associated Withย cancerย Developmentโ€”In Reply
  2760. Risk ofย diabetesย complications among those withย diabetesย receiving androgen deprivation therapy for localized prostateย cancer
  2761. Risk ofย diabetes,ย cancer, large vessel disease and mortality in young women with Polycystic Ovary Syndrome: a retrospective database analysis
  2762. Risk of endometrial and breastย cancerย in patients withย diabetesย mellitus
  2763. Risk of esophagealย cancerย inย diabetesย mellitus: a meta-analysis of observational studies
  2764. Risk of esophagusย cancerย inย diabetesย mellitus: a population-based case-control study in Taiwan
  2765. Risk of head and neckย cancerย in patients withย diabetesย mellitus: a retrospective cohort study in Taiwan
  2766. Risk of Myocardial Infarction orย diabetesย During Androgen Deprivation Therapy for Prostateย cancer: Does Comorbidity Influence Risk?
  2767. Risk of prostateย cancerย across different racial/ethnic groups in men withย diabetes: A retrospective cohort study
  2768. Risk of skinย cancerย in patients withย diabetesย mellitus: a nationwide retrospective cohort study in Taiwan
  2769. Risk of type 2ย diabetesย mellitus in female breastย cancerย patients treated with morphine: a retrospective population-based time-dependent cohort study
  2770. Risks of breast and endometrialย cancerย in women withย diabetes: a population-based cohort study
  2771. Risks of Colorectalย cancers Associated withย diabetesย Were Particularly Increased in Middle-aged Men Running title: Colorectalย cancerย in Diabetic Patients
  2772. Role forย diabetesย in colorectalย cancerย risk
  2773. Role of breastย cancerย inhibitors onย diabetesย mellitusโ€“an in silico approach
  2774. Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectalย cancerย in type 2ย diabetes
  2775. Role of Heat Shock Protein 90 inย diabetesย and Pancreaticย cancerย Management
  2776. Role of Mitochondria in Pancreatic Metabolism,ย diabetes, andย cancer
  2777. Role of pre-existing type 2ย diabetesย in colorectalย cancerย survival among older Americans: a SEER-Medicare population-based study 2002-2011.
  2778. Role of pre-existing type 2ย diabetesย in colorectalย cancerย survival among older Americans: a SEER-Medicare population-based study 2002โ€“2011
  2779. Role of signal dynamics in the link between type 2ย diabetesย andย cancer
  2780. Role of the tumor suppressor IQGAP2 in metabolic homeostasis: Possible link betweenย diabetesย andย cancer
  2781. Roles of microRNA-124a and microRNA-30d in breastย cancerย patients with type 2ย diabetesย mellitus
  2782. Rosemary leaf extract inhibits glycation, breastย cancerย proliferation, andย diabetesย risks
  2783. Rosiglitazone may reduce thyroidย cancerย risk in patients with type 2ย diabetes
  2784. Rosiglitazone reduces breastย cancerย risk in Taiwanese female patients with type 2ย diabetesย mellitus
  2785. Rosiglitazone use and the risk of bladderย cancerย in patients with type 2ย diabetes
  2786. SAT-134 Association between Serum Branched-Chain Amino Acids andย cancerย Risk: The Hong Kongย diabetesย Register (HKDR)
  2787. Screening for Pancreaticย cancerย in Individuals With New-onsetย diabetesย Mellitus
  2788. Screening Strategy of Pancreaticย cancerย in Patients withย diabetesย Mellitus
  2789. Secondaryย diabetesย associated with 5โ€fluorouracilโ€based chemotherapy regimens in nonโ€diabetic patients with colorectalย cancer: results from a singleโ€centre cohort โ€ฆ
  2790. Secondhand Smoke Exposure,ย diabetes, Elevated Glucose Level Are Risk Factors for Uterine Cervicalย cancer: A Cross-Sectional Study From the Korea โ€ฆ
  2791. Secular trend for mortality from breastย cancerย and the association betweenย diabetesย and breastย cancerย in Taiwan between 1995 and 2006
  2792. Sedentary behaviour and risk of all-cause, cardiovascular andย cancerย mortality, and incident type 2ย diabetes: a systematic review and dose response meta โ€ฆ
  2793. Selenium supplementation trials forย cancerย prevention and the subsequent risk of type 2ย diabetesย mellitus: selenium and vitamin Eย cancerย prevention trial and after
  2794. Self reported non-insulin dependentย diabetes, family history, and risk of prevalent colorectalย cancer: population based, cross sectional study
  2795. Self-rated health and type 2ย diabetesย risk in the European Prospective Investigation intoย cancerย and Nutrition-InterAct study: a case-cohort study
  2796. Self-reportedย diabetesย mellitus and risk of mortality from all causes, cardiovascular disease, andย cancerย in Takayama: a population-based prospective cohort study in โ€ฆ
  2797. Self-reported memory problems in adult-onsetย cancerย survivors in the United States with or without: Type 2ย diabetesย mellitus, hypertension and hyperlipidemia.
  2798. Senile Colonย cancerย withย diabetesย Patients Perioperative Features and Nursing Intervention [J]
  2799. Sera anti-p53 antibody provides new information which explains the link betweenย diabetesย andย cancer
  2800. Serious illness in childhood: the different threats ofย cancerย andย diabetesย from a parent perspective
  2801. Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2ย diabetes,ย cancerย and mortality: the Tromsรธ โ€ฆ
  2802. Serum HSP70 level in patients with endometrialย cancerย with and withoutย diabetes
  2803. Serum Levels of 8-Hydroxy-2โ€ฒ-Deoxyguanosine DNA in Patients with Breastย cancerย and Endometrialย cancerย with and withoutย diabetesย Mellitus
  2804. Serum metabolomics differentiating pancreaticย cancerย from new-onsetย diabetes
  2805. Serum proteomic analysis of pancreaticย cancerย associatedย diabetes
  2806. Serum vascular adhesion protein-1 predicts 10-year cardiovascular andย cancerย mortality in individuals with type 2ย diabetes
  2807. Session 4: CVD,ย diabetesย andย cancerย A dietary portfolio for management and prevention of heart disease: Symposium on โ€˜Dietary management of diseaseโ€™
  2808. Session 4: CVD,ย diabetesย andย cancerย Diet, insulin resistance andย diabetes: the right (pro) portions: Symposium on โ€˜Dietary management of diseaseโ€™
  2809. Session 4: CVD,ย diabetesย andย cancerย Evidence for the use of the Mediterranean diet in patients with CHD: Symposium on โ€˜Dietary management of diseaseโ€™
  2810. SESSION IA| HEALTHCARE DISPARITIES: TYPE 2ย diabetesย & BREASTย cancer
  2811. Severe hypoglycemia identifies vulnerable patients with type 2ย diabetesย at risk for premature death and all-siteย cancer: the Hong Kongย diabetesย registry
  2812. Severe Visceral Obesity, Fatty Liver andย diabetesย after Orchiectomy for Prostateย cancer
  2813. Sex differences in obesity relatedย cancerย incidence in relation to type 2ย diabetesย diagnosis (ZODIAC-49)
  2814. Sex differences in the association betweenย diabetesย andย cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and โ€ฆ
  2815. Sex differences in the association betweenย diabetesย and risk of cardiovascular disease,ย cancer, and all-cause and cause-specific mortality: a systematic โ€ฆ
  2816. Sex-and site-specific differences in colorectalย cancerย risk among people with type 2ย diabetes
  2817. Sex-specific association between family history ofย diabetesย and risk of colorectalย cancer: two prospective cohort studies
  2818. SGLT2 inhibitors and risk ofย cancerย in type 2ย diabetes: a systematic review and meta-analysis of randomised controlled trials
  2819. Shaping environments for reductions in type 2ย diabetesย risk behaviors: A look at CVD andย cancerย interventions
  2820. Shortโ€term risk ofย cancerย among women with previous gestationalย diabetes: a populationโ€based study
  2821. Should healthcare be guaranteed forย cancerย but notย diabetes?
  2822. Significance of angiotensin targeting on treatment of liver metastasis in colorectalย cancerย patients withย diabetes
  2823. Significance of preoperative HbA1c level in patients withย diabetesย mellitus and clinically localized prostateย cancer
  2824. Significantly increased risk ofย cancerย inย diabetesย mellitus patients: a metaโ€analysis of epidemiological evidence in Asians and nonโ€Asians
  2825. Significantly increased risk ofย cancerย in patients withย diabetesย mellitus: a systematic review and meta-analysis
  2826. Sitagliptin and oralย cancerย risk in type 2ย diabetesย patients
  2827. Sitagliptin and pancreaticย cancerย risk in patients with type 2ย diabetes
  2828. Sitagliptin may reduce breastย cancerย risk in women with type 2ย diabetes
  2829. Sitagliptin may reduce prostateย cancerย risk in male patients with type 2ย diabetes
  2830. Sitagliptin use and thyroidย cancerย risk in patients with type 2ย diabetes
  2831. Sitagliptin use may reduce oralย cancerย risk in patients with type 2ย diabetes
  2832. Site-specificย cancerย risk due toย diabetesย mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study
  2833. Site-specificย cancerย risk in patients with type 2ย diabetes: a nationwide population-based cohort study in Korea
  2834. Site-specificย cancerย risk in people with type 2ย diabetes: Nationwide population-based cohort study in Korea
  2835. Skeletal muscle microRNAs in humanย cancerย cachexia and Type 2ย diabetes
  2836. Sleep apnea: a common mechanism for the deadly triadโ€”cardiovascular disease,ย diabetes, andย cancer?
  2837. Small cell lungย cancerย expressing glutamate decarboxylase with latent autoimmuneย diabetesย in adults
  2838. Small cell lungย cancerย starting withย diabetesย mellitus: Two case reports and literature review
  2839. Small-cell lungย cancerย presenting asย diabetesย insipidus and cushingโ€™s syndrome
  2840. Smoking Despite Lungย cancerย orย diabetes: A Pressing Challenge to Smoking Abstinence
  2841. Smoking, alcohol,ย diabetes, obesity, socioeconomic status, and the risk of colorectalย cancerย in a population-based caseโ€“control study
  2842. Smoking, family history ofย cancer, andย diabetesย mellitus are associated with the age of onset of pancreaticย cancerย in Japanese patients
  2843. Social Welfare Approaches for Patients with Concurrentย diabetesย andย cancer.
  2844. Socioeconomic characteristics, life style,ย diabetes, family history ofย cancerย and risk of pancreaticย cancer
  2845. Sodiumโ€“glucose cotransporter 2 inhibitors and the short-term risk of breastย cancerย among women with type 2ย diabetes
  2846. SOX7 expression correlates with better prognosis in pancreaticย cancerย patients and is negatively related to pancreaticย cancerย associatedย diabetes
  2847. Speaking with one voice on worksite wellness: the Americanย cancerย Society, the Americanย diabetesย Association, and the American Heart Association
  2848. Spontaneous remission of cranialย diabetesย insipidus due to concomitant development of ADH-producing lungย cancerโ€“an autopsied case
  2849. Sporadic Pancreaticย cancer: Glucose Homeostasis and Pancreatogenic Type 3ย diabetes
  2850. Standard and competing risk analysis of the effect of albuminuria on cardiovascular andย cancerย mortality in patients with type 2ย diabetesย mellitus
  2851. Standard risk factors for lungย cancer, cardiac infarct, apoplexy,ย diabetesย mellitus and their changes in psychosocial context
  2852. Statin use andย cancerย incidence in patients with type 2ย diabetesย mellitus: a network meta-analysis
  2853. Statin Use and the Risk of Colorectalย cancerย in Patients withย diabetes: 881
  2854. Statins and finasteride use differentially modify the impact of metformin on prostateย cancerย incidence in men with type 2ย diabetes
  2855. Statins and the risk of gastricย cancerย inย diabetesย patients
  2856. Statistical analysis of the effect of metformin use on endometrialย cancerย incidence in patients with type 2ย diabetes
  2857. Stem cell-based approach inย diabetesย and pancreaticย cancerย management
  2858. Steroid-inducedย diabetesย inย cancerย patients
  2859. Storage of vitamin D in adipose tissue and associations between vitamin D related genetic variants andย diabetes, myocardial infarction,ย cancer, death, and low bone โ€ฆ
  2860. Stratification ofย cancerย andย diabetesย based on circulating levels of formate and glucose
  2861. Stratification ofย cancerย andย diabetesย based on circulating levels of formate and glucose
  2862. Stratified medicine for the use of antidiabetic medication in treatment of type IIย diabetesย andย cancer: where do we go from here?
  2863. Stroke, lungย cancer, andย diabetesย health beliefs and lifestyle practices of Vietnamese elders: Implications for geriatric rehabilitation
  2864. Structural and Biophysical Characterization of SPOP-Client Interactions Involved inย diabetesย andย cancer
  2865. Studies on prevention of obesity, metabolic syndrome,ย diabetes, cardiovascular diseases andย cancerย by tea
  2866. Studies on the relationships between blood trace metal concentrations and the clinical status of patients with cerebrovascular disease, gastricย cancerย andย diabetesย โ€ฆ
  2867. Study of correlation between pancreaticย cancerย andย diabetesย mellitus [J]
  2868. Study of serum IGF-1, IGFBP-3 and insulin levels in patients with type 2ย diabetesย mellitus and their relationship with colorectalย cancer
  2869. Study of the Association Between Antihyperglycemic Therapy andย cancerย in Patients with Type 2ย diabetesย Mellitus
  2870. Study of the Prevalence of Chronic Diseases (cancer,ย diabetes, Heart Disease) and Its Relationship with the Elderlyโ€™s Quality Of Life
  2871. Study on the association between the different levels of C-peptide of type 2ย diabetesย and colorectalย cancerย risk
  2872. Study on the effect of metformin in patients of metastatic renal cellย cancerย withย diabetesย receiving tyrosine kinase inhibitor therapy
  2873. Study On The Prevalence Of Various Forms Ofย cancerย In Diabetic Patients Hospitalized In The National Institute Ofย diabetes, Nutrition And Metabolic โ€ฆ
  2874. STUDY ON THE RELATIONSHIP BETWEEN PANCREATICย cancerย ANDย diabetesย MELLITUS, OTHER MEDICAL CONDITIONS AND FAMILIAL HISTORY
  2875. STUDY ON THE RELATIONSHIP BETWEEN PANCREATICย cancerย ANDย diabetesย MELLITUS, OTHER MEDICAL CONDITIONS AND FAMILIAL HISTORY
  2876. Studying host genetic background effects on multimorbidity of intestinalย cancerย development, type 2ย diabetesย and obesity in response to oral bacterial infection and โ€ฆ
  2877. Subsequentย cancerย risk in the incidence cohort of Rochester, Minnesota, residents withย diabetesย mellitus
  2878. Substantially increased risk ofย cancerย in patients withย diabetesย mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan
  2879. Substitutions between dairy product subgroups and risk of type 2ย diabetes: the Danish Diet,ย cancerย and Health cohort
  2880. Successful use of endoscopic argon plasma coagulation for patients with early gastricย cancerย andย diabetesย mellitus
  2881. SUN-675 Breastย cancerย Treatment Causesย diabetes
  2882. SUN-688 Pancreaticย cancerย in Longstandingย diabetes
  2883. Superior Mesenteric Artery Syndrome Preceded byย diabetesย Insipidus in Advanced Lungย cancerย with Pituitary Metastasisโ€“A Case Report
  2884. Superoxide dismutases: significances in aging,ย diabetes, ischemia andย cancer
  2885. Supplemental Material The Association of Arsenic Metabolism withย cancer, Cardiovascular Disease andย diabetes: A Systematic Review of the Epidemiological โ€ฆ
  2886. Surgical treatment of gastricย cancerย in elderly patients combinded withย diabetes
  2887. Surgical Treatment of Large Bowelย cancerย withย diabetesย Mellitus
  2888. Survival advantage associated with metformin usage in patients with colorectalย cancerย (CRC) and type II noninsulin-dependentย diabetesย (NIDDM).
  2889. Survival advantage observed with the use of metformin in patients with type IIย diabetesย and colorectalย cancer
  2890. Survival after breastย cancerย in women with type 2ย diabetesย using antidiabetic medication and statins: a retrospective cohort study
  2891. Survival among patients with pancreaticย cancerย and long-standing or recent-onsetย diabetesย mellitus
  2892. Survival and glycemic control in patients with colorectalย cancerย andย diabetesย mellitus
  2893. Survival and glycemic control outcomes among patients with coexisting pancreaticย cancerย andย diabetesย mellitus
  2894. Survival benefit associated with metformin use in inoperable non-small cell lungย cancerย patients withย diabetes: A population-based retrospective cohort study
  2895. Survival benefits of metformin for colorectalย cancerย patients withย diabetes: a systematic review and meta-analysis
  2896. Survival impact ofย diabetesย and paraneoplastic thrombocytosis in women with breastย cancer
  2897. Survival of colorectalย cancerย patients withย diabetesย mellitus: A meta-analysis
  2898. Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease,ย cancerย and smoking in patients with type 2ย diabetes: BioBank Japan cohort
  2899. Survival of non-small cell lungย cancerย (NSCLC) patients with and withoutย diabetesย mellitus (DM): Findings from theย cancerย Care Outcomes Research and Surveillance โ€ฆ
  2900. Survival of patients with cervicalย cancerย andย diabetes: An exploratory study.
  2901. Survival of patients with lungย cancerย andย diabetesย mellitus
  2902. Survival of patients with stage IV lungย cancerย withย diabetesย treated with metformin
  2903. Survival of resectable pancreaticย cancerย patients withย diabetes
  2904. Suva Residentsโ€™ Views onย cancer,ย diabetesย and HIV in The Fiji Times
  2905. Switching the sphingolipid rheostat in the treatment ofย diabetesย andย cancerย comorbidity from a problem to an advantage
  2906. SYMPOSIUMS:ย diabetesย ANDย cancer: CAN RESVERATROL BE A GOOD CANDIDATE IN THIS TSUNAMI?
  2907. Syndecan as a messenger to linkย diabetesย andย cancer
  2908. Synergistic effects of low LDL cholesterol with other factors for the risk ofย cancerย in type 2ย diabetes: the Hong Kongย diabetesย Registry
  2909. Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lungย cancerย and type 2ย diabetes
  2910. Synthesis of Tin Oxide Nanofibers for Lungย cancer,ย diabetesย and Kidney Malfunction Detection
  2911. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrialย cancerย and type 2ย diabetesย mellitus
  2912. Systematic review and metaโ€analysis of the association betweenย diabetesย mellitus and incidence and mortality in breast and colorectalย cancer
  2913. Systematic Survey of the Role of IGF in the Link Betweenย diabetesย andย cancer
  2914. Systemicย cancerย presenting asย diabetesย insipidus. Clinical and radiographic features of 11 patients with a review of metastaticโ€inducedย diabetesย insipidus
  2915. Targeting acidity inย cancerย andย diabetes
  2916. Targeting dipeptidyl peptidase-4 (DPP-4) and fibroblast activation protein (FAP) forย diabetesย andย cancerย therapy
  2917. Targeting receptors of advanced glycation end products (RAGE): preventingย diabetesย inducedย cancerย and diabetic complications
  2918. Targeting unfolded protein response inย cancerย andย diabetes
  2919. Taxane-induced peripheral sensorial neuropathy inย cancerย patients is associated with duration ofย diabetesย mellitus: a single-center retrospective study
  2920. TCF7L2 type 2ย diabetesย risk variant, lifestyle factors, and incidence of prostateย cancer
  2921. Technology-Enhanced consultations inย diabetes,ย cancer, and heart failure: protocol for the qualitative analysis of remote consultations (QuARC) project
  2922. Television watching and incidentย diabetes: findings from the European Prospective Investigation intoย cancerย and Nutritionโ€“Potsdam Study
  2923. Testโ€“retest reliability of self-reportedย diabetesย diagnosis in the Norwegian Women andย cancerย Study: a population-based longitudinal study (n= 33,919)
  2924. Testing Mice at Risk of Pancreaticย cancerย for Altered Protein Pathways Found inย diabetes
  2925. Texas Health Insurance Coverage for Prevention and Screening ofย cancer, Cardiovascular Disease, andย diabetes
  2926. TGFBIp mediated apoptosis: A role inย cancerย andย diabetesย mellitus type II
  2927. TH1 and TH2 cytokines dataset in insulin users withย diabetesย mellitus and newly diagnosed breastย cancer
  2928. The activation of ERK1/2 and JNK MAPK signaling by insulin/IGF-1 is responsible for the development of colonย cancerย with type 2ย diabetesย mellitus
  2929. The advanced glycation endโ€product Nฯตโ€carboxymethyllysine promotes progression of pancreaticย cancer: implications forย diabetesโ€associated risk and its โ€ฆ
  2930. The Americanย diabetesย Association, the Americanย cancerย Society, and the American Heart Association
  2931. The Americanย diabetesย Association, the Americanย cancerย Society, and the American Heart Association: A triumvirate of hope for the nationโ€™s health
  2932. The application of refined nursing in postoperative patients with breastย cancerย andย diabetes
  2933. The assessment of molecular markers of cell interaction and lipid peroxidation in rats with alloxanย diabetesย and trans-planted liverย cancerย after intravenous injection of โ€ฆ
  2934. The association betweenย cancer-related fatigue andย diabetesย from pre-chemotherapy to 6-months post-chemotherapy
  2935. The association betweenย diabetesย and breastย cancerย stage at diagnosis: a population-based study
  2936. The association betweenย diabetesย andย cancerย incidence and mortality in the NIH-AARP study
  2937. The association betweenย diabetesย and thyroidย cancerย risk: a hospital-based case-control study in China
  2938. The Association betweenย diabetesย Mellitus and Colorectalย cancerย Stage at Presentation: Presidential Poster: 1559
  2939. The association betweenย diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrialย cancer
  2940. The association betweenย diabetes, insulin use, and colorectalย cancerย among Whites and African Americans
  2941. The association betweenย diabetes/hyperglycemia and the prognosis of cervicalย cancerย patients: A systematic review and meta-analysis
  2942. The association between fasting blood glucose trajectory andย cancerย risk in Chinese population withoutย diabetes
  2943. The association between gestationalย diabetesย mellitus andย cancerย in women: a systematic review and meta-analysis of observational studies
  2944. The association between glucose-lowering drug use and mortality among breastย cancerย patients with type 2ย diabetes
  2945. The association between metformin use and colorectalย cancerย survival among patients withย diabetesย mellitus: An updated meta-analysis
  2946. The association between paternal prostateย cancerย and type 2ย diabetes
  2947. The Association between Patient Characteristics and Use of Statin and Metformin among Elderly Women with Breastย cancerย andย diabetes
  2948. The association between self-reportedย diabetesย andย cancerย incidence in the NIH-AARP Diet and Health Study
  2949. The Association between thyroidย cancerย and type 2ย diabetesย mellitus
  2950. The association between type 2ย diabetesย mellitus and bladderย cancerย risk among postmenopausal women
  2951. The Association between Type 2ย diabetesย Mellitus and Colorectalย cancer.
  2952. The Association between Type 2ย diabetesย Mellitus and Colorectalย cancer.
  2953. The association between type 2ย diabetesย mellitus and thyroidย cancer
  2954. The association between type 2ย diabetesย mellitus and womenย cancer: the epidemiological evidences and putative mechanisms
  2955. The association of arsenic metabolism patterns withย cancer, cardiovascular disease andย diabetes: A systematic review of the epidemiological evidence
  2956. The association of arsenic metabolism withย cancer, cardiovascular disease, andย diabetes: a systematic review of the epidemiological evidence
  2957. The Association of Arsenic Metabolism withย cancer, Cardiovascular Disease, andย diabetes: A Systematic Review of the Epidemiological Evidence
  2958. The association ofย diabetesย and obesity with prostateย cancerย aggressiveness among Black Americans and White Americans in a population-based study
  2959. The association ofย diabetesย and obesity with prostateย cancerย progression: HCaPโ€NC
  2960. The association ofย diabetesย mellitus and high-grade prostateย cancerย in a multiethnic biopsy series
  2961. The Association ofย diabetesย Mellitus with Colorectalย cancerย and Polyps in Asymptomatic Patients Undergoing Screening Colonoscopy: 447
  2962. The association ofย diabetesย mellitus with liver, colon, lung, and prostateย cancerย is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients
  2963. The association ofย diabetesย mellitus with liver, colon, lung, and prostateย cancerย is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients
  2964. The association ofย diabetesย with breastย cancerย incidence and mortality in the Long Island Breastย cancerย Study Project
  2965. The association ofย diabetesย with colorectalย cancerย risk: the Multiethnic Cohort
  2966. The association ofย diabetesย with risk of prostateย cancerย defined by clinical and molecular features
  2967. The association of high-density lipoprotein cholesterol withย cancerย incidence in type IIย diabetes: a case of reverse causality?
  2968. The association of hyperglycemia andย diabetesย mellitus and the risk of chemotherapy-induced neutropenia amongย cancerย patients: a systematic review with meta โ€ฆ
  2969. The association of hyperinsulinemia with cardiovascular risk andย cancerย poses new challenges in the treatment of the insulin resistance type 2ย diabetesย patient
  2970. The association of recently-diagnosedย diabetesย and long-termย diabetesย with survival in pancreaticย cancerย patients: a pooled analysis
  2971. The Baltimore Alliance for the Prevention and Control of Hypertension andย diabetes: a model for developing a colorectalย cancerย community outreach program.
  2972. The bidirectional interation between pancreaticย cancerย andย diabetes
  2973. The Biology of the Deadly Love Connection Between Obesity,ย diabetes, and Breastย cancer
  2974. Theย cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk ofย diabetes
  2975. The clinical dependabilities between type 2ย diabetesย and lungย cancer.
  2976. The clinical effect of metformin on the survival of lungย cancerย patients withย diabetes: a comprehensive systematic review and meta-analysis of retrospective โ€ฆ
  2977. The Clinical Features of Patients with Type 2ย diabetesย and Colorectalย cancer
  2978. The Clinical Observation ofย diabetesย Mellitus Following Cisplatin-based Chemotherapy on Head and Neckย cancerย [J]
  2979. The Combined Impact of Chronic Kidney Disease andย diabetesย on the Risk of Colorectalย cancerย Depends on Sex: A Nationwide Population-Based Study
  2980. The complex dual diagnosis ofย diabetesย andย cancer.
  2981. The complex role of branched chain amino acids inย diabetesย andย cancer
  2982. The complexities of obesity andย diabetesย with the development and progression of pancreaticย cancer
  2983. The correlation analysis of primary liverย cancerย with Type 2ย diabetes
  2984. The Correlation Between Dairy Product Consumption and Gastrointestinal Bleed, Ovarianย cancer, andย diabetesย in Infants: A Metaโ€Analysis Approach
  2985. The correlation betweenย diabetesย and pancreaticย cancerย and the imaging findings
  2986. The correlation between type-2ย diabetesย and lungย cancer
  2987. The decline inย cancerย incidence in patients with long-duration type 1ย diabetes: what really happens over time?
  2988. The design, synthesis and evaluation of new chemical entities for the development of drugs againstย cancer,ย diabetes, autoimmune disorders and infectious โ€ฆ
  2989. The development of fulminant type 1ย diabetesย during chemotherapy for rectalย cancer
  2990. Theย diabetesย Drug Canagliflozin Enhances the Response of Prostateย cancerย to Radiotherapy
  2991. Theย diabetesย medication Canagliflozin reducesย cancerย cell proliferation by inhibiting mitochondrial complex-I supported respiration
  2992. Theย diabetesโ€“cancerย link
  2993. The direct medical cost of cardiovascular diseases, hypertension,ย diabetes,ย cancer, pregnancy and female infertility in a large HMO in Israel
  2994. The double trouble of metabolic diseases: theย diabetesโ€“cancerย link
  2995. The Dual Specificity Role of Transcription Factor FOXO in Type 2-diabetesย andย cancer
  2996. The duration of obesity and the risk of type-2ย diabetes, cardiovascular disease,ย cancerย and mortality
  2997. The dysfunction of NK cells in patients with type 2ย diabetesย and colonย cancer
  2998. The early diagnosis of pancreaticย cancerย andย diabetes: whatโ€™s the relationship?
  2999. The Effect of Aging Lungย cancerย Combined with Type โ…กย diabetesย Mellitus by Shenmai Injection
  3000. The effect of Benign Thyroid Disease,ย diabetesย Mellitus and Physical Activity on Breastย cancerย Risk
  3001. The effect ofย diabetesย and metformin on clinical outcomes is negligible in risk-adjusted endometrialย cancerย cohorts
  3002. The effect ofย diabetesย mellitus on lungย cancerย prognosis: a PRISMA-compliant meta-analysis of cohort studies
  3003. The effect ofย diabetesย mellitus on prognosis of patients with non-small-Cell lungย cancer: a systematic review and meta-analysis
  3004. The effect ofย diabetesย on the perioperative outcomes of colorectalย cancerย surgery patients
  3005. The effect ofย diabetesย on the risk of endometrialย cancer: an updated a systematic review and meta-analysis
  3006. The effect ofย diabetesย with pharmacotherapy for breastย cancerย on care resource use
  3007. The effect of exposure to thiazolidinediones on the development of head-and-neckย cancerย in patients withย diabetesย mellitus
  3008. The effect of incidentย cancer, depression and pulmonary disease exacerbations on type 2ย diabetesย control
  3009. The Effect of intensive Glycemic Control on Postoperative Gastricย cancerย Patients Combined withย diabetes
  3010. The effect of long Roux-en-Y gastrojejunostomy in gastricย cancerย patients with type 2ย diabetesย and body mass index< 35 kg/m2: preliminary results
  3011. The effect of metformin on breastย cancerย outcomes in patients with type 2ย diabetes
  3012. The effect of metformin on esophagealย cancerย risk in patients with type 2ย diabetesย mellitus: a systematic review and metaโ€‘analysis
  3013. The effect of metformin on gastricย cancerย in patients with type 2ย diabetes: a systematic review and meta-analysis
  3014. The effect of metformin on lungย cancerย risk and survival in patients with type 2ย diabetesย mellitus: A metaโ€analysis
  3015. The effect of metformin on mortality followingย cancerย among patients withย diabetes
  3016. The effect of metformin on oncological outcomes in patients with cervicalย cancerย with type 2ย diabetesย mellitus
  3017. The effect of metformin on prognosis in patients with locally advanced gastricย cancerย associated with type 2ย diabetesย mellitus
  3018. The effect of metformin on responses to chemotherapy and survival in stage IV colorectalย cancerย withย diabetes
  3019. The effect of metformin on the clinicopathological features of breastย cancerย with type 2ย diabetes
  3020. The effect of metformin on the progression of non-small cell lungย cancerย withย diabetesย mellitus: A review of studies between 2015 and 2017
  3021. The effect of metformin use and the incidence of prostateย cancerย in type 2ย diabetesย mellitus patients: A nationwide population-based study
  3022. The effect of neoadjuvant chemoradiation on pancreaticย cancer-associatedย diabetesย mellitus
  3023. The Effect of Obesity andย diabetesย on Intermediate to High Grade Prostateย cancerย Patients Treated with Radical Prostatectomy
  3024. The effect of obesity on the formation ofย cancerย risk in patients with type 2ย diabetesย mellitus (literature review)
  3025. The Effect of Pre-existingย diabetesย on the Incidence of Postradiation Retinopathy in Head and Neckย cancerย Patients
  3026. The Effect of Prostateย cancerย Diagnosis on Adherence to Medications for Patients with Type 2ย diabetes
  3027. The effect of smoking, obesity andย diabetesย on recurrenceโ€free and overall survival in patients with stage III colonย cancerย receiving adjuvant chemotherapy
  3028. The effect of type 2ย diabetesย on selected clinical parameters and disease outcome in patients with colorectalย cancer
  3029. The effects ofย diabetesย and fasting plasma glucose on treatment of breastย cancerย with neoadjuvant chemotherapy
  3030. The effects of metformin on the survival of colorectalย cancerย patients withย diabetesย mellitus
  3031. The Elusive Link Betweenย cancerย FDG Uptake and Glycolytic Flux Explains the Preserved Diagnostic Accuracy of PET/CT inย diabetes
  3032. The Emerging Link between Metformin Therapy for Type 2ย diabetesย Mellitus and Colorectalย cancer
  3033. The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease,ย cancerย andย diabetesย mellitus
  3034. The epidemiologic relationship betweenย diabetesย andย cancer
  3035. The epidemiologicalcharacteristics of 1205ย cancerย patients with previous type 2ย diabetesย mellitus
  3036. The epidemiology and molecular mechanisms linking obesity,ย diabetes, andย cancer
  3037. The epidemiology ofย diabetesย andย cancer
  3038. The Estimation of Thyroidย cancerย Risk based on Type 2ย diabetesย Mellitus and ABO Blood Group.
  3039. The estrogen connection: the etiological relationship betweenย diabetes,ย cancer, rheumatoid arthritis and psychiatric disorders
  3040. The evaluation of Entamoeba gingivalis occurrence in samples from patients withย cancerย andย diabetes
  3041. The excess mortality related to cardiovascular diseases andย cancerย among adults pharmacologically treated forย diabetesโ€”the 2001โ€“2006 ENTRED cohort
  3042. The experience of developing new-onsetย diabetesย afterย cancerย treatments in middle age and older adults
  3043. The expression and significance of IGF1R-Ras/RAGE-HMGB1 pathway in colorectalย cancerย patients with type 2ย diabetesย mellitus
  3044. The expression of Transgelin in pancreaticย cancerย accompanied withย diabetesย and its effects on the migration and invasion of SW1990 cell line
  3045. The frequency ofย cancerย inย diabetesย mellitus
  3046. THE GENETICAL ASSOCIATION BETWEEN PROSTATEย cancerย AND TYPE 2ย diabetes
  3047. The global implications ofย diabetesย andย cancer.
  3048. The health benefits of dietary fiber: beyond the usual suspects of type 2ย diabetesย mellitus, cardiovascular disease and colonย cancer
  3049. The impact of body mass index and type 2ย diabetesย on breastย cancer: current therapeutic measures of prevention
  3050. The impact ofย cancerย onย diabetesย outcomes
  3051. The Impact of Comorbidย diabetesย on Short-Term Postoperative Outcomes in Stage I/II Colonย cancerย Patients Undergoing Open Colectomy
  3052. The Impact of Comorbidย diabetesย Type 2 on Quality of Life inย cancerย Patients Undergoing Chemotherapy.
  3053. The impact ofย diabetesย and metformin on clinical outcomes is negligible in risk-adjusted endometrialย cancerย cohorts
  3054. The impact ofย diabetesย and obesity on endometrialย cancerย outcomes.
  3055. The impact ofย diabetesย and other metabolic disorders on prostateย cancerย prognosis
  3056. The impact ofย diabetesย in head and neckย cancer
  3057. The impact ofย diabetesย mellitus and metformin on survival of patients with advanced pancreaticย cancerย receiving chemotherapy.
  3058. The impact ofย diabetesย mellitus and metformin treatment on survival of patients with advanced pancreaticย cancerย undergoing chemotherapy
  3059. The impact ofย diabetesย mellitus and obesity on pathologic complete response rate of neoadjuvant chemoradation for gastroesophagealย cancer: A retrospective review.
  3060. The impact ofย diabetesย mellitus on breastย cancerย outcomes: a single center retrospective study
  3061. The impact ofย diabetesย mellitus on clinical outcomes following chemotherapy for the patients with pancreaticย cancer: a meta-analysis
  3062. The impact ofย diabetesย mellitus on early cervicalย cancerย in ฮ‘sia: A population-based cohort study.
  3063. The impact ofย diabetesย mellitus on prognosis of early breastย cancerย in Asia
  3064. The impact ofย diabetesย mellitus on survival following resection and adjuvant chemotherapy for pancreaticย cancer
  3065. The Impact ofย diabetesย Mellitus on Survival in Men with Clinically Localized Prostateย cancerย Treated with Permanent Interstitial Brachytherapy
  3066. The impact ofย diabetesย mellitus on survival in men with clinically localized prostateย cancerย treated with permanent interstitial brachytherapy
  3067. The Impact ofย diabetesย Mellitus on the Second Primary Malignancies in Colorectalย cancerย Patients
  3068. The impact ofย diabetesย mellitus on the toxicity of therapy for advanced ovarianย cancer
  3069. The impact ofย diabetesย on breastย cancerย treatments and outcomes: a population-based study
  3070. The Impact ofย diabetesย on Breastย cancerย Treatments and Outcomes: A Population-Based Study
  3071. The Impact ofย diabetesย on Colorectalย cancerย Stage at Diagnosis: A Population-Based Cohort Study
  3072. The impact ofย diabetesย on gynecologicย cancer: Current status and future directions
  3073. The impact ofย diabetesย on neuropathic symptoms and receipt of chemotherapy among colorectalย cancerย patients: results from the PROFILES registry
  3074. The impact ofย diabetesย on survival following breastย cancer
  3075. The impact ofย diabetesย on survival in women with ovarianย cancer
  3076. The impact ofย diabetesย on the risk of prostateย cancerย development according to body mass index: a 10-year nationwide cohort study
  3077. The Impact ofย diabetesย on the Symptoms of Breastย cancerย Survivors
  3078. The impact ofย diabetesย process and outcome quality measures on overall survival in patients with co-morbid colorectalย cancer
  3079. The Impact ofย diabetesย Treatment on Survival in a Breastย cancer/diabetesย Model
  3080. The impact of gastrectomy onย diabetesย and related conditions, coronary heart disease, stroke,ย cancer, and survival: follow-up from the Honolulu heart program
  3081. The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectalย cancer, and type 2ย diabetesย and metabolic traits โ€ฆ
  3082. The impact of having bothย cancerย andย diabetesย on patient-reported outcomes: a systematic review and directions for future research
  3083. The impact of metformin use on survival in kidneyย cancerย patients withย diabetes: a meta-analysis
  3084. The Impact of obesity andย diabetesย mellitus on pancreaticย cancer: Molecular mechanisms and clinical perspectives
  3085. The impact of physician communication onย diabetesย management inย cancerย survivors.
  3086. The Impact of Race andย diabetesย on Mortality among Breastย cancerย Patients
  3087. The Impact of Resolution ofย diabetesย After Radical Pancreatic Resection on Long-term Survival of Patients With Pancreaticย cancer
  3088. The impact of thiazolidinediones on the risk for prostateย cancerย in patients with type 2ย diabetesย mellitus: A review and meta-analysis
  3089. The impact of type 2ย diabetesย and antidiabetic drugs onย cancerย cell growth
  3090. The impact of type 2ย diabetesย mellitus onย cancerโ€specific survival: a followโ€up study in Sweden
  3091. The impact of type 2ย diabetesย mellitus on mortality in hospitalized femaleย cancerย patients in T aiwan
  3092. The impact on clinical outcome of high prevalence ofย diabetesย mellitus in Taiwanese patients with colorectalย cancer
  3093. The implication ofย diabetesย metabolomics in the early diagnosis and pathogenesis of pancreaticย cancer.
  3094. The incidence of cardiovascular disease,ย cancerย and type 2ย diabetesย comorbidities in HIV infection: A systematic review
  3095. The increased risk ofย cancerย in obesity and type 2ย diabetes: potential mechanisms
  3096. The individual and combined effect of colorectalย cancerย andย diabetesย on health-related quality of life and sexual functioning: results from the PROFILES registry
  3097. The individual and combined effects of obesity and type 2ย diabetesย onย cancerย predisposition and survival
  3098. The influence of alloxanย diabetesย on experimentalย cancer.
  3099. The influence ofย diabetesย and antidiabetic medications on the risk of pancreaticย cancer: a nationwide population-based study in Korea
  3100. The influence ofย diabetesย mellitus and metformin on distant metastases in oropharyngealย cancer: a multicenter study
  3101. The Influence ofย diabetesย Mellitus and Metformin on Distant Metastases in Oropharyngealย cancer: A Multicenter Study
  3102. The influence ofย diabetesย severity on guideline-concordant treatment for stage I-III breastย cancerย in the National Program ofย cancerย Registries (NPCR) patterns of care โ€ฆ
  3103. The influence ofย diabetesย severity on receipt of guideline-concordant treatment for breastย cancer
  3104. The influence of glucose-lowering therapies onย cancerย risk in type 2ย diabetes
  3105. The influence of psychological stress on the initiation and progression ofย diabetesย andย cancer
  3106. The influence of type 2ย diabetesย and glucose-lowering therapies onย cancerย risk in the Taiwanese
  3107. The influence of type 2ย diabetesย on the risk ofย cancer
  3108. The influence on survival of glucocorticoid inducedย diabetesย inย cancerย patients with metastatic spinal cord compression
  3109. The interface of pancreaticย cancerย withย diabetes, obesity, and inflammation: research gaps and opportunities: summary of a National Institute ofย diabetesย and โ€ฆ
  3110. The Interplay Between Type Twoย diabetesย Mellitus and Prostateย cancer
  3111. The intricate relationship betweenย diabetes, obesity and pancreaticย cancer
  3112. The levels of interleukin-2 and interleukin-10 in patients with type 2ย diabetesย and colonย cancer
  3113. The link between personality dimensions and pain perception in patients withย diabetesย mellitus orย cancer
  3114. The links between insulin resistance,ย diabetes, andย cancer
  3115. The management ofย diabetesย in patients with advancedย cancer
  3116. The management ofย diabetesย in terminal illness related toย cancer
  3117. The mechanisms of Fenretinide-mediated anti-cancerย activity and prevention of obesity and type-2ย diabetes
  3118. The Mechanistic Link Between Type 2ย diabetesย and Colorectalย cancer
  3119. The metformin effect on survival in Middle Eastern patients (pts) with type IIย diabetesย (DM) and colorectalย cancerย (CRC).
  3120. The modern nutritional diseases: Heart disease, stroke, type-2ย diabetes, obesity,ย cancer: and how to prevent them
  3121. The morbidity and associated risk factors ofย cancerย in chronic liver disease patients withย diabetesย mellitus: a multicenter field survey
  3122. The mutual aggravation syndrome in pancreaticย cancerย andย diabetesย mellitus
  3123. The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment ofย diabetesย andย cancer
  3124. The neglected insulin: IGF-II, a metabolic regulator with implications forย diabetes, obesity, andย cancer
  3125. The nutritional value and health benefits of pulses in relation to obesity,ย diabetes, heart disease andย cancer
  3126. The obesity paradox: defining the impact of body mass index andย diabetesย mellitus for patients with nonโ€muscleโ€invasive bladderย cancerย treated with bacillus โ€ฆ
  3127. The occurrence and impact on survival of type 2ย diabetesย mellitus and thrombocytosis in colorectalย cancer, before and after the surgical resection of the primary tumor
  3128. The OMEGA-3 Miracle: The Icelandic Longevity Secret that Offers Super Protection Against Heart Disease,ย cancer,ย diabetes
  3129. The orphan nuclear receptors inย cancerย andย diabetes
  3130. The pathway fromย diabetesย and obesity toย cancer, on the route to targeted therapy
  3131. The performance of different artificial intelligence models in predicting breastย cancerย among individuals having type 2ย diabetesย mellitus
  3132. The possible involvement of glycogen synthase kinase-3 (GSK-3) inย diabetes,ย cancerย and central nervous system diseases
  3133. The possible role ofย diabetesย in the etiology of laryngealย cancer
  3134. The potential cost-effectiveness of a risk-based pancreaticย cancerย screening strategy in new-onsetย diabetes.
  3135. The potential of glycemic control and body weight change as early markers for pancreaticย cancerย in patients with long-standingย diabetesย mellitus: a case-control study
  3136. The potential of lupin as a functional food for the prevention ofย diabetesย and pancreaticย cancer
  3137. The predictive effect of body mass index on type 2ย diabetesย in the Norwegian women andย cancerย study
  3138. The present state of knowledge on the problem of the relation betweenย diabetesย mellitus and breastย cancer
  3139. The prevalence of disability among people withย cancer, cardiovascular disease, chronic respiratory disease and/orย diabetes: a systematic review
  3140. The Prevention and Control ofย cancerย by Metformin in Patients with Type 2ย diabetes: A Systematic Mapping Review Protocol
  3141. The Prime Cause of Type-2 (T2D), Type-1ย diabetesย (T1D) and the Relation Betweenย diabetesย andย cancer
  3142. The prognostic impact of type 2ย diabetesย mellitus on early cervicalย cancerย in Asia
  3143. The prognostic value of metformin forย cancerย patients with concurrentย diabetes: a systematic review and metaโ€analysis
  3144. The protective effect ofย diabetesย mellitus against prostateย cancer: role of sex hormones
  3145. The Protein Myth: Significantly Reducing the Risk ofย cancer, Heart Disease, Stoke andย diabetesย While Saving the Animals and the Planet
  3146. The quality ofย diabetesย care amongย cancerย survivors: a retrospective cohort study
  3147. The relation between theย cancerย andย diabetesย death-rates
  3148. The Relation ofย diabetesย Mellitus with Short-term Outcomes in Patients with Gastricย cancerย [J]
  3149. The relation of type 2ย diabetesย and breastย cancerย incidence in Asian, Hispanic and African American Populationsโ€”a review
  3150. The relation of type 2ย diabetesย andย cancer
  3151. The relationship between body mass index,ย diabetes, and triple-negative breastย cancerย prognosis.
  3152. The relationship betweenย diabetesย andย cancer
  3153. The relationship betweenย diabetesย and colorectalย cancerย prognosis: a meta-analysis based on the cohort studies
  3154. The relationship betweenย diabetesย and pancreaticย cancer
  3155. The relationship betweenย diabetes, prostate-specific antigen screening tests, and prostateย cancer
  3156. The Relationship Between Insulin Therapy andย cancerย Incidences in Patients withย diabetes: Follow up study in Korea
  3157. The relationship between metformin andย cancerย in patients with type 2ย diabetes
  3158. The relationship between new-onsetย diabetesย mellitus and pancreaticย cancerย risk: a caseโ€“control study
  3159. The relationship between obesity andย cancerย mortality in type 2ย diabetes: a ten-year follow-up study (ZODIAC-21)
  3160. The relationship between pancreaticย cancerย and type 2ย diabetes: cause and consequence
  3161. ThE RElATIONShIp BETwEEN TypE 2ย diabetesย ANDย cancer: AN INTEgRATIvE REvIEw
  3162. The Relationship between Type 2ย diabetesย andย cancer: An Integrative Review
  3163. The relationship between type 2ย diabetesย mellitus andย cancer-related mortality and survival using linked CPRD data
  3164. The relationship between vitamin B6,ย diabetesย andย cancer
  3165. The Relationship of Neutrophil-to-Lymphocyte Ratio or Platelet-to-Lymphocyte Ratio and Pancreaticย cancerย in Patients with Type 2ย diabetes.
  3166. The Relationship of Type 2ย diabetes, Oralย diabetesย Medications, and Insulin Therapy to Risk for Breastย cancer
  3167. The Research Progress of Metformin in Type โ…กย diabetesย Mellitus with Liverย cancer
  3168. The Risk of Bladderย cancerย in Korean Diabetic Subjects Treated with Pioglitazone (diabetesย Metab J 2012; 36: 371-8)
  3169. The Risk of Bladderย cancerย in Korean Diabetic Subjects Treated with Pioglitazone (diabetesย Metab J 2012; 36: 371-8)
  3170. The risk of breastย cancerย in women withย diabetes
  3171. The Risk ofย cancerย inย diabetesย Patients: A Review
  3172. The risk ofย cancerย in people withย diabetesย and chronic kidney disease
  3173. The risk of colorectalย cancerย in patients with type 2ย diabetesย mellitus: associations with treatment stage and obesity
  3174. The risk of colorectalย cancerย in patients with type 2ย diabetes: associations with treatment stage and obesity
  3175. The Risk of Onset of the Illnesses Based on Gender, Age, and Monthly Income; Focusing onย cancer, hypertension, stroke,ย diabetes, arthritis, cardiac disorders
  3176. The role of adiposity in the association between type 2ย diabetesย and the risk of breastย cancer.
  3177. The role ofย diabetesย andย diabetesย treatments in colorectalย cancerย mortality, incidence, and survival
  3178. The role ofย diabetesย and other co-morbidities on survival after esophagealย cancerย surgery in a population-based study
  3179. The Role ofย diabetesย in Molecular Pathogenesis ofย cancer
  3180. The role ofย diabetesย mellitus in the aetiology of renal cellย cancer
  3181. The Role of early-life psychological factors in the development of chronic disease: a longitudinal analysis applied to the onset ofย cancer,ย diabetes, and asthma in mid โ€ฆ
  3182. The Role of Hypoxia Inducible Factor-1ฮฑ in Pancreaticย cancerย andย diabetesย Mellitus
  3183. The role of insulin and insulin-like growth factors in the increased risk ofย cancerย inย diabetes
  3184. The Role of Insulin, IGF-1 and PRAS40 in the Processes of Oncogenesis in Women with Type 2ย diabetesย Mellitus and Endometrialย cancer
  3185. The Role of Islet Amyloid Polypeptide (IAPP) in theย diabetesย and Anorexia of Pancreaticย cancer
  3186. THE ROLE OF METFORMIN AND STATINS IN OVARIAN AND BREASTย cancerย IN WOMEN WITH TYPE 2ย diabetes
  3187. The role of metformin and statins in the incidence of epithelial ovarianย cancerย in type 2ย diabetes: a cohort and nested caseโ€“control study
  3188. The Role of Obesity-induced Inflammation During the Pathogenesis of Type 2ย diabetesย andย cancer
  3189. The role of obesity, type 2ย diabetes, and metabolic factors in pancreaticย cancer: a Mendelian randomization study
  3190. The role of oestrogen in the pathogenesis of obesity, type 2ย diabetes, breastย cancerย and prostate disease
  3191. The Role of Pi, Glutamine and the Essential Amino Acids in Modulating the Metabolism inย diabetesย andย cancer
  3192. The Role of Pre-Existing Type 2ย diabetesย Mellitus in Colorectalย cancerย Stage and Survival in Elderly Americans: A Seer-Medicare Population-Based Study 2002 โ€ฆ
  3193. The role of preexistingย diabetesย mellitus on incidence and mortality of endometrialย cancer: a meta-analysis of prospective cohort studies
  3194. The Role of RNASE L in Type Iย diabetesย and Development of Quantitative LC-MS/MS Methods for the Pharmacological Studies of Anti-cancerย Drug Candidates
  3195. The role of the adaptive stress response in the pathogenesis of neurodegenerative diseases,ย cancerย andย diabetesย mellitus type 2
  3196. The role of the pentose phosphate pathway inย diabetesย andย cancer
  3197. The role of type 2ย diabetesย mellitus in colorectalย cancerย patients
  3198. The study of the etiology and pathogenesis of schizophrenia, the psychosomatic illnesses,ย diabetesย mellitus andย cancer.
  3199. The study of the relationship betweenย diabetesย mellitus and pancreaticย cancerย [J]
  3200. The survival advantage of milk and dairy consumption: an overview of evidence from cohort studies of vascular diseases,ย diabetesย andย cancer
  3201. The temporal relationship betweenย diabetesย andย cancer: A populationโ€based study
  3202. The type 2ย diabetes-associated Th17 cytokines IL-21 and IL-22 promote breastย cancerย cell survival.
  3203. The use of glyburide compared with other sulfonylureas and the risk ofย cancerย in patients with type 2ย diabetes
  3204. The Use of Long-Acting Insulin Analogs and the Risk of Colorectalย cancerย Among Patients with Type 2ย diabetes: A Population-Based Cohort Study
  3205. The use of metformin and colorectalย cancerย incidence in patients with type IIย diabetesย mellitus
  3206. The use of metformin and the incidence of lungย cancerย in patients with type 2ย diabetes
  3207. The use of pioglitazone and the risk of bladderย cancerย in people with type 2ย diabetes: nested case-control study
  3208. Therapeutic Nanotechnology and Immunoengineering for Cellular Therapy in Autoimmuneย diabetesย andย cancer
  3209. Therapeutic use of metformin inย diabetesย and survival outcomes in endometrialย cancerย patients withย diabetes
  3210. Therapeutic uses of epicatechin inย diabetesย andย cancer
  3211. Therapeutically and pharmacological virtues of godโ€™s mushroom-Agaricus blazei Murill. inhibitory effects in infection,ย cancerย andย diabetes.
  3212. Therapy insight: influence of type 2ย diabetesย on the development, treatment and outcomes ofย cancer
  3213. Thiazolidinedione use andย cancerย incidence in type 2ย diabetes: a systematic review and meta-analysis
  3214. Thiazolidinediones and risk of colorectalย cancerย in patients withย diabetesย mellitus: A meta-analysis
  3215. Thiazolidinediones and the risk of lung, prostate, and colonย cancerย in patients withย diabetes
  3216. Thioredoxin binding protein (TBP)-2/Txnip and ฮฑ-arrestin proteins inย cancerย andย diabetesย mellitus
  3217. Thousands of cases of diseases such asย cancerย andย diabetesย could go on diagnosed if we put off visiting the doctor since the start of the covert crisis, GPS have โ€ฆ
  3218. Thyroid hormones inย diabetes,ย cancer, and aging
  3219. Time perspective in healthy individuals and patients suffering fromย cancerย andย diabetes
  3220. Time-dependent risk ofย cancerย after aย diabetesย diagnosis in a cohort of 2.3 million adults
  3221. Time-varying incidence ofย cancerย after the onset of type 2ย diabetes: evidence of potential detection bias
  3222. Time-varying risk for breastย cancerย following initiation of glucose-lowering therapy in women with type 2ย diabetes: Exploring detection bias
  3223. TNMย cancerย staging: can it help develop a novel staging system for type 2ย diabetes?
  3224. Total pancreatectomy for pancreatic headย cancerโ€“trading pancreatic fistulas forย diabetes
  3225. Total-Body Irradiation is a Major Risk Factor for Young Adult Onsetย diabetesย Mellitus and Hyperlipidemia in Childhoodย cancerย Survivors after Hematopoietic Stem โ€ฆ
  3226. Towards a pathway definition of Parkinsonโ€™s disease: a complex disorder with links toย cancer,ย diabetesย and inflammation
  3227. Toxicity after external beam radiotherapy for prostateย cancer: an analysis of late morbidity in men withย diabetesย mellitus
  3228. Trace element profile and incidence of type 2ย diabetes, cardiovascular disease and colorectalย cancer: results from the EPIC-Potsdam cohort study
  3229. Traditionalย diabetesย risk factors in pancreaticย cancerย associatedย diabetesย (PacDM): A prospective study of 512 patients
  3230. Traditional knowledge for modern ailments plants used for the treatment ofย diabetesย andย cancerย in Northern Peru
  3231. Trans fatty acids and lipid profile: a serious risk factor to cardiovascular disease,ย cancerย andย diabetes
  3232. Transcriptome of CD8+ tumor-infiltrating T cells: a link betweenย diabetesย and colorectalย cancer
  3233. Transcriptomic Analyses and Potential Therapeutic Targets of Pancreaticย cancerย With Concomitantย diabetes
  3234. Transforming growth factorโ€ฮฒ signaling, a potential mechanism associated withย diabetesย mellitus and pancreaticย cancer?
  3235. Trastuzumab-related cardiotoxicity in patients with breastย cancerย with comorbidities of obesity, dyslipidemia, andย diabetes.
  3236. Treament-relatedย diabetesย and cardiovascular disease in prostateย cancerย survivors
  3237. Treatment and outcome in non-Hodgkinโ€™s lymphoma patients with and without prevalentย diabetesย mellitus in a population-basedย cancerย registry
  3238. Treatment outcomes in men with metastatic castration-resistant prostateย cancerย (mCRPC) and cardiovascular disorders orย diabetes: The Prostateย cancerย Registry.
  3239. Treatment with human insulin does not increase thyroidย cancerย risk in patients with type 2ย diabetes
  3240. Treatment with insulin (analogues) and breastย cancerย risk in women withย diabetes; a systematic review and meta-analysis of in vitro, animal and human โ€ฆ
  3241. Treatment with insulin glargine (Lantusยฎ) increases the proliferative potency of the serum of patients with type-1ย diabetes: a pilot study on MCF-7 breastย cancerย cells
  3242. Trends in breastย cancerย incidence among women with type-2ย diabetesย in British general practice
  3243. Trends inย cancerย mortality among people with vs withoutย diabetesย in the USA, 1988โ€“2015
  3244. Trends in overall, cardiovascular andย cancer-related mortality among individuals withย diabetesย reported on death certificates in the United States between โ€ฆ
  3245. trouble, deafness, spider bite,ย diabetes,ย cancerย and other conยฌ
  3246. Tuesday, November 14, 2000-3: 00 PM Abstract# 8961 Enabling the nationโ€™s schools to prevent cardiovascular disease,ย cancer, andย diabetes: A CDC initiative
  3247. Two diseases with one hit: inhibiting a potentialย diabetesย target to reduceย cancerย risk and to improve anti-cancerย therapy
  3248. Two variants on chromosome 17 confer prostateย cancerย risk, and the one in TCF2 protects against type 2ย diabetes
  3249. Two-year Changes of Adiponectin after Bariatric Surgery and Their Association with Incident Type 2ย diabetes, Cardiovascular Disease,ย cancerย and Mortality: Results โ€ฆ
  3250. Type 1 and type 2ย diabetesย andย cancerย mortality in the 2002-2009 cohort of 39 811 French dialyzed patients
  3251. Type 1ย diabetesย mellitus and risk ofย cancer: a meta-analysis of observational studies
  3252. Type 1ย diabetes, ACTH Deficiency, and Hypothyroidism Simultaneously Induced by Nivolumab Therapy in a Patient with Gastricย cancer: A Case Report
  3253. Type 2ย diabetesย and Breastย cancerย Survivorship: A Case Report
  3254. Type 2ย diabetesย and breastย cancer-the role of hyperinsulinaemia in breastย cancerย development and mortality
  3255. Type 2ย diabetesย and breastย cancer: the interplay between impaired glucose metabolism and oxidant stress
  3256. Type 2ย diabetesย andย cancer
  3257. Type 2ย diabetesย andย cancerย as redox diseases?
  3258. Type 2ย diabetesย andย cancerโ€“cancerย incidence and mortality among 457,473 persons with type 2ย diabetesย compared to 2,287,365 matched controls in Sweden: an โ€ฆ
  3259. Type 2ย diabetesย andย cancer: an overview of epidemiological evidence and potential mechanisms
  3260. Type 2ย diabetesย andย cancer: Should we prefer antihyperglycaemic treatments without unnecessarily increasing insulin levels?
  3261. Type 2ย diabetesย andย cancer: The Nitric Oxide Connection
  3262. Type 2ย diabetesย andย cancer: umbrella review of meta-analyses of observational studies
  3263. Type 2ย diabetesย andย cancer: what is the connection?
  3264. Type 2ย diabetesย and colorectalย cancerย screening: Findings from the English Longitudinal Study of Ageing
  3265. Type 2ย diabetesย and colorectalย cancerย survival: The multiethnic cohort
  3266. Type 2ย diabetesย and gender differences in liverย cancerย by considering different confounding factors: a meta-analysis of cohort studies
  3267. Type 2ย diabetesย and glycemic traits in relation to colorectalย cancerย risk: a Mendelian randomization study
  3268. Type 2ย diabetesย and increased risk of estrogen receptor-negative breastย cancerย in African American women
  3269. Type 2ย diabetesย and obesity in midlife and breastย cancerย risk in the Reykjavik cohort
  3270. Type 2ย diabetesย and obesity metabolic interactions: common factors for breastย cancerย risk and novel approaches to prevention and therapy
  3271. Type 2ย diabetesย and Pancreaticย cancerโ€“A Possible Reason
  3272. Type 2ย diabetesย and prostateย cancerย risk in Korean men with low PSA
  3273. Type 2ย diabetesย and risk ofย cancer
  3274. Type 2ย diabetesย and risk of colorectalย cancerย in two large US prospective cohorts
  3275. Type 2ย diabetesย and risk of incidentย cancerย in China: a prospective study among 0.5 million Chinese adults
  3276. Type 2ย diabetesย and risk of prostateย cancer: a meta-analysis of observational studies
  3277. Type 2ย diabetesย and subsequent incidence of breastย cancerย in the Nursesโ€™ Health Study
  3278. Type 2ย diabetesย and the risk of mortality among patients with prostateย cancer
  3279. Type 2ย diabetesย and the risk of renal cellย cancerย in women
  3280. Type 2ย diabetesย as a potential risk marker for early onset colorectalย cancer.
  3281. Type 2ย diabetesย as a predictor of survival among breastย cancerย patients: the multiethnic cohort
  3282. Type 2ย diabetesย associated with abnormal p53 immunohistochemical patterns in colorectalย cancer
  3283. Type 2ย diabetesย increases and metformin reduces total, colorectal, liver and pancreaticย cancerย incidences in Taiwanese: a representative population โ€ฆ
  3284. Type 2ย diabetesย may increase breastย cancerย risk
  3285. Type 2ย diabetesย May Increase Breastย cancerย Risk in African-American Women
  3286. Type 2ย diabetesย mellitus accompanied by isolated adrenocorticotropic hormone deficiency and gastricย cancer
  3287. Type 2ย diabetesย mellitus andย cancer: the role of pharmacotherapy
  3288. Type 2ย diabetesย mellitus and characteristics of breastย cancerย in China
  3289. Type 2ย diabetesย Mellitus and Colorectalย cancerย Risk and Survival in Oman
  3290. Type 2ย diabetesย mellitus and colorectalย cancerย risk: is homocysteine the missing link?
  3291. Type 2ย diabetesย mellitus and colorectalย cancer: meta-analysis on sex-specific differences
  3292. Type 2ย diabetesย mellitus and gastrointestinalย cancer: Disease, drugs, or distortion?
  3293. Type 2ย diabetesย mellitus and habits lifestyle increases the risk of cervicalย cancer: a cross-sectional population-based study
  3294. Type 2ย diabetesย mellitus and kidneyย cancerย risk: a retrospective cohort analysis of the National Health Insurance
  3295. Type 2ย diabetesย mellitus and medications for type 2ย diabetesย mellitus are associated with risk for and mortality fromย cancerย in a German primary care cohort
  3296. Type 2ย diabetesย mellitus and pancreaticย cancer
  3297. Type 2ย diabetesย mellitus and pancreaticย cancerย in related family
  3298. Type 2ย diabetesย mellitus and prognosis in early stage breastย cancerย women
  3299. Type 2ย diabetesย mellitus and risk of gallbladderย cancer: a systematic review and metaโ€analysis of observational studies
  3300. Type 2ย diabetesย mellitus and risk of head and neckย cancerย subtypes: a systematic review and meta-analysis of observational studies
  3301. Type 2ย diabetesย mellitus and risk of oralย cancerย and precancerous lesions: a meta-analysis of observational studies
  3302. Type 2ย diabetesย mellitus and the risk of colorectalย cancer
  3303. Type 2ย diabetesย mellitus as a risk factor for female breastย cancerย in the population of Northern Pakistan
  3304. Type 2ย diabetesย mellitus as risk factor for colorectalย cancer
  3305. Type 2ย diabetesย mellitus associated with increased risk for colorectalย cancer: evidence from an international ecological study and population-based risk analysis in โ€ฆ
  3306. Type 2ย diabetesย mellitus does not increase the risk of lungย cancerย among never-smokers: a nationwide cohort study
  3307. Type 2ย diabetesย Mellitus Increases Economic Burden of Colorectalย cancerย Surgery: 2252
  3308. Type 2ย diabetesย Mellitus Induced Paracrine Effects on Breastย cancerย Metastasis Through Extracellular Vesicles Derived from Human Mesenchymal Stem Cells
  3309. Type 2ย diabetesย Mellitus Is Associated With Increased Mortality in Chinese Asian Patients Receiving Curative Surgery for Colonย cancer
  3310. Type 2ย diabetesย mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colonย cancer
  3311. Type 2ย diabetesย mellitus is associated with increased risk of pancreaticย cancer: a veteran administration registry study
  3312. Type 2ย diabetesย mellitus predicts worse outcomes in patients with high-grade T1 bladderย cancerย receiving bacillus Calmette-Guรฉrin after transurethral resection of the โ€ฆ
  3313. Type 2ย diabetesย mellitus, blood cholesterol, triglyceride and colorectalย cancerย risk in Lynch syndrome
  3314. Type 2ย diabetesย mellitus, glycemic control, andย cancerย risk
  3315. Type 2ย diabetesย mellitus, insulinโ€use and risk of bladderย cancerย in a large cohort study
  3316. Type 2ย diabetesย mellitus, oral diabetic medications, insulin therapy, and overall breastย cancerย risk
  3317. Type 2ย diabetesย mellitus, smoking, and colorectalย cancer
  3318. Type 2ย diabetesย mellitus: a marker or a risk factor for pancreaticย cancer?
  3319. Type 2ย diabetesย mellitus: a risk indicator for colorectalย cancer
  3320. Type 2ย diabetesย risk variants and colorectalย cancerย risk: the Multiethnic Cohort and PAGE studies
  3321. Type 2ย diabetes, adiposity andย cancerย morbidity and mortality risk taking into account competing risk of noncancerย deaths in a prospective cohort setting
  3322. Type 2ย diabetes, antidiabetic medications, and colorectalย cancerย risk: two caseโ€“control studies from Italy and Spain
  3323. Type 2ย diabetes, Body Mass Index andย cancerย Mortality: A Population-Based Matched Cohort Study of 1.0 Million Adults in England
  3324. Type 2ย diabetes, breastย cancerย specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor โ€ฆ
  3325. Type 2ย diabetes, but not insulin (analog) treatment, is associated with more advanced stages of breastย cancer: a national linkage ofย cancerย and pharmacy registries
  3326. Type 2ย diabetes, insulin treatment and prognosis of breastย cancer
  3327. Type 2ย diabetes, metformin, and the risk of mortality in patients with prostateย cancer
  3328. Type 2ย diabetes, obesity, and breastย cancerย risk among Japanese women of the atomic bomb survivor cohort
  3329. Type 2ย diabetes, Obesity, andย cancerย Share Some Common and Critical Pathways
  3330. Type 2ย diabetes, socioeconomic status and risk ofย cancerย in Scotland 2001โ€“2007
  3331. Type 2ย diabetes: a protective factor for prostateย cancer? An overview of proposed mechanisms
  3332. Type 3c (pancreatogenic)ย diabetesย mellitus secondary to chronic pancreatitis and pancreaticย cancer
  3333. Type 3cย diabetesย and Pancreaticย cancer
  3334. Type IIย diabetesย and breastย cancer.
  3335. Type IIย diabetesย and incidence of estrogen receptor negative breastย cancerย in African American women
  3336. Type IIย diabetesย mellitus and the incidence of epithelial ovarianย cancerย in theย cancerย prevention study-II nutrition cohort
  3337. Type IIย diabetes, obesity, and breastย cancerย risk: the Multiethnic Cohort
  3338. Type ofย diabetesย mellitus and the odds of Gleason score 8 to 10 prostateย cancer
  3339. Type-IIย diabetesย and pancreaticย cancer: a meta-analysis of 36 studies
  3340. UCP 2 gene polymorphisms in obesity andย diabetes, and the role of UCP 2 inย cancer
  3341. UNDERSTANDING ROLE OF 9P21 GENE DESERT SNPS INย cancer, AGING,ย diabetes, AND CARDIO-VASCULAR DISEASES
  3342. Understanding the association of type 2ย diabetesย mellitus in breastย cancerย among African American and European American populations in South Carolina
  3343. Understanding the Relationship Between Type 2ย diabetesย and Bladderย cancer
  3344. Undiagnosedย diabetesย in breast, colorectal, lung, and prostateย cancer: incidence and risk factors
  3345. Unfolding link betweenย diabetesย andย cancer
  3346. Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connectingย diabetesย andย cancer
  3347. Unravelling the link betweenย diabetes, insulin treatment and breastย cancer
  3348. Upregulation of REG Ia accelerates tumor progression in pancreaticย cancerย withย diabetes
  3349. Upregulation of REG Iฮฑ accelerates tumor progression in pancreaticย cancerย withย diabetes
  3350. Urinary markers of nucleic acid oxidation andย cancerย in type 2ย diabetes
  3351. Use of an ฮฑ-glucosidase inhibitor and the risk of colorectalย cancerย in patients withย diabetes: a nationwide, population-based cohort study
  3352. Use of Anti-Diabetic Medication is Not Associated withย cancerย Risk in Chinese Patients with Type 2ย diabetes
  3353. Use of family history in clinical guidelines forย diabetesย and colorectalย cancer
  3354. Use of insulin and mortality from breastย cancerย among Taiwanese women withย diabetes
  3355. Use of Insulin and Risk ofย cancerย among Patients withย diabetesย Mellitus: A Nonconcurrent Prospective Study
  3356. Use of insulin glargine andย cancerย incidence in Scotland: a study from the Scottishย diabetesย Research Network Epidemiology Group
  3357. Use of metformin and risk of kidneyย cancerย in patients with type 2ย diabetes
  3358. Use of metformin is associated with lower incidence ofย cancerย in patients with type 2ย diabetes
  3359. Use of sulphonylurea andย cancerย in type 2ย diabetesโ€”the Hong Kongย diabetesย Registry
  3360. Use of thiazolidinedione andย cancerย risk in Type 2ย diabetes: The Hong Kongย diabetesย registry
  3361. Use of thiazolidinediones and the risk of bladderย cancerย among people with type 2ย diabetes: a meta-analysis
  3362. Use of thiazolidinediones and the risk of colorectalย cancerย in patients withย diabetes: a nationwide, population-based, case-control study
  3363. Usefulness of CA 19โ€“9 for pancreaticย cancerย screening in patients with new-onsetย diabetes
  3364. Using genetics to decipher the link between type 2ย diabetesย andย cancer: shared aetiology or downstream consequence?
  3365. Using genetics to decipher the link between type 2ย diabetesย andย cancer: shared aetiology or downstream consequence?
  3366. Using mouse and Drosophila models to investigate the mechanistic links between diet, obesity, type IIย diabetes, andย cancer
  3367. Utility of KRAS Gene and Clinicopathological Features in the Assessment of the Risk of Type 2ย diabetesย in the Etiology of Colonย cancer
  3368. Vacuolar H+-ATPase inย cancerย andย diabetes
  3369. Validation of Breastย cancerย and Bladderย cancerย Among Patients With Type 2ย diabetesย Mellitus in US Medicare: A Pilot Study
  3370. Validation of the enriching new-onsetย diabetesย for pancreaticย cancerย model in a diverse and integrated healthcare setting
  3371. Validation of the survival benefit from metformin use in patients with type 2ย diabetesย and colorectalย cancer.
  3372. Validation of the survival benefits of metformin in middle Eastern patients with type IIย diabetesย mellitus and colorectalย cancer
  3373. Value of adipokines in the diagnosis and prognosis of pancreaticย cancerย complicated withย diabetes
  3374. Value of glycated hemoglobin in the diagnosis ofย diabetesย and prediabetesย inย cancerย patients
  3375. Variable effect of streptozotocin-diabetesย on the growth of hamster pancreaticย cancerย (H2T) in the Syrian hamster and nude mouse
  3376. Venous thromboembolism and risk ofย cancerย in patients withย diabetesย mellitus
  3377. Ventures with venoms: several toxin-based products are in the running as treatments forย cancer, stroke, andย diabetes
  3378. Very small embryonic-like stem cells are involved in pancreatic regeneration and their dysfunction with age may lead toย diabetesย andย cancer
  3379. Video consultations between patients and clinicians inย diabetes,ย cancer, and heart failure services: Linguistic ethnographic study of video-mediated interaction
  3380. VIewpoInt sectIon reference fraMeworks for the health ManaGeMent of Measles, Breastย cancerย andย diabetesย (type II)
  3381. Visit-to-visit hemoglobin A1c variability is associated with laterย cancerย development in patients withย diabetesย mellitus
  3382. Vitamin D and pancreas: the role of sunshine vitamin in the pathogenesis ofย diabetesย mellitus and pancreaticย cancer
  3383. VNN1, a potential biomarker for pancreaticย cancer-associated new-onsetย diabetes, aggravates paraneoplastic islet dysfunction by increasing oxidative stress
  3384. Waist circumference, body mass index, and colorectalย cancerย risk according toย diabetesย status: A Korean nationwide populationโ€based cohort study
  3385. Weight change and blood glucose concentration as markers for pancreaticย cancerย in subjects with new-onsetย diabetesย mellitus: A matched case-control study
  3386. Weight cycling,ย diabetesย and risk of postmenopausal breastย cancer.
  3387. Weight loss precedesย cancerย specific symptoms in pancreaticย cancerย associatedย diabetesย mellitus
  3388. Weight loss,ย diabetes, fatigue, and depression preceding pancreaticย cancer
  3389. Weight Status and All-Cause Mortality in Older Adults: A Study of Patients With Type 2ย diabetesย Undergoing Subtotal Gastrectomy forย cancer
  3390. Weight-lowering effects of glucagon-like peptide-1 receptor agonists and detection of breastย cancerย among obese women withย diabetes
  3391. Werner syndrome andย diabetesย mellitus accompanied by adrenal cortexย cancer
  3392. What doย cancer,ย diabetes, and cardiovascular disease have in common?
  3393. What every dentist should know about metformin,ย diabetes, andย cancer
  3394. White blood cell count and reninโ€“angiotensin system inhibitors for the risk ofย cancerย in type 2ย diabetes
  3395. Why areย diabetes, stomachย cancerย and circulatory diseases more common in Northern Sweden?
  3396. Whyย diabetesย patients are more prone to the development of colonย cancer?
  3397. Why doesย diabetesย offer protective effects against prostateย cancer? The possible role of its microvascular complications
  3398. Why should you care about free radicals? Because these molecules appear to play a role in the development of heart disease,ย cancer,ย diabetes, and other diseases โ€ฆ
  3399. WITHDRAWN: Association of Type 2ย diabetesย Mellitus with the Histopathological Features of Early-Stage Breastย cancerย Patients: A Retrospective Cross-Sectional โ€ฆ
  3400. Within-class differences inย cancerย risk for sulfonylurea treatments in patients with type 2ย diabetesย (ZODIAC-55)โ€“a study protocol
  3401. Youngโ€onset colorectalย cancerย is associated with a personal history of type 2ย diabetes
  3402. US-JAPAN CONFERENCE: INFLAMMATION,ย diabetesย ANDย cancerย held at the Beckman Research Institute of City of Hope, Duarte, CA, USA
  3403. โ€ฆ -6-phenylimidazo (4, 5-b) pyridine (PhIP) induces gene expression changes in JAK/STAT and MAPK pathways related to inflammation,ย diabetesย andย cancer
  3404. โ€ฆ -control study of the association between metabolic syndrome and colorectalย cancer: a comparison of Internationalย diabetesย Federation, National Cholesterol โ€ฆ
  3405. โ€ฆ -free survival and overall survival are associated withย diabetesย mellitus but inversely associated with levels of blood glucose in patients with lungย cancer
  3406. โ€ฆ -persistent environmental pollutants and risk of type 2ย diabetesย in a Spanish sub-cohort from the European Prospective Investigation intoย cancerย and Nutrition study
  3407. โ€ฆ -Spectrum Biomarkers for Atherosclerosis, Acute Ischemic Stroke, Cardiovascular Disease,ย diabetesย Mellitus, Chronic Kidney Disease, and Digestive Organย cancer
  3408. โ€ฆ -term effects of gestationalย diabetesย on bone mineral density and fracture risk: Analysis of the Norfolk cohort of the European Prospective Investigation intoย cancerย โ€ฆ
  3409. โ€ฆ โ€Binding Globulin (SHBG) gene, related to both serum testosterone and SHBG levels and the risk of myocardial infarction, type 2ย diabetes,ย cancerย and mortality in โ€ฆ
  3410. โ€ฆ , adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective ofย diabetes, obesity, andย cancer
  3411. โ€ฆ , and Practices Related to Noncommunicable Diseases Among Korean Adults Residing in Urban and Rural Areas-Focusing on Hypertension,ย diabetes, andย cancer
  3412. โ€ฆ , but What About Pancreaticย cancer?: Comment on โ€œGlucagonlike Peptide 1โ€“Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2ย diabetesย โ€ฆ
  3413. โ€ฆ , gonadotrophins and SHBG by type 2ย diabetesย in postmenopausal women: Clinical implications for the incidence of breastย cancer, and cardiovascular risk in diabetic โ€ฆ
  3414. โ€ฆ , Simon M, Yehezkel E, Laron Z, Werner H. Insulin analogues display IGFโ€Iโ€like mitogenic and antiโ€apoptotic activity in culturedย cancerย cells.ย diabetesย Metab Res Rev โ€ฆ
  3415. โ€ฆ , such as obesity and malnutrition, respectively (Rodrรญguez-Arauz et al., 2016). In western countries hypertension,ย cancer,ย diabetesย and cardiovascular diseases โ€ฆ
  3416. โ€ฆ , ฮ”6 desaturase, and stearoyl-CoA desaturase activity and incident type 2ย diabetesย in the European Prospective Investigation intoย cancerย and Nutritionโ€“Potsdam โ€ฆ
  3417. โ€ฆ ; Hematology: Metachronous Doubleย cancerย Included B-Cell Chronic Lymphocytic Leukemia and Pancreaticย cancerย That Diagnosed After Progression ofย diabetes
  3418. โ€ฆ : Ethnic differences in the relationship betweenย diabetes, early age adiposity, and mortality among breastย cancerย survivors: The Breastย cancerย Health Disparities Study
  3419. โ€ฆ : glycated hemoglobin,ย diabetes, and incident colorectalย cancerย in men and women: a prospective analysis from the European prospective investigation intoย cancerย โ€ฆ
  3420. โ€ฆ : TP-65;ย diabetesย Mellitus Predicts Poor Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase inhibitor (TKI) in Non-Small Cell Lungย cancerย โ€ฆ
  3421. โ€ฆ : WHAT WE ARE LEARNING ABOUT HOW TO TREAT AND BEAT LUNGย cancer: The Impact Of Hba1c Levels On Survival Of Lungย cancerย Patients Withย diabetesย โ€ฆ
  3422. โ€ฆ . 02c-019 The Use of Metformin and the Incidence of Metastases at the Time of Diagnosis in Patients with Lungย cancerย and Type 2ย diabetes: Topic: Targeted Therapy
  3423. โ€ฆ (BMA) has increased over the last decade due to its association with, and potential role, in a range of diseases (osteoporosis,ย diabetes, anorexia,ย cancer) as well as โ€ฆ
  3424. โ€ฆ (Curcuma longa): from a variety of traditional medicinal applications to its novel roles as active antioxidant, anti-inflammatory, anti-cancer, and anti-diabetes
  3425. โ€ฆ (f) chromen-3-one as a potential inhibitor of NF-ฮบB: A key regulatory molecule in inflammationmediated pathogenesis ofย diabetes, Alzheimerโ€™s, andย cancer
  3426. โ€ฆ (MHN-01) carbohydrate-adjusted fluid diet in improving the metabolism of carbohydrates and lipids in patients with esophagealย cancerย complicated byย diabetesย โ€ฆ
  3427. โ€ฆ (to RAR); a fellowship from a NIHย diabetes, Endocrinology and Metabolism Training Grant (NIH DK07217)(to GT); an Americanย diabetesย Association mentor Based โ€ฆ
  3428. โ€ฆ 25-hydroxyvitamin D concentration and the risk of type 2ย diabetes: results from the European Prospective Investigation intoย cancerย (EPIC)-Norfolk cohort and โ€ฆ
  3429. โ€ฆ 2SI โ€œVP Komisarenko Institute of Endocrinology and Metabolism of NAMS of Ukraineโ€, Kyiv BREASTย cancerย IN WOMEN WITHย diabetesย MELLITUS TYPE 2
  3430. โ€ฆ 7 and its closest paralog tetraspanin 6: membrane organizers with key functions in brain development, viral infection, innate immunity,ย diabetesย andย cancer
  3431. โ€ฆ a high index of suspicion for endometrial malignancy or hyperplasia with atypia in Hispanic patients who have hypertension,ย diabetes, history of hormone โ€ฆ
  3432. โ€ฆ A. ferox leaf gel may show promise in alleviating symptoms associated with/or prevention of cardiovascular diseases,ย cancer, neurodegeneration, andย diabetesย โ€ฆ
  3433. โ€ฆ activity is associated with increased risk of mortality, incident type 2ย diabetes, cardiovascular events, chronic kidney disease andย cancerโ€“a narrative review
  3434. โ€ฆ acute recurrent and chronic pancreatitis: Protocol of a multicenter randomized controlled trial from the study of chronic pancreatitis,ย diabetesย and pancreaticย cancerย โ€ฆ
  3435. โ€ฆ al.(2010) Associations of Hyperglycemia and Insulin Usage With the Risk ofย cancerย in Type 2ย diabetes: The Hong Kongย diabetesย Registry.ย diabetes; 59: 1254โ€“1260
  3436. โ€ฆ And Assessment of Small Molecules as Free Radical Scavengers and Potential Multi-Target Therapeutic Agents against Alzheimerโ€™s Disease,ย diabetesย andย cancer
  3437. โ€ฆ and evaluation of the curriculum for BOLD (Bronx Oncology Living Daily) Healthy Living: aย diabetesย prevention and control program for underservedย cancerย survivors
  3438. โ€ฆ and harmonized Internationalย diabetesย Federation criteria tools to assess impact on cardiovascular risk assessmentRole of primary care management inย cancerย โ€ฆ
  3439. โ€ฆ and intestinal breastย cancerย resistance protein activities and expression to increased oral glibenclamide exposure in rats with streptozotocin-inducedย diabetesย โ€ฆ
  3440. โ€ฆ and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2ย diabetesย mellitus and aggressive pancreaticย cancer
  3441. โ€ฆ and Mechanisms ofย diabetesย Resolution According to the Range of Gastric Resection and the Length of Anastomosis in Animal Models: Implication for Gastricย cancerย โ€ฆ
  3442. โ€ฆ and Mortality Risk in Individuals With Pancreaticย cancerโ€“Relatedย diabetesย and Postpancreatitisย diabetes: A Nationwide Cohort Study.ย diabetesย Care 2019; 42: 1675 โ€ฆ
  3443. โ€ฆ and Mortality Risk in Individuals With Pancreaticย cancerโ€“Relatedย diabetesย and Postpancreatitisย diabetes: A Nationwide Cohort Study.ย diabetesย Care 2019; 42: 1675 โ€ฆ
  3444. โ€ฆ and Risks Associated With Use of Social Media by People With Health Issues: Focusing on Mental Illness, HIV/AIDS,ย cancer, Intellectual Disability, andย diabetes
  3445. โ€ฆ and Yoga in prediabetic and type 2ย diabetesย under the National Programme for Prevention and Control ofย cancer,ย diabetes, Cardiovascular Diseases and โ€ฆ
  3446. โ€ฆ antigen nadir concentration, hypertension andย diabetesย as risk factors for biochemical failure after permanent 125I seed brachytherapy for prostateย cancer
  3447. โ€ฆ as simulated patientsCaring and communicating in critical casesImplementation of the expanded chronic care model for the management ofย diabetesย in a community โ€ฆ
  3448. โ€ฆ assessment of pancreatic fibrosis (MINIMAP): a comprehensive study design from the consortium for the study of chronic pancreatitis,ย diabetes, and pancreaticย cancer
  3449. โ€ฆ association between anti-platelet drug use and reducedย cancerย prevalence in diabetic patients: results from the Vermontย diabetesย Information System Study
  3450. โ€ฆ Atlas of Major Disease Mortalities for Cities, Towns and Villages in Japan: All Causes of Death,ย cancer, Cardiovascular Diseases,ย diabetesย Mellitus, Liver Cirrhosis โ€ฆ
  3451. โ€ฆ Beneficial Effect of this Adipokine? Commentary to: Higher circulating adiponectin concentrations predict incidentย cancerย in type 2ย diabetesโ€“the adiponectin paradox
  3452. โ€ฆ Beneficial Effect on Breastย cancerย by Study Design Re:โ€œLow-Dose Aspirin Reduces Breastย cancerย Risk in Women withย diabetes: A Nationwide Retrospective Cohort โ€ฆ
  3453. โ€ฆ between non-permanent migration and non-communicable chronic disease outcomes forย cancer, heart disease andย diabetesโ€“a systematic review
  3454. โ€ฆ between type of dietary fish and seafood intake and the risk of incident type 2ย diabetes: the European prospective investigation ofย cancerย (EPIC)-Norfolk cohort study
  3455. โ€ฆ blood sugar levels but notย diabetesย mellitus significantly enhance oxaliplatin chemoresistance in patients with stage III colorectalย cancerย receiving adjuvant FOLFOX6 โ€ฆ
  3456. โ€ฆ by food-frequency questionnaire and the risk of new-onset type 2ย diabetes: a pilot study in the European Prospective Investigation intoย cancerย and Nutrition (EPIC) โ€ฆ
  3457. โ€ฆย cancerย in diabetics and clinical characteristics ofย diabetes-associated with pancreaticย cancerโ€“comparison betweenย diabetesย with and without pancreaticย cancer
  3458. โ€ฆย cancerย resistance protein expression and function at the bloodโ€“brain barrier and bloodโ€“cerebrospinal fluid barrier (choroid plexus) in streptozotocin-inducedย diabetesย โ€ฆ
  3459. โ€ฆย cancerย Society, Americanย diabetesย Association, and American Heart Association joint statement on preventingย cancer, cardiovascular disease, andย diabetes: where โ€ฆ
  3460. โ€ฆ cascade in the mononuclear cells of peripheral blood: association with insulin and insulin-like growth factor levels in the blood of patients withย cancerย andย diabetes
  3461. โ€ฆ cause and cause-specific mortality among Medicaid-insured women with preexisting type 2ย diabetesย diagnosed with breastย cancer: Aย cancerย registry-Medicaid linkage
  3462. โ€ฆ circulating immune signatures for recurrent acute pancreatitis, chronic pancreatitis and pancreaticย cancer: A pilot study of these conditions with and withoutย diabetes
  3463. โ€ฆ concentrations are associated with lower mortality among individuals with type 2ย diabetes: a case-cohort study in the Danish Diet,ย cancerย and Health cohort
  3464. โ€ฆ cytokines and the risk to develop type 2ย diabetes: results of the prospective population-based European Prospective Investigation intoย cancerย and Nutrition (EPIC) โ€ฆ
  3465. โ€ฆ D levels are associated with greater all-cause andย cancer-related mortality among Australian adults: findings from the Australianย diabetes, Obesity and Lifestyle Study โ€ฆ
  3466. โ€ฆ D, Wilde J, Schubert P: Mu-tations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases,ย diabetesย andย cancer. Clin Lab 2005; 51 โ€ฆ
  3467. โ€ฆ dependent insulinotropic polypeptide receptor modifies the association between carbohydrate and fat intake and risk of type 2ย diabetesย in the Malmรถ Diet andย cancerย โ€ฆ
  3468. โ€ฆย diabetesย as risk factor for pancreaticย cancer: miRNA expression profiling in plasma uncovers a role for miR-20b-5p, miR-29a, and miR-18a-5p inย diabetesย of โ€ฆ
  3469. โ€ฆย diabetesย mellitus induced by immune checkpoint inhibitor therapy in an insulinoma-associated antigen-2 autoantibody-positive patient with advanced gastricย cancer
  3470. โ€ฆย diabetesย mellitus influence pathologic complete response and tumor downstaging after neoadjuvant chemoradiation for esophageal and gastroesophagealย cancerย โ€ฆ
  3471. โ€ฆย diabetesย mellitus may negatively influence clinical progression and response to androgen deprivation therapy in patients with advanced prostateย cancer
  3472. โ€ฆย diabetesย mellitus, glycated haemoglobin and incidence of and mortality fromย cancer: analysis of longitudinal data from England and Scotland linked toย cancerย โ€ฆ
  3473. โ€ฆ diabetic retinopathy and diabetic kidney disease on allโ€cause,ย cancer, vascular and nonโ€cancerย nonโ€vascular mortality in patients with type 2ย diabetes: A realโ€world โ€ฆ
  3474. โ€ฆ diagnosis of endometrial precancerย andย cancerย by combined use of progesterone test and transvaginal ultrasonography in high risk groups of patients withย diabetesย โ€ฆ
  3475. โ€ฆ DIE ANOTHER DAY: WHAT WE ARE LEARNING ABOUT HOW TO TREAT AND BEAT LUNGย cancer: The Impact Ofย diabetesย And Its Treatment On Lungย cancerย โ€ฆ
  3476. โ€ฆ dietary intake, lifestyle and incident symptomatic peripheral arterial disease among individuals withย diabetesย mellitus: insights from the Malmรถ Diet andย cancerย study
  3477. โ€ฆ disease, arthritis, cerebralstroke,ย diabetes, cardiovasculardisease,ย cancer, andotherconditions. The consequencesformanyarenumerousexpensivemedications โ€ฆ
  3478. โ€ฆ drugs versus the combined oral contraceptive pill for hirsutism, acne and risk ofย diabetes, cardiovascular disease, and endometrialย cancerย in polycystic ovary โ€ฆ
  3479. โ€ฆ education programmes for patients with type 1 and 2ย diabetes, asthma and COPD, coronary heart disease, hypertension, congestive heart failure, and breastย cancerย โ€ฆ
  3480. โ€ฆ et al.(2010) Associations of hyperglycemia and insulin usage with the risk ofย cancerย in type 2ย diabetes: the Hong Kongย diabetesย Registry.ย diabetes; 59: 1254โ€“1260
  3481. โ€ฆ Exploration of the Relationship Between Insulin Glargine and Incidentย cancer: A Retrospective Cohort Study of Older Medicare Patients.ย diabetesย Care 2011; 34 โ€ฆ
  3482. โ€ฆ Exploration of the Relationship Between Insulin Glargine and Incidentย cancer: A Retrospective Cohort Study of Older Medicare Patients.ย diabetesย Care 2011; 34 โ€ฆ
  3483. โ€ฆ fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2ย diabetesย in the European Prospective Investigation intoย cancerย and Nutrition (EPIC) โ€ฆ
  3484. โ€ฆ for a CuRE (INSPPIRE 2) Cohort Study: Design and Rationale From the Consortium for the Study of Chronic Pancreatitis,ย diabetes, and Pancreaticย cancer
  3485. โ€ฆ for chronic pancreatitis by using CT, MRI, and MR cholangiopancreatography: the consortium for the study of chronic pancreatitis,ย diabetes, and pancreaticย cancer
  3486. โ€ฆ for evaluating the comparative safety ofย diabetesย medications: An evaluation of pioglitazone use and risk of bladderย cancerย in older US adults with typeโ€2ย diabetes
  3487. โ€ฆ for vitamin D. Many observational and some interventional studies have linked vitamin D to car-diovascular disease,ย cancer, andย diabetes. In addition, reduced levels โ€ฆ
  3488. โ€ฆ Furthermore, it is well documented that obesity is a risk factor for certain chronic diseases, especially heart diseases, hypertension,ย diabetesย and some forms ofย cancerย โ€ฆ
  3489. โ€ฆ gastrointestinal reconstruction methods after distal subtotal gastrectomy on nutritional status and blood glucose in patients with type 2ย diabetesย and gastricย cancer
  3490. โ€ฆ genes and macronutrient intake on the risk of developing type 2ย diabetes: systematic review and findings from European Prospective Investigation intoย cancerย (EPIC) โ€ฆ
  3491. โ€ฆ has identified numerous functional compounds in peanuts that promote health and may reduce the risk of cardiovascular disease,ย cancer, andย diabetes.
  3492. โ€ฆ Heart Attack, Stroke,ย cancer, Ovarianย cancer, Lungย cancer,ย diabetes, Dementia, Colonย cancer, Pneumonia, Pancreaticย cancer, Emphysema and More
  3493. โ€ฆ impact of newly diagnosedย diabetesย mellitus onย cancer-free survival in patients without colorectal polyps: A secondary analysis of Korean multicenterย cancerย โ€ฆ
  3494. โ€ฆ importance of Cannabis sativa L. in regulation of insulin and IL-6R/MAO-A inย cancerย cell progression and migration of breastย cancerย patients withย diabetes
  3495. โ€ฆ important regulatory system with multiple options in the treatment ofย diabetesย mellitus, inflammatory bowel disease and in the chemoprevention of colonย cancer?
  3496. โ€ฆ in glioma and acute myeloid leukemia 398 Circulating tumour cells inย cancerย patients: challenges and perspectives 407 The emerging genetics of type 2ย diabetes
  3497. โ€ฆ in the association betweenย diabetesย mellitus-associated polymorphic locus rs4430796 of the HNF1beta gene and prostateย cancer: a systematic review and โ€ฆ
  3498. โ€ฆ in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated withย diabetesย mellitus and prostateย cancer: findings from a population โ€ฆ
  3499. โ€ฆ in Type 2ย diabetes, Coronary Heart Disease andย cancerย Subgroups in the UK Biobank, and Their Modification by Smoking.ย diabetesย Care,[dc172508]. https โ€ฆ
  3500. โ€ฆ insulin-usingย diabetesย mellitus patients, non-insulin-usingย diabetesย mellitus patients and patients withoutย diabetesย mellitus after partial gastrectomy for gastricย cancer
  3501. โ€ฆ Learning from Genetically Modified Animals Guest Editor: Junichi FujiiThioredoxin binding protein (TBP)-2/Txnip and. ALPHA.-arrestin proteins inย cancerย andย diabetesย โ€ฆ
  3502. โ€ฆ level, fruit and vegetable consumption, and the risk of new-onset type 2ย diabetesย mellitus: the European prospective investigation ofย cancerโ€“Norfolk prospective study
  3503. โ€ฆ levels and acute ischemic stroke, acute myocardial infarction,ย diabetesย mellitus, chronic kidney disease and digestive organย cancer, and their possible โ€ฆ
  3504. โ€ฆ Lifestyle and Metabolic Health Status With New-Onsetย diabetesย and Major Cardiovascular Events: The China Cardiometabolic Disease andย cancerย Cohort (4C) Study
  3505. โ€ฆ Lipoic Acid Breakthrough: The Superb Antioxidant that May Slow Aging, Repair Liver Damage, and Reduce the Risk ofย cancer, Heart Disease, andย diabetes
  3506. โ€ฆ LONG-TERM OUTCOMES IN LIVE KIDNEY DONORS: PREVALENCE OF ISCHEMIC HEART DISEASE,ย diabetes,ย cancerย AND CEREBROVASCULAR DISEASE โ€ฆ
  3507. โ€ฆ Lungย cancer:ย diabetesย Mellitus Predicts Poor Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase inhibitor (TKI) in Non-Small Cell Lungย cancerย โ€ฆ
  3508. โ€ฆ matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association betweenย diabetesย andย cancer
  3509. โ€ฆ measured lifestyle factors and BMI explain differences in health-related quality of life between colorectalย cancerย patients with and without comorbidย diabetes
  3510. โ€ฆ medicinal property of sage (Salvia) to prevent and cure illnesses such as obesity,ย diabetes, depression, dementia, lupus, autism, heart disease, andย cancer
  3511. โ€ฆ metabolism and gut hormone modulations after Billroth II gastrojejunostomy in nonobese gastricย cancerย patients with type 2ย diabetesย mellitus, impaired glucose โ€ฆ
  3512. โ€ฆ metformin use andย cancerย stage at diagnosis among elderly medicare beneficiaries with preexisting type 2ย diabetesย mellitus and incident prostateย cancer
  3513. โ€ฆ morphometric studies on pancreatic endocrine cells, including IAPP in the normal pancreas and in pancreatic tissues from type 2ย diabetesย and pancreaticย cancer
  3514. โ€ฆ Natural products forย diabetesย and its complication as nephropathyA study to assess the effectiveness of informative booklet regarding knowledge of breastย cancerย โ€ฆ
  3515. โ€ฆ newโ€onsetย diabetesย mellitus and worsening glycaemic variables for establishedย diabetesย in men undergoing androgenโ€deprivation therapy for prostateย cancer
  3516. โ€ฆ nutrition and total parenteral nutrition on the nutritional status and blood glucose in patients with gastricย cancerย complicated withย diabetesย mellitus after radical โ€ฆ
  3517. โ€ฆ Oโ€™Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation therapy andย diabetesย control among diabetic men with prostateย cancer. Eur Urol 2014; 65 โ€ฆ
  3518. โ€ฆ of artificial sweetener in packets or tablets and type 2ย diabetesย risk: evidence from the E3N-European prospective investigation intoย cancerย and nutrition study
  3519. โ€ฆ of common comorbidities, such as hypertension, dyslipidemia,ย diabetesย mellitus, cardiovascular disease, cerebrovascular disease andย cancer, in older Japanese โ€ฆ
  3520. โ€ฆ ofย diabetesย mellitus in pancreaticย cancerย population. Comparative study between new onset and long standingย diabetesย mellitus on 76 patients with pancreaticย cancerย โ€ฆ
  3521. โ€ฆ of dietary and lifestyle interventions in elderly or people diagnosed withย diabetes, metabolic disorders, cardiovascular disease,ย cancerย and micronutrient deficiency on โ€ฆ
  3522. โ€ฆ of genetic association of Thyroidย cancerย with Parkinsons disease, Osteoporosis, chronic heart failure, Chronic kidney disease, Type 1ย diabetesย and Type 2ย diabetes
  3523. โ€ฆ of Hospitalization for Pancreaticย cancerย in the First 8 Years after a Gestationalย diabetesย Mellitus regardless of Subsequent Type 2ย diabetes: A Nationwide Population โ€ฆ
  3524. โ€ฆ of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: a crossroad betweenย cancerย andย diabetes?
  3525. โ€ฆ of preexisting type 2ย diabetesย mellitus and antidiabetic drugs on all-cause and cause-specific mortality among Medicaid-insured women diagnosed with breastย cancer
  3526. โ€ฆ of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinaseโ€”significance forย diabetesย andย cancer
  3527. โ€ฆ of Roux-en-Y gastrojejunostomy vs. gastroduodenostomy with respect to the improvement of type 2ย diabetesย mellitus after distal gastrectomy in gastricย cancerย โ€ฆ
  3528. โ€ฆ of serum markers of oxidative stress with incident major cardiovascular events,ย cancerย incidence, and all-cause mortality in type 2ย diabetesย patients: pooled results โ€ฆ
  3529. โ€ฆ of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2ย diabetes, cardiovascular diseases, andย cancer: a systematic review
  3530. โ€ฆ of the Mammalian Target of Rapamycin, Protein Tyrosine Phosphatase 1b and Dipeptidase 4 Signaling Pathways inย cancerย andย diabetes: A Narrative Review.
  3531. โ€ฆ of total energy consumption and activity-related energy expenditure with risks of cardiovascular disease,ย cancer, andย diabetesย among postmenopausal women
  3532. โ€ฆ on Chronic Diseases: Cardiovascular Diseases, Oxidative Stress, Dyslipidemia,ย diabetesย Mellitus, Blood Pressure,ย cancer, Neurodegenerative Disease and โ€ฆ
  3533. โ€ฆ patients withย diabetesย mellitus is associated with bladderย cancerย diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladderย cancer
  3534. โ€ฆ PEPTIDASE-4 INHIBITORS ON CISPLATIN-INDUCED ACUTE NEPHROTOXICITY INย cancerย PATIENTS WITHย diabetesย MELLITUS: A RETROSPECTIVE โ€ฆ
  3535. โ€ฆ pneumonitis in patients with NSCLC treated with concomitant chemoradiotherapyโ€“โ€“Are we underestimatingย diabetes?โ€“โ€“Turkish oncology group (TOG)/Lungย cancerย โ€ฆ
  3536. โ€ฆ polyunsaturated fatty acids intake and risk of all-cause mortality, cardiovascular disease, breastย cancer, mental health, and type 2ย diabetes: a systematic review โ€ฆ
  3537. โ€ฆ preferred components for physical activity interventions in African-American survivors of breast or endometrialย cancerย with type 2ย diabetes: the SUCCESS framework
  3538. โ€ฆ primary androgen deprivation therapy: validation of Japanย cancerย of the Prostate Risk Assessment (J-CAPRA) score and impacts of pre-existing obesity andย diabetesย โ€ฆ
  3539. โ€ฆ procedures for biospecimen collection, processing, and storage: from the consortium for the study of chronic pancreatitis,ย diabetes, and pancreaticย cancer
  3540. โ€ฆ review and meta-analysis of adherence to physical activity interventions among three chronic conditions:ย cancer, cardiovascular disease, andย diabetes
  3541. โ€ฆ RHEUMATOID ARTHRITIS37 PATTERNS OF CARDIOVASCULAR RISK AND DISEASE AMONG PEOPLE WITH TYPE 2ย diabetesย STARTING INSULIN: BASELINE โ€ฆ
  3542. โ€ฆ RNAย cancerย susceptibility candidate 2 (CASC2) alleviates the high glucose-induced injury of CIHP-1 cells via regulating miR-9-5p/PPARฮณ axis inย diabetesย โ€ฆ
  3543. โ€ฆ Roux-en-Y Construction Really Bring Benefit of Type 2ย diabetesย Mellitus Remission After Gastrectomy in Patients with Gastricย cancer? A Systematic Review โ€ฆ
  3544. โ€ฆ Safety of Pioglitazone versus Clinically Meaningful Treatment Alternatives Concerning the Risk of Bladderย cancerย in Older US Adults with Type 2ย diabetes
  3545. โ€ฆ self-management of long-term conditions: a systematic metareview ofย diabetes, heart failure, asthma, chronic obstructive pulmonary disease, andย cancer
  3546. โ€ฆ senescence-evasion mechanism involving Grap2 and Cyclin D interacting protein inactivation by Ras associated withย diabetesย inย cancerย cells under doxorubicin โ€ฆ
  3547. โ€ฆ Society of Gastroenterology& SLDDS 2035: Slide Session; K-BP-25: Pancreatobiliary; Isย diabetesย a Useful Diagnostic Clue to Detect Early Stage of Pancreaticย cancerย โ€ฆ
  3548. โ€ฆ Stat3 pathways respectively promotes and inhibitsย diabetesโ€associated centrosome amplification by targeting at the ROCK1/14โ€3โ€3ฯƒ complex in human colonย cancerย โ€ฆ
  3549. โ€ฆ strategies for addressing high levels of โ€˜I donโ€™t knowโ€™responding to risk perception questions for colorectalย cancerย andย diabetes: an experimental investigation
  3550. โ€ฆ Stress, Blood Sugar, Blood Lipid, Body Mass Index, Fat Mass, and Body Weight in Patients with Type 2ย diabetes. Journal ofย diabetesย Nursing and Midwifery โ€ฆ
  3551. โ€ฆ Study to Establish a New-Onsetย diabetesย (NOD) Cohort: From the Consortium for the Study of Chronic Pancreatitis,ย diabetes, and Pancreaticย cancer
  3552. โ€ฆ that shed new light on the possible pathogenesis of a disease or an adverse effect: Atypical early onset ofย diabetes, deafness and lungย cancerย in a male โ€ฆ
  3553. โ€ฆ the novel effect in relief, prevention, and treatment of a number of serious illnesses such asย diabetes, cardiovascular disease, Alzheimerโ€™s disease, andย cancer
  3554. โ€ฆ the synergistic interaction ofย diabetes, tobacco smoking, alcohol consumption, and hypercholesterolemia on the risk of pancreaticย cancer: a case-control โ€ฆ
  3555. โ€ฆ the Ten-Step Action Plan Scientifically Proven to Prevent or Reverse Obesity, Memory Loss, Alzheimerโ€™s,ย diabetes, Autoimmunity,ย cancer, and Heart Disease
  3556. โ€ฆ the validity and reliability of the health literacy questionnaire in Iran: Recognizing the risk factors for cardiovascular diseases,ย diabetes, andย cancer
  3557. โ€ฆ theory as a possible mechanism of action for the remission of type 2ย diabetesย in low body mass index patients undergoing subtotal gastrectomy for gastricย cancer
  3558. โ€ฆ time of insulin glargine and risk of breast and prostateย cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients withย diabetes
  3559. โ€ฆ to impaired fatty acid and phospholipid metabolism and toย diabetes, cardiovascular disease, immunological abnormalities,ย cancer, ageing and osteoporosis possible โ€ฆ
  3560. โ€ฆ to incidence of type 2ย diabetes: results from the Greek cohort of the population-based European Prospective Investigation intoย cancerย and Nutrition (EPIC)
  3561. โ€ฆ to Letter to the Editor on comments on Use of metformin and risk of kidneyย cancerย in patients with type 2ย diabetesย Chin-Hsiao Tseng, Eur Jย cancer, 2016, No. 52, pp โ€ฆ
  3562. โ€ฆ to prevent hospital admission and delay chemotherapy treatment in patient with a small cell lungย cancer. Kamal Abouglilaย diabetesย centre, University Hospital of โ€ฆ
  3563. โ€ฆ Translational StuDies (PROCEED): Rationale and Study Design From the Consortium for the Study of Chronic Pancreatitis,ย diabetes, and Pancreaticย cancer
  3564. โ€ฆ vitamin D deficiency, part 2: deficiency and its association with autoimmune disease,ย cancer, infection, asthma, dermopathies, insulin resistance, and type 2ย diabetes.
  3565. โ€ฆ With Carboplatin as First-Line Therapy in Patients With Advanced Nonโ€“Small-Cell Lungย cancer: Analysis of Safety and Efficacy in Patients Withย diabetes
  3566. โ€ฆ with Incidence of Type 2ย diabetesย after Adjustment for Overall Dietary Quality in the European Prospective Investigation intoย cancerย and Nutritionโ€“Netherlands (EPIC โ€ฆ
  3567. โ€ฆ women with preexisting type 2ย diabetesย mellitus diagnosed with breastย cancer: An epidemiological analysis of linked New York State Medicaid andย cancerย โ€ฆ
  3568. โ€ฆ workbook: an educational tool outlining disease risk and healthy guidelines to reduce risk of heart disease,ย diabetes, breastย cancerย and colorectalย cancer
  3569. [Obesity, hypertension andย diabetesย mellitus in patients with endometrialย cancer]
  3570. [PP. 37.06] A GENETIC RISK SCORE FOR TYPE 2ย diabetesย IS INDEPENDENTLY ASSOCIATED WITH ARTERIAL STIFFNESS: THE MALMO DIETย cancerย โ€ฆ
  3571. 07 Surgery for Upper Gastrointestinalย cancerย in a Morbidly Obese Patient withย diabetesย and Renal Impairment
  3572. 09 Incontinence Developing During Chemotherapy in a Patient with Advanced Ovarianย cancerย andย diabetes
  3573. 1045 Higher Pancreaticย cancerย Risk Following New Onset ofย diabetesย Mellitus in Non-Obese Patients With Chronic Pancreatitis
  3574. 1095-P: Exendin 4 Decreases Tumor Volume through Attenuation of psma-Induced Activation of NfฮบB Pathway in HPV-Inducedย diabetes/cancerย Model
  3575. 1110โ€“1082 and TNFa-863 gene polymorphisms may favor the onset of chronic pancreatic diseases and of the associatedย diabetes, but not pancreaticย cancerย โ€ฆ
  3576. 120P Breastย cancerย andย diabetes: Retrospective Study
  3577. 128: Androgen Deprivation Therapy and Risk ofย diabetesย Mellitus in Men Undergoing Androgen Deprivation Therapy for Prostateย cancer
  3578. 1297-P: Mortality and Glycemic Control among Patients with Endometrialย cancerย andย diabetesย Mellitus: A Case-Control Study
  3579. 1347ย diabetesย MELLITUS PREDICTS POOR RESPONSE TO INDUCTION BCG IN NON-MUSCLE INVASIVE BLADDERย cancer
  3580. 137-Quality ofย diabetesย Care Amongย cancerย Survivors
  3581. 14 Obesity,ย diabetes, and Risk ofย cancer
  3582. 14.4 A POSITIVE FAMILY HISTORY OFย diabetesย IS ASSOCIATED WITH ARTERIAL STIFFNESS: THE MALMO DIETย cancerย STUDY
  3583. 1475-P: CA19-9, miR-200, and GIP in Patients withย diabetesย Mellitus and Pancreaticย cancer
  3584. 1506-P: Breastย cancerย as a Risk Factor for Newย diabetes
  3585. 152: The Association between Androgen-Deprivation Therapy and the Incidence ofย diabetesย Among Males with Prostateย cancer
  3586. 1550-P: Trends inย cancerย Mortality among US Adults With and Withoutย diabetes, 1988-2015
  3587. 158 Assessing the impact ofย diabetesย mellitus and end stage renal disease on cervicalย cancerย prognosis in an urban population
  3588. 1597-P: Increased Pancreaticย cancerย Risk Associated with Dietary Iron in Whites, but Not Blacks withย diabetes
  3589. 160-OR: Pretreatmentย diabetesย Has Lower Mortality Rate, Independent of Immune-Related Adverse Events, inย cancerย Patients with Immune-Check Point Inhibitor
  3590. 1609-P:ย diabetesย and Risk of All-Cause andย cancer-Specific Mortality in Breast, Prostate, and Colorectalย cancerย Survivors
  3591. 1646-P: Role Of Microbiota Inย diabetes-Associated Colorectalย cancer
  3592. 167 SERUM GLUCOSE IS ASSOCIATED WITH BIOCHEMICAL RECURRENCE IN MEN WITHOUTย diabetesย TREATED FOR LOCALIZED PROSTATEย cancer
  3593. 1685-P: Type 1ย diabetesย Mellitus and Incident Bladderย cancer: A Systematic Review and Meta-analysis
  3594. 1749 IMPACT OFย diabetesย MELLITUS ON THE RECURRENCE AND PROGRESSION OF PATIENTS WITH NON MUSCLE INVASIVE BLADDERย cancer: A โ€ฆ
  3595. 179 INDIVIDUALS WITHย diabetesย HAVE AN INCREASED RISK OF COLORECTALย cancer.
  3596. 18. Doesย diabetesย have an effect on FDG PET standardized uptake values in lungย cancer?
  3597. 191-LB: Comorbidย diabetesย andย cancer: Differences by Patient Characteristics and Symptom Outcomes
  3598. 2017 update on the relationship betweenย diabetesย and colorectalย cancer: epidemiology, potential molecular mechanisms and therapeutic implications
  3599. 2157 THE ASSOCIATION OFย diabetesย MELLITUS AND HIGH-GRADE PROSTATEย cancerย IN A MULTIETHNIC BIOPSY SERIES
  3600. 216-LB: Risk Factors of Pancreaticย cancerย in Persons with Advancingย diabetes
  3601. 2280-PUB: Cluster of Metabolic Disorders Increases Risk ofย cancerย in Chinese Patients with Type 2ย diabetes
  3602. 2283-PUB: Metformin Treatment and Prostateย cancerย Risk: Cox Regression Analysis with Time-Dependent Covariates of 150,000 Men with Incidentย diabetesย Mellitus
  3603. 25-Hydroxyvitamin D status and risk for colorectalย cancerย and type 2ย diabetesย mellitus: a systematic review and meta-analysis of epidemiological studies
  3604. 259 THE IMPACT OFย diabetesย AND METFORMIN USE IN CLINICALLY LOCALIZED PROSTATEย cancerย TREATED BY RADICAL PROSTATECTOMY
  3605. 32nd National Medicinal Chemistry Symposiumโ€“medicinal chemistry developments for neurodegeneration,ย diabetesย andย cancer.
  3606. 335ย diabetesย MELLITUS AND THE RISK OF HIGH-GRADE PROSTATEย cancer: RESULTS FROM THE DUKE PROSTATE CENTER
  3607. 4 The influence of glucose-lowering therapies onย cancerย risk 5 in type 2ย diabetes
  3608. 434-P:ย diabetesย in Patients with Pancreaticย cancer: Relationship of Tumor Grade with Glycemic Control
  3609. 487-P: The Activation of mTORC1 in Leukocytes of Patients withย cancerย andย diabetes
  3610. 8-Hydroxydeoxyguanosine: A valuable predictor of oxidative DNA damage inย cancerย andย diabetesย mellitus
  3611. 8. Application Of Pharmacogenetics In Dose Individualization Inย diabetes, Psychiatry,ย cancerย And Cardiology
  3612. 856 Preliminary review of diabetes Mellitus incidence in patients treated with immune checkpoint inhibitors (ICI) therapyโ€“Roswell Park Comprehensive cancer Center …
Related Posts

Lipotoxicity

Sulfonylureas

Ketogenic Diet

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping